1 00:01:54,596 --> 00:01:54,897 ASK THAT YOU 2 00:01:54,897 --> 00:01:58,167 RYE MAIN MUTED WHEN YOU'RE NOT 3 00:01:58,167 --> 00:01:59,034 SPEAKING, ACTIVELY SPEAKING, 4 00:01:59,034 --> 00:02:02,104 PLEASE NOTE THAT THE HOST OF THE 5 00:02:02,104 --> 00:02:04,640 MEETING HAS THE ABILITY TO 6 00:02:04,640 --> 00:02:06,575 CONTROL YOUR MICS. 7 00:02:06,575 --> 00:02:08,243 THEY CAN TURN YOU OFF IF YOU 8 00:02:08,243 --> 00:02:09,344 FORGET TO DO SO. 9 00:02:09,344 --> 00:02:11,180 ALSO LIKE AT OUR LAST MEETING WE 10 00:02:11,180 --> 00:02:19,388 ASK THAT YOU TURN YOUR VIDEOS ON 11 00:02:19,388 --> 00:02:20,489 THROUGHOUT THE MEETING, EVEN IF 12 00:02:20,489 --> 00:02:22,691 YOU DON'T SPEAK, WE LIKE TO SEE 13 00:02:22,691 --> 00:02:22,891 YOU. 14 00:02:22,891 --> 00:02:24,393 IF YOU'D LIKE TO MAKE A COMMENT 15 00:02:24,393 --> 00:02:26,295 OR ASK A QUESTION USE THE "RAISE 16 00:02:26,295 --> 00:02:29,131 HAND" FEATURE OR ENTER YOUR 17 00:02:29,131 --> 00:02:30,132 COMMENT OR QUESTION, DIRECTLY 18 00:02:30,132 --> 00:02:31,567 INTO THE CHAT BOX. 19 00:02:31,567 --> 00:02:34,770 ONE OF US WILL CALL ON YOU TO 20 00:02:34,770 --> 00:02:36,572 UNMUTE YOUR MICROPHONE IN THE 21 00:02:36,572 --> 00:02:40,642 ORDER THAT YOU RECEIVED THE 22 00:02:40,642 --> 00:02:41,844 HANDS RAISED FOR THE COMMENTS. 23 00:02:41,844 --> 00:02:44,813 NEXT WE'LL DO THE ROLL CALL OR 24 00:02:44,813 --> 00:02:45,214 INTRODUCTIONS. 25 00:02:45,214 --> 00:02:50,285 I WILL ASK COUNCIL MEMBERS TO 26 00:02:50,285 --> 00:02:53,455 INTRODUCE THEMSELVES, TELLING US 27 00:02:53,455 --> 00:02:54,323 YOUR NAME, INSTITUTIONAL 28 00:02:54,323 --> 00:02:57,192 AFFILIATION, INDICATE IF YOU 29 00:02:57,192 --> 00:02:59,828 HAVE SERVED OR ARE SERVING ON 30 00:02:59,828 --> 00:03:02,097 NIH INSTITUTE OR CENTER ADVISORY 31 00:03:02,097 --> 00:03:02,331 COUNCIL. 32 00:03:02,331 --> 00:03:05,067 AND ON WHICH ONE. 33 00:03:05,067 --> 00:03:15,511 I WILL CALL YOUR NAMES IN 34 00:03:17,946 --> 00:03:21,717 ALPHABETICAL ORDER, INTRODUCE 35 00:03:21,717 --> 00:03:24,019 YOURSELF. 36 00:03:24,019 --> 00:03:30,459 I'LL START WITH DR. CHRISTINE 37 00:03:30,459 --> 00:03:31,026 ARDLEY. 38 00:03:31,026 --> 00:03:32,794 >> I'M BEEN ON THE COUNCIL FOR 39 00:03:32,794 --> 00:03:33,962 FOUR YEARS NOW, I'M COMING TO 40 00:03:33,962 --> 00:03:35,731 THE END OF MY TENURE, I DO NOT 41 00:03:35,731 --> 00:03:42,538 SERVE ON ANY OTHER COUNCILS. 42 00:03:42,538 --> 00:03:43,272 >> THANK YOU. 43 00:03:43,272 --> 00:03:47,876 DR. LINDA CHANG. 44 00:03:47,876 --> 00:03:49,645 >> HI, I HAVE BEEN ON COUNCIL 45 00:03:49,645 --> 00:03:52,781 FOR FIVE YEARS, I THINK THIS IS 46 00:03:52,781 --> 00:03:56,184 ALSO MY LAST YEAR. 47 00:03:56,184 --> 00:03:58,820 SO, I AM A PROFESSOR IN 48 00:03:58,820 --> 00:04:00,355 DEPARTMENT OF RADIOLOGY AND 49 00:04:00,355 --> 00:04:02,658 NEUROLOGY AT UNIVERSITY OF 50 00:04:02,658 --> 00:04:04,927 MARYLAND, BALTIMORE, ALSO JOINT 51 00:04:04,927 --> 00:04:06,795 APPOINTMENT AT JOHNS HOPKINS 52 00:04:06,795 --> 00:04:08,730 BECAUSE OF OUR CLOSE 53 00:04:08,730 --> 00:04:11,733 COLLABORATIONS, AND I HAVE 54 00:04:11,733 --> 00:04:15,270 SERVED ON BOTH NIDA BOARD OF 55 00:04:15,270 --> 00:04:16,038 SCIENTIFIC COUNSELORS AND NIDA 56 00:04:16,038 --> 00:04:16,738 COUNCIL IN THE PAST. 57 00:04:16,738 --> 00:04:17,573 THANK YOU. 58 00:04:17,573 --> 00:04:20,075 >> THANK YOU, LINDA. 59 00:04:20,075 --> 00:04:23,679 DR. GRAHAM COLDITZ. 60 00:04:23,679 --> 00:04:25,280 >> GOOD MORNING, PROFESSOR AT 61 00:04:25,280 --> 00:04:27,382 WASHINGTON UNIVERSITY, SCHOOL OF 62 00:04:27,382 --> 00:04:30,786 MEDICINE, ASSOCIATE DIRECTOR FOR 63 00:04:30,786 --> 00:04:34,456 PREVENTION AND CONTROL AT 64 00:04:34,456 --> 00:04:36,158 SITEMAN CANCER CENTER, ON THE 65 00:04:36,158 --> 00:04:37,826 BOARD OF SCIENTIFIC ADVISORS, MY 66 00:04:37,826 --> 00:04:39,027 LAST YEAR TOO. 67 00:04:39,027 --> 00:04:44,833 >> THANK YOU, GRAHAM. 68 00:04:44,833 --> 00:04:45,500 DR. MONICA GANDHI. 69 00:04:45,500 --> 00:04:48,170 >> I'M MONICA GANDHI, PROFESSOR 70 00:04:48,170 --> 00:04:50,606 OF MEDICINE, IN THE DIVISION OF 71 00:04:50,606 --> 00:04:52,374 INFECTIOUS DISEASE AND HIV AT 72 00:04:52,374 --> 00:04:56,311 UCSF, I HAVE SERVED ON THE 73 00:04:56,311 --> 00:04:58,280 ADVISORY COUNCIL, RECENTLY THAT 74 00:04:58,280 --> 00:04:59,381 TERM ENDED, I'M EXCITED ABOUT 75 00:04:59,381 --> 00:05:02,684 THIS ROLE ON COUNCIL OF 76 00:05:02,684 --> 00:05:05,087 COUNCILS. 77 00:05:05,087 --> 00:05:07,923 >> THANK YOU. 78 00:05:07,923 --> 00:05:08,724 DR. RAFAEL IRIZARRY. 79 00:05:08,724 --> 00:05:15,364 >> CHAIR OF DEPARTMENT OF DATA 80 00:05:15,364 --> 00:05:17,566 SCIENCE, DANA-FARBER CANCER 81 00:05:17,566 --> 00:05:18,200 INSTITUTE, HARVARD BIOSTATISTICS 82 00:05:18,200 --> 00:05:20,102 DEPARTMENT, THIS IS MY FIRST 83 00:05:20,102 --> 00:05:23,405 YEAR IN THIS COUNCIL, AND I HAVE 84 00:05:23,405 --> 00:05:25,474 SERVED IN NHGRI COUNCIL. 85 00:05:25,474 --> 00:05:28,443 >> THANK YOU. 86 00:05:28,443 --> 00:05:34,349 DR. KEVIN JOHNSON. 87 00:05:34,349 --> 00:05:36,752 I THINK KEVIN HAD TO STEP AWAY, 88 00:05:36,752 --> 00:05:42,357 IF I GET THAT RIGHT. 89 00:05:42,357 --> 00:05:42,991 OKAY. 90 00:05:42,991 --> 00:05:46,395 DR. KAREN JOHNSTON. 91 00:05:46,395 --> 00:05:48,797 >> HI, CARE JOHNSTON, I'M A 92 00:05:48,797 --> 00:05:50,766 PROFESSOR OF NEUROLOGY AT THE 93 00:05:50,766 --> 00:05:53,001 UNIVERSITY OF VIRGINIA, AND I 94 00:05:53,001 --> 00:05:59,207 HAVE PREVIOUSLY SERVED ON THE 95 00:05:59,207 --> 00:06:00,175 NINDS COUNCIL. 96 00:06:00,175 --> 00:06:01,176 >> THANK YOU, KAREN. 97 00:06:01,176 --> 00:06:05,113 I WAS ONE HEAD. 98 00:06:05,113 --> 00:06:06,515 MS. BARBARA KELLEY. 99 00:06:06,515 --> 00:06:08,183 >> I'M EXECUTIVE DIRECTOR OF THE 100 00:06:08,183 --> 00:06:09,251 HEARING LOSS ASSOCIATION OF 101 00:06:09,251 --> 00:06:10,552 AMERICA IN THE D.C. AREA, THIS 102 00:06:10,552 --> 00:06:16,058 IS MY FIRST YEAR ON THE COUNCIL 103 00:06:16,058 --> 00:06:17,793 AND I PREVIOUSLY SERVED ON 104 00:06:17,793 --> 00:06:19,094 NATIONAL INSTITUTE OF DEAFNESS 105 00:06:19,094 --> 00:06:19,761 AND OTHER COMMUNICATION 106 00:06:19,761 --> 00:06:21,296 DISORDERS AT NIH. 107 00:06:21,296 --> 00:06:24,933 >> THANK YOU, BARBARA. 108 00:06:24,933 --> 00:06:28,270 DR. JEAN KING. 109 00:06:28,270 --> 00:06:32,240 >> JEAN KING, DEAN OF ARTS AND 110 00:06:32,240 --> 00:06:33,875 SCIENCES, WORCESTER POLYTECHNIC 111 00:06:33,875 --> 00:06:37,179 INSTITUTE, AFFILIATE PROFESSOR 112 00:06:37,179 --> 00:06:38,680 OF RADIOLOGY, NEUROLOGY, 113 00:06:38,680 --> 00:06:40,248 PSYCHIATRY, AT UMass MEDICAL 114 00:06:40,248 --> 00:06:44,052 SCHOOL, STUDY IMPACT OF STRESS 115 00:06:44,052 --> 00:06:45,821 AND RESILIENCE, USING DIFFERENT 116 00:06:45,821 --> 00:06:47,122 METHODS INCLUDING MRI. 117 00:06:47,122 --> 00:06:50,092 I HAVE SERVED ON NCCIH AND 118 00:06:50,092 --> 00:06:52,928 GRATEFUL TO BE SERVING WITH YOU 119 00:06:52,928 --> 00:06:53,295 NOW. 120 00:06:53,295 --> 00:06:55,897 >> THANK YOU, JEAN. 121 00:06:55,897 --> 00:06:58,433 DR. MICHAEL KOTLIKOFF. 122 00:06:58,433 --> 00:07:02,904 >> HI, PROFESSOR AND PROVOST AT 123 00:07:02,904 --> 00:07:04,773 CORNELL, ON MY FIRST YEAR ON 124 00:07:04,773 --> 00:07:07,843 COUNCIL AND I PREVIOUSLY SERVED 125 00:07:07,843 --> 00:07:10,679 ON AND CHAIRED THE BOARD OF 126 00:07:10,679 --> 00:07:13,548 SCIENTIFIC COUNSELORS FOR THE 127 00:07:13,548 --> 00:07:13,982 NHLBI. 128 00:07:13,982 --> 00:07:19,654 >> THANK YOU, MIKE. 129 00:07:19,654 --> 00:07:21,623 DR. DICK KRUGMAN. 130 00:07:21,623 --> 00:07:22,824 >> DISTINGUISHED PROFESSOR OF 131 00:07:22,824 --> 00:07:24,025 PEDIATRICS, UNIVERSITY OF 132 00:07:24,025 --> 00:07:25,994 COLORADO SCHOOL OF MEDICINE, NOT 133 00:07:25,994 --> 00:07:27,429 VICE CHANCELLOR FOR HEALTH 134 00:07:27,429 --> 00:07:29,064 AFFAIRS AS THE ROSTER SAYS, I 135 00:07:29,064 --> 00:07:32,701 DID THAT TEN YEARS AGO. 136 00:07:32,701 --> 00:07:34,770 AND IT'S MY -- THE END OF MY 137 00:07:34,770 --> 00:07:36,571 EITHER FOURTH OR FIFTH YEAR ON 138 00:07:36,571 --> 00:07:40,809 THE COUNCIL, HARD TO KEEP TRACK. 139 00:07:40,809 --> 00:07:44,846 I WAS PREVIOUSLY ON THE NICHD 140 00:07:44,846 --> 00:07:45,080 COUNCIL. 141 00:07:45,080 --> 00:07:47,149 >> WE'LL MAKE A NOTE AND MAKE 142 00:07:47,149 --> 00:07:50,085 THAT CHANGE. 143 00:07:50,085 --> 00:07:50,385 >> THANKS. 144 00:07:50,385 --> 00:07:52,621 >> DR. KENT LLOYD. 145 00:07:52,621 --> 00:07:53,889 >> GOOD MORNING, PROFESSOR OF 146 00:07:53,889 --> 00:07:58,093 SURGERY, SCHOOL OF MED SIB, 147 00:07:58,093 --> 00:08:00,395 CANCER CENTER, RETURNING MEMBER 148 00:08:00,395 --> 00:08:03,331 TO THIS COUNCIL OF COUNCILS. 149 00:08:03,331 --> 00:08:04,332 >> THANK YOU, KENT. 150 00:08:04,332 --> 00:08:05,400 THANK YOU FOR YOUR SERVICE. 151 00:08:05,400 --> 00:08:08,370 EVERYBODY, OF COURSE. 152 00:08:08,370 --> 00:08:11,673 DR. JENNIFER MANLY. 153 00:08:11,673 --> 00:08:13,842 >> HELLO, I'M A PROFESSOR AT 154 00:08:13,842 --> 00:08:17,145 COLUMBIA UNIVERSITY, DEPARTMENT 155 00:08:17,145 --> 00:08:17,913 OF NEUROLOGY, NEUROPSYCHOLOGIST, 156 00:08:17,913 --> 00:08:22,050 AND I HAVE BEEN ROTATING OFF OF 157 00:08:22,050 --> 00:08:24,352 THE AGING COUNCIL FOR QUITE SOME 158 00:08:24,352 --> 00:08:28,323 TIME NOW, BECAUSE THEY ARE 159 00:08:28,323 --> 00:08:30,525 WORKING ON REPLACING THE OLD 160 00:08:30,525 --> 00:08:31,827 COUNCIL MEMBERS, WITH THE NEW 161 00:08:31,827 --> 00:08:35,430 ONES, BUT I'M HAPPY TO BE HERE. 162 00:08:35,430 --> 00:08:40,769 >> THANK YOU, JENNIFER. 163 00:08:40,769 --> 00:08:48,443 DR. RHONDA ROBINSON-BEALE. 164 00:08:48,443 --> 00:08:50,212 >> PLEASE UNMUTE YOURSELF AND GO 165 00:08:50,212 --> 00:08:54,783 AHEAD. 166 00:08:54,783 --> 00:08:55,650 >> ALL RIGHT. 167 00:08:55,650 --> 00:08:57,652 I WONDER IF WE HAVE VIDEO ISSUES 168 00:08:57,652 --> 00:09:02,791 OR AUDIO ISSUES. 169 00:09:02,791 --> 00:09:11,533 CAN YOU HELP, CHRISTINA? 170 00:09:11,533 --> 00:09:17,472 171 00:09:17,472 --> 00:09:20,942 >> DR. ROBINSON-BEALE, CAN YOU 172 00:09:20,942 --> 00:09:22,711 HEAR US? 173 00:09:22,711 --> 00:09:24,479 >> WHY █DON'T WE TRY HER AT THE 174 00:09:24,479 --> 00:09:25,080 END AGAIN. 175 00:09:25,080 --> 00:09:29,384 LET'S SEE IF THAT CAN BE FIXED 176 00:09:29,384 --> 00:09:29,618 OFFLINE. 177 00:09:29,618 --> 00:09:33,221 NEXT I HAVE DR. SUSAN SANCHEZ. 178 00:09:33,221 --> 00:09:35,090 >> GOOD MORNING, EVERYONE. 179 00:09:35,090 --> 00:09:36,424 SUSAN SANCHEZ, PROFESSOR OF 180 00:09:36,424 --> 00:09:39,527 INFECTIOUS DISEASES, COLLEGE OF 181 00:09:39,527 --> 00:09:40,328 VETERINARY MEDICINE, UNIVERSITY 182 00:09:40,328 --> 00:09:42,530 OF GEORGIA, I'VE BEEN I THINK 183 00:09:42,530 --> 00:09:44,466 FIVE YEARS ON COUNCIL, HAVE NOT 184 00:09:44,466 --> 00:09:47,002 SERVED IN ANY OTHER COUNCILS AT 185 00:09:47,002 --> 00:09:47,168 NIH. 186 00:09:47,168 --> 00:09:50,071 THANK YOU. 187 00:09:50,071 --> 00:09:52,374 >> THANK YOU, SUSAN. 188 00:09:52,374 --> 00:09:54,542 MS. LAUREN SILVIS. 189 00:09:54,542 --> 00:09:55,744 >> LAUREN SILVIS, SENIOR 190 00:09:55,744 --> 00:09:59,481 INVOLVED OF EXTERNAL AFFAIRS 191 00:09:59,481 --> 00:10:00,682 TEMPUS, NOT SERVED ON ANOTHER 192 00:10:00,682 --> 00:10:01,917 NIH COUNCIL, IN MY FIRST YEAR ON 193 00:10:01,917 --> 00:10:03,685 THE COUNCIL. 194 00:10:03,685 --> 00:10:05,787 THANK YOU. 195 00:10:05,787 --> 00:10:06,154 >> THANK YOU. 196 00:10:06,154 --> 00:10:10,191 CHRISTINE, HOW ARE WE DOING WITH 197 00:10:10,191 --> 00:10:12,827 DR. ROBINSON-BEALE? 198 00:10:12,827 --> 00:10:13,261 AUDIO PROBLEMS? 199 00:10:13,261 --> 00:10:15,563 SO I THINK I'M GOING BACK TO 200 00:10:15,563 --> 00:10:18,166 WHAT ELSE I NEED TO SAY AFTER 201 00:10:18,166 --> 00:10:19,034 THE ROLL CALL. 202 00:10:19,034 --> 00:10:21,002 WE'LL TAKE IT FROM THERE. 203 00:10:21,002 --> 00:10:25,840 I DO HAVE A COUPLE MORE 204 00:10:25,840 --> 00:10:26,641 ANNOUNCEMENTS. 205 00:10:26,641 --> 00:10:28,243 THE MEETING MATERIALS FOR THIS 206 00:10:28,243 --> 00:10:30,745 ROUND FOR THIS MAY COUNCIL HAVE 207 00:10:30,745 --> 00:10:31,880 BEEN SENT TO YOU IN 208 00:10:31,880 --> 00:10:35,216 COMMUNICATION THAT CAME FROM DR. 209 00:10:35,216 --> 00:10:38,320 SCHWETZ ON MAY 16. 210 00:10:38,320 --> 00:10:39,321 AND THAT ALWAYS ALERTS YOU TO 211 00:10:39,321 --> 00:10:40,622 THE INFORMATION THAT YOU CAN 212 00:10:40,622 --> 00:10:43,024 ACCESS AND THAT WE WILL BE 213 00:10:43,024 --> 00:10:43,591 DISCUSSING. 214 00:10:43,591 --> 00:10:46,328 AS MEMBERS OF THIS COUNCIL, YOU 215 00:10:46,328 --> 00:10:47,629 ARE SPECIAL GOVERNMENT 216 00:10:47,629 --> 00:10:51,766 EMPLOYEES, AND YOU'RE THEREFORE 217 00:10:51,766 --> 00:10:53,635 SUBJECT TO RULES OF CONDUCT THAT 218 00:10:53,635 --> 00:10:55,170 APPLY TO FEDERAL EMPLOYEES. 219 00:10:55,170 --> 00:10:57,706 THESE RULES AND REGULATIONS ARE 220 00:10:57,706 --> 00:11:02,043 EXPLAINED IN THE REPORT, 221 00:11:02,043 --> 00:11:02,844 STANDARDS OF ETHICAL EMPLOYEES 222 00:11:02,844 --> 00:11:04,579 FOR EMPLOYEES OF THE EXECUTIVE 223 00:11:04,579 --> 00:11:05,447 BRANCH, WHICH YOU RECEIVED WHEN 224 00:11:05,447 --> 00:11:08,616 YOU WERE FIRST APPOINTED TO THE 225 00:11:08,616 --> 00:11:08,917 COUNCIL. 226 00:11:08,917 --> 00:11:12,354 AT EVERY MEETING IN ADDITION TO 227 00:11:12,354 --> 00:11:13,455 REMINDING YOU ABOUT THE 228 00:11:13,455 --> 00:11:14,222 IMPORTANCE OF FOLLOWING ETHICS 229 00:11:14,222 --> 00:11:17,726 RULES WE ALWAYS LIKE TO REVIEW 230 00:11:17,726 --> 00:11:19,661 THE STEPS THAT WE TAKE AND ASK 231 00:11:19,661 --> 00:11:22,864 YOU TO TAKE TO ENSURE ANY 232 00:11:22,864 --> 00:11:24,899 CONFLICT OF INTEREST BETWEEN 233 00:11:24,899 --> 00:11:27,235 YOUR PUBLIC RESPONSIBILITIES AND 234 00:11:27,235 --> 00:11:29,838 YOUR PRIVATE INTERESTS AND 235 00:11:29,838 --> 00:11:32,574 ACTIVITIES ARE IDENTIFIED AND 236 00:11:32,574 --> 00:11:32,841 ADDRESSED. 237 00:11:32,841 --> 00:11:34,209 THEREFORE, THREE TIMES A YEAR 238 00:11:34,209 --> 00:11:37,846 YOU PROVIDE US WITH INFORMATION 239 00:11:37,846 --> 00:11:40,081 ABOUT YOUR PERSONAL, 240 00:11:40,081 --> 00:11:41,716 PROFESSIONAL, AND FINANCIAL 241 00:11:41,716 --> 00:11:43,551 INTERESTS, WE USE THIS 242 00:11:43,551 --> 00:11:45,420 INFORMATION AS BASIS FOR 243 00:11:45,420 --> 00:11:48,056 ASSESSING WHETHER YOU ARE -- YOU 244 00:11:48,056 --> 00:11:51,226 HAVE ANY REAL POTENTIAL OR 245 00:11:51,226 --> 00:11:52,927 APPARENT CONFLICT OF INTEREST 246 00:11:52,927 --> 00:11:54,863 THAT COULD COMPROMISE YOUR 247 00:11:54,863 --> 00:11:58,233 ABILITY TO BE OBJECTIVE IN 248 00:11:58,233 --> 00:12:00,435 GIVING ADVICE DURING THE COUNCIL 249 00:12:00,435 --> 00:12:00,802 MEETINGS. 250 00:12:00,802 --> 00:12:03,738 IF SUCH CONFLICTS ARE 251 00:12:03,738 --> 00:12:06,141 IDENTIFIED, WE EITHER ISSUE A 252 00:12:06,141 --> 00:12:07,242 WAIVER OR RECUSE YOU FROM A 253 00:12:07,242 --> 00:12:09,277 PARTICULAR PORTION OF THE 254 00:12:09,277 --> 00:12:10,145 MEETING. 255 00:12:10,145 --> 00:12:13,014 WE ALSO RELY TO A GREAT DEGREE 256 00:12:13,014 --> 00:12:17,385 ON YOU TO BE ATTENTIVE DURING 257 00:12:17,385 --> 00:12:18,720 OUR MEETINGS TO THE POSSIBILITY 258 00:12:18,720 --> 00:12:22,323 IF ANY ISSUE ARISES THAT COULD 259 00:12:22,323 --> 00:12:26,261 AFFECT OR APPEAR TO AFFECT YOUR 260 00:12:26,261 --> 00:12:27,328 INTERESTS IN ANY SPECIFIC WAY, 261 00:12:27,328 --> 00:12:30,065 IF THAT HAPPENS WE ASK YOU TO 262 00:12:30,065 --> 00:12:32,067 RECUSE YOURSELF FROM THE 263 00:12:32,067 --> 00:12:33,902 DISCUSSION, PLEASE NOTIFY US BY 264 00:12:33,902 --> 00:12:35,670 USING THE CHAT FEATURE AND THE 265 00:12:35,670 --> 00:12:37,539 HOST WILL MOVE YOU TO A WAITING 266 00:12:37,539 --> 00:12:42,877 ROOM,IF THAT IS NEEDED. 267 00:12:42,877 --> 00:12:44,312 IF YOU HAVE ANY QUESTIONS DURING 268 00:12:44,312 --> 00:12:48,116 THE YEAR OR ANY TIME ABOUT THE 269 00:12:48,116 --> 00:12:51,653 RULES OF CONDUCT OR CONFLICT OF 270 00:12:51,653 --> 00:12:54,956 INTEREST, OUR COMMITTEE 271 00:12:54,956 --> 00:12:56,124 MANAGEMENT SPECIALIST OR I WILL 272 00:12:56,124 --> 00:12:57,125 BE HAPPY TO ADDRESS THEM. 273 00:12:57,125 --> 00:13:00,195 FAITH IS THE ONE WHO USUALLY 274 00:13:00,195 --> 00:13:00,962 CONTACTS YOU ABOUT FORMS YOU 275 00:13:00,962 --> 00:13:03,364 NEED TO FILL OUT WITH THE 276 00:13:03,364 --> 00:13:05,233 CONFLICT OF INTEREST 277 00:13:05,233 --> 00:13:06,868 INFORMATION. 278 00:13:06,868 --> 00:13:08,803 A COUPLE MORE ITEMS. 279 00:13:08,803 --> 00:13:12,307 TIME IS ALLOTTED IN THE AGENDA 280 00:13:12,307 --> 00:13:13,541 FOR DISCUSSION BY COUNCIL 281 00:13:13,541 --> 00:13:14,609 FOLLOWING EACH PRESENTATION. 282 00:13:14,609 --> 00:13:16,144 UNFORTUNATELY THERE IS LIMITED 283 00:13:16,144 --> 00:13:20,215 TIME FOR ANY COMMENTS FROM OTHER 284 00:13:20,215 --> 00:13:20,915 ATTENDEES. 285 00:13:20,915 --> 00:13:23,284 THE PUBLIC IS WELCOME TO SUBMIT 286 00:13:23,284 --> 00:13:26,988 COMMENTS IN WRITING AFTER THE 287 00:13:26,988 --> 00:13:28,623 MEETING, INSTRUCTIONS FOR DOING 288 00:13:28,623 --> 00:13:30,792 SO ARE IN THE FEDERAL REGISTER 289 00:13:30,792 --> 00:13:35,063 NOTICE THAT WAS PUBLISHED FOR 290 00:13:35,063 --> 00:13:39,134 THIS MEETING ON APRIL 22 THIS 291 00:13:39,134 --> 00:13:39,334 YEAR. 292 00:13:39,334 --> 00:13:41,736 AS ALWAYS, APPROVED MINUTES WILL 293 00:13:41,736 --> 00:13:43,738 BE -- OF THIS MEETING OF COURSE 294 00:13:43,738 --> 00:13:47,675 WILL BE POSTED ON THE DPCPSI 295 00:13:47,675 --> 00:13:50,512 WEBSITE FOR THE COUNCIL. 296 00:13:50,512 --> 00:13:51,546 IMPORTANTLY, NEXT MEETINGS, THE 297 00:13:51,546 --> 00:13:53,047 NEXT MEETINGS, THERE'S ONLY ONE 298 00:13:53,047 --> 00:13:58,319 LEFT FOR THIS YEAR. 299 00:13:58,319 --> 00:13:58,987 IT'S SCHEDULED FOR SEPTEMBER 12 300 00:13:58,987 --> 00:13:59,721 AND 13. 301 00:13:59,721 --> 00:14:01,923 I ALREADY MADE THE COMMENT 302 00:14:01,923 --> 00:14:04,225 EARLIER ON THAT IT'S -- WE'RE 303 00:14:04,225 --> 00:14:07,162 PLANNING ON AN IN-PERSON 304 00:14:07,162 --> 00:14:07,428 MEETING. 305 00:14:07,428 --> 00:14:09,364 SO GET READY FOR THAT. 306 00:14:09,364 --> 00:14:10,798 THE MEETING THEREAFTER IS OUR 307 00:14:10,798 --> 00:14:14,035 EARLY IN THE YEAR MEETING, IT'S 308 00:14:14,035 --> 00:14:16,938 SCHEDULED FOR FEBRUARY 6 AND 7. 309 00:14:16,938 --> 00:14:25,446 ARE THERE ANY QUESTIONS AT THIS 310 00:14:25,446 --> 00:14:26,548 POINT FOR ME? 311 00:14:26,548 --> 00:14:30,385 I DO NOT SEE ANY HANDS, ANY 312 00:14:30,385 --> 00:14:35,190 RAISED HANDS OR COMMENTS IN THE 313 00:14:35,190 --> 00:14:35,657 CHAT. 314 00:14:35,657 --> 00:14:37,292 I WITH THAT I HADN'T IT BACK 315 00:14:37,292 --> 00:14:39,327 OVER TO TARA. 316 00:14:39,327 --> 00:14:41,896 >> GREAT, THANKS. 317 00:14:41,896 --> 00:14:42,630 ALL RIGHT. 318 00:14:42,630 --> 00:14:44,165 REMINDER, AGAIN, WE'RE IN OPEN 319 00:14:44,165 --> 00:14:45,400 SESSION AT TODAY'S MEETING. 320 00:14:45,400 --> 00:14:46,467 THAT'S OPEN TO THE PUBLIC 321 00:14:46,467 --> 00:14:49,103 INCLUDING MEMBERS OF THE PRESS. 322 00:14:49,103 --> 00:14:54,475 WE ARE VIDEOCASTING THIS MEETING 323 00:14:54,475 --> 00:14:55,577 SO EVERYONE CAN LISTEN. 324 00:14:55,577 --> 00:14:56,878 LET'S GET THINGS KICKED OFF. 325 00:14:56,878 --> 00:15:00,481 WE HAVE A REALLY GREAT DAY 326 00:15:00,481 --> 00:15:01,015 PLANNED. 327 00:15:01,015 --> 00:15:03,451 I -- WE HAVE THE AGENDA UP, I'LL 328 00:15:03,451 --> 00:15:05,420 RUN THROUGH IT QUICKLY. 329 00:15:05,420 --> 00:15:08,022 I'LL PROVIDE SOME UPDATES HERE 330 00:15:08,022 --> 00:15:11,759 IN A SECOND FROM DPCPSI, BUT 331 00:15:11,759 --> 00:15:12,627 ALSO NIH-WIDE. 332 00:15:12,627 --> 00:15:16,564 AND THEN WE WILL ALSO HAVE A 333 00:15:16,564 --> 00:15:18,866 PRESENTATION FROM DR. DIANA 334 00:15:18,866 --> 00:15:20,501 BIANCHI, DIRECTOR OF THE EUNICE 335 00:15:20,501 --> 00:15:21,336 KENNEDY SHRIVER NATIONAL 336 00:15:21,336 --> 00:15:22,904 INSTITUTE OF CHILD HEALTH AND 337 00:15:22,904 --> 00:15:24,806 HUMAN DEVELOPMENT, PROVIDING A 338 00:15:24,806 --> 00:15:29,644 BIT OF OVERVIEW ON THE FUTURE 339 00:15:29,644 --> 00:15:34,215 VISION FOR NICHD'S STRATEGIC 340 00:15:34,215 --> 00:15:34,515 PRIORITIES. 341 00:15:34,515 --> 00:15:36,517 WE'LL HEAR UPDATES FROM DPCPSI'S 342 00:15:36,517 --> 00:15:38,286 OFFICE OF RESEARCH ON WOMEN'S 343 00:15:38,286 --> 00:15:41,122 HEALTH ON THE WHITE HOUSE 344 00:15:41,122 --> 00:15:42,323 WOMEN'S HEALTH RESEARCH 345 00:15:42,323 --> 00:15:43,024 INITIATIVE, IN PARTICULAR, AND 346 00:15:43,024 --> 00:15:45,627 ON THE OFFICE OF DIETARY 347 00:15:45,627 --> 00:15:46,594 SUPPLEMENTS FROM THEIR NEW 348 00:15:46,594 --> 00:15:48,563 STRATEGIC PLAN THEY ARE PUTTING 349 00:15:48,563 --> 00:15:48,930 OUT. 350 00:15:48,930 --> 00:15:50,965 AND WE DO HAVE TWO CONCEPT 351 00:15:50,965 --> 00:15:53,167 CLEARANCES THAT WE'LL HEAR A BIT 352 00:15:53,167 --> 00:15:54,469 MORE ABOUT TODAY. 353 00:15:54,469 --> 00:15:58,673 AND WE HOPE TO FINISH BY AROUND 354 00:15:58,673 --> 00:16:00,308 3:40, MAYBE EVEN A LITTLE 355 00:16:00,308 --> 00:16:00,541 EARLIER. 356 00:16:00,541 --> 00:16:03,911 WE'LL SEE HOW THINGS GO. 357 00:16:03,911 --> 00:16:06,080 BUT HOPEFULLY WE'LL HAVE SOME 358 00:16:06,080 --> 00:16:08,616 GREAT DISCUSSION ON ALL OF THOSE 359 00:16:08,616 --> 00:16:09,484 TOPICS. 360 00:16:09,484 --> 00:16:11,619 SO, AS YOU ALL KNOW, THE 361 00:16:11,619 --> 00:16:15,056 DIRECTORS OF EACH OF THE DPCPSI 362 00:16:15,056 --> 00:16:17,258 PROGRAM OFFICES SERVE AS 363 00:16:17,258 --> 00:16:22,196 NON-VOTING LIAISONS TO THIS 364 00:16:22,196 --> 00:16:22,430 COUNCIL. 365 00:16:22,430 --> 00:16:23,131 AND THEY ARE LISTED HERE WITH 366 00:16:23,131 --> 00:16:24,932 PHOTOS ON THE SLIDE. 367 00:16:24,932 --> 00:16:26,501 THEY ARE AVAILABLE, MOST OR 368 00:16:26,501 --> 00:16:28,002 THEIR REPRESENTATIVES ARE ON THE 369 00:16:28,002 --> 00:16:30,805 CALL AND AVAILABLE FOR INPUT OR 370 00:16:30,805 --> 00:16:33,341 COMMENTS IF NEEDED, AND AS 371 00:16:33,341 --> 00:16:34,475 APPROPRIATE. 372 00:16:34,475 --> 00:16:37,345 SO FEEL FREE TO ASK QUESTIONS AS 373 00:16:37,345 --> 00:16:39,347 NEAT THE. 374 00:16:39,347 --> 00:16:39,714 ALL RIGHT. 375 00:16:39,714 --> 00:16:44,819 I WANT TO START OUR NIH-WIDE AND 376 00:16:44,819 --> 00:16:47,889 DPCPSI UPDATES BY ANNOUNCING 377 00:16:47,889 --> 00:16:51,392 STAFF CHANGES, WE'LL START AT 378 00:16:51,392 --> 00:16:52,927 THE SORT OF INSTITUTE LEVEL. 379 00:16:52,927 --> 00:16:54,462 WE HAVE A BRAND-NEW I.C. 380 00:16:54,462 --> 00:16:56,564 DIRECTOR WHO JUST STARTED A 381 00:16:56,564 --> 00:17:00,268 MONTH OR SO AGO. 382 00:17:00,268 --> 00:17:02,904 , SHE WAS NAMED THE 13th 383 00:17:02,904 --> 00:17:05,306 DIRECTOR OF THE FOGARTY 384 00:17:05,306 --> 00:17:07,642 INTERNATIONAL CENTER 385 00:17:07,642 --> 00:17:10,478 DR. KATHLEEN NEUZIL, FIRST WOMAN 386 00:17:10,478 --> 00:17:12,113 TO HOLD THE PERMANENT FOGARTY 387 00:17:12,113 --> 00:17:15,116 DIRECTOR POSITION SINCE THE 388 00:17:15,116 --> 00:17:16,718 CENTER'S FOUNDING IN 1968. 389 00:17:16,718 --> 00:17:19,554 AND SO SHE IS GOING TO LEAD 390 00:17:19,554 --> 00:17:21,089 FOGARTY IN ITS MISSION 391 00:17:21,089 --> 00:17:22,523 SUPPORTING AND FACILITATING 392 00:17:22,523 --> 00:17:23,591 GLOBAL HEALTH RESEARCH CONDUCTED 393 00:17:23,591 --> 00:17:26,894 BY U.S.-BASED AND INTERNATIONAL 394 00:17:26,894 --> 00:17:29,497 INVESTIGATORS BUILDING 395 00:17:29,497 --> 00:17:30,398 PARTNERSHIPS ON GLOBAL HEALTH 396 00:17:30,398 --> 00:17:32,233 RESEARCH AND TRAINING THE NEXT 397 00:17:32,233 --> 00:17:33,234 GENERATION OF SCIENTISTS TO 398 00:17:33,234 --> 00:17:34,669 ADDRESS GLOBAL HEALTH NEEDS. 399 00:17:34,669 --> 00:17:37,605 IT'S A REALLY CRITICAL PART OF 400 00:17:37,605 --> 00:17:41,876 FOGARTY'S PORTFOLIO. 401 00:17:41,876 --> 00:17:45,680 AND DR. NEUZIL JOINT FROM 402 00:17:45,680 --> 00:17:46,814 UNIVERSITY OF MARYLAND SCHOOL OF 403 00:17:46,814 --> 00:17:47,682 MEDICINE IN BALTIMORE, EXCITED 404 00:17:47,682 --> 00:17:51,519 TO HAVE HER IN THIS NEW ROLE. 405 00:17:51,519 --> 00:18:02,029 AND THEN ON FEBRUARY 29, DR. 406 00:18:04,365 --> 00:18:05,500 BERTAGNOLLI ANNOUNCED THE 407 00:18:05,500 --> 00:18:07,902 DEPARTURE OF JOSHUA GORDON, HE 408 00:18:07,902 --> 00:18:13,174 JOINT IN AUGUST OF 2016 FROM 409 00:18:13,174 --> 00:18:15,476 COLUMBIA, WHERE HE WAS ASSOCIATE 410 00:18:15,476 --> 00:18:16,644 PROFESSOR OF PSYCHIATRY, 411 00:18:16,644 --> 00:18:22,350 RESEARCH PSYCHIATRIST AT NEW 412 00:18:22,350 --> 00:18:24,752 NEW 413 00:18:24,752 --> 00:18:26,287 YORK STATE. 414 00:18:26,287 --> 00:18:29,123 HE'S GOING BACK TO COLUMBIA AS 415 00:18:29,123 --> 00:18:30,758 CHAIR OF DEPARTMENT OF 416 00:18:30,758 --> 00:18:31,325 PSYCHIATRY, PSYCHIATRIST IN 417 00:18:31,325 --> 00:18:34,262 CHIEF OF THE NEW YORK 418 00:18:34,262 --> 00:18:35,129 PRESBYTERIAN HOSPITAL CAMPUS AT 419 00:18:35,129 --> 00:18:38,766 COLUMBIA AND IS GOING TO RETURN 420 00:18:38,766 --> 00:18:41,502 AS THE DIRECTOR OF NSPI. 421 00:18:41,502 --> 00:18:43,671 SAD TO SEE JOSH GO. 422 00:18:43,671 --> 00:18:45,106 HE'S BEEN A GREAT COLLEAGUE, BUT 423 00:18:45,106 --> 00:18:48,276 WE'RE USHERING IN THIS NEW ERA I 424 00:18:48,276 --> 00:18:49,343 GUESS FOR NIMH AS WE'LL LAUNCH 425 00:18:49,343 --> 00:18:52,780 THE SEARCH FOR THE NEW DIRECTOR 426 00:18:52,780 --> 00:18:53,548 SOON. 427 00:18:53,548 --> 00:19:00,855 IN THE MEANTIME SHOW THE NIMH 428 00:19:00,855 --> 00:19:02,190 DEPUTY DIRECTOR SHELLI AVENEVOLI 429 00:19:02,190 --> 00:19:06,427 IS GOING TO SERVE AS THE ACTING 430 00:19:06,427 --> 00:19:06,694 DIRECTOR. 431 00:19:06,694 --> 00:19:10,598 AND SHE JOINED NIMH BACK IN 2001 432 00:19:10,598 --> 00:19:12,333 AS STAFF SCIENTIST AND HAS 433 00:19:12,333 --> 00:19:14,435 BOUNCED AROUND IN VARIOUS ROLES 434 00:19:14,435 --> 00:19:17,371 AND LED A NUMBER OF KEY NIMH 435 00:19:17,371 --> 00:19:17,605 EFFORTS. 436 00:19:17,605 --> 00:19:22,310 SO THE INSTITUTE WILL BE IN GOOD 437 00:19:22,310 --> 00:19:23,711 HANDS WITH SHELLI WHILE WE SERVE 438 00:19:23,711 --> 00:19:26,013 FOR A NEW PERMANENT DIRECTOR. 439 00:19:26,013 --> 00:19:26,881 ALL RIGHT. 440 00:19:26,881 --> 00:19:32,920 IF WE SHIFT TO SOME CHANGES IN 441 00:19:32,920 --> 00:19:35,323 DPCPSI LEADERSHIP, REALLY 442 00:19:35,323 --> 00:19:38,259 EXCITED TO ANNOUNCE THREE DEPUTY 443 00:19:38,259 --> 00:19:39,727 DIRECTORS, OFFICE OF DEPUTY 444 00:19:39,727 --> 00:19:41,662 DIRECTORS WHO JOINED OVER THE 445 00:19:41,662 --> 00:19:42,430 LAST SEVERAL MONTHS. 446 00:19:42,430 --> 00:19:48,135 WITHIN OFFICE OF DIETARY 447 00:19:48,135 --> 00:19:49,971 SUPPLEMENTS, ODS, DR. STEPHANIE 448 00:19:49,971 --> 00:19:52,073 GEORGE JOINED AS NEW DEPUTY 449 00:19:52,073 --> 00:19:52,740 DIRECTOR, COMES FROM THE 450 00:19:52,740 --> 00:19:54,675 NATIONAL INSTITUTE OF ARTHRITIS 451 00:19:54,675 --> 00:19:56,677 AND MUSCULOSKELETAL AND SKIN 452 00:19:56,677 --> 00:19:59,814 DISEASES, WHERE SHE WAS AN 453 00:19:59,814 --> 00:20:01,816 EPIDEMIOLOGIST AND PROGRAM 454 00:20:01,816 --> 00:20:02,750 DIRECTOR. 455 00:20:02,750 --> 00:20:04,318 AND OVERSAW NIH'S LARGEST 456 00:20:04,318 --> 00:20:08,923 INVESTMENT IN PHYSICAL ACTIVITY 457 00:20:08,923 --> 00:20:14,195 RESEARCH, WHICH WE CALL 458 00:20:14,195 --> 00:20:15,396 MOPORPAC, A COMMON FUND PROGRAM, 459 00:20:15,396 --> 00:20:22,436 SHE HAD THAT CONNECTION TO 460 00:20:22,436 --> 00:20:25,239 DPCPSI AND WAS IN THE OFFICE OF 461 00:20:25,239 --> 00:20:26,340 DISEASE PREVENTION. 462 00:20:26,340 --> 00:20:30,044 SO, REALLY EXCITED TO HAVE HER 463 00:20:30,044 --> 00:20:31,779 BACK IN THAT ROLE. 464 00:20:31,779 --> 00:20:35,182 NOW, IN THE OFFICE OF BEHAVIORAL 465 00:20:35,182 --> 00:20:38,252 AND SOCIAL SCIENCES RESEARCH, 466 00:20:38,252 --> 00:20:40,121 DR. JANINE SIMMONS IS NEW DEPUTY 467 00:20:40,121 --> 00:20:43,090 DIRECTOR THERE. 468 00:20:43,090 --> 00:20:45,359 SHE COMES TO OBSSR BY WAY OF 469 00:20:45,359 --> 00:20:46,494 NATIONAL INSTITUTE OF MENTAL 470 00:20:46,494 --> 00:20:49,530 HEALTH AND NATIONAL INSTITUTE ON 471 00:20:49,530 --> 00:20:50,164 AGING. 472 00:20:50,164 --> 00:20:53,901 SHE WAS AT NIMH, SHE WAS HEAD OF 473 00:20:53,901 --> 00:20:56,304 THE SOCIAL AND EFFECTIVE 474 00:20:56,304 --> 00:20:57,171 NEUROSCIENCE PROGRAM, REALLY 475 00:20:57,171 --> 00:21:00,474 INVOLVED IN THE BRAIN 476 00:21:00,474 --> 00:21:01,375 INITIATIVE'S BRAIN BEHAVIOR 477 00:21:01,375 --> 00:21:05,746 QUANTIFICATION AND SYNCHRONIZE 478 00:21:05,746 --> 00:21:10,318 ACE, AND AT NIA WAS CHIEF OF THE 479 00:21:10,318 --> 00:21:10,952 INDIVIDUAL BEHAVIORAL PROCESSES 480 00:21:10,952 --> 00:21:18,326 BRANCH, HAS HAD A PRETTY 481 00:21:18,326 --> 00:21:19,160 LONGSTANDING RELATIONSHIP WITH 482 00:21:19,160 --> 00:21:21,162 OBSSR, HAS CHAIRED ONE OF THE 483 00:21:21,162 --> 00:21:27,001 WORKING GROUPS THAT OBSSR LEADS. 484 00:21:27,001 --> 00:21:29,704 SO SHE'S NOW OFFICIALLY IN 485 00:21:29,704 --> 00:21:29,937 DPCPSI. 486 00:21:29,937 --> 00:21:31,572 AND THEN FINALLY IN THE OFFICE 487 00:21:31,572 --> 00:21:35,276 OF RESEARCH ON WOMEN'S HEALTH 488 00:21:35,276 --> 00:21:37,912 DR. VIVIAN OTA WANG, YOU'LL HEAR 489 00:21:37,912 --> 00:21:39,246 FROM HER THIS AFTERNOON, 490 00:21:39,246 --> 00:21:42,617 SELECTED TO SERVE AS THE DEPUTY 491 00:21:42,617 --> 00:21:44,385 DIRECTOR OF THAT OFFICE. 492 00:21:44,385 --> 00:21:51,158 SHE WAS PREVIOUSLY THE POLICY 493 00:21:51,158 --> 00:21:52,693 AND COVID LEAD IN OFFICE OF DATA 494 00:21:52,693 --> 00:21:58,132 SCIENCE AND STRATEGY IN DPCPSI, 495 00:21:58,132 --> 00:22:00,334 AND WAS RESPONSIBLE FOR ETHICS, 496 00:22:00,334 --> 00:22:02,637 EQUITY, AND ISSUES RELATED TO 497 00:22:02,637 --> 00:22:06,807 DATA ACCESS AND SHARING POLICY 498 00:22:06,807 --> 00:22:07,775 DEVELOPMENT IMPLEMENTATION, AND 499 00:22:07,775 --> 00:22:09,644 COVID ACTIVITIES. 500 00:22:09,644 --> 00:22:14,982 AND PRIOR TO JOINING NIH SHE 501 00:22:14,982 --> 00:22:17,385 SERVE IN BUSH AND OBAMA 502 00:22:17,385 --> 00:22:20,021 ADMINISTRATIONS, EXECUTIVE 503 00:22:20,021 --> 00:22:22,223 OFFICE OF THE PRESIDENT NATIONAL 504 00:22:22,223 --> 00:22:24,392 SCIENCE AND TECHNOLOGY COUNCIL, 505 00:22:24,392 --> 00:22:25,159 NSTC. 506 00:22:25,159 --> 00:22:27,128 BUT SHE ALSO SERVED AS SENIOR 507 00:22:27,128 --> 00:22:29,864 ADVISER TO THE DIRECTOR AT OBSSR 508 00:22:29,864 --> 00:22:32,733 SO HAS CONNECTIONs TO DPCPSI. 509 00:22:32,733 --> 00:22:35,102 WE'RE GLAD TO KEEP HER IN THE 510 00:22:35,102 --> 00:22:39,607 FOLD SINCE SHE WAS AT ODSS AND 511 00:22:39,607 --> 00:22:41,575 NOW AT ORWH. 512 00:22:41,575 --> 00:22:44,512 SO REALLY EXCITED TO WELCOME ALL 513 00:22:44,512 --> 00:22:48,783 THREE OF THESE WOMEN TO 514 00:22:48,783 --> 00:22:51,519 LEADERSHIP ROLES WITHIN DPCPSI. 515 00:22:51,519 --> 00:22:51,719 OKAY. 516 00:22:51,719 --> 00:22:57,425 WE'RE GOING TO SWITCH GEARS AND 517 00:22:57,425 --> 00:23:01,028 TALK ABOUT THE BUDGET I WANT TO 518 00:23:01,028 --> 00:23:02,663 OFFER A FEW UPDATES, IN GENERAL. 519 00:23:02,663 --> 00:23:04,098 WE'LL START WITH THE BUDGET 520 00:23:04,098 --> 00:23:05,966 SINCE WE HAVE ONE SINCE THE LAST 521 00:23:05,966 --> 00:23:07,034 FULL MEETING IN JANUARY, WE DID 522 00:23:07,034 --> 00:23:08,803 AT THE END OF MARCH GET AN 523 00:23:08,803 --> 00:23:12,640 ACTUAL BUDGET THIS YEAR. 524 00:23:12,640 --> 00:23:14,775 SO, OUR BUDGET OVERALL FOR NIH 525 00:23:14,775 --> 00:23:20,381 IN FISCAL YEAR 24 IS ABOUT $47 526 00:23:20,381 --> 00:23:22,049 BILLION. 527 00:23:22,049 --> 00:23:23,584 OUR TOTAL DPCPSI BUDGET FOR SAME 528 00:23:23,584 --> 00:23:26,220 TIME FRAME FOR THIS YEAR IS 529 00:23:26,220 --> 00:23:29,924 ABOUT $2.1 BILLION. 530 00:23:29,924 --> 00:23:32,660 THAT INCLUDES ECHO AND "ALL OF 531 00:23:32,660 --> 00:23:36,931 US," IN THE PROCESS OF SHIFTING 532 00:23:36,931 --> 00:23:37,264 TO DPCPSI. 533 00:23:37,264 --> 00:23:42,837 NOW, AS PART OF THAT WE HAD SOME 534 00:23:42,837 --> 00:23:45,039 GOOD NEWS IN WHICH ORWH RECEIVED 535 00:23:45,039 --> 00:23:49,043 A SMALL INCREASE OF $2 MILLION, 536 00:23:49,043 --> 00:23:51,178 PROVIDED FOR THE BUILDING 537 00:23:51,178 --> 00:23:51,712 INTERDISCIPLINARY RESEARCH 538 00:23:51,712 --> 00:23:54,248 CAREERS IN WOMEN'S HEALTH OR 539 00:23:54,248 --> 00:23:55,983 BIRCWH PROGRAM TO HELP FUND 540 00:23:55,983 --> 00:23:58,185 FELLOWS AT SOME OF THE EXISTING 541 00:23:58,185 --> 00:24:01,055 SITES THAT THEY SUPPORT THROUGH 542 00:24:01,055 --> 00:24:01,789 THAT EFFORT. 543 00:24:01,789 --> 00:24:02,890 UNFORTUNATELY, THOUGH, WE DID 544 00:24:02,890 --> 00:24:07,728 HAVE A FEW BUDGET CUTS. 545 00:24:07,728 --> 00:24:09,230 WE HAD SOME HAIRCUTS ACROSS THE 546 00:24:09,230 --> 00:24:10,765 BOARD, BUT IN PARTICULAR TWO 547 00:24:10,765 --> 00:24:13,334 THAT ARE WORTH NOTING, FAIRLY 548 00:24:13,334 --> 00:24:14,635 SIGNIFICANT. 549 00:24:14,635 --> 00:24:17,671 THE "ALL OF US" PROGRAM AGAIN 550 00:24:17,671 --> 00:24:18,906 NOT OFFICIALLY TECHNICALLY IN 551 00:24:18,906 --> 00:24:19,974 DPCPSI JUST YET BUT 552 00:24:19,974 --> 00:24:22,943 UNFORTUNATELY THAT PROGRAM WAS 553 00:24:22,943 --> 00:24:27,414 CUT BY ABOUT 34%, THAT IS DUE TO 554 00:24:27,414 --> 00:24:29,183 A REDUCTION, PLANNED REDUCTIONS 555 00:24:29,183 --> 00:24:30,251 IN MANDATORY MONEY THAT "ALL OF 556 00:24:30,251 --> 00:24:33,754 US" HAS BEEN RECEIVING FOR THE 557 00:24:33,754 --> 00:24:36,824 LAST MANY YEARS. 558 00:24:36,824 --> 00:24:38,125 AND THEN ADDITIONALLY THE COMMON 559 00:24:38,125 --> 00:24:42,396 FUND WAS ALSO CUT BY $50 560 00:24:42,396 --> 00:24:42,730 MILLION. 561 00:24:42,730 --> 00:24:45,566 LAST YEAR THEY RECEIVED AN 562 00:24:45,566 --> 00:24:49,069 INCREASE OF $50 MILLION, SO I 563 00:24:49,069 --> 00:24:50,371 GUESS THE ONE POSITIVE WAY TO 564 00:24:50,371 --> 00:24:54,074 LOOK AT THIS IS THAT IT'S FLAT 565 00:24:54,074 --> 00:24:56,143 FROM FY 22. 566 00:24:56,143 --> 00:24:59,847 BUT OF COURSE, YOU KNOW, WE ARE 567 00:24:59,847 --> 00:25:03,851 NAVIGATING ACROSS ALL OF THESE 568 00:25:03,851 --> 00:25:04,552 EFFORTS. 569 00:25:04,552 --> 00:25:06,587 AND THEN SOME CALL-OUTS THAT 570 00:25:06,587 --> 00:25:09,223 WERE INCLUDED IN THE BUDGET 571 00:25:09,223 --> 00:25:11,392 SPECIFICALLY TO DPCPSI BUT 572 00:25:11,392 --> 00:25:16,931 DIDN'T REALLY IMPACT THE OVERALL 573 00:25:16,931 --> 00:25:18,165 BUDGET NUMBERS INCLUDE SOME 574 00:25:18,165 --> 00:25:19,733 LANGUAGE AROUND CONTINUATION OF 575 00:25:19,733 --> 00:25:23,904 THE OFFICE OF NUTRITION RESEARCH 576 00:25:23,904 --> 00:25:27,508 AT THE FISCAL YEAR 23 LEVEL AND 577 00:25:27,508 --> 00:25:28,609 THE "INCLUDE" PROGRAM, FOCUSED 578 00:25:28,609 --> 00:25:30,211 ON SUPPORTING RESEARCH FOR 579 00:25:30,211 --> 00:25:33,614 PEOPLE WITH DOWN SYNDROME THAT 580 00:25:33,614 --> 00:25:35,449 WILL CONTINUE TO RECEIVE NOT 581 00:25:35,449 --> 00:25:36,917 LESS THAN $90 MILLION. 582 00:25:36,917 --> 00:25:42,456 SO THOSE ARE THE SORT OF BUDGET 583 00:25:42,456 --> 00:25:43,791 IMPLICATIONS OF THE FY 24 BUDGET 584 00:25:43,791 --> 00:25:45,426 FOR DPCPSI AND I JUST WANTED TO 585 00:25:45,426 --> 00:25:53,400 MAKE SURE THAT YOU ALL WERE 586 00:25:53,400 --> 00:25:53,834 AWARE. 587 00:25:53,834 --> 00:25:54,168 NEXT SLIDE. 588 00:25:54,168 --> 00:25:55,836 I WANT TO TALK ABOUT EXCITING 589 00:25:55,836 --> 00:25:59,773 SCIENCE THAT WE HAVE COMING UP 590 00:25:59,773 --> 00:26:01,508 AND SOME OTHER ACTIVITIES THAT 591 00:26:01,508 --> 00:26:02,610 WE'RE READY TO ANNOUNCE. 592 00:26:02,610 --> 00:26:04,979 I WANT TO START WITH SOME PRIZE 593 00:26:04,979 --> 00:26:08,749 WINNERS FOR A FEW PRIZES THAT WE 594 00:26:08,749 --> 00:26:11,051 HAVE LAUNCHED. 595 00:26:11,051 --> 00:26:14,655 SO, IN EARLY 2023, THE OFFICE OF 596 00:26:14,655 --> 00:26:18,492 DATA SCIENCE STRATEGY PARTNERED 597 00:26:18,492 --> 00:26:20,995 WITH FEDERATION OF AMERICAN 598 00:26:20,995 --> 00:26:22,229 SOCIETIES FOR EXPERIMENTAL 599 00:26:22,229 --> 00:26:25,266 BIOLOGY, FASEB, TO LAUNCH THE 600 00:26:25,266 --> 00:26:27,568 SECOND ANNUAL DATAWORKS PRIZE TO 601 00:26:27,568 --> 00:26:30,104 HIGHLIGHT EXAMPLES OF INNOVATIVE 602 00:26:30,104 --> 00:26:34,241 DATA SHARING AND REUSE, AND THIS 603 00:26:34,241 --> 00:26:38,612 YEAR 39 TEAMS WITH OVER 215 TEAM 604 00:26:38,612 --> 00:26:40,481 MEMBERS REGISTERED FOR THE 605 00:26:40,481 --> 00:26:42,683 CHALLENGE TO DEMONSTRATE THEIR 606 00:26:42,683 --> 00:26:45,619 ACCOMPLISHMENTS AND WE ANNOUNCED 607 00:26:45,619 --> 00:26:47,721 WINNERS IN FEBRUARY. 608 00:26:47,721 --> 00:26:49,256 SO THE GRAND PRIZE, $100,000, 609 00:26:49,256 --> 00:26:55,396 WAS AWARDED TO A TEAM FROM 610 00:26:55,396 --> 00:26:57,765 LIFESPAN HEALTH FOR CCC 19, THIS 611 00:26:57,765 --> 00:27:02,937 IS A COLLABORATION THAT 612 00:27:02,937 --> 00:27:04,571 COLLECTED AND DISSEMINATED 613 00:27:04,571 --> 00:27:05,339 PROSPECTIVE GRANULAR UNIFORMLY 614 00:27:05,339 --> 00:27:07,841 ORGANIZED INFORMATION ON 615 00:27:07,841 --> 00:27:10,477 PATIENTS WITH CANCER DIAGNOSED 616 00:27:10,477 --> 00:27:13,213 WITH COVID-19 ALSO. 617 00:27:13,213 --> 00:27:14,415 SO, REALLY EXCITED ABOUT THE 618 00:27:14,415 --> 00:27:18,686 WORK THAT ALL OF THOSE TEAMS ARE 619 00:27:18,686 --> 00:27:19,787 DOING. 620 00:27:19,787 --> 00:27:21,855 ALSO IN FEBRUARY, WE ANNOUNCED 621 00:27:21,855 --> 00:27:25,292 FOUR PHASE 2 WINNERS OF THE 622 00:27:25,292 --> 00:27:27,027 NEUROMOD PRIZE. 623 00:27:27,027 --> 00:27:29,063 THIS IS ALMOST $10 MILLION 624 00:27:29,063 --> 00:27:31,265 COMPETITION TO ACCELERATE 625 00:27:31,265 --> 00:27:33,334 DEVELOPMENT OF TARGETED 626 00:27:33,334 --> 00:27:35,035 NEUROMODULATION THERAPIES, AND 627 00:27:35,035 --> 00:27:40,107 THIS NEUROMOD PRIZE IS PART OF 628 00:27:40,107 --> 00:27:44,511 THE SPARK OR STIMULATING 629 00:27:44,511 --> 00:27:46,013 ACTIVITY TO RELIEF CONDITIONS, 630 00:27:46,013 --> 00:27:47,715 ON COMMON FUND PROGRAM. 631 00:27:47,715 --> 00:27:49,516 WITH THIS COMPETITION NIH IS 632 00:27:49,516 --> 00:27:51,385 USING OPEN INNOVATION TO FOSTER 633 00:27:51,385 --> 00:27:56,323 APPROACHES THAT ARE CAPABLE OF 634 00:27:56,323 --> 00:27:58,392 SELECTING -- TARGETING MULTIPLE 635 00:27:58,392 --> 00:28:01,362 ORGANS AND FUNCTIONS WITHOUT 636 00:28:01,362 --> 00:28:03,998 UNINTENDED EFFECTS ON NON-TARGET 637 00:28:03,998 --> 00:28:04,865 ORGANISMS. 638 00:28:04,865 --> 00:28:06,600 EXCUSE ME, ORGANS, NOT 639 00:28:06,600 --> 00:28:07,134 ORGANISMS. 640 00:28:07,134 --> 00:28:10,104 AND THE FOUR WINNERS OF THE 641 00:28:10,104 --> 00:28:11,672 PHASE 2 USED VARIETY OF 642 00:28:11,672 --> 00:28:14,842 APPROACHES TO STIMULATE A RANGE 643 00:28:14,842 --> 00:28:16,243 OF TARGETS, INCLUDING THINGS 644 00:28:16,243 --> 00:28:19,747 LIKE SPINAL AND PELVIC NERVES, 645 00:28:19,747 --> 00:28:22,049 AND DEMONSTRATED POTENTIAL TO 646 00:28:22,049 --> 00:28:24,885 RESTORE FUNCTION AND ADDRESS 647 00:28:24,885 --> 00:28:25,452 DEBILITATING CONDITIONS, SO 648 00:28:25,452 --> 00:28:27,221 REALLY EXCITING WORK THEY ARE 649 00:28:27,221 --> 00:28:27,654 DOING. 650 00:28:27,654 --> 00:28:29,189 AND THEN FINALLY THE LAST 651 00:28:29,189 --> 00:28:32,259 CHALLENGE WE WANTED TO HIGHLIGHT 652 00:28:32,259 --> 00:28:34,561 WAS THE COMMON FUND 653 00:28:34,561 --> 00:28:35,763 COMPLEMENTARY PROGRAM, WHICH 654 00:28:35,763 --> 00:28:37,197 YOU'VE HEARD ABOUT PREVIOUSLY, 655 00:28:37,197 --> 00:28:38,332 BECAUSE THAT RECENTLY ANNOUNCED 656 00:28:38,332 --> 00:28:41,769 THE PRIZE WINNERS OF THE 657 00:28:41,769 --> 00:28:43,404 COMPLEMENTARY CHALLENGE WHICH 658 00:28:43,404 --> 00:28:46,040 WAS A CROWDSOURCING COMPETITION 659 00:28:46,040 --> 00:28:55,783 FOR INNOVATIVE IDEAS ON NEW 660 00:28:55,783 --> 00:28:56,784 APPROACH METHODOLOGY APPROACHES, 661 00:28:56,784 --> 00:29:00,721 NAMS, TO MODEL HUMAN BIOLOGY. 662 00:29:00,721 --> 00:29:01,922 THE 20 PRIZE WINNERS WERE 663 00:29:01,922 --> 00:29:03,557 AWARDED AND THEY ARE GOING TO 664 00:29:03,557 --> 00:29:05,859 SHARE THAT TOTAL PRIZE PURSE OF 665 00:29:05,859 --> 00:29:08,929 A MILLION DOLLARS, EACH TEAM GOT 666 00:29:08,929 --> 00:29:11,999 ABOUT $50,000 FOR THEIR EFFORTS. 667 00:29:11,999 --> 00:29:15,836 AND THE WINNING SOLUTIONS 668 00:29:15,836 --> 00:29:16,470 DEMONSTRATED REALLY 669 00:29:16,470 --> 00:29:17,371 OUT-OF-THE-BOX SOLUTIONS ACROSS 670 00:29:17,371 --> 00:29:18,672 COMPETITION AREAS. 671 00:29:18,672 --> 00:29:20,140 AGAIN, THIS WAS FOCUSED ON 672 00:29:20,140 --> 00:29:22,943 BUILDING OUT THINGS IN SILICO, 673 00:29:22,943 --> 00:29:26,380 IN VITRO, IN CHEMICO, OR THINGS 674 00:29:26,380 --> 00:29:31,051 THAT INTEGRATED MORE, ONE OR 675 00:29:31,051 --> 00:29:32,786 MORE OF THOSE APPROACHES. 676 00:29:32,786 --> 00:29:34,254 SO CONGRATULATIONS TO ALL OF 677 00:29:34,254 --> 00:29:35,355 THOSE PRIZE WINNERS. 678 00:29:35,355 --> 00:29:37,825 REALLY EXCITING STUFF THEY HAVE 679 00:29:37,825 --> 00:29:40,127 GOING ON. 680 00:29:40,127 --> 00:29:41,995 AND CONTINUING WITH THOSE REALLY 681 00:29:41,995 --> 00:29:43,697 INTERESTING AND EXCITING 682 00:29:43,697 --> 00:29:46,066 RESEARCH UPDATES, I WANTED TO 683 00:29:46,066 --> 00:29:48,268 HIGHLIGHT SOME WORK THAT WAS 684 00:29:48,268 --> 00:29:51,338 REALLY SUPPORTED BY THE OFFICE 685 00:29:51,338 --> 00:29:52,406 OF RESEARCH INFRASTRUCTURE 686 00:29:52,406 --> 00:29:56,910 PROGRAMS THAT LEAD GROUND WORK 687 00:29:56,910 --> 00:29:59,780 FOR THIS CLINICAL ADVANCEMENT. 688 00:29:59,780 --> 00:30:02,282 SO RESEARCH THAT WAS CONDUCTED 689 00:30:02,282 --> 00:30:05,152 BY THE NATIONAL SWINE RESOURCE 690 00:30:05,152 --> 00:30:06,420 AND RESEARCH CENTER WAS -- THIS 691 00:30:06,420 --> 00:30:10,190 IS ONE OF THE ORIP-FUNDED 692 00:30:10,190 --> 00:30:13,460 RESOURCE CENTERS, RESULTED IN 693 00:30:13,460 --> 00:30:16,630 SUCCESSFUL PIG-TO-PIG 694 00:30:16,630 --> 00:30:21,135 ALLOTRANSPLANT MODELS, AND 695 00:30:21,135 --> 00:30:21,869 PIG-TO-NON-HUMAN PRIMATE 696 00:30:21,869 --> 00:30:23,737 XENOTRANSPLANT MODELS, SHOWED 697 00:30:23,737 --> 00:30:25,839 THE SOUNDNESS OF THE HEART 698 00:30:25,839 --> 00:30:26,573 TRANSPLANT TECHNOLOGY, IMPORTED 699 00:30:26,573 --> 00:30:27,341 OVER TO HUMANS. 700 00:30:27,341 --> 00:30:32,846 YOU SEE THE PICTURE OF THE CUTE 701 00:30:32,846 --> 00:30:34,615 SMILING KID HERE, OWEN MONROE, 702 00:30:34,615 --> 00:30:36,884 17 DAYS OLD WHEN HE BECAME THE 703 00:30:36,884 --> 00:30:40,087 WORLD'S FIRST PARTIAL HEART 704 00:30:40,087 --> 00:30:41,288 TRANSPLANT RECIPIENT. 705 00:30:41,288 --> 00:30:43,490 THIS REVOLUTIONARY SURGERY WAS 706 00:30:43,490 --> 00:30:46,426 PERFORMED BACK IN APRIL OF 2022, 707 00:30:46,426 --> 00:30:48,896 AND A STUDY THAT WAS PUBLISHED 708 00:30:48,896 --> 00:30:52,933 JUST IN JANUARY A FEW MONTHS AGO 709 00:30:52,933 --> 00:30:54,535 IN JAMA SHOWED MONROE'S VALVES 710 00:30:54,535 --> 00:30:55,836 AND ARTERIES ARE FUNCTIONING 711 00:30:55,836 --> 00:30:58,906 WELL AND GROWING AS EXPECTED, 712 00:30:58,906 --> 00:31:03,810 AND AS A RESULT HE WILL NEED 713 00:31:03,810 --> 00:31:04,811 FEWER SURGERIES AND LESS 714 00:31:04,811 --> 00:31:05,913 IMMUNOSUPPRESSANTS OVER HIS 715 00:31:05,913 --> 00:31:06,180 LIFETIME. 716 00:31:06,180 --> 00:31:08,282 SO THIS IS REALLY EXCITING WORK. 717 00:31:08,282 --> 00:31:11,251 AND WE'VE SEEN, YOU KNOW, KIND 718 00:31:11,251 --> 00:31:12,920 OF THE DEVELOPMENT FROM VERY 719 00:31:12,920 --> 00:31:16,089 BASIC RESEARCH ALL THE WAY TO 720 00:31:16,089 --> 00:31:20,494 NOW HAVING THIS CLINICAL EXAMPLE 721 00:31:20,494 --> 00:31:22,329 AND BEING ABLE TO IMPROVE THE 722 00:31:22,329 --> 00:31:26,600 LIFE OF THIS LITTLE BOY AND MANY 723 00:31:26,600 --> 00:31:27,935 OTHERS DOWN THE ROAD. 724 00:31:27,935 --> 00:31:34,041 SO AS WE GO TO THE NEXT SLIDE, I 725 00:31:34,041 --> 00:31:35,676 ALSO WANT TO HIGHLIGHT TWO 726 00:31:35,676 --> 00:31:38,712 STRATEGIC PLANS THAT WERE 727 00:31:38,712 --> 00:31:40,814 RECENTLY RELEASED FROM TWO OF 728 00:31:40,814 --> 00:31:42,349 THE DPCPSI OFFICES. 729 00:31:42,349 --> 00:31:47,955 THE OFFICE OF DISEASE PREVENTION 730 00:31:47,955 --> 00:31:49,389 RECENTLY RELEASED THEIR 24-28 731 00:31:49,389 --> 00:31:51,892 STRATEGIC PLAN FOR CREATING A 732 00:31:51,892 --> 00:31:54,294 HEALTHIER FUTURE FOR ALL, WHICH 733 00:31:54,294 --> 00:31:55,195 OUTLINES THE GUIDING ACTIVITIES 734 00:31:55,195 --> 00:32:00,634 OF THE OFFICE OVER THE NEXT FIVE 735 00:32:00,634 --> 00:32:00,834 YEARS. 736 00:32:00,834 --> 00:32:02,402 SO ODP OBVIOUSLY DISEASE 737 00:32:02,402 --> 00:32:06,139 PREVENTION, THEY ARE GOING TO 738 00:32:06,139 --> 00:32:07,774 HELP TO MAKE NIH RESEARCH HAVE 739 00:32:07,774 --> 00:32:10,844 MORE OF AN IMMEDIATE IMPACT ON 740 00:32:10,844 --> 00:32:13,914 THE WELL-BEING OF AMERICANS BY 741 00:32:13,914 --> 00:32:14,781 ENCOURAGING GREATER ATTENTION TO 742 00:32:14,781 --> 00:32:16,750 LEADING CAUSES OF DEATH AND 743 00:32:16,750 --> 00:32:19,820 DEVELOPMENT AND TESTING OF 744 00:32:19,820 --> 00:32:21,021 PREVENTIVE INTERVENTIONS. 745 00:32:21,021 --> 00:32:22,656 SO ODP IS CONTRIBUTING TO 746 00:32:22,656 --> 00:32:24,524 BRIDGING THAT GAP BETWEEN 747 00:32:24,524 --> 00:32:26,593 RESEARCH AND REAL WORLD 748 00:32:26,593 --> 00:32:28,762 PRACTICE, WE JUST HEARD AN 749 00:32:28,762 --> 00:32:30,530 EXAMPLE FROM ORIP DOING THAT, 750 00:32:30,530 --> 00:32:31,832 BUT ODP IS GOING TO HELP 751 00:32:31,832 --> 00:32:33,500 UNDERSTAND HOW CONDITIONS AND 752 00:32:33,500 --> 00:32:35,569 SYSTEMS IN WHICH WE'RE BORN, WE 753 00:32:35,569 --> 00:32:39,740 GROW, WE LIVE, WORK, PLAY, AGE, 754 00:32:39,740 --> 00:32:42,943 ALL AFFECT OUR HEALTH. 755 00:32:42,943 --> 00:32:45,545 AND WE'LL HEAR A LITTLE BIT MORE 756 00:32:45,545 --> 00:32:47,281 ABOUT THIS LATER. 757 00:32:47,281 --> 00:32:49,349 AND THEN THE OFFICE OF RESEARCH 758 00:32:49,349 --> 00:32:52,352 ON WOMEN'S HEALTH ALSO RECENTLY 759 00:32:52,352 --> 00:32:54,521 RELEASED THEIR NIH-WIDE 760 00:32:54,521 --> 00:32:56,823 STRATEGIC PLAN FOR RESEARCH ON 761 00:32:56,823 --> 00:33:00,427 THE HEALTH OF WOMEN OVER THE 762 00:33:00,427 --> 00:33:01,728 SAME TIME PERIOD, 24-28. 763 00:33:01,728 --> 00:33:09,169 AND THEY -- THE PLAN OUTLINES 764 00:33:09,169 --> 00:33:12,105 FIVE STRATEGIC GOALS TO SUPPORT 765 00:33:12,105 --> 00:33:14,308 NIH-GUIDED RESEARCH, LIKE 766 00:33:14,308 --> 00:33:15,609 ADVANCING RESEARCH THAT EXAMINES 767 00:33:15,609 --> 00:33:16,209 MULTIPLE FACTORS TO INFLUENCE 768 00:33:16,209 --> 00:33:19,346 HEALTH OF WOMEN AS WELL AS 769 00:33:19,346 --> 00:33:20,414 INTERSECTIONS OF THOSE FACTORS. 770 00:33:20,414 --> 00:33:22,316 SECOND THING IS TO IMPROVE DATA 771 00:33:22,316 --> 00:33:25,919 SCIENCE AND DATA MANAGEMENT 772 00:33:25,919 --> 00:33:27,220 PRACTICES. 773 00:33:27,220 --> 00:33:29,423 THIRD IS TO FOSTER WOMEN 774 00:33:29,423 --> 00:33:31,091 SCIENTIST CAREER DEVELOPMENT AND 775 00:33:31,091 --> 00:33:31,525 PROMOTION. 776 00:33:31,525 --> 00:33:34,261 AND TO PROMOTE SCIENTIFIC 777 00:33:34,261 --> 00:33:35,762 WORKFORCE TRAINING AND 778 00:33:35,762 --> 00:33:36,263 EDUCATION. 779 00:33:36,263 --> 00:33:38,732 THE FOURTH THING TO SUPPORT 780 00:33:38,732 --> 00:33:40,600 BASIC AND TRANSLATIONAL STUDY, 781 00:33:40,600 --> 00:33:41,668 BIOLOGY UNDERLYING SEX 782 00:33:41,668 --> 00:33:43,203 DIFFERENCES AND HOW THAT PLAYS 783 00:33:43,203 --> 00:33:46,506 OUT WITH THE INTERSECTION OF 784 00:33:46,506 --> 00:33:48,675 DISEASE ACROSS THE LIFE COURSE. 785 00:33:48,675 --> 00:33:50,577 AND THEN FINALLY TO ADVANCE 786 00:33:50,577 --> 00:33:52,412 COMMUNITY ENGAGED SCIENCE ACROSS 787 00:33:52,412 --> 00:33:55,916 THE RESEARCH AND PRACTICE 788 00:33:55,916 --> 00:33:56,917 CONTINUUM, AND ENHANCE 789 00:33:56,917 --> 00:33:59,086 DISSEMINATION, IMPLEMENTATION OF 790 00:33:59,086 --> 00:34:00,053 EVIDENCE-BASED SOLUTIONS. 791 00:34:00,053 --> 00:34:01,054 ALL RIGHT. 792 00:34:01,054 --> 00:34:05,225 WE'RE ALSO GOING TO HEAR FROM 793 00:34:05,225 --> 00:34:06,426 OFFICE OF DIETARY SUPPLEMENTS A 794 00:34:06,426 --> 00:34:08,795 LITTLE BIT ABOUT THEIR STRATEGIC 795 00:34:08,795 --> 00:34:10,497 PLAN AS WELL. 796 00:34:10,497 --> 00:34:10,697 OKAY. 797 00:34:10,697 --> 00:34:13,233 IF WE GO TO THE NEXT SLIDE. 798 00:34:13,233 --> 00:34:14,000 ALL RIGHT. 799 00:34:14,000 --> 00:34:16,269 ONE THING WE WANT TO CALL OUT 800 00:34:16,269 --> 00:34:17,504 BECAUSE THIS MADE GOOD MORNING 801 00:34:17,504 --> 00:34:19,573 AMERICA, INVOLVED A COUPLE OF 802 00:34:19,573 --> 00:34:21,742 OUR DIFFERENT OFFICES ACROSS 803 00:34:21,742 --> 00:34:21,975 DPCPSI. 804 00:34:21,975 --> 00:34:25,278 I THINK WE ALL CAN RECOGNIZE AND 805 00:34:25,278 --> 00:34:28,882 APPRECIATE THAT NUTRITION PLAYS 806 00:34:28,882 --> 00:34:30,417 AN AN INTEGRAL RULE IN 807 00:34:30,417 --> 00:34:31,151 DEVELOPMENT AND PREVENTION AND 808 00:34:31,151 --> 00:34:32,953 TREATMENT OF DISEASE BUT THERE'S 809 00:34:32,953 --> 00:34:39,926 NO SUCH THING AS A PERFECT 810 00:34:39,926 --> 00:34:43,764 ONE-FITS-ALL DIET. 811 00:34:43,764 --> 00:34:46,099 WE HAVE A PROGRAM PRECISION 812 00:34:46,099 --> 00:34:47,801 HEALTH, LED BY OFFICE OF 813 00:34:47,801 --> 00:34:50,103 NUTRITION RESEARCH, HELPS TO 814 00:34:50,103 --> 00:34:52,506 BUILD ON RECENT ADVANCES IN 815 00:34:52,506 --> 00:34:53,940 BIOMEDICAL SCIENCE INCLUDING 816 00:34:53,940 --> 00:34:58,645 BRINGING TOGETHER THINGS LIKE 817 00:34:58,645 --> 00:34:59,346 ARTIFICIAL INTELLIGENCE, 818 00:34:59,346 --> 00:34:59,980 MICROBIOME RESEARCH, 819 00:34:59,980 --> 00:35:01,615 INFRASTRUCTURE THAT WE CAN 820 00:35:01,615 --> 00:35:03,517 LEVERAGE AS WELL AS DIVERSE 821 00:35:03,517 --> 00:35:05,452 PARTICIPANT COHORT, THE "ALL OF 822 00:35:05,452 --> 00:35:07,421 US" RESEARCH PROGRAM, BRING ALL 823 00:35:07,421 --> 00:35:10,056 OF THESE THINGS TOGETHER. 824 00:35:10,056 --> 00:35:12,826 AND THE GOAL OF THE NUTRITION 825 00:35:12,826 --> 00:35:14,661 PRECISION HEALTH PROGRAM IS 826 00:35:14,661 --> 00:35:16,530 REALLY TO DEVELOP ALGORITHMS 827 00:35:16,530 --> 00:35:17,397 THAT PREDICT INDIVIDUAL 828 00:35:17,397 --> 00:35:21,134 RESPONSES TO FOOD AND DIETARY 829 00:35:21,134 --> 00:35:22,002 PATTERNS BY STUDYING 830 00:35:22,002 --> 00:35:24,938 INTERACTIONS BETWEEN THINGS LIKE 831 00:35:24,938 --> 00:35:27,474 THE DIET, GENES, PROTEINS, 832 00:35:27,474 --> 00:35:29,876 MICROBIOME, METABOLISM, AND 833 00:35:29,876 --> 00:35:33,146 OTHER FACTORS AND LEVERAGE A.I. 834 00:35:33,146 --> 00:35:35,782 AND ALGORITHMS THAT CAN THEN BE 835 00:35:35,782 --> 00:35:36,450 APPLIED FOR CLINICAL 836 00:35:36,450 --> 00:35:37,551 APPLICATION. 837 00:35:37,551 --> 00:35:39,619 AND AS I MENTIONED, THIS WAS 838 00:35:39,619 --> 00:35:44,024 FEATURED ON A SEGMENT ON MAY 3 839 00:35:44,024 --> 00:35:45,659 ON "GOOD MORNING AMERICA" AND 840 00:35:45,659 --> 00:35:46,860 IT'S WORTH WATCHING IF YOU HAVE 841 00:35:46,860 --> 00:35:48,061 A FEW MINUTES. 842 00:35:48,061 --> 00:35:52,866 IT'S ONLY A COUPLE MINUTES LONG. 843 00:35:52,866 --> 00:35:54,534 BUT THE STORY REALLY GARNERED A 844 00:35:54,534 --> 00:35:56,369 LOT OF ATTENTION AND THAT 845 00:35:56,369 --> 00:36:00,106 COUPLED WITH OUR LOCAL EFFORTS 846 00:36:00,106 --> 00:36:01,541 RESULTED IN OVER 4400 NEW 847 00:36:01,541 --> 00:36:02,609 CONSENTS THROUGH THAT WEEKEND SO 848 00:36:02,609 --> 00:36:05,078 I THINK THAT WAS THE MOST WE GOT 849 00:36:05,078 --> 00:36:07,214 IN THAT SHORT OF A TIME PERIOD, 850 00:36:07,214 --> 00:36:13,687 SO A GREAT OPPORTUNITY TO 851 00:36:13,687 --> 00:36:14,421 INCREASE AWARENESS OF "ALL OF 852 00:36:14,421 --> 00:36:17,424 US" AS A WHOLE BUT IN PARTICULAR 853 00:36:17,424 --> 00:36:18,925 NUTRITION FOR PRECISION HEALTH 854 00:36:18,925 --> 00:36:19,159 PROGRAM. 855 00:36:19,159 --> 00:36:20,760 ALL RIGHT. 856 00:36:20,760 --> 00:36:21,761 AND NEXT SLIDE. 857 00:36:21,761 --> 00:36:24,297 AND A COUPLE WEEKS AGO, TWO 858 00:36:24,297 --> 00:36:26,733 WEEKS AGO, WE CELEBRATED 859 00:36:26,733 --> 00:36:28,368 NATIONAL WOMEN'S HEALTH WEEK. 860 00:36:28,368 --> 00:36:31,872 ORWH WAS PRETTY BUSY WITH A 861 00:36:31,872 --> 00:36:36,343 VARIETY OF ACTIVITIES INCLUDING 862 00:36:36,343 --> 00:36:38,111 HOSTING THE EIGHTH ANNUAL VIVIAN 863 00:36:38,111 --> 00:36:40,313 PINN SYMPOSIUM, ON ENERGY AND 864 00:36:40,313 --> 00:36:40,747 SCIENCE. 865 00:36:40,747 --> 00:36:42,382 THEY ALSO HAD OPTIMIZING 866 00:36:42,382 --> 00:36:45,652 MID-LIFE HEALTH OF WOMEN 867 00:36:45,652 --> 00:36:49,256 ROUNDTABLE, ON FUTURE DIRECTIONS 868 00:36:49,256 --> 00:36:51,258 IN MENOPAUSE RESEARCH. 869 00:36:51,258 --> 00:36:54,327 THEY ANNOUNCED AND SHARED A 870 00:36:54,327 --> 00:36:58,832 VARIETY OF THINGS THAT WEEK 871 00:36:58,832 --> 00:37:00,033 INCLUDING BIENNIAL WORD, 872 00:37:00,033 --> 00:37:01,034 FACTSHEETS ON WOMEN'S HEALTH 873 00:37:01,034 --> 00:37:04,104 RESEARCH THAT WE SUPPORT AT NIH, 874 00:37:04,104 --> 00:37:07,707 THE HEALTH OF WOMEN OF U3 875 00:37:07,707 --> 00:37:12,412 POPULATIONS DATA BOOK, RELEASED 876 00:37:12,412 --> 00:37:15,148 SOME VIDEOS, AND INCLUDE FORGING 877 00:37:15,148 --> 00:37:16,116 INTO THE FUTURE RESEARCH ON THE 878 00:37:16,116 --> 00:37:20,854 HEALTH OF WOMEN AT NIH AND 879 00:37:20,854 --> 00:37:21,721 BEYOND VIDEO. 880 00:37:21,721 --> 00:37:23,590 SO WORTH CHECKING OUT THE ORWH 881 00:37:23,590 --> 00:37:26,326 WEBSITE TO SEE THE VARIOUS 882 00:37:26,326 --> 00:37:29,262 DIFFERENT ACTIVITIES THAT THEY 883 00:37:29,262 --> 00:37:32,332 WORK TO PROMOTE, DURING THE 884 00:37:32,332 --> 00:37:34,301 NATIONAL WOMEN'S HEALTH WEEK. 885 00:37:34,301 --> 00:37:35,168 ALL RIGHT. 886 00:37:35,168 --> 00:37:38,338 AND THEN KIND OF BUILDING ON 887 00:37:38,338 --> 00:37:41,741 SOME OF THOSE EFFORTS, NIH AND 888 00:37:41,741 --> 00:37:44,911 IN PARTICULAR ODP IS LAUNCHING 889 00:37:44,911 --> 00:37:46,546 ITS FIRST-EVER PATHWAYS TO 890 00:37:46,546 --> 00:37:49,182 PREVENTION SERIES ON MENOPAUSE 891 00:37:49,182 --> 00:37:53,019 AND THE MANAGEMENT OF MENOPAUSE. 892 00:37:53,019 --> 00:37:56,756 ODP IS PARTNERING WITH ORWH, 893 00:37:56,756 --> 00:37:59,392 NCI, NHLBI, NIA, NICHD, AND NIMH 894 00:37:59,392 --> 00:38:01,127 IN THIS EFFORT. 895 00:38:01,127 --> 00:38:02,796 AND THE PATHWAYS TO PREVENTION 896 00:38:02,796 --> 00:38:05,298 WORKSHOP IS GOING TO COLLECT 897 00:38:05,298 --> 00:38:06,499 EVIDENCE-BASED INFORMATION 898 00:38:06,499 --> 00:38:08,702 RELEVANT TO MANAGING MENOPAUSAL 899 00:38:08,702 --> 00:38:11,972 SYMPTOMS AND OPTIMIZING HEALTH 900 00:38:11,972 --> 00:38:13,506 IN THAT EARLY POST-MENOPAUSE 901 00:38:13,506 --> 00:38:15,475 PERIOD, TO IDENTIFY WHAT 902 00:38:15,475 --> 00:38:16,977 ADDITIONAL RESEARCH IS NEEDED TO 903 00:38:16,977 --> 00:38:19,412 HELP WOMEN AND HEALTHCARE 904 00:38:19,412 --> 00:38:20,280 PROVIDERS NAVIGATE THAT 905 00:38:20,280 --> 00:38:21,615 TRANSITION, AND PROMOTE 906 00:38:21,615 --> 00:38:22,349 WELL-BEING THROUGHOUT MID-LIFE 907 00:38:22,349 --> 00:38:23,783 AND BEYOND. 908 00:38:23,783 --> 00:38:26,286 SO AT THE END OF ALL OF THIS 909 00:38:26,286 --> 00:38:27,821 WE'LL HOPEFULLY HAVE REALLY 910 00:38:27,821 --> 00:38:30,924 THOROUGH ASSESSMENT OF THE 911 00:38:30,924 --> 00:38:31,992 PORTFOLIO AND RECOMMENDATIONS 912 00:38:31,992 --> 00:38:34,527 FROM AN INDEPENDENT PANEL ON 913 00:38:34,527 --> 00:38:36,596 MOVING FORWARD AND WE'LL HAVE A 914 00:38:36,596 --> 00:38:38,932 WORKSHOP THAT IS GOING TO BE 915 00:38:38,932 --> 00:38:40,600 HELD IN LATE 2025 TO REALLY GO 916 00:38:40,600 --> 00:38:41,935 THROUGH AND DISCUSS THE DETAILS 917 00:38:41,935 --> 00:38:45,005 OF THESE THINGS AND GET TO THOSE 918 00:38:45,005 --> 00:38:46,473 RECOMMENDATIONS. 919 00:38:46,473 --> 00:38:47,974 ALL RIGHT. 920 00:38:47,974 --> 00:38:51,378 AND NEXT SLIDE, YES, SO ON 921 00:38:51,378 --> 00:38:54,114 JANUARY -- EXCUSE ME, APRIL 15 922 00:38:54,114 --> 00:38:59,486 AND 16 WE HOSTED THE NIH 923 00:38:59,486 --> 00:39:00,587 "INCLUDE" MEETING, "INCLUDE" 924 00:39:00,587 --> 00:39:02,255 INVESTIGATORS MEETING ON CAMPUS. 925 00:39:02,255 --> 00:39:06,393 WE HAD MORE THAN 250 926 00:39:06,393 --> 00:39:07,227 RESEARCHERS, INCLUDING 14 927 00:39:07,227 --> 00:39:10,997 TRAINEES, HERE TO DISCUSS THEIR 928 00:39:10,997 --> 00:39:13,400 RESEARCH AND RESEARCH UPDATES TO 929 00:39:13,400 --> 00:39:14,801 HELP BUILD COLLABORATION AND, 930 00:39:14,801 --> 00:39:17,570 YOU KNOW, JUST DISCUSS HOW NIH 931 00:39:17,570 --> 00:39:18,438 CAN HELP ADVANCE DOWN SYNDROME 932 00:39:18,438 --> 00:39:21,841 RESEARCH OVER THE NEXT SEVERAL 933 00:39:21,841 --> 00:39:22,042 YEARS. 934 00:39:22,042 --> 00:39:25,345 AND WE ENDED UP HAVING AN 935 00:39:25,345 --> 00:39:28,415 OVERWHELMING NUMBER OF POSTER 936 00:39:28,415 --> 00:39:31,151 ABSTRACTS, SO MANY SO THAT WE 937 00:39:31,151 --> 00:39:32,919 INCREASED THE NUMBER WE 938 00:39:32,919 --> 00:39:35,422 SUPPORTED SO WE'RE EXCITED ABOUT 939 00:39:35,422 --> 00:39:38,391 THE INTEREST AND TURNOUT. 940 00:39:38,391 --> 00:39:41,995 WE ALSO HAD ALMOST 30 SPEAKERS 941 00:39:41,995 --> 00:39:43,863 COME AND TALK, AND THREE 942 00:39:43,863 --> 00:39:45,498 SELF-ADVOCATES, AND IT WAS 943 00:39:45,498 --> 00:39:50,637 REALLY A GREAT AND FASCINATING 944 00:39:50,637 --> 00:39:50,870 MEETING. 945 00:39:50,870 --> 00:39:52,939 I WAS ABLE TO JOIN FOR PART OF 946 00:39:52,939 --> 00:39:53,373 IT. 947 00:39:53,373 --> 00:39:56,109 WE HAD AN INVITED SPEAKER AND 948 00:39:56,109 --> 00:39:57,477 DOWN SYNDROME RESEARCH ADVOCATE, 949 00:39:57,477 --> 00:40:02,248 DAVID EGAN, WHO I THINK 950 00:40:02,248 --> 00:40:04,984 ENCAPSULATED THE SORT OF OVERALL 951 00:40:04,984 --> 00:40:07,053 MOOD AND TAKEAWAY FROM THE 952 00:40:07,053 --> 00:40:08,822 MEETING WITH THIS QUOTE. 953 00:40:08,822 --> 00:40:10,890 HE SAID BEING HEALTHY IS A GOAL 954 00:40:10,890 --> 00:40:13,960 FOR EVERY PERSON ON THIS EARTH, 955 00:40:13,960 --> 00:40:15,929 INCLUDING INDIVIDUALS WITH DOWN 956 00:40:15,929 --> 00:40:16,429 SYNDROME. 957 00:40:16,429 --> 00:40:18,231 SO, AGAIN, IT WAS REALLY GREAT 958 00:40:18,231 --> 00:40:21,835 AND REALLY AMAZING TO SEE ALL OF 959 00:40:21,835 --> 00:40:24,037 THE ADVANCES THAT HAVE TAKEN 960 00:40:24,037 --> 00:40:27,407 PLACE OVER THE SHORT I GUESS 961 00:40:27,407 --> 00:40:30,977 DURATION OF THIS PROGRAM'S 962 00:40:30,977 --> 00:40:32,946 EXISTENCE. 963 00:40:32,946 --> 00:40:33,413 ALL RIGHT. 964 00:40:33,413 --> 00:40:35,982 AND THEN MY -- GETTING TO THE 965 00:40:35,982 --> 00:40:42,722 END HERE, I WANTED TO MENTION ON 966 00:40:42,722 --> 00:40:45,592 JUNE 6-8 OBSSR IS HOSTING THE 967 00:40:45,592 --> 00:40:46,059 FUTURE OF SCIENTIFIC 968 00:40:46,059 --> 00:40:47,227 CONFERENCING WORKSHOP, WHICH IS 969 00:40:47,227 --> 00:40:51,965 GOING TO BRING TOGETHER DIVERSE 970 00:40:51,965 --> 00:40:53,233 PERSPECTIVES TO EXPLORE 971 00:40:53,233 --> 00:40:53,900 ADVANTAGES, BARRIERS, GAPS, AND 972 00:40:53,900 --> 00:40:57,403 OPPORTUNITIES IN THE FUTURE OF 973 00:40:57,403 --> 00:40:58,938 SCIENTIFIC CONFERENCING FOR THE 974 00:40:58,938 --> 00:41:00,039 BEHAVIORAL AND SOCIAL SCIENCES. 975 00:41:00,039 --> 00:41:01,775 IT'S GOING TO FOCUS ON A VARIETY 976 00:41:01,775 --> 00:41:03,743 OF DIFFERENT AREAS WHICH YOU CAN 977 00:41:03,743 --> 00:41:08,782 SEE ON THE SLIDE, RANGING FROM 978 00:41:08,782 --> 00:41:11,317 TECHNOLOGICAL INNOVATIONS AND 979 00:41:11,317 --> 00:41:13,686 THEIR IMPACT AND ENVIRONMENTAL 980 00:41:13,686 --> 00:41:14,821 SUSTAINABILITY AS WELL. 981 00:41:14,821 --> 00:41:16,790 SO FOR MORE INFORMATION AND TO 982 00:41:16,790 --> 00:41:20,293 REGISTER, YOU CAN GO TO THE 983 00:41:20,293 --> 00:41:22,729 OBSSR WEBSITE AND TAKE A LOOK AT 984 00:41:22,729 --> 00:41:25,131 THAT INFORMATION THERE ON THAT 985 00:41:25,131 --> 00:41:25,465 WORKSHOP. 986 00:41:25,465 --> 00:41:27,100 ALL RIGHT. 987 00:41:27,100 --> 00:41:29,836 AND THEN FINALLY, I WANTED TO 988 00:41:29,836 --> 00:41:31,237 SHARE WITH EVERYONE SOME 989 00:41:31,237 --> 00:41:34,307 INFORMATION ABOUT AN OFFERING WE 990 00:41:34,307 --> 00:41:34,941 HAVE THAT'S A PARTNERSHIP 991 00:41:34,941 --> 00:41:39,679 THROUGH THE NIH CENTER FOR 992 00:41:39,679 --> 00:41:40,346 INFORMATION TECHNOLOGY, AND OUR 993 00:41:40,346 --> 00:41:42,215 DPCPSI OFFICE OF DATA SCIENCE 994 00:41:42,215 --> 00:41:42,582 STRATEGY. 995 00:41:42,582 --> 00:41:45,385 THIS IS THE NIH CLOUD LAB, AND 996 00:41:45,385 --> 00:41:47,053 IT REALLY ENABLES RESEARCHERS TO 997 00:41:47,053 --> 00:41:52,325 TRY OUT THE CLOUD IN A SECURE 998 00:41:52,325 --> 00:41:53,726 AND NIH-APPROVED ENVIRONMENT. 999 00:41:53,726 --> 00:41:57,564 THE CLOUD LAB IS A NO-COST 1000 00:41:57,564 --> 00:41:59,332 90-DAY CLOUD ADOPTION PROGRAM 1001 00:41:59,332 --> 00:42:03,269 THAT PROVIDES AN ACCOUNT WITH 1002 00:42:03,269 --> 00:42:05,772 $500 OF CREDITS FOR AMAZON WEB 1003 00:42:05,772 --> 00:42:07,974 SERVICES, GOOGLE CLOUD, OR 1004 00:42:07,974 --> 00:42:11,344 MICROSOFT AZURE, AND IT ALSO 1005 00:42:11,344 --> 00:42:13,746 PROVIDES ACCESS TO CURATED 1006 00:42:13,746 --> 00:42:15,415 BIOINFORMATICS TUTORIALS AND 1007 00:42:15,415 --> 00:42:17,817 SUPPORT FROM NIH EXPERTS. 1008 00:42:17,817 --> 00:42:20,787 SO IF YOU'RE EITHER A NOVICE OR 1009 00:42:20,787 --> 00:42:22,222 AN EXPERT, IT'S AN OPPORTUNITY 1010 00:42:22,222 --> 00:42:24,924 TO BE ABLE TO PLAY AROUND A 1011 00:42:24,924 --> 00:42:26,926 LITTLE BIT IN A SECURE 1012 00:42:26,926 --> 00:42:28,228 ENVIRONMENT AND LEARN AND, 1013 00:42:28,228 --> 00:42:31,698 AGAIN, IT COMES WITH THE CREDITS 1014 00:42:31,698 --> 00:42:33,800 THAT WE OFFER. 1015 00:42:33,800 --> 00:42:35,001 AND IT'S BEEN AVAILABLE 1016 00:42:35,001 --> 00:42:36,736 INTERNALLY TO OUR INTRAMURAL 1017 00:42:36,736 --> 00:42:38,271 RESEARCHERS AND OUR NIH STAFF 1018 00:42:38,271 --> 00:42:40,573 FOR THE LAST COUPLE YEARS. 1019 00:42:40,573 --> 00:42:42,876 BUT IT'S NEWLY AVAILABLE TO 1020 00:42:42,876 --> 00:42:44,711 RECIPIENTS OF NIH FUNDING AND 1021 00:42:44,711 --> 00:42:45,778 RESEARCHERS AT INSTITUTIONS THAT 1022 00:42:45,778 --> 00:42:48,248 ARE ELIGIBLE FOR NIH FUNDING 1023 00:42:48,248 --> 00:42:50,216 INCLUDING THOSE WHO MAY NOT HAVE 1024 00:42:50,216 --> 00:42:51,084 AN ACTIVE AWARD. 1025 00:42:51,084 --> 00:42:54,254 YOU CAN DO A BUNCH OF THINGS. 1026 00:42:54,254 --> 00:42:54,921 THERE'S INFORMATION HERE THAT 1027 00:42:54,921 --> 00:42:56,356 I'M NOT GOING TO GO THROUGH. 1028 00:42:56,356 --> 00:42:59,626 IF YOU WANT TO LEARN MORE YOU 1029 00:42:59,626 --> 00:43:02,061 CAN VISIT THE CLOUD LAB HOME 1030 00:43:02,061 --> 00:43:03,463 PAGE BY SCANNING THE QR CODE YOU 1031 00:43:03,463 --> 00:43:09,602 SEE IN THE MIDDLE OF THE SCREEN. 1032 00:43:09,602 --> 00:43:09,936 OKAY. 1033 00:43:09,936 --> 00:43:11,771 OBVIOUSLY I CAN CONTINUE TALKING 1034 00:43:11,771 --> 00:43:14,274 ABOUT ALL OF THE VARIOUS THINGS 1035 00:43:14,274 --> 00:43:18,444 THAT WE HAVE ONGOING ACROSS NOT 1036 00:43:18,444 --> 00:43:20,079 JUST DPCPSI BUT NIH FOR A VERY 1037 00:43:20,079 --> 00:43:22,615 LONG TIME BUT IN ORDER TO KEEP 1038 00:43:22,615 --> 00:43:24,284 US ON TIME, I'M GOING TO STOP 1039 00:43:24,284 --> 00:43:26,219 NOW SO WE CAN ACTUALLY GET TO 1040 00:43:26,219 --> 00:43:28,321 THE REST OF OUR AGENDA. 1041 00:43:28,321 --> 00:43:31,391 BUT OBVIOUSLY WE'VE MADE A TON 1042 00:43:31,391 --> 00:43:33,359 OF WONDERFUL ADVANCES AND 1043 00:43:33,359 --> 00:43:34,694 INVESTMENTS IN VARIOUS PROGRAMS 1044 00:43:34,694 --> 00:43:36,562 AND ACTIVITIES ACROSS ALL OF OUR 1045 00:43:36,562 --> 00:43:36,796 OFFICES. 1046 00:43:36,796 --> 00:43:41,668 THAT WAS JUST A LITTLE UPDATE ON 1047 00:43:41,668 --> 00:43:45,271 A FEW OF THOSE. 1048 00:43:45,271 --> 00:43:47,807 SO WE'RE GOING TO SHIFT GEARS, 1049 00:43:47,807 --> 00:43:49,208 AND I'M GOING TO TURN IT OVER IN 1050 00:43:49,208 --> 00:43:51,844 JUST A MINUTE TO GO OVER OUR 1051 00:43:51,844 --> 00:43:53,479 FIRST CONCEPT CLEARANCE FOR 1052 00:43:53,479 --> 00:43:54,480 TODAY. 1053 00:43:54,480 --> 00:43:57,317 THIS IS FROM THE OFFICE OF 1054 00:43:57,317 --> 00:43:59,819 STRATEGIC COORDINATION, ALSO 1055 00:43:59,819 --> 00:44:10,330 KNOWN - AS COMMON FUND OFFICE. 1056 00:44:10,330 --> 00:44:16,336 DR. TIMOTHY LAVAUTE WILL 1057 00:44:16,336 --> 00:44:17,136 PRESENT, SCGE. 1058 00:44:17,136 --> 00:44:19,105 THE PRESENTATION WILL BE 1059 00:44:19,105 --> 00:44:19,872 FOLLOWED BY COMMENTS AND 1060 00:44:19,872 --> 00:44:25,645 DISCUSSION FROM TWO OF OUR 1061 00:44:25,645 --> 00:44:26,512 ASSIGNED COUNCIL MEMBERS, 1062 00:44:26,512 --> 00:44:27,947 DOCTORS KENT LLOYD AND JEAN 1063 00:44:27,947 --> 00:44:28,648 KING. 1064 00:44:28,648 --> 00:44:29,949 THANK YOU FOR AGREEING TO DO 1065 00:44:29,949 --> 00:44:30,249 THAT. 1066 00:44:30,249 --> 00:44:31,684 WITH THAT I'M NOW GOING TO TURN 1067 00:44:31,684 --> 00:44:34,854 IT OVER TO TIM TO RUN THROUGH 1068 00:44:34,854 --> 00:44:36,923 THIS CONCEPT CLEARANCE. 1069 00:44:36,923 --> 00:44:43,730 SO, TIM, TAKE IT AWAY. 1070 00:44:43,730 --> 00:44:48,201 WE CAN'T HEAR YOU. 1071 00:44:48,201 --> 00:44:51,704 WE CAN'T HEAR YOU IN THE ROOM; I 1072 00:44:51,704 --> 00:44:54,640 DON'T KNOW IF OTHERS CAN HEAR 1073 00:44:54,640 --> 00:44:56,743 HIM. 1074 00:44:56,743 --> 00:44:58,511 >> I'M GOING TO JUMP IN. 1075 00:44:58,511 --> 00:44:59,912 I LEARNED BEFORE THAT WE CAN'T 1076 00:44:59,912 --> 00:45:01,147 UNMUTE YOU. 1077 00:45:01,147 --> 00:45:05,284 YOU NEED TO UNMUTE YOURSELF. 1078 00:45:05,284 --> 00:45:08,588 I LEARNED THAT WITH THE 1079 00:45:08,588 --> 00:45:09,122 INTRODUCTIONS. 1080 00:45:09,122 --> 00:45:11,624 >> ZOOM CAN HEAR BUT YOU'RE VERY 1081 00:45:11,624 --> 00:45:12,592 QUIET, TIM. 1082 00:45:12,592 --> 00:45:14,894 MAYBE IT'S A MATTER OF TURNING 1083 00:45:14,894 --> 00:45:17,630 UP YOUR MICROPHONE? 1084 00:45:17,630 --> 00:45:23,036 1085 00:45:23,036 --> 00:45:26,973 >> HOW ABOUT NOW? 1086 00:45:26,973 --> 00:45:27,907 >> PERFECT. 1087 00:45:27,907 --> 00:45:28,274 >> OKAY. 1088 00:45:28,274 --> 00:45:30,576 WE'LL START WITH TECHNICAL 1089 00:45:30,576 --> 00:45:32,678 DIFFICULTY. 1090 00:45:32,678 --> 00:45:35,481 GOOD AFTERNOON, I'M TIMOTHY 1091 00:45:35,481 --> 00:45:37,583 LAVAUTE, PROGRAM DIRECTOR, ALSO 1092 00:45:37,583 --> 00:45:42,388 CO-COORDINATOR OF COMMON FUND 1093 00:45:42,388 --> 00:45:44,590 SOMATIC CELL GENOME EDITING, 1094 00:45:44,590 --> 00:45:46,192 SCGE, TODAY SEEKING APPROVAL FOR 1095 00:45:46,192 --> 00:45:51,664 CONCEPT FOR NEW INITIATIVE OF 1096 00:45:51,664 --> 00:45:52,932 LIMITED COMPETITION COMPETITIVE 1097 00:45:52,932 --> 00:45:54,734 REVISION, NOTICE OF FUNDING 1098 00:45:54,734 --> 00:45:57,370 OPPORTUNITY, FOR ADDING CLINICAL 1099 00:45:57,370 --> 00:45:58,905 TRIALS TO EXISTING SCGE THERAPY 1100 00:45:58,905 --> 00:46:00,640 DEVELOPMENT AWARD. 1101 00:46:00,640 --> 00:46:02,842 THE OBJECTIVE OF THE PROPOSED 1102 00:46:02,842 --> 00:46:06,112 CONCEPT IS TO EXPAND THE SCOPE 1103 00:46:06,112 --> 00:46:10,583 OF THERAPY DEVELOPMENT AWARDS TO 1104 00:46:10,583 --> 00:46:11,584 SUPPORT FIRST-IN-HUMAN OR EARLY 1105 00:46:11,584 --> 00:46:12,885 STAGE CLINICAL TRIALS. 1106 00:46:12,885 --> 00:46:14,754 THE INITIATIVE WILL REQUIRE UP 1107 00:46:14,754 --> 00:46:18,391 TO $6 MILLION TO FUND TWO AWARDS 1108 00:46:18,391 --> 00:46:21,027 AND THAT WOULD BE CONTINGENT OF 1109 00:46:21,027 --> 00:46:21,994 SUBMISSION OF QUALITY 1110 00:46:21,994 --> 00:46:27,667 APPLICATIONS AND AVAILABILITY OF 1111 00:46:27,667 --> 00:46:30,303 FUNDING. 1112 00:46:30,303 --> 00:46:32,171 NEXT SLIDE PLEASE. 1113 00:46:32,171 --> 00:46:33,406 WE'RE SEEKING APPROVAL FOR A 1114 00:46:33,406 --> 00:46:35,741 CONCEPT FOR ADDING CLINICAL 1115 00:46:35,741 --> 00:46:39,479 TRIALS TO EXISTING THERAPY 1116 00:46:39,479 --> 00:46:41,114 DEVELOPMENT AWARDS, OBJECTIVE IS 1117 00:46:41,114 --> 00:46:44,317 TO SUPPORT FIRST-IN-HUMAN AND 1118 00:46:44,317 --> 00:46:47,687 EARLY-STAGE CLINICAL TRIALS, 1119 00:46:47,687 --> 00:46:50,857 REQUIRING UP TO $6 MILLION FOR 1120 00:46:50,857 --> 00:46:51,724 FUNDING TWO AWARDS CONTINGENT 1121 00:46:51,724 --> 00:46:53,693 UPON SUBMISSION OF QUALITY 1122 00:46:53,693 --> 00:46:54,927 APPLICATIONS AND AVAILABILITY OF 1123 00:46:54,927 --> 00:46:55,795 FUNDING, WE EXPECT THE PROJECT 1124 00:46:55,795 --> 00:46:56,996 PERIOD TO LAST ABOUT TWO YEARS. 1125 00:46:56,996 --> 00:47:01,801 NEXT SLIDE PLEASE. 1126 00:47:01,801 --> 00:47:04,637 I'D LIKE TO SPEND A MINUTE OR 1127 00:47:04,637 --> 00:47:05,671 TWO GIVING AN OVERVIEW. 1128 00:47:05,671 --> 00:47:08,908 THE PROGRAM IS IN ITS SECOND 1129 00:47:08,908 --> 00:47:11,210 FIVE-YEAR PERIOD, ENTERING ITS 1130 00:47:11,210 --> 00:47:12,912 SEVENTH YEAR. 1131 00:47:12,912 --> 00:47:15,748 FIRST PHASE WAS FOCUSED ON 1132 00:47:15,748 --> 00:47:17,450 GENOME EDITING TECHNOLOGY 1133 00:47:17,450 --> 00:47:17,750 DEVELOPMENT. 1134 00:47:17,750 --> 00:47:19,352 AND THE SUCCESS OF IT WAS THE 1135 00:47:19,352 --> 00:47:21,854 RESULT OF FUNDING A GROUP OF 1136 00:47:21,854 --> 00:47:23,055 REALLY TALENTED INVESTIGATORS 1137 00:47:23,055 --> 00:47:27,226 AND A WELL-DESIGNED PROGRAM. 1138 00:47:27,226 --> 00:47:28,661 WHICH INCORPORATED VALIDATION 1139 00:47:28,661 --> 00:47:30,163 AND REPLICATION STUDIES. 1140 00:47:30,163 --> 00:47:33,799 IT CONSISTED OF FIVE 1141 00:47:33,799 --> 00:47:35,234 INITIATIVES, AND THEY WERE ONE, 1142 00:47:35,234 --> 00:47:38,037 FIRST, TO EXPAND REPERTOIRE OF 1143 00:47:38,037 --> 00:47:39,372 GENOME EDITORS, REPRESENTED IN 1144 00:47:39,372 --> 00:47:39,805 BLUE. 1145 00:47:39,805 --> 00:47:44,677 A SECOND TO DEVELOP NEW DELIVERY 1146 00:47:44,677 --> 00:47:47,246 METHODS, TO DELIVER GENOME 1147 00:47:47,246 --> 00:47:49,015 EDITING, CORRECT TISSUES AND 1148 00:47:49,015 --> 00:47:50,416 CELL TYPES, HIGHLIGHTS HERE 1149 00:47:50,416 --> 00:47:53,386 WHERE DEVELOPMENT OF HIGHLY 1150 00:47:53,386 --> 00:47:55,288 EFFICIENT BLOOD-BRAIN BARRIER 1151 00:47:55,288 --> 00:48:00,026 PENETRATING AAV SEROTYPES. 1152 00:48:00,026 --> 00:48:03,329 ANOTHER WAS FOCUSED ON ASSAYS TO 1153 00:48:03,329 --> 00:48:05,631 DEVELOP -- DETECT ADVERSE 1154 00:48:05,631 --> 00:48:09,669 CONSEQUENCES OF GENOME EDITING. 1155 00:48:09,669 --> 00:48:11,971 AN INITIATIVE FOR THE SETTING UP 1156 00:48:11,971 --> 00:48:14,607 AND STANDING UP LARGE AND SMALL 1157 00:48:14,607 --> 00:48:16,776 ANIMAL TESTING CENTERS FOR 1158 00:48:16,776 --> 00:48:17,777 DEVELOPING REPORTER ANIMALS, 1159 00:48:17,777 --> 00:48:18,644 CONDUCTING REPLICATION STUDIES. 1160 00:48:18,644 --> 00:48:20,913 AS MENTIONED, THIS WAS A KEY 1161 00:48:20,913 --> 00:48:22,715 FEATURE TO THE SUCCESS OF PHASE 1162 00:48:22,715 --> 00:48:22,915 1. 1163 00:48:22,915 --> 00:48:24,150 IT'S REPRESENTED BY THE ARROWS 1164 00:48:24,150 --> 00:48:27,954 AT THE BOTTOM OF THE DIAGRAM 1165 00:48:27,954 --> 00:48:29,689 HERE WHERE NEW EDITORS OR 1166 00:48:29,689 --> 00:48:31,691 DELIVERY SYSTEMS WERE TESTED AT 1167 00:48:31,691 --> 00:48:33,659 THESE INDEPENDENT LARGE AND 1168 00:48:33,659 --> 00:48:35,928 SMALL ANIMAL REPORTING SYSTEMS. 1169 00:48:35,928 --> 00:48:38,464 AND THEN BEFORE INFORMATION WAS 1170 00:48:38,464 --> 00:48:44,604 DEPOSITED INTO OUR DISSEMINATION 1171 00:48:44,604 --> 00:48:46,272 AND COORDINATION CENTERS, 1172 00:48:46,272 --> 00:48:48,841 REPLICATION HAD TO BE POSITIVE. 1173 00:48:48,841 --> 00:48:50,509 THERE WAS DISSEMINATION AND 1174 00:48:50,509 --> 00:48:51,811 COORDINATION CENTER TO 1175 00:48:51,811 --> 00:48:53,012 DISTRIBUTE THE FINDINGS FROM 1176 00:48:53,012 --> 00:48:55,848 PHASE 1 TO THE GENOME EDITING 1177 00:48:55,848 --> 00:48:56,115 COMMUNITY. 1178 00:48:56,115 --> 00:49:00,119 AND MANY ACHIEVEMENTS HAVE NOW 1179 00:49:00,119 --> 00:49:01,320 BEEN DISSEMINATED AND ADOPTED BY 1180 00:49:01,320 --> 00:49:02,655 INVESTIGATORS ACROSS THE FIELD. 1181 00:49:02,655 --> 00:49:04,924 AND MANY WERE UTILIZED BY 1182 00:49:04,924 --> 00:49:06,025 INVESTIGATORS THAT ENDED UP 1183 00:49:06,025 --> 00:49:08,661 BEING FUNDED IN THE SECOND PHASE 1184 00:49:08,661 --> 00:49:13,032 OF THE PROGRAM. 1185 00:49:13,032 --> 00:49:14,600 NEXT SLIDE PLEASE. 1186 00:49:14,600 --> 00:49:17,303 SO IN PHASE 2 THE PROGRAM'S 1187 00:49:17,303 --> 00:49:18,838 FOCUS ADVANCED FROM TOOL 1188 00:49:18,838 --> 00:49:19,939 DEVELOPMENT TO THERAPY 1189 00:49:19,939 --> 00:49:21,907 DEVELOPMENT WITH GOALS BEING 1190 00:49:21,907 --> 00:49:23,109 MOVING GENOME EDITING 1191 00:49:23,109 --> 00:49:26,379 THERAPEUTICS INTO THE CLINIC. 1192 00:49:26,379 --> 00:49:28,347 ALSO ESTABLISHING THROUGH 1193 00:49:28,347 --> 00:49:29,782 INTERACTIONS WITH FDA, 1194 00:49:29,782 --> 00:49:33,152 ESTABLISHING DEFINED REGULATORY 1195 00:49:33,152 --> 00:49:35,454 PATH FOR APPROVAL FOR THERAPIES, 1196 00:49:35,454 --> 00:49:37,523 AND FINALLY ALSO ESTABLISHING 1197 00:49:37,523 --> 00:49:40,626 GENOME EDITING AS A PLATFORM 1198 00:49:40,626 --> 00:49:42,795 THERAPY WITH THE FDA. 1199 00:49:42,795 --> 00:49:46,198 AND THAT WOULD BE THAT IF YOU 1200 00:49:46,198 --> 00:49:47,933 HAVE SAME TISSUE YOU'RE TRYING 1201 00:49:47,933 --> 00:49:50,469 TO ADDRESS A DISEASE, AS YOU'RE 1202 00:49:50,469 --> 00:49:51,671 TRYING TO ADDRESS THE SAME 1203 00:49:51,671 --> 00:49:53,973 TISSUE, USING THE SAME DELIVERY 1204 00:49:53,973 --> 00:49:55,274 SYSTEM, SAME ROUTE OF 1205 00:49:55,274 --> 00:49:56,042 ADMINISTRATION AND GENOME 1206 00:49:56,042 --> 00:49:57,710 EDITOR, ALL THAT IS CHANGING IS 1207 00:49:57,710 --> 00:50:00,579 THE GUIDE RNA TO TELL THE GENOME 1208 00:50:00,579 --> 00:50:03,182 EDITOR WHERE TO GO ON THE 1209 00:50:03,182 --> 00:50:04,917 GENOME, THAT PERHAPS AS YOU CAME 1210 00:50:04,917 --> 00:50:08,387 IN WITH A SECOND VARIANT THE 1211 00:50:08,387 --> 00:50:15,328 PATHWAY WOULD BE MUCH SIMPLER. 1212 00:50:15,328 --> 00:50:16,662 WE'VE FUNDED AWARDS THROUGH 1213 00:50:16,662 --> 00:50:18,631 THESE FOUR INITIATIVES, FIVE 1214 00:50:18,631 --> 00:50:21,033 AWARDS FOR DEVELOPMENT OF NEW 1215 00:50:21,033 --> 00:50:25,171 ASSAYS FOR MEASURING OFF-TARGET 1216 00:50:25,171 --> 00:50:25,838 ASSAYS. 1217 00:50:25,838 --> 00:50:28,140 NEXT SLIDE. 1218 00:50:28,140 --> 00:50:32,411 WELL, ANYWAY, SO GO BACK ONE 1219 00:50:32,411 --> 00:50:32,712 SLIDE. 1220 00:50:32,712 --> 00:50:36,682 THESE FIVE INITIATIVES, SO ONE 1221 00:50:36,682 --> 00:50:40,753 FOR DEVELOPING ASSAYS TO DETECT 1222 00:50:40,753 --> 00:50:43,356 ADVERSE GENOME EDITING EVENTS, A 1223 00:50:43,356 --> 00:50:46,192 SECOND ONE, FIVE AWARDS FUNDED 1224 00:50:46,192 --> 00:50:47,860 FOR IND-ENABLING PRE-CLINICAL 1225 00:50:47,860 --> 00:50:49,729 STUDIES. 1226 00:50:49,729 --> 00:50:50,429 THERE'S BEEN ONE PLATFORM 1227 00:50:50,429 --> 00:50:52,698 CLINICAL TRIAL HAS BEEN FUNDED. 1228 00:50:52,698 --> 00:50:55,000 AND THEN ALSO THERE WAS 1229 00:50:55,000 --> 00:50:56,202 CONTINUATION OF DISSEMINATION 1230 00:50:56,202 --> 00:50:58,604 AND COORDINATION CENTER. 1231 00:50:58,604 --> 00:51:01,440 NEXT SLIDE PLEASE. 1232 00:51:01,440 --> 00:51:02,341 THE FIVE IND-ENABLING PROGRAM 1233 00:51:02,341 --> 00:51:03,943 PROJECTS WHICH ARE THE FOCUS OF 1234 00:51:03,943 --> 00:51:05,277 THIS CONCEPT CLEARANCE ARE 1235 00:51:05,277 --> 00:51:07,780 LISTED HERE. 1236 00:51:07,780 --> 00:51:08,981 AND EACH OF THESE CONTAINS THREE 1237 00:51:08,981 --> 00:51:10,950 DISTINCT PROJECTS FOR THE 1238 00:51:10,950 --> 00:51:12,518 DEVELOPMENT OF GENOME EDITING 1239 00:51:12,518 --> 00:51:13,252 BASED THERAPEUTIC LEADS. 1240 00:51:13,252 --> 00:51:16,222 ONE OF THE PROJECTS IS 1241 00:51:16,222 --> 00:51:18,524 IDENTIFIED AS A TRAILBLAZER 1242 00:51:18,524 --> 00:51:19,492 POISED TO ADVANCE THERAPEUTIC 1243 00:51:19,492 --> 00:51:21,594 CANDIDATE TO IND WITHIN THE 1244 00:51:21,594 --> 00:51:24,663 FIVE-YEAR PROJECT PERIOD. 1245 00:51:24,663 --> 00:51:28,234 THE OTHERS ARE AT EARLIER STAGE 1246 00:51:28,234 --> 00:51:30,669 OF DEVELOPMENTS AND WOULD 1247 00:51:30,669 --> 00:51:31,704 PROBABLY -- HOPEFULLY IDENTIFY 1248 00:51:31,704 --> 00:51:32,505 CLINICAL CANDIDATE WITHIN THE 1249 00:51:32,505 --> 00:51:34,273 PROJECT PERIOD. 1250 00:51:34,273 --> 00:51:36,942 THESE ARE SUPPORTED BY 1251 00:51:36,942 --> 00:51:39,178 ADMINISTRATIVE CORE AND ONE OR 1252 00:51:39,178 --> 00:51:47,286 MORE SCIENTIFIC CORES, MANY 1253 00:51:47,286 --> 00:51:49,054 CONTAINING REGULATORY FOR FDA OR 1254 00:51:49,054 --> 00:51:49,722 THERAPEUTIC PRODUCTION. 1255 00:51:49,722 --> 00:51:50,990 ADVANCING TO CLINICAL TRIALS WAS 1256 00:51:50,990 --> 00:51:53,526 NOT PART OF THIS INITIATIVE. 1257 00:51:53,526 --> 00:51:57,463 WE JUST DIDN'T ANTICIPATE 1258 00:51:57,463 --> 00:51:58,364 INVESTIGATORS PROGRESSING SO 1259 00:51:58,364 --> 00:52:00,733 QUICKLY, AND A FEW OF THEM HAVE. 1260 00:52:00,733 --> 00:52:07,740 THEY ARE POISED TO HAVE THEIR 1261 00:52:07,740 --> 00:52:08,407 INDs EARLIER THAN ANTICIPATED. 1262 00:52:08,407 --> 00:52:09,608 NEXT SLIDE PLEASE. 1263 00:52:09,608 --> 00:52:12,344 GOALS OF THIS CONCEPT AND 1264 00:52:12,344 --> 00:52:15,314 COMPETING REVISION NOFO ARE TO 1265 00:52:15,314 --> 00:52:18,250 CAPITALIZE ON SUCCESS OF THE 1266 00:52:18,250 --> 00:52:21,420 INVESTIGATORS IN DEVELOPING NEW 1267 00:52:21,420 --> 00:52:23,722 GENOME EDITING THERAPIES, 1268 00:52:23,722 --> 00:52:24,523 ACTUALLY ANTICIPATED. 1269 00:52:24,523 --> 00:52:28,928 TO EXPAND SCOPE OF THEIR AWARDS 1270 00:52:28,928 --> 00:52:30,963 TO ALLOW HUMAN SUBJECTS 1271 00:52:30,963 --> 00:52:32,832 RESEARCH. 1272 00:52:32,832 --> 00:52:36,001 TO USE NIH AND SCG AWARD DOLLARS 1273 00:52:36,001 --> 00:52:37,670 EFFICIENTLY BY ALLOWING 1274 00:52:37,670 --> 00:52:39,538 INVESTIGATORS TO REBUDGET 1275 00:52:39,538 --> 00:52:41,874 EXISTING AWARD AND REDIRECT 1276 00:52:41,874 --> 00:52:44,443 THOSE FUNDS TOWARDS CLINICAL 1277 00:52:44,443 --> 00:52:45,845 TRIAL READINESS ACTIVITIES. 1278 00:52:45,845 --> 00:52:47,746 FINALLY TO SUPPORT 1279 00:52:47,746 --> 00:52:49,515 FIRST-IN-HUMAN CLINICAL TRIALS 1280 00:52:49,515 --> 00:52:51,817 OF NOVEL GENOME EDITING 1281 00:52:51,817 --> 00:52:52,084 THERAPIES. 1282 00:52:52,084 --> 00:52:55,955 NEXT SLIDE PLEASE. 1283 00:52:55,955 --> 00:52:58,257 ONE THING WE ARE AWARE OF AS 1284 00:52:58,257 --> 00:53:00,226 WE'RE DEVELOPING THIS NEW 1285 00:53:00,226 --> 00:53:02,962 INITIATIVE IS IMPORTANCE OF 1286 00:53:02,962 --> 00:53:03,929 INCLUDING DIVERSE PERSPECTIVES, 1287 00:53:03,929 --> 00:53:08,033 HELPING SHAPE THIS NOFO. 1288 00:53:08,033 --> 00:53:09,668 THE SCGE WILL REQUIRE APPLICANTS 1289 00:53:09,668 --> 00:53:11,737 TO DEVELOP STRATEGIES FOR 1290 00:53:11,737 --> 00:53:12,404 ENGAGING WITH VARIOUS 1291 00:53:12,404 --> 00:53:14,039 STAKEHOLDERS, DEVELOPING BEST 1292 00:53:14,039 --> 00:53:15,674 PRACTICES FOR SHARING MEDICAL 1293 00:53:15,674 --> 00:53:17,743 AND RELEVANT INFORMATION ON 1294 00:53:17,743 --> 00:53:22,147 RISKS AND BENEFITS OF GENOME 1295 00:53:22,147 --> 00:53:24,917 EDITING AND DEVELOPING 1296 00:53:24,917 --> 00:53:28,921 STRATEGIES FOR THOUGHTFUL OF 1297 00:53:28,921 --> 00:53:29,488 ENGAGEMENT OF MARGINALIZED 1298 00:53:29,488 --> 00:53:31,323 POPULATIONS ON THE RISKS AND 1299 00:53:31,323 --> 00:53:32,525 BENEFITS OF GENOME EDITING. 1300 00:53:32,525 --> 00:53:33,826 FINALLY WE'D LIKE TO MENTION 1301 00:53:33,826 --> 00:53:36,662 WHAT WE SEE AS THE POTENTIAL 1302 00:53:36,662 --> 00:53:38,230 IMPACT OF THIS NOFO. 1303 00:53:38,230 --> 00:53:40,032 FIRST, THERE'S THE IMPACT ON THE 1304 00:53:40,032 --> 00:53:40,499 PROGRAM. 1305 00:53:40,499 --> 00:53:42,134 IT WILL REPRESENT THE 1306 00:53:42,134 --> 00:53:45,871 CULMINATION OF YEARS OF WORK BY 1307 00:53:45,871 --> 00:53:46,739 SCGE INVESTIGATORS AND DELIVER 1308 00:53:46,739 --> 00:53:49,808 ON ONE OF THE MAJOR GOALS MOVING 1309 00:53:49,808 --> 00:53:50,576 GENOME EDITING THERAPIES INTO 1310 00:53:50,576 --> 00:53:51,343 THE CLINIC. 1311 00:53:51,343 --> 00:53:53,979 THERE'S THE IMPACT ON THE FIELD. 1312 00:53:53,979 --> 00:53:57,249 IT WILL PROVIDE EXAMPLE OF 1313 00:53:57,249 --> 00:53:59,218 GENOME EDITING THERAPEUTICS 1314 00:53:59,218 --> 00:54:03,822 THROUGH REGULATORY PROCESS FROM 1315 00:54:03,822 --> 00:54:04,456 PRE-CLINICAL DEVELOPMENT TO IND 1316 00:54:04,456 --> 00:54:05,491 AND CLINICAL TRIALS. 1317 00:54:05,491 --> 00:54:06,959 THE INFORMATION THAT'S GENERATED 1318 00:54:06,959 --> 00:54:08,861 ON THAT REGULATORY PROCESS WILL 1319 00:54:08,861 --> 00:54:15,534 BE SHARED THROUGH THE SCGE 1320 00:54:15,534 --> 00:54:18,604 CONSORTIUM AND PROVIDE A ROAD 1321 00:54:18,604 --> 00:54:19,471 MAP FROM PRE-CLINICAL 1322 00:54:19,471 --> 00:54:20,806 DEVELOPMENT TO CLINICAL TRIALS 1323 00:54:20,806 --> 00:54:22,608 FOR GENE EDITING THERAPIES. 1324 00:54:22,608 --> 00:54:23,742 FINALLY THE IMPACT ON THE 1325 00:54:23,742 --> 00:54:26,378 PATIENTS. 1326 00:54:26,378 --> 00:54:29,682 SOME OF THESE CASES WILL PROVIDE 1327 00:54:29,682 --> 00:54:32,618 HOPE FOR TRUE CURES FOR 1328 00:54:32,618 --> 00:54:33,485 DEBILITATING GENETIC DISORDERS 1329 00:54:33,485 --> 00:54:34,420 AND DISEASES. 1330 00:54:34,420 --> 00:54:36,655 I'LL STOP. THERE I'D LIKE TO 1331 00:54:36,655 --> 00:54:38,624 THANK YOU FOR YOUR CONSIDERATION 1332 00:54:38,624 --> 00:54:45,631 AND I WOULD BE HAPPY TO ANSWER 1333 00:54:45,631 --> 00:54:46,832 ANY QUESTIONS. 1334 00:54:46,832 --> 00:54:49,234 >> HELPS TO TURN ON THE MIC 1335 00:54:49,234 --> 00:54:49,568 HERE. 1336 00:54:49,568 --> 00:54:50,135 GREAT PRESENTATION, TIM. 1337 00:54:50,135 --> 00:54:52,438 THANK YOU FOR GOING OVER THIS 1338 00:54:52,438 --> 00:54:53,038 CONCEPT. 1339 00:54:53,038 --> 00:54:56,475 BEFORE WE OPEN IT UP BROADLY FOR 1340 00:54:56,475 --> 00:54:59,745 QUESTIONS, I'M GOING TO TURN IT 1341 00:54:59,745 --> 00:55:03,816 TO DR. LLOYD, WHO IS ONE OF THE 1342 00:55:03,816 --> 00:55:04,516 DISCUSSANTS. 1343 00:55:04,516 --> 00:55:06,018 KENT, IF YOU WOULDN'T MIND 1344 00:55:06,018 --> 00:55:07,052 PLEASE SHARING ANY COMMENTS YOU 1345 00:55:07,052 --> 00:55:14,693 HAVE, THAT WOULD BE GREAT. 1346 00:55:14,693 --> 00:55:16,762 >> HI. 1347 00:55:16,762 --> 00:55:19,064 SO THANKS FOR YOUR PRESENTATION. 1348 00:55:19,064 --> 00:55:21,333 CAN YOU HEAR ME ALL RIGHT? 1349 00:55:21,333 --> 00:55:22,868 >> YES, I CAN. 1350 00:55:22,868 --> 00:55:25,738 >> SO I MEAN, THIS IS ONE OF 1351 00:55:25,738 --> 00:55:28,273 THOSE PROJECTS THAT'S A POSTER 1352 00:55:28,273 --> 00:55:30,009 CHILD FOR -- MAYBE FORGET THE 1353 00:55:30,009 --> 00:55:32,211 NAME BUT POSTER CHILD FOR 1354 00:55:32,211 --> 00:55:33,012 SUCCESS AT NIH FUNDING. 1355 00:55:33,012 --> 00:55:35,714 YOU WANT TO BE ABLE TO SAY 1356 00:55:35,714 --> 00:55:38,217 ESPECIALLY UP ON THE HILL WE 1357 00:55:38,217 --> 00:55:42,154 INVESTED IN A PROJECT THAT'S 1358 00:55:42,154 --> 00:55:43,088 OVERDELIVERED AND BEYOND 1359 00:55:43,088 --> 00:55:44,556 EXPECTATIONS, FASTER THAN WE 1360 00:55:44,556 --> 00:55:44,857 ANTICIPATED. 1361 00:55:44,857 --> 00:55:45,991 SO THOSE ARE THE ONES YOU WANT 1362 00:55:45,991 --> 00:55:48,193 TO KEEP IN YOUR BACK POCKET TO 1363 00:55:48,193 --> 00:55:51,664 PRESENT WHEN ASKED WHAT'S THE 1364 00:55:51,664 --> 00:55:53,098 VALUE OF THE INVESTMENT BY THE 1365 00:55:53,098 --> 00:55:54,533 FEDERAL GOVERNMENT TO THE TAX 1366 00:55:54,533 --> 00:55:57,036 DOLLARS INTO THE NIH. 1367 00:55:57,036 --> 00:55:58,804 CONGRATULATIONS ON THAT. 1368 00:55:58,804 --> 00:56:04,043 I'M GOING TO -- NORMALLY I WOULD 1369 00:56:04,043 --> 00:56:06,011 GIVE AN OVERVIEW OF THE PROGRAM 1370 00:56:06,011 --> 00:56:09,014 AND SO ON BUT I THINK THERE ARE 1371 00:56:09,014 --> 00:56:12,384 A FEW COMMENTS I HAVE OR 1372 00:56:12,384 --> 00:56:14,319 QUESTIONS REGARDING THE 1373 00:56:14,319 --> 00:56:19,158 ORGANIZATION, AND THE PLAN 1374 00:56:19,158 --> 00:56:19,558 FOR 1375 00:56:19,558 --> 00:56:20,626 ADMINISTERING THIS NON-COMPETING 1376 00:56:20,626 --> 00:56:21,794 REVISION PROCESS I'D LIKE TO 1377 00:56:21,794 --> 00:56:25,364 FOCUS ON, HOPEFULLY ALL THE 1378 00:56:25,364 --> 00:56:28,133 COUNCIL MEMBERS APPRECIATE THE 1379 00:56:28,133 --> 00:56:30,102 SOMATIC GENE EDITING PROGRAM, 1380 00:56:30,102 --> 00:56:32,304 VALUE AS WAS PRESENTED, SINCE 1381 00:56:32,304 --> 00:56:34,273 2018, THE PROGRESS IT'S MADE, 1382 00:56:34,273 --> 00:56:35,808 TEN YEAR COMMON FUND. 1383 00:56:35,808 --> 00:56:37,543 SO IF I UNDERSTAND CORRECTLY 1384 00:56:37,543 --> 00:56:39,178 WE'RE AT 2024, SO IN THE FIRST 1385 00:56:39,178 --> 00:56:43,015 YEAR OF PHASE 2, IS THAT 1386 00:56:43,015 --> 00:56:43,248 CORRECT? 1387 00:56:43,248 --> 00:56:43,782 >> THAT'S CORRECT. 1388 00:56:43,782 --> 00:56:45,651 >> ON ONE OF YOUR SLIDES -- AND 1389 00:56:45,651 --> 00:56:51,023 THE SECOND THING IS THAT THIS 1390 00:56:51,023 --> 00:56:52,558 PROPOSAL IS TO ENABLE THE 1391 00:56:52,558 --> 00:56:54,860 CURRENT GRANTEES, IT'S A LIMITED 1392 00:56:54,860 --> 00:56:58,163 COMPETITION, SO ENABLE CURRENT 1393 00:56:58,163 --> 00:57:03,001 GRANTEES IN THE IND-ENABLING 1394 00:57:03,001 --> 00:57:03,736 COMPONENT TO SPEND THEIR MONEY 1395 00:57:03,736 --> 00:57:05,804 ON CLINICAL TRIALS. 1396 00:57:05,804 --> 00:57:07,139 IS THAT CORRECT? 1397 00:57:07,139 --> 00:57:08,674 >> THAT'S CORRECT. 1398 00:57:08,674 --> 00:57:09,675 >> OKAY. 1399 00:57:09,675 --> 00:57:11,944 BUT I GOT THE IMPRESSION FROM 1400 00:57:11,944 --> 00:57:14,146 YOUR PRESENTATION THAT IN 1401 00:57:14,146 --> 00:57:16,782 ADDITION TO SPENDING EXISTING 1402 00:57:16,782 --> 00:57:18,884 AWARD PLANT AWARD MONEY THERE'S 1403 00:57:18,884 --> 00:57:19,551 ADDITIONAL MONEY BEING ADDED, 1404 00:57:19,551 --> 00:57:21,186 NEW MONEY BEING ADDED TO THIS 1405 00:57:21,186 --> 00:57:21,487 PROGRAM. 1406 00:57:21,487 --> 00:57:24,757 HAVE I GOT THAT RIGHT? 1407 00:57:24,757 --> 00:57:27,192 >> THAT'S CORRECT. 1408 00:57:27,192 --> 00:57:30,229 IT COULD BE THAT THE EXISTING 1409 00:57:30,229 --> 00:57:34,733 BUDGETS WOULD NOT BE ENOUGH TO 1410 00:57:34,733 --> 00:57:36,769 COVER THE ENTIRE PREPARATION AND 1411 00:57:36,769 --> 00:57:38,237 ADMINISTERING OF A CLINICAL 1412 00:57:38,237 --> 00:57:38,470 TRIAL. 1413 00:57:38,470 --> 00:57:41,106 AND WE WOULD ALLOW PEOPLE TO, 1414 00:57:41,106 --> 00:57:43,942 WHEN THEY ARE SUBMITTING 1415 00:57:43,942 --> 00:57:44,810 APPLICATIONS, TO RESTRUCTURE 1416 00:57:44,810 --> 00:57:46,445 THEIR BUDGET OF CURRENT AWARD 1417 00:57:46,445 --> 00:57:47,446 BUT ASK FOR ADDITIONAL DOLLARS 1418 00:57:47,446 --> 00:57:50,549 IF THEY ARE NECESSARY. 1419 00:57:50,549 --> 00:57:51,416 >> OKAY. 1420 00:57:51,416 --> 00:57:56,155 AND IN ONE ONE OF YOUR SLIDES, 1421 00:57:56,155 --> 00:57:59,825 NUMBER 4, WERE LISTED THE SCGE 1422 00:57:59,825 --> 00:58:03,695 OVERVIEW PHASE 2 THERAPY 1423 00:58:03,695 --> 00:58:04,296 DEVELOPMENT, FOUR COMPONENTS, 1424 00:58:04,296 --> 00:58:07,065 IND-ENABLING STUDIES WAS SECOND. 1425 00:58:07,065 --> 00:58:08,300 THIRD WAS PLATFORM CLINICAL 1426 00:58:08,300 --> 00:58:08,634 TRIALS. 1427 00:58:08,634 --> 00:58:10,769 SO, DO I UNDERSTAND -- 1428 00:58:10,769 --> 00:58:11,170 >> THAT'S CORRECT 1429 00:58:11,170 --> 00:58:16,041 >> -- THAT THERE ARE FUNDED 1430 00:58:16,041 --> 00:58:16,942 CLINICAL TRIALS MECHANISM IN 1431 00:58:16,942 --> 00:58:19,344 THIS PHASE 2, WHY THEN IS THERE 1432 00:58:19,344 --> 00:58:23,148 A NEED FOR CLINICAL TRIALS FOR 1433 00:58:23,148 --> 00:58:24,383 THE IND-ENABLING STUDIES 1434 00:58:24,383 --> 00:58:24,783 COMPONENT? 1435 00:58:24,783 --> 00:58:28,420 >> RIGHT, SO THEY WERE TWO 1436 00:58:28,420 --> 00:58:30,088 STAND-ALONE FUNDING 1437 00:58:30,088 --> 00:58:32,958 ANNOUNCEMENTS, ONE FUNDED 1438 00:58:32,958 --> 00:58:34,860 IND-ENABLING STUDIES. 1439 00:58:34,860 --> 00:58:36,295 THE SECOND ALLOWED FOR CLINICAL 1440 00:58:36,295 --> 00:58:38,564 TRIALS TO BE PROPOSED BUT THEY 1441 00:58:38,564 --> 00:58:41,099 ARE MUCH LIKE THE IND-ENABLING 1442 00:58:41,099 --> 00:58:42,201 STUDIES. 1443 00:58:42,201 --> 00:58:44,203 THE INVESTIGATOR THAT WAS 1444 00:58:44,203 --> 00:58:46,104 AWARDED DID NOT ACTUALLY POSSESS 1445 00:58:46,104 --> 00:58:48,774 AND IND AT THE TIME OF AWARD. 1446 00:58:48,774 --> 00:58:50,175 AND STILL DON'T. 1447 00:58:50,175 --> 00:58:51,944 WE'RE EXPECTING THEM TO HAVE 1448 00:58:51,944 --> 00:58:53,812 THAT AT THE END OF YEAR 2. 1449 00:58:53,812 --> 00:58:55,881 AND THEN THEY WOULD MOVE INTO 1450 00:58:55,881 --> 00:58:58,183 THE CLINICAL TRIAL ONCE THEY HAD 1451 00:58:58,183 --> 00:59:03,422 THE IND IN HAND. 1452 00:59:03,422 --> 00:59:05,324 SOME OF OUR U19 IND-ENABLING 1453 00:59:05,324 --> 00:59:07,593 STUDY INVESTIGATORS ARE AT THE 1454 00:59:07,593 --> 00:59:10,229 SAME STAGE AS THAT INVESTIGATOR, 1455 00:59:10,229 --> 00:59:13,198 AND SO WE WOULD LIKE THE 1456 00:59:13,198 --> 00:59:15,367 OPPORTUNITY TO PROVIDE THEM -- 1457 00:59:15,367 --> 00:59:16,168 PROVIDE THEM THE OPPORTUNITY TO 1458 00:59:16,168 --> 00:59:18,103 MOVE INTO CLINICAL TRIALS AS 1459 00:59:18,103 --> 00:59:20,939 WELL BUT THEY WERE TWO SEPARATE 1460 00:59:20,939 --> 00:59:22,274 FUNDING ANNOUNCEMENTS, TO SETS 1461 00:59:22,274 --> 00:59:23,675 OF APPLICATIONS AND AWARDS. 1462 00:59:23,675 --> 00:59:24,343 >> RIGHT. 1463 00:59:24,343 --> 00:59:25,077 SO TO ALLOW THIS FORWARD YOU 1464 00:59:25,077 --> 00:59:27,179 NEED TO BRING IT TO COUNCIL 1465 00:59:27,179 --> 00:59:30,782 BECAUSE IT'S A BUREAUCRATIC 1466 00:59:30,782 --> 00:59:31,783 CHANGE, RIGHT. 1467 00:59:31,783 --> 00:59:34,953 SO IS THERE PRECEDENT FOR WHAT 1468 00:59:34,953 --> 00:59:38,757 YOU'RE ASKING TO DO IN PROGRAMS 1469 00:59:38,757 --> 00:59:42,394 BEFORE OR IS THIS DONE ALL THE 1470 00:59:42,394 --> 00:59:42,594 TIME? 1471 00:59:42,594 --> 00:59:43,595 >> NOT DONE ALL THE TIME. 1472 00:59:43,595 --> 00:59:45,030 BUT IT IS NOT UNIQUE. 1473 00:59:45,030 --> 00:59:49,334 THERE HAVE BEEN A COUPLE OF 1474 00:59:49,334 --> 00:59:49,601 INSTANCES. 1475 00:59:49,601 --> 00:59:53,872 AND ONE OR TWO RECENT ONES 1476 00:59:53,872 --> 00:59:56,041 DURING COVID FOR MOVING 1477 00:59:56,041 --> 00:59:57,609 THERAPIES THERE FROM SOMETHING 1478 00:59:57,609 --> 01:00:00,946 THAT WAS NOT GOING TO BE A 1479 01:00:00,946 --> 01:00:02,414 CLINICAL TRIAL INTO A CLINICAL 1480 01:00:02,414 --> 01:00:03,181 TRIAL DURING AN EMERGENCY. 1481 01:00:03,181 --> 01:00:06,485 THERE ARE EXAMPLES BUT IT'S NOT 1482 01:00:06,485 --> 01:00:10,489 DONE VERY FREQUENTLY. 1483 01:00:10,489 --> 01:00:13,025 >> TWO LAST QUICK QUESTIONS. 1484 01:00:13,025 --> 01:00:14,793 DOES THIS -- BECAUSE THIS IS 1485 01:00:14,793 --> 01:00:17,095 PART OF THE COMMON FUND THERE'S 1486 01:00:17,095 --> 01:00:19,698 A 10-YEAR LIMIT ON COMMON FUND 1487 01:00:19,698 --> 01:00:20,265 PROGRAMS. 1488 01:00:20,265 --> 01:00:22,668 WILL THIS THEN MAKE THIS PROGRAM 1489 01:00:22,668 --> 01:00:24,202 GO BEYOND THE LIMIT OF 10 YEARS 1490 01:00:24,202 --> 01:00:25,971 OR WOULD THIS ALL THEN HAVE TO 1491 01:00:25,971 --> 01:00:29,841 BE PACKAGED WITHIN THE FULL 10 1492 01:00:29,841 --> 01:00:31,543 YEARS OF THE COMMON FUND 1493 01:00:31,543 --> 01:00:31,777 PROGRAM? 1494 01:00:31,777 --> 01:00:34,279 >> IT WOULD HAVE TO BE COMPLETED 1495 01:00:34,279 --> 01:00:36,248 WITHIN THE 10-YEAR PERIOD. 1496 01:00:36,248 --> 01:00:38,216 THERE WOULD BE THE AVAILABILITY 1497 01:00:38,216 --> 01:00:43,021 OF A KNOW-COST EXTENSION BUT NO 1498 01:00:43,021 --> 01:00:44,289 MORE MONEY PROVIDED. 1499 01:00:44,289 --> 01:00:46,425 BUT WE COULD STILL HAVE 1500 01:00:46,425 --> 01:00:50,996 ADMINISTRATIVE OVERSIGHT DURING 1501 01:00:50,996 --> 01:00:52,431 THE NO-COST EXTENSION. 1502 01:00:52,431 --> 01:00:56,268 >> WHAT IS PLAN FOR DIVERSITY OF 1503 01:00:56,268 --> 01:00:57,469 PATIENTS INTO CLINICAL TRIALS 1504 01:00:57,469 --> 01:01:00,205 SPONSORED BY THIS NEW PROGRAM? 1505 01:01:00,205 --> 01:01:00,739 >> RIGHT. 1506 01:01:00,739 --> 01:01:03,709 SO, AT OUR KICKOFF MEETING, FOR 1507 01:01:03,709 --> 01:01:07,646 PHASE 2, A LARGE COMPONENT WAS A 1508 01:01:07,646 --> 01:01:08,847 WORKSHOP ON HEALTH DISPARITIES 1509 01:01:08,847 --> 01:01:10,949 AND HEALTH EQUITY, AND 1510 01:01:10,949 --> 01:01:12,951 ESPECIALLY AROUND GENE THERAPIES 1511 01:01:12,951 --> 01:01:14,219 AND SPECIFICALLY AROUND GENOME 1512 01:01:14,219 --> 01:01:16,855 EDITING THERAPIES. 1513 01:01:16,855 --> 01:01:20,993 AND INVESTIGATORS PROVIDED MANY 1514 01:01:20,993 --> 01:01:24,596 STRATEGIES ABOUT HOW TO 1515 01:01:24,596 --> 01:01:25,931 INCORPORATE DIVERSE POPULATIONS 1516 01:01:25,931 --> 01:01:27,766 IN FUTURE CLINICAL APPLICATIONS 1517 01:01:27,766 --> 01:01:32,371 OF THIS TECHNOLOGY, AND SOME OF 1518 01:01:32,371 --> 01:01:33,638 THOSE STRATEGIES ARE HOUSING, 1519 01:01:33,638 --> 01:01:36,408 WHERE THE THERAPY WOULD BE 1520 01:01:36,408 --> 01:01:37,609 DELIVERED, IN NEIGHBORHOODS THAT 1521 01:01:37,609 --> 01:01:38,276 ARE UNDERSERVED. 1522 01:01:38,276 --> 01:01:40,946 SO ONE OF THE INVESTIGATORS IS 1523 01:01:40,946 --> 01:01:44,316 FROM THE UNIVERSITY OF 1524 01:01:44,316 --> 01:01:45,484 PENNSYLVANIA AND CHILDREN'S 1525 01:01:45,484 --> 01:01:48,487 HOSPITAL OF PHILADELPHIA. 1526 01:01:48,487 --> 01:01:50,889 THEY HAVE ACCESS TO DIVERSE 1527 01:01:50,889 --> 01:01:51,289 POPULATIONS THERE. 1528 01:01:51,289 --> 01:01:53,425 THAT'S ONE EXAMPLE. 1529 01:01:53,425 --> 01:01:57,796 ANOTHER EXAMPLE IS STRATEGIES 1530 01:01:57,796 --> 01:01:59,898 FOR IDENTIFYING VARIANTS THAT 1531 01:01:59,898 --> 01:02:02,968 AFFECT BROADER POPULATIONS, OR 1532 01:02:02,968 --> 01:02:05,704 MAYBE EVEN TARGET UNDERSERVED 1533 01:02:05,704 --> 01:02:07,439 POPULATIONS, A VARIANT THAT MAY 1534 01:02:07,439 --> 01:02:09,074 BE HIGHER IN A CERTAIN 1535 01:02:09,074 --> 01:02:11,276 POPULATION SO THAT YOU COULD 1536 01:02:11,276 --> 01:02:14,446 ADDRESS IT IN THAT ACTION AS 1537 01:02:14,446 --> 01:02:14,780 WELL. 1538 01:02:14,780 --> 01:02:15,447 MANY STRATEGIES WERE TALKED 1539 01:02:15,447 --> 01:02:15,647 ABOUT. 1540 01:02:15,647 --> 01:02:22,454 S SO -- THOSE WERE SOME, WE 1541 01:02:22,454 --> 01:02:23,755 WOULD ENCOURAGE INVESTIGATORS 1542 01:02:23,755 --> 01:02:25,390 WHEN THEY COME IN WITH 1543 01:02:25,390 --> 01:02:27,826 APPLICATIONS TO ADDRESS HOW THEY 1544 01:02:27,826 --> 01:02:30,562 ARE GOING TO MAKE SURE THAT THE 1545 01:02:30,562 --> 01:02:35,600 THERAPY IS ABLE TO BE DELIVERED 1546 01:02:35,600 --> 01:02:37,135 TO AS BROAD POPULATIONS AS 1547 01:02:37,135 --> 01:02:39,571 POSSIBLE. 1548 01:02:39,571 --> 01:02:40,205 >> I MIGHT ENCOURAGE, I DON'T 1549 01:02:40,205 --> 01:02:41,840 KNOW IF YOU CAN REQUIRE, I THINK 1550 01:02:41,840 --> 01:02:43,942 IT NEEDS TO BE A COMPONENT OF 1551 01:02:43,942 --> 01:02:45,377 ALL THESE TYPE OF PROJECTS 1552 01:02:45,377 --> 01:02:50,282 MOVING FORWARD THERE MUST BE A 1553 01:02:50,282 --> 01:02:51,283 PLAN FOR ENHANCING DIVERSITY. 1554 01:02:51,283 --> 01:02:53,552 THANKS VERY MUCH. 1555 01:02:53,552 --> 01:02:55,654 I'M A LONG FAN OF THE SCGE 1556 01:02:55,654 --> 01:02:57,756 PROGRAM, AND I'M STRONGLY, 1557 01:02:57,756 --> 01:02:59,624 STRONGLY IN FAVOR OF THE PROGRAM 1558 01:02:59,624 --> 01:03:01,493 AS ORIGINALLY WRITTEN AND I'M IN 1559 01:03:01,493 --> 01:03:04,329 FAVOR OF YOUR PLAN FOR THIS 1560 01:03:04,329 --> 01:03:04,996 LIMITED COMPETITION NOFO FOR 1561 01:03:04,996 --> 01:03:08,400 ALLOWING CLINICAL TRIALS. 1562 01:03:08,400 --> 01:03:09,367 SO THANKS VERY MUCH. 1563 01:03:09,367 --> 01:03:13,538 >> THANK YOU FOR YOUR KIND WORDS 1564 01:03:13,538 --> 01:03:16,041 AND WE'LL CERTAINLY INCLUDE 1565 01:03:16,041 --> 01:03:17,476 EXACTLY WHAT YOU'VE SAID THERE 1566 01:03:17,476 --> 01:03:22,948 AT THE END, THAT WE WOULD 1567 01:03:22,948 --> 01:03:24,916 REQUIRE A PLAN FOR DIVERSE 1568 01:03:24,916 --> 01:03:25,217 POPULATIONS. 1569 01:03:25,217 --> 01:03:28,186 >> THANKS, KENT, FOR YOUR 1570 01:03:28,186 --> 01:03:30,388 THOUGHTFUL QUESTIONS AND 1571 01:03:30,388 --> 01:03:31,156 SUGGESTIONS. 1572 01:03:31,156 --> 01:03:33,425 VERY MUCH WORTH EMPHASIZING. 1573 01:03:33,425 --> 01:03:33,625 OKAY. 1574 01:03:33,625 --> 01:03:35,627 I'M GOING TO TURN IT OVER TO DR. 1575 01:03:35,627 --> 01:03:36,261 KING. 1576 01:03:36,261 --> 01:03:37,829 JEAN, IF THERE ARE ADDITIONAL 1577 01:03:37,829 --> 01:03:39,564 QUESTIONS OR COMMENTS YOU WOULD 1578 01:03:39,564 --> 01:03:41,666 LIKE TO MAKE PLEASE FEEL FREE. 1579 01:03:41,666 --> 01:03:45,604 >> NO, I WANT TO THANK YOU BOTH 1580 01:03:45,604 --> 01:03:46,671 FOR CLARIFICATIONS AND 1581 01:03:46,671 --> 01:03:48,874 PRESENTATIONS. 1582 01:03:48,874 --> 01:03:50,642 IT REALLY DID PUT SOME OF THE 1583 01:03:50,642 --> 01:03:51,943 PIECES TOGETHER. 1584 01:03:51,943 --> 01:03:53,278 I HAD SIMILAR CONCERNS, AFTER 1585 01:03:53,278 --> 01:03:55,547 READING THIS I HAVE TO SAY I 1586 01:03:55,547 --> 01:03:56,915 TOTALLY LOVE THE IDEA OF 1587 01:03:56,915 --> 01:03:58,850 LEVERAGING THE WAY YOU ARE TO 1588 01:03:58,850 --> 01:04:00,385 GET THERE FASTER BECAUSE MOST OF 1589 01:04:00,385 --> 01:04:02,154 WHAT WE GET STUCK WITH IS GOING 1590 01:04:02,154 --> 01:04:03,788 TO THE CLINICAL TRIALS. 1591 01:04:03,788 --> 01:04:06,191 AND I LIKE THE IDEA OF NOT ONLY 1592 01:04:06,191 --> 01:04:09,594 ARE WE DOING IT BUT THESE 1593 01:04:09,594 --> 01:04:10,896 REGULATORY PROCESSES WILL THEN 1594 01:04:10,896 --> 01:04:12,264 BE AVAILABLE TO EVERYBODY ELSE 1595 01:04:12,264 --> 01:04:14,599 SO THAT THEY CAN FOLLOW IT AND 1596 01:04:14,599 --> 01:04:16,368 NOT KEEP CREATING THE WHEEL. 1597 01:04:16,368 --> 01:04:17,903 I SEE WE DO A LOT OF THAT. 1598 01:04:17,903 --> 01:04:19,971 SO I'M REALLY GRATEFUL FOR YOU 1599 01:04:19,971 --> 01:04:22,073 MAKING SURE WE HIGHLIGHT THAT 1600 01:04:22,073 --> 01:04:23,909 THESE PROCESSES WILL THEN BE 1601 01:04:23,909 --> 01:04:25,143 AVAILABLE TO EVERYBODY IN THAT 1602 01:04:25,143 --> 01:04:28,213 FIELD, THAT CAN MOVE US FASTER 1603 01:04:28,213 --> 01:04:29,614 TO CLINICAL TRIALS. 1604 01:04:29,614 --> 01:04:33,018 I DO WANT TO GO BACK A LITTLE 1605 01:04:33,018 --> 01:04:35,187 BIT TO JUST ONE SLIDE BEFORE THE 1606 01:04:35,187 --> 01:04:38,256 LAST, WHICH REALLY DOES GO ALONG 1607 01:04:38,256 --> 01:04:41,893 WITH DR. LLOYD'S COMMENTS 1608 01:04:41,893 --> 01:04:43,862 BECAUSE MOST OF THE PERSPECTIVES 1609 01:04:43,862 --> 01:04:45,397 ARE DEVELOPING STRATEGIES, SO 1610 01:04:45,397 --> 01:04:47,132 DEVELOPING STRATEGIES TO BETTER 1611 01:04:47,132 --> 01:04:48,233 ENGAGE PARTICIPANTS, NEXT ONE 1612 01:04:48,233 --> 01:04:49,334 DEVELOPING BEST PRACTICES, AND 1613 01:04:49,334 --> 01:04:51,937 THE THIRD ONE WHICH I CONSIDER 1614 01:04:51,937 --> 01:04:53,705 SHOULD BE MORE THAN DEVELOPING 1615 01:04:53,705 --> 01:04:55,473 BUT DEVELOPING AND IMPLEMENTING 1616 01:04:55,473 --> 01:04:57,309 IS THE UNIQUE CONCERNS AND 1617 01:04:57,309 --> 01:05:00,378 STRATEGIES TO BE APPLIED IN A 1618 01:05:00,378 --> 01:05:01,780 THOUGHTFUL ENGAGEMENT OF 1619 01:05:01,780 --> 01:05:02,547 MARGINALIZED POPULATIONS. 1620 01:05:02,547 --> 01:05:04,883 SO, I THINK WHEN WE ASKED PEOPLE 1621 01:05:04,883 --> 01:05:07,052 TO CONSIDER IT OR WE ENCOURAGED 1622 01:05:07,052 --> 01:05:08,820 THAT, THEY MAY OR MAY NOT DO IT. 1623 01:05:08,820 --> 01:05:12,857 I FEEL THAT THE LANGUAGE HAS TO 1624 01:05:12,857 --> 01:05:16,695 BE A LOT STRONGER SO THAT COULD 1625 01:05:16,695 --> 01:05:17,896 BECOME SOMETHING THAT WE THINK 1626 01:05:17,896 --> 01:05:19,531 ABOUT AND SOLVE IT BECAUSE I 1627 01:05:19,531 --> 01:05:20,432 THINK THEY CAN. 1628 01:05:20,432 --> 01:05:21,967 I LIKE THE IDEA MAKING SURE WE 1629 01:05:21,967 --> 01:05:24,369 HAVE PARTICIPANTS ON THE TEAM 1630 01:05:24,369 --> 01:05:26,638 THAT ARE FROM DIVERSE BACKGROUND 1631 01:05:26,638 --> 01:05:30,809 TO BRING THEIR PERSPECTIVES WHO 1632 01:05:30,809 --> 01:05:32,244 -- WHO HOW WE DO IT AND WHY 1633 01:05:32,244 --> 01:05:33,712 WE DO WHAT WE DO. 1634 01:05:33,712 --> 01:05:35,513 I'M TOTALLY BEHIND THE SAME 1635 01:05:35,513 --> 01:05:37,249 QUESTIONING AROUND HOW WE MAKE 1636 01:05:37,249 --> 01:05:39,684 SURE WE DON'T ASK THEM TO 1637 01:05:39,684 --> 01:05:40,752 CONSIDER, BECAUSE CONSIDER MEANS 1638 01:05:40,752 --> 01:05:43,054 YOU COULD, YOU COULD NOT. 1639 01:05:43,054 --> 01:05:46,124 SO GOING FROM CONSIDER AND 1640 01:05:46,124 --> 01:05:47,325 UNDEVELOPING TO IMPLEMENTED THE 1641 01:05:47,325 --> 01:05:49,427 BEST PRACTICES IN THAT STUDY. 1642 01:05:49,427 --> 01:05:51,830 SO OUTSIDE OF THAT I LOVE THE 1643 01:05:51,830 --> 01:05:52,897 IDEA HAVING PLATFORMS THAT WOULD 1644 01:05:52,897 --> 01:05:53,898 BE AVAILABLE TO OTHERS OUTSIDE 1645 01:05:53,898 --> 01:05:55,867 OF THE PEOPLE THAT HAPPEN TO BE 1646 01:05:55,867 --> 01:06:00,138 IN THIS GROUP RIGHT NOW. 1647 01:06:00,138 --> 01:06:01,006 >> THANK YOU. 1648 01:06:01,006 --> 01:06:04,509 I HEAR THE MESSAGE AND WE'LL 1649 01:06:04,509 --> 01:06:07,579 MAKE THE LANGUAGE STRONGER AND 1650 01:06:07,579 --> 01:06:09,114 PROVIDING NO WIGGLE ROOM FOR 1651 01:06:09,114 --> 01:06:11,082 INVESTIGATORS THAT ARE APPLYING. 1652 01:06:11,082 --> 01:06:16,755 I WOULD MENTION THAT OUR 1653 01:06:16,755 --> 01:06:19,624 INVESTIGATORS ARE LEADERS IN 1654 01:06:19,624 --> 01:06:22,460 THIS PARTICULAR ASPECT OF THE 1655 01:06:22,460 --> 01:06:24,963 THERAPY DELIVERY. 1656 01:06:24,963 --> 01:06:26,831 THEY WANT -- THEY ARE BEYOND 1657 01:06:26,831 --> 01:06:29,034 JUST TALKING ABOUT IT. 1658 01:06:29,034 --> 01:06:30,902 THEY ARE THINKING ABOUT 1659 01:06:30,902 --> 01:06:32,771 STRATEGIES TO PROVIDE THIS 1660 01:06:32,771 --> 01:06:33,638 TECHNOLOGY TO BROADER 1661 01:06:33,638 --> 01:06:34,472 POPULATIONS, WHAT NEEDS TO BE 1662 01:06:34,472 --> 01:06:36,841 DONE, WHAT NEEDS TO BE PUT IN 1663 01:06:36,841 --> 01:06:38,576 PLACE TO MAKE SURE THAT ALL 1664 01:06:38,576 --> 01:06:41,880 COMMUNITIES ARE SERVED BY THIS 1665 01:06:41,880 --> 01:06:43,948 TECHNOLOGY. 1666 01:06:43,948 --> 01:06:45,383 >> THAT'S A VERY CRITICAL 1667 01:06:45,383 --> 01:06:45,617 ASPECT. 1668 01:06:45,617 --> 01:06:47,786 SORRY, JEAN. 1669 01:06:47,786 --> 01:06:49,954 >> I WAS JUST SAYING THANK YOU. 1670 01:06:49,954 --> 01:06:53,024 >> THANK YOU VERY MUCH. 1671 01:06:53,024 --> 01:06:53,591 >> GREAT. 1672 01:06:53,591 --> 01:06:54,459 ALL RIGHT. 1673 01:06:54,459 --> 01:06:57,762 WELL, NOW LET'S OPEN UP FOR 1674 01:06:57,762 --> 01:07:00,465 BROADER QUESTION AND DISCUSSION, 1675 01:07:00,465 --> 01:07:03,568 IF OTHERS ON COUNCIL HAVE ANY 1676 01:07:03,568 --> 01:07:07,405 ADDITIONAL COMMENTS, I SEE, 1677 01:07:07,405 --> 01:07:08,473 KAREN, YOU'RE ECHOING SOME OF 1678 01:07:08,473 --> 01:07:09,674 THE COMMENTS THAT HAVE ALREADY 1679 01:07:09,674 --> 01:07:11,976 BEEN MADE ABOUT DIVERSITY OF 1680 01:07:11,976 --> 01:07:12,944 RECRUITMENT STRATEGIES. 1681 01:07:12,944 --> 01:07:16,381 JENNIFER, I SEE YOUR HAND UP. 1682 01:07:16,381 --> 01:07:18,116 >> YES, I JUST WANTED TO, YOU 1683 01:07:18,116 --> 01:07:23,488 KNOW, SAY I THOUGHT THE REVIEWS 1684 01:07:23,488 --> 01:07:26,891 WERE GREAT OF THIS CONCEPT. 1685 01:07:26,891 --> 01:07:30,061 AND WONDER IF PART OF WHAT DR. 1686 01:07:30,061 --> 01:07:32,797 KING MENTIONED WAS ABOUT THE 1687 01:07:32,797 --> 01:07:35,300 TEAM COMING IN FOR THESE 1688 01:07:35,300 --> 01:07:39,571 RENEWALS OR FOR THIS ADDITIONAL 1689 01:07:39,571 --> 01:07:44,042 FUNDING, THAT THEY INCLUDE 1690 01:07:44,042 --> 01:07:46,044 EXPERTS IN EITHER DISPARITIES IN 1691 01:07:46,044 --> 01:07:47,779 THE DISEASE UNDER STUDY OR 1692 01:07:47,779 --> 01:07:50,081 CERTAINLY EXPERTS IN THE SCIENCE 1693 01:07:50,081 --> 01:07:51,082 OF INCLUSION. 1694 01:07:51,082 --> 01:07:54,986 I WONDER IF THE LANGUAGE OF THE 1695 01:07:54,986 --> 01:08:01,559 NOFO COULD BE STRENGTHENED BY 1696 01:08:01,559 --> 01:08:03,128 STATING EXPLICITLY THAT RESPONSE 1697 01:08:03,128 --> 01:08:05,830 OF APPLICATIONS WOULD INCLUDE 1698 01:08:05,830 --> 01:08:08,032 EXPERTS IN SCIENCE OF INCLUSION. 1699 01:08:08,032 --> 01:08:12,937 YOU KNOW, I THINK THAT, AGAIN, 1700 01:08:12,937 --> 01:08:16,674 IT'S REASSURING AND HEARTENING 1701 01:08:16,674 --> 01:08:19,844 THAT THESE INVESTIGATORS HAVE 1702 01:08:19,844 --> 01:08:20,912 BEEN CONSIDERING THESE 1703 01:08:20,912 --> 01:08:23,782 DISPARITIES IN DELIVERY OF 1704 01:08:23,782 --> 01:08:25,417 TREATMENTS, BUT THEY ARE NOT 1705 01:08:25,417 --> 01:08:27,719 LIKELY TO BE EXPERTS IN THE 1706 01:08:27,719 --> 01:08:28,820 SCIENCE OF INCLUSION. 1707 01:08:28,820 --> 01:08:33,525 AND JUST TO SAY THAT MANY OF 1708 01:08:33,525 --> 01:08:35,927 THESE DISORDERS, YOU KNOW, THE 1709 01:08:35,927 --> 01:08:39,964 PLACES WHERE PEOPLE ARE TREATED 1710 01:08:39,964 --> 01:08:43,568 WITH THEM DIFFERS WIDELY, 1711 01:08:43,568 --> 01:08:47,639 DEPENDING ON SOME OF THESE 1712 01:08:47,639 --> 01:08:50,942 BACKGROUND CHARACTERISTICS, YOU 1713 01:08:50,942 --> 01:08:54,312 KNOW, SOURCES OF DISPARITIES, 1714 01:08:54,312 --> 01:08:56,181 GROUP DIFFERENCES, SUBGROUP 1715 01:08:56,181 --> 01:08:57,582 DIFFERENCES, FINALLY IF THERE 1716 01:08:57,582 --> 01:09:01,853 ARE -- IF THE APPLICATIONS ARE 1717 01:09:01,853 --> 01:09:03,288 GOING TO INCLUDE ANALYSIS OF 1718 01:09:03,288 --> 01:09:04,722 WHETHER THE TREATMENTS HAVE 1719 01:09:04,722 --> 01:09:05,490 SIMILAR EFFECTS ACROSS GROUPS 1720 01:09:05,490 --> 01:09:07,892 THEY NEED TO BE WELL POWERED IN 1721 01:09:07,892 --> 01:09:10,061 ORDER TO DO THAT. 1722 01:09:10,061 --> 01:09:14,365 AND SO A VERY THOUGHTFUL SET OF 1723 01:09:14,365 --> 01:09:19,604 ANALYSES NOT JUST CONVENIENCE 1724 01:09:19,604 --> 01:09:21,906 SAMPLING IS NEEDED IN ORDER TO 1725 01:09:21,906 --> 01:09:28,446 MAKE THOSE ANALYSES SUCCESSFUL. 1726 01:09:28,446 --> 01:09:32,383 >> THANK YOU FOR THE COMMENTS. 1727 01:09:32,383 --> 01:09:34,486 AND I, AGAIN, HEAR THAT 1728 01:09:34,486 --> 01:09:37,121 SUGGESTION AND I WILL BE SURE 1729 01:09:37,121 --> 01:09:45,864 THAT THAT IS INCLUDED IN THE 1730 01:09:45,864 --> 01:09:46,764 FUNDING ANNOUNCEMENT, 1731 01:09:46,764 --> 01:09:48,600 APPROPRIATE EXPERTISE FOR 1732 01:09:48,600 --> 01:09:51,135 RECRUITING DIVERSE POPULATIONS 1733 01:09:51,135 --> 01:09:54,506 IS INCLUDED IN THE TEAM, WHERE 1734 01:09:54,506 --> 01:09:59,444 THEY SUBMIT APPLICATIONS, OR AS 1735 01:09:59,444 --> 01:10:00,945 A RESPONSIVENESS CRITERIA FOR 1736 01:10:00,945 --> 01:10:04,816 SUCCESSFUL APPLICATION. 1737 01:10:04,816 --> 01:10:07,218 >> I'M SEEING A FEW ECHOES OF 1738 01:10:07,218 --> 01:10:09,521 SUPPORT FOR THOSE COMMENTS AND 1739 01:10:09,521 --> 01:10:09,821 STATEMENTS. 1740 01:10:09,821 --> 01:10:11,155 SO IMPORTANT TO CONSIDER. 1741 01:10:11,155 --> 01:10:12,690 ALL RIGHT. 1742 01:10:12,690 --> 01:10:14,993 I'M LOOKING TO SEE -- 1743 01:10:14,993 --> 01:10:16,961 >> CAN I ASK A FOLLOW-UP 1744 01:10:16,961 --> 01:10:17,529 QUESTION? 1745 01:10:17,529 --> 01:10:19,597 >> SURE, GO AHEAD. 1746 01:10:19,597 --> 01:10:22,534 >> I MIGHT BE MISSING SOMETHING. 1747 01:10:22,534 --> 01:10:25,737 IS THERE SOMETHING SPECIFIC TO 1748 01:10:25,737 --> 01:10:27,071 THIS CONCEPT, CLINICAL TRIALS, 1749 01:10:27,071 --> 01:10:30,108 COMPARED TO OTHERS THAT THIS IS 1750 01:10:30,108 --> 01:10:34,045 MORE OF A CONCERN? 1751 01:10:34,045 --> 01:10:36,948 ISN'T THIS -- DOESN'T NIH ALWAYS 1752 01:10:36,948 --> 01:10:40,618 DO THIS FOR CLINICAL TRIALS, 1753 01:10:40,618 --> 01:10:44,122 REQUIRE THAT POPULATIONS BE 1754 01:10:44,122 --> 01:10:44,956 REPRESENTED? 1755 01:10:44,956 --> 01:10:46,124 >> WE HAVE AN INCLUSION POLICY. 1756 01:10:46,124 --> 01:10:48,092 I THINK YOU'RE REFERRING TO OUR 1757 01:10:48,092 --> 01:10:53,898 INCLUSION POLICY THAT WE HAVE 1758 01:10:53,898 --> 01:10:56,501 FOR PARTICULAR GROUPS, INCLUDING 1759 01:10:56,501 --> 01:10:59,470 WOMEN AND RACIAL AND ETHNIC 1760 01:10:59,470 --> 01:10:59,771 MINORITIES. 1761 01:10:59,771 --> 01:11:01,139 BUT, TIM, I DON'T KNOW IF YOU 1762 01:11:01,139 --> 01:11:06,945 WANT TO SPEAK FURTHER ON THIS 1763 01:11:06,945 --> 01:11:07,378 SPECIFICALLY. 1764 01:11:07,378 --> 01:11:09,547 >> YOU'RE CORRECT, IT IS A 1765 01:11:09,547 --> 01:11:11,182 REQUIREMENT FOR ALL FUNDING 1766 01:11:11,182 --> 01:11:13,284 ANNOUNCEMENTS, BUT IF THE 1767 01:11:13,284 --> 01:11:14,152 LANGUAGE IS ABSENT, 1768 01:11:14,152 --> 01:11:17,121 INVESTIGATORS MAY NOT BE 1769 01:11:17,121 --> 01:11:17,922 REMINDED. 1770 01:11:17,922 --> 01:11:21,125 AND SO I THINK IT'S IMPERATIVE 1771 01:11:21,125 --> 01:11:24,329 ON THE SCGE TO BE SURE THAT 1772 01:11:24,329 --> 01:11:25,863 LANGUAGE SIN INCLUDED IN ANY 1773 01:11:25,863 --> 01:11:28,399 FUNDING ANNOUNCEMENT WE PUT OUT 1774 01:11:28,399 --> 01:11:30,335 SO WE'LL MAKE SURE THAT IS 1775 01:11:30,335 --> 01:11:30,902 INCLUDED. 1776 01:11:30,902 --> 01:11:33,504 I THINK THERE IS SOME -- THERE 1777 01:11:33,504 --> 01:11:35,039 ARE SOME SPECIAL CONSIDERATIONS 1778 01:11:35,039 --> 01:11:37,875 HERE FOR GENE THERAPIES AND 1779 01:11:37,875 --> 01:11:38,643 GENOME EDITING THERAPY, IT'S 1780 01:11:38,643 --> 01:11:39,310 RELATIVELY NEW. 1781 01:11:39,310 --> 01:11:42,480 PEOPLE ARE NOT FAMILIAR WITH THE 1782 01:11:42,480 --> 01:11:43,381 TECHNOLOGY, HAVING PEOPLE 1783 01:11:43,381 --> 01:11:47,085 COMFORTABLE WITH THE TECHNOLOGY 1784 01:11:47,085 --> 01:11:49,487 IS GOING TO REQUIRE WORK, AND SO 1785 01:11:49,487 --> 01:11:50,488 I THINK INCLUDING APPROPRIATE 1786 01:11:50,488 --> 01:11:52,757 EXPERTISE TO MAKE SURE ALL 1787 01:11:52,757 --> 01:11:55,059 COMMUNITIES THAT ARE CONSIDERING 1788 01:11:55,059 --> 01:11:56,594 PARTICIPATING IN THE TRIAL ARE 1789 01:11:56,594 --> 01:11:57,895 COMFORTABLE WITH THE TECHNOLOGY 1790 01:11:57,895 --> 01:12:01,232 AND THE RISK AND BENEFITS OF 1791 01:12:01,232 --> 01:12:02,734 THOSE THINGS. 1792 01:12:02,734 --> 01:12:04,469 AND SO WE'LL MAKE EXTRA EFFORT 1793 01:12:04,469 --> 01:12:07,271 TO BE SURE THAT THOSE THINGS ARE 1794 01:12:07,271 --> 01:12:08,973 INCLUDED IN THIS PARTICULAR 1795 01:12:08,973 --> 01:12:09,741 FUNDING ANNOUNCEMENT. 1796 01:12:09,741 --> 01:12:14,445 >> THANK YOU. 1797 01:12:14,445 --> 01:12:14,779 >> OKAY. 1798 01:12:14,779 --> 01:12:20,118 I'M NOT SEEING ANY ADDITIONAL 1799 01:12:20,118 --> 01:12:21,219 HANDS OR COMMENTS. 1800 01:12:21,219 --> 01:12:25,923 MONICA PUT IN ONE ECHOING 1801 01:12:25,923 --> 01:12:29,460 SUPPORT FOR DIVERSITY OF TEAM 1802 01:12:29,460 --> 01:12:29,894 MEMBERS. 1803 01:12:29,894 --> 01:12:31,396 BUT NOT SEEING ANYTHING ELSE, 1804 01:12:31,396 --> 01:12:34,966 MAYBE WE'LL OPEN IT UP NOW FOR 1805 01:12:34,966 --> 01:12:35,667 THE VOTE. 1806 01:12:35,667 --> 01:12:38,336 >> ALL RIGHT. 1807 01:12:38,336 --> 01:12:39,404 GREAT. 1808 01:12:39,404 --> 01:12:41,372 THANK YOU, TARA AND COUNCIL AND 1809 01:12:41,372 --> 01:12:41,639 PRESENTER. 1810 01:12:41,639 --> 01:12:45,510 I'LL BE CALLING FOR A VOTE. 1811 01:12:45,510 --> 01:12:50,148 ALTHOUGH THE WORDS WRITTEN IN 1812 01:12:50,148 --> 01:12:54,052 THE VOTE REFLECT -- WILL BE 1813 01:12:54,052 --> 01:12:54,819 REFLECTING THE STATEMENT, 1814 01:12:54,819 --> 01:12:57,488 MODIFIED A LITTLE BIT WITH THE 1815 01:12:57,488 --> 01:12:58,790 PREAMBLE OF WHAT I HEARD. 1816 01:12:58,790 --> 01:13:03,161 SO I WILL BE CALLING FOR A VOTE 1817 01:13:03,161 --> 01:13:08,199 FOR THE PRESENTED CONCEPT, FROM 1818 01:13:08,199 --> 01:13:09,300 OSC, INCLUDING COMPONENT TO 1819 01:13:09,300 --> 01:13:11,803 ENHANCE DIVERSITY WITH STRONG 1820 01:13:11,803 --> 01:13:14,906 LANGUAGE TO ENHANCE DIVERSE 1821 01:13:14,906 --> 01:13:17,709 BACKGROUNDS AND EXPERT IN 1822 01:13:17,709 --> 01:13:22,747 SCIENCE OF INCLUSION AND 1823 01:13:22,747 --> 01:13:24,949 ASSOCIATED ANALYSIS, FOR THE 1824 01:13:24,949 --> 01:13:28,219 CONCEPT CLEARANCE ENTITLED 1825 01:13:28,219 --> 01:13:31,289 SOMATIC CELL GENOME EDITING 1826 01:13:31,289 --> 01:13:32,323 CLINICAL TRIALS. 1827 01:13:32,323 --> 01:13:32,957 TO SUPPORT PLEASE TYPE. 1828 01:13:32,957 --> 01:13:34,358 SO MOVE INTO THE CHAT. 1829 01:13:34,358 --> 01:13:35,760 I HOPE IT WAS CLEAR WHAT I WAS 1830 01:13:35,760 --> 01:13:37,829 TRYING TO DO, I ADDED THE 1831 01:13:37,829 --> 01:13:40,031 DISCUSSION I HEARD WITH THE 1832 01:13:40,031 --> 01:13:40,598 STRONG SUPPORT. 1833 01:13:40,598 --> 01:13:42,233 I SEE SO MOVED. 1834 01:13:42,233 --> 01:13:43,735 BEFORE I COULD SAY THANK YOU 1835 01:13:43,735 --> 01:13:46,170 VERY MUCH, I SEE A SECOND. 1836 01:13:46,170 --> 01:13:49,807 I WILL NOW ASK IF THERE'S ANY 1837 01:13:49,807 --> 01:13:52,643 ADDITIONAL DISCUSSION ON THIS 1838 01:13:52,643 --> 01:14:00,184 VOTE. 1839 01:14:00,184 --> 01:14:03,588 I DO NOT SEE ANYTHING IN THE 1840 01:14:03,588 --> 01:14:04,956 CHAT. 1841 01:14:04,956 --> 01:14:08,860 I DO NOT SEE ANY HANDS RAISED. 1842 01:14:08,860 --> 01:14:09,927 SO I'M GOING TO TURN IT OVER TO 1843 01:14:09,927 --> 01:14:14,665 THE HOST FOR THE VOTE. 1844 01:14:14,665 --> 01:14:16,634 >> THANK YOU, DR. GRIEDER. 1845 01:14:16,634 --> 01:14:18,402 OF POLL SHOULD AUTOMATICALLY 1846 01:14:18,402 --> 01:14:19,904 APPEAR ON YOUR SCREEN, WHEN 1847 01:14:19,904 --> 01:14:20,338 LAUNCHED. 1848 01:14:20,338 --> 01:14:21,672 PLEASE REMEMBER TO HIT SUBMIT 1849 01:14:21,672 --> 01:14:22,874 AFTER YOU HAVE SELECTED YOUR 1850 01:14:22,874 --> 01:14:28,579 VOTE AND AS A REMINDER ONLY 1851 01:14:28,579 --> 01:14:29,046 COUNCIL MEMBERS SHOULD 1852 01:14:29,046 --> 01:14:29,981 PARTICIPATE IN THE POLL. 1853 01:14:29,981 --> 01:14:38,956 THE POLL IS STARTING NOW. 1854 01:14:38,956 --> 01:14:43,895 1855 01:14:43,895 --> 01:14:45,429 YOU HAVE ABOUT 15 SECONDS 1856 01:14:45,429 --> 01:14:48,132 REMAINING IN ORDER TO CAST YOUR 1857 01:14:48,132 --> 01:14:48,933 VOTE. 1858 01:14:48,933 --> 01:14:52,403 PLEASE REMEMBER TO HIT SUBMIT. 1859 01:14:52,403 --> 01:14:55,907 1860 01:14:55,907 --> 01:14:57,542 ALL RIGHT. 1861 01:14:57,542 --> 01:15:00,711 THE POLL IS NOW CLOSING. 1862 01:15:00,711 --> 01:15:02,046 1863 01:15:02,046 --> 01:15:03,581 I WILL SHARE THE RESULTS WITH 1864 01:15:03,581 --> 01:15:07,318 THE MEETING. 1865 01:15:07,318 --> 01:15:11,689 THE MOTION AS STATED HAS PASSED. 1866 01:15:11,689 --> 01:15:12,423 >> GREAT. 1867 01:15:12,423 --> 01:15:14,091 THANK YOU, CHRISTINA AND COUNCIL 1868 01:15:14,091 --> 01:15:15,960 MEMBERS AND PRESENTERS FOR THIS 1869 01:15:15,960 --> 01:15:16,561 CONCEPT. 1870 01:15:16,561 --> 01:15:17,795 WE WILL MOVE FORWARD AND I'LL 1871 01:15:17,795 --> 01:15:21,199 HAND IT BACK OVER TO TARA. 1872 01:15:21,199 --> 01:15:23,067 WE'RE RIGHT ON TIME. 1873 01:15:23,067 --> 01:15:24,135 >> I SEE THAT. 1874 01:15:24,135 --> 01:15:27,004 THE SWISS TIME KEEPING WE HAVE 1875 01:15:27,004 --> 01:15:27,538 HERE. 1876 01:15:27,538 --> 01:15:28,306 ALL RIGHT. 1877 01:15:28,306 --> 01:15:30,808 SO, WE'RE ACTUALLY NOW GOING TO 1878 01:15:30,808 --> 01:15:33,878 TRANSITION TO TAKE A LUNCH 1879 01:15:33,878 --> 01:15:34,212 BREAK. 1880 01:15:34,212 --> 01:15:38,149 SO, BEFORE WE DO, I THANK YOU 1881 01:15:38,149 --> 01:15:40,885 ALL FOR THOUGHTFUL COMMENTS AND 1882 01:15:40,885 --> 01:15:43,287 SUGGESTIONS RELATED TO THAT 1883 01:15:43,287 --> 01:15:43,521 CONCEPT. 1884 01:15:43,521 --> 01:15:44,488 OF COURSE THEY WILL TAKE THEM 1885 01:15:44,488 --> 01:15:46,657 INTO CONSIDERATION AND GO BACK 1886 01:15:46,657 --> 01:15:47,992 AND CONSIDER HOW TO WORK TO 1887 01:15:47,992 --> 01:15:51,829 ENHANCE SOME OF IN A LANG -- 1888 01:15:51,829 --> 01:15:53,030 SOME OF THAT LANGUAGE. 1889 01:15:53,030 --> 01:15:56,968 AS WE TRANSITION TO LUNCH, WE 1890 01:15:56,968 --> 01:15:59,503 ASK YOU AGAIN TO PLEASE REMAIN 1891 01:15:59,503 --> 01:16:00,805 LOGGED IN, AND MUTED, COUNCIL 1892 01:16:00,805 --> 01:16:01,239 MEMBERS. 1893 01:16:01,239 --> 01:16:03,307 COME BACK A COUPLE MINUTES 1894 01:16:03,307 --> 01:16:05,810 BEFORE 1:00, AND AT THAT POINT 1895 01:16:05,810 --> 01:16:09,080 WE'LL GET GOING ON THE AFTERNOON 1896 01:16:09,080 --> 01:16:09,780 PRESENTATIONS, INCLUDING OUR 1897 01:16:09,780 --> 01:16:11,182 FIRST PRESENTATION BACK FROM 1898 01:16:11,182 --> 01:16:13,584 LUNCH FROM DR. DIANA BIANCHI, 1899 01:16:13,584 --> 01:16:15,753 WHO IS DIRECTOR OF NICHD. 1900 01:16:15,753 --> 01:16:17,622 SO WITH THAT, PLEASE ENJOY YOUR 1901 01:16:17,622 --> 01:16:18,823 LUNCH, OR MAYBE IT'S JUST A 1902 01:16:18,823 --> 01:16:20,791 SNACK BREAK FOR THOSE ON THE 1903 01:16:20,791 --> 01:16:21,359 WEST COAST. 1904 01:16:21,359 --> 01:16:24,095 AND WE'LL SEE YOU BACK IN ABOUT 1905 01:16:24,095 --> 01:16:25,730 25 MINUTES OR SO. 1906 01:16:25,730 --> 01:16:28,001 THANKS. 1907 01:16:28,001 --> 01:16:28,735 >> ALL RIGHT, EVERYONE. 1908 01:16:28,735 --> 01:16:29,436 WELCOME BACK. 1909 01:16:29,436 --> 01:16:35,241 WE'RE GOING TO KICK THINGS OFF 1910 01:16:35,241 --> 01:16:37,110 POST-LUNCH, OR AS RICHARD 1911 01:16:37,110 --> 01:16:38,144 INDICATED, A LATE BREAKFAST FOR 1912 01:16:38,144 --> 01:16:43,550 THOSE WHO ARE ON THE WEST COAST. 1913 01:16:43,550 --> 01:16:46,620 OUR NEXT PRESENTATION IS FROM 1914 01:16:46,620 --> 01:16:51,224 THE DIRECTOR OF THE EUNICE 1915 01:16:51,224 --> 01:16:54,628 KENNEDY SHRIVER NATIONAL 1916 01:16:54,628 --> 01:16:56,796 INSTITUTE OF CHILD HEALTH AND 1917 01:16:56,796 --> 01:16:59,132 HUMAN DEVELOPMENT, DR. DIANA 1918 01:16:59,132 --> 01:17:01,301 BIANCHI, IN THIS ROLE SINCE 1919 01:17:01,301 --> 01:17:03,269 2016, EIGHT YEARS, OVERSEES 1920 01:17:03,269 --> 01:17:04,671 INSTITUTE'S RESEARCH ON 1921 01:17:04,671 --> 01:17:05,672 PEDIATRIC HEALTH AND 1922 01:17:05,672 --> 01:17:07,741 DEVELOPMENT, MATERNAL AND 1923 01:17:07,741 --> 01:17:09,309 REPRODUCTIVE HEALTH, 1924 01:17:09,309 --> 01:17:11,711 INTELLECTUAL AND DEVELOPMENTAL 1925 01:17:11,711 --> 01:17:16,950 DISABILITIES ANDREHABILITATION 1926 01:17:16,950 --> 01:17:19,386 MEDICINE, AMONG OTHER AREAS, 1927 01:17:19,386 --> 01:17:20,253 SPEARHEADING EFFORTS ON THE 1928 01:17:20,253 --> 01:17:22,555 NICHD STRATEGIC PLAN AND OVERSAW 1929 01:17:22,555 --> 01:17:25,825 CRAFTING AND VETTING OF 1930 01:17:25,825 --> 01:17:27,927 INSTITUTE'S NEW VISION AND 1931 01:17:27,927 --> 01:17:29,129 MISSION STATEMENTS. 1932 01:17:29,129 --> 01:17:32,799 SHE ALSO LEADS AND INTRAMURAL 1933 01:17:32,799 --> 01:17:35,802 RESEARCH LAB IN HER SPARE TIME, 1934 01:17:35,802 --> 01:17:38,471 IN THIS PRECISION HEALTH 1935 01:17:38,471 --> 01:17:40,840 RESEARCH AT NATIONAL HUMAN 1936 01:17:40,840 --> 01:17:42,709 GENOME RESEARCH INSTITUTE, 1937 01:17:42,709 --> 01:17:44,110 FOCUSING ON PRENATAL GENOMICS 1938 01:17:44,110 --> 01:17:47,414 WITH THE GOAL OF ADVANCING 1939 01:17:47,414 --> 01:17:49,349 NON-INVASIVE PRENATAL DNA 1940 01:17:49,349 --> 01:17:52,819 SCREENING AND ALSO THE DIAGNOSIS 1941 01:17:52,819 --> 01:17:54,421 AND INVESTIGATION OF THE FETAL 1942 01:17:54,421 --> 01:17:55,722 TRANSCRIPTOME TO HELP DEVELOP 1943 01:17:55,722 --> 01:17:57,123 NEW THERAPIES FOR GENETIC 1944 01:17:57,123 --> 01:17:59,959 DISORDERS THAT CAN BE GIVEN 1945 01:17:59,959 --> 01:18:01,294 PRENATALLY. 1946 01:18:01,294 --> 01:18:02,696 WITH THAT I WILL TURN IT OVER TO 1947 01:18:02,696 --> 01:18:05,231 DIANA TO TALK MORE ABOUT SOME OF 1948 01:18:05,231 --> 01:18:15,775 THE COOL THINGS SHE HAS GOING ON 1949 01:18:17,877 --> 01:18:18,912 AT NICHD. 1950 01:18:18,912 --> 01:18:20,113 DIANA? 1951 01:18:20,113 --> 01:18:24,918 >> NOT QUITE EIGHT YEARS, 1952 01:18:24,918 --> 01:18:26,252 NOVEMBER 2016, SO ELECTION DAY 1953 01:18:26,252 --> 01:18:29,322 IN 2024 WILL BE MY EIGHTH YEAR 1954 01:18:29,322 --> 01:18:29,923 ANNIVERSARY, AND IT'S BEEN A 1955 01:18:29,923 --> 01:18:31,291 WILD TIME. 1956 01:18:31,291 --> 01:18:32,492 THIS IS THE FIRST TIME I'VE 1957 01:18:32,492 --> 01:18:34,360 SPOKEN TO THE COUNCIL OF 1958 01:18:34,360 --> 01:18:35,328 COUNCILS, SO IT'S A GREAT 1959 01:18:35,328 --> 01:18:37,664 PLEASURE TO BE WITH ALL OF YOU 1960 01:18:37,664 --> 01:18:38,298 IF ONLY VIRTUALLY. 1961 01:18:38,298 --> 01:18:40,700 MAY I HAVE THE NEXT SLIDE 1962 01:18:40,700 --> 01:18:40,934 PLEASE. 1963 01:18:40,934 --> 01:18:43,570 SO, I HAVE A LOT TO COVER. 1964 01:18:43,570 --> 01:18:45,805 I'M PLANNING TO TALK FOR 35 1965 01:18:45,805 --> 01:18:49,776 MINUTES AND LEAVE 10 MINUTES FOR 1966 01:18:49,776 --> 01:18:50,343 QUESTIONS. 1967 01:18:50,343 --> 01:18:52,979 OVERVIEW OF NICHD, AND THEN TALK 1968 01:18:52,979 --> 01:18:55,181 ABOUT OUR THREE MAIN FOCUS 1969 01:18:55,181 --> 01:18:57,484 AREAS, WHICH IS WOMEN'S HEALTH 1970 01:18:57,484 --> 01:18:59,319 WHICH WE'RE CALLING BELOW THE 1971 01:18:59,319 --> 01:19:03,056 BELT, I'LL EXPLAIN WHAT THAT 1972 01:19:03,056 --> 01:19:03,389 MEANS. 1973 01:19:03,389 --> 01:19:03,923 PEDIATRIC RESEARCH, 1974 01:19:03,923 --> 01:19:04,691 REHABILITATION RESEARCH, AND 1975 01:19:04,691 --> 01:19:08,962 BECAUSE THE COUNCIL OF COUNCILS 1976 01:19:08,962 --> 01:19:12,565 IS REALLY LOOKING AT THESE 1977 01:19:12,565 --> 01:19:14,334 CROSS-I.C. LARGE PROGRAMS, I'M 1978 01:19:14,334 --> 01:19:17,036 GOING TO HIGHLIGHT THREE THAT 1979 01:19:17,036 --> 01:19:19,239 WE'RE INVOLVED IN, THE "IMPROVE" 1980 01:19:19,239 --> 01:19:21,307 INITIATIVE TO ADDRESS MATERNAL 1981 01:19:21,307 --> 01:19:23,176 MORTALITY, THE "INCLUDE" 1982 01:19:23,176 --> 01:19:23,977 PROGRAM, LOOKING AT IMPROVING 1983 01:19:23,977 --> 01:19:27,447 THE LIVES OF PEOPLE WITH DOWN 1984 01:19:27,447 --> 01:19:30,283 SYNDROME, AND THEN HELPING TO 1985 01:19:30,283 --> 01:19:31,484 END ADDICTION LONG TERM AND HOW 1986 01:19:31,484 --> 01:19:33,353 THAT AFFECTS PAIN IN OUR 1987 01:19:33,353 --> 01:19:35,889 POPULATIONS AS WELL AS 1988 01:19:35,889 --> 01:19:37,824 PARTICULARLY NEONATES, WHO ARE 1989 01:19:37,824 --> 01:19:41,227 BORN TO MOTHERS WHO MISUSED 1990 01:19:41,227 --> 01:19:42,896 SUBSTANCES DURING THEIR 1991 01:19:42,896 --> 01:19:44,664 PREGNANCIES. 1992 01:19:44,664 --> 01:19:46,199 NEXT SLIDE PLEASE. 1993 01:19:46,199 --> 01:19:46,966 NEXT SLIDE PLEASE. 1994 01:19:46,966 --> 01:19:49,035 SO, ONE OF THE THINGS THAT WE 1995 01:19:49,035 --> 01:19:51,104 DID ACCOMPLISH IN THE LAST EIGHT 1996 01:19:51,104 --> 01:19:54,374 YEARS OR SO HAS BEEN TO RECRAFT 1997 01:19:54,374 --> 01:19:56,476 OUR MISSION AND VISION 1998 01:19:56,476 --> 01:19:56,910 STATEMENTS. 1999 01:19:56,910 --> 01:20:00,180 WHEN I CAME ON BOARD WE HAD A 2000 01:20:00,180 --> 01:20:01,848 VERY LONG MISSION STATEMENT THAT 2001 01:20:01,848 --> 01:20:02,549 NOBODY COULD REMEMBER, AND IT 2002 01:20:02,549 --> 01:20:04,350 WAS QUITE FRANKLY A LITTLE BIT 2003 01:20:04,350 --> 01:20:06,319 ON THE DEPRESSING SIDE. 2004 01:20:06,319 --> 01:20:09,622 SO, AFTER A LOT OF WORK WE CAME 2005 01:20:09,622 --> 01:20:12,258 UP WITH A NEW MISSION STATEMENT, 2006 01:20:12,258 --> 01:20:15,295 THAT NICHD LEADS RESEARCH AND 2007 01:20:15,295 --> 01:20:17,597 TRAINING TO UNDERSTAND HUMAN 2008 01:20:17,597 --> 01:20:18,164 DEVELOPMENT, IMPROVE 2009 01:20:18,164 --> 01:20:19,899 REPRODUCTIVE HEALTH, ENHANCE 2010 01:20:19,899 --> 01:20:22,101 LIVES OF CHILDREN AND 2011 01:20:22,101 --> 01:20:24,070 ADOLESCENTS, OPTIMIZE ABILITIES 2012 01:20:24,070 --> 01:20:24,838 FOR ALL. 2013 01:20:24,838 --> 01:20:26,606 AND IF WE'RE ABLE TO ACCOMPLISH 2014 01:20:26,606 --> 01:20:30,510 OUR MISSION, OUR VISION TO HAVE 2015 01:20:30,510 --> 01:20:32,178 HEALTHY PREGNANCIES, HEALTHY 2016 01:20:32,178 --> 01:20:33,913 CHILDREN, HEALTHY AND OPTIMAL 2017 01:20:33,913 --> 01:20:34,113 LIVES. 2018 01:20:34,113 --> 01:20:36,216 NEXT SLIDE PLEASE. 2019 01:20:36,216 --> 01:20:39,953 SO IN 2020, WE UNDERWENT OUR 2020 01:20:39,953 --> 01:20:46,759 FIRST STRATEGIC PLAN IN OVER 20 2021 01:20:46,759 --> 01:20:46,960 YEARS. 2022 01:20:46,960 --> 01:20:48,695 WE'RE $1.75 BILLION INSTITUTE, 2023 01:20:48,695 --> 01:20:50,330 AND IT'S AMAZING THERE WAS NO 2024 01:20:50,330 --> 01:20:52,765 STRATEGIC PLAN. 2025 01:20:52,765 --> 01:20:56,369 SO WHAT THERE WAS, THERE WERE A 2026 01:20:56,369 --> 01:20:57,437 LOT OF GRANTS, BUT THEY WERE 2027 01:20:57,437 --> 01:21:05,578 VERY DIFFUSION. -- DIFFUSE, WE O 2028 01:21:05,578 --> 01:21:05,778 DEEP. 2029 01:21:05,778 --> 01:21:08,815 WITH THE STRATEGIC PLAN WE 2030 01:21:08,815 --> 01:21:12,452 STARTED WITH 270 POSSIBLE THEMES 2031 01:21:12,452 --> 01:21:15,188 AND DISTILLED TO FIVE. 2032 01:21:15,188 --> 01:21:15,822 UNDERSTANDING MOLECULAR, 2033 01:21:15,822 --> 01:21:26,332 CELLULAR, STRUCTURAL BASIS OF 2034 01:21:27,967 --> 01:21:28,768 DEVELOPMENT; PROMOTING GIN 2035 01:21:28,768 --> 01:21:30,937 CONGESTIONIC AND REPRODUCTIVE 2036 01:21:30,937 --> 01:21:33,239 HEALTH, SETTING FOUNDATION FOR 2037 01:21:33,239 --> 01:21:35,541 HEALTHY PREGNANCY AND WELLNESS, 2038 01:21:35,541 --> 01:21:36,709 IMPROVING CHILD AND ADOLESCENT 2039 01:21:36,709 --> 01:21:40,346 HEALTH IN TRANSITION TO 2040 01:21:40,346 --> 01:21:45,051 ADULTHOOD AND ADVANCING SAFE AND 2041 01:21:45,051 --> 01:21:46,486 EFFECTIVE THERAPEUTICS. 2042 01:21:46,486 --> 01:21:48,254 WE THINK THE THEMES HAVE HELD UP 2043 01:21:48,254 --> 01:21:48,855 WELL. 2044 01:21:48,855 --> 01:21:50,890 WHEN WE WROTE THEM THIS WAS 2045 01:21:50,890 --> 01:21:55,128 PRIOR TO THE PANDEMIC AND PRIOR 2046 01:21:55,128 --> 01:21:58,765 TO THE GEORGE FLOYD EPISODE, ET 2047 01:21:58,765 --> 01:21:59,732 CETERA. 2048 01:21:59,732 --> 01:22:01,401 WE'RE PLANNING TO KEEP THESE 2049 01:22:01,401 --> 01:22:02,902 THEMES BUT TWEAK THEM IN THE 2050 01:22:02,902 --> 01:22:04,137 REFRESH OF OUR STRATEGIC PLAN, 2051 01:22:04,137 --> 01:22:06,005 WHICH IS GOING TO COME FIVE 2052 01:22:06,005 --> 01:22:10,376 YEARS LATER, IN THE SPRING OF 2053 01:22:10,376 --> 01:22:11,577 2025. 2054 01:22:11,577 --> 01:22:15,081 NEXT SLIDE PLEASE. 2055 01:22:15,081 --> 01:22:16,816 SO, OUR NAME DOESN'T CONVEY WHAT 2056 01:22:16,816 --> 01:22:17,050 WE DO. 2057 01:22:17,050 --> 01:22:18,885 YOU GOT A SENSE FROM WHAT I'VE 2058 01:22:18,885 --> 01:22:20,386 SAID. 2059 01:22:20,386 --> 01:22:22,755 WE WERE NAMED FOR EUNICE KENNEDY 2060 01:22:22,755 --> 01:22:23,456 SHRIVER, PRESIDENT KENNEDY'S 2061 01:22:23,456 --> 01:22:24,557 SISTER. 2062 01:22:24,557 --> 01:22:26,926 THIS IS A TERRIFIC BIOGRAPHY, IF 2063 01:22:26,926 --> 01:22:29,095 YOU'RE INTERESTED IN SORT OF THE 2064 01:22:29,095 --> 01:22:30,964 HISTORY OF THE INSTITUTE AS WELL 2065 01:22:30,964 --> 01:22:33,700 AS SPECIAL OLYMPICS AND THE 2066 01:22:33,700 --> 01:22:34,701 KENNEDY FAMILY. 2067 01:22:34,701 --> 01:22:36,035 OUR RELATIONSHIP WITH THE 2068 01:22:36,035 --> 01:22:37,036 KENNEDY FAMILY CONTINUES TODAY. 2069 01:22:37,036 --> 01:22:38,538 THE PICTURE ON THE RIGHT IS A 2070 01:22:38,538 --> 01:22:41,074 PICTURE THAT WAS JUST TAKEN A 2071 01:22:41,074 --> 01:22:42,809 FEW WEEKS AGO. 2072 01:22:42,809 --> 01:22:44,811 AND IT REALLY RELATES TO WHAT'S 2073 01:22:44,811 --> 01:22:47,313 GOING ON NOW, MARIA SHRIVER IS 2074 01:22:47,313 --> 01:22:55,121 ONE OF THE LEADING FIGURES IN 2075 01:22:55,121 --> 01:23:05,598 THE -- [ AUDIO DISTORTION ] 2076 01:23:10,870 --> 01:23:11,170 >> DR. BIANCHI? 2077 01:23:11,170 --> 01:23:11,738 >> YES? 2078 01:23:11,738 --> 01:23:16,476 >> WE LOST YOU THERE FOR A 2079 01:23:16,476 --> 01:23:16,976 MOMENT. 2080 01:23:16,976 --> 01:23:19,078 >> CAN YOU HEAR ME NOW? 2081 01:23:19,078 --> 01:23:19,612 >> YES. 2082 01:23:19,612 --> 01:23:22,048 >> LET ME GO OFF VPN TOO, I 2083 01:23:22,048 --> 01:23:25,084 REALIZED I'M ON VPN. 2084 01:23:25,084 --> 01:23:25,418 OKAY. 2085 01:23:25,418 --> 01:23:29,255 AT WHAT POINT DID YOU LOSE ME? 2086 01:23:29,255 --> 01:23:32,658 >> YOU WERE TALKING ABOUT 2087 01:23:32,658 --> 01:23:33,993 KENNEDY SHRIVER. 2088 01:23:33,993 --> 01:23:35,661 >> THE SISTER OF PRESIDENT 2089 01:23:35,661 --> 01:23:38,331 KENNEDY, WHOSE IDEA IT WAS TO 2090 01:23:38,331 --> 01:23:40,833 HAVE AN INSTITUTE DEVOTED TO OUR 2091 01:23:40,833 --> 01:23:42,068 POPULATIONS, BY THE WAY MATERNAL 2092 01:23:42,068 --> 01:23:45,671 HEALTH WAS THERE FROM THE VERY 2093 01:23:45,671 --> 01:23:45,938 BEGINNING. 2094 01:23:45,938 --> 01:23:47,940 ON THE RIGHT IS A PICTURE THAT 2095 01:23:47,940 --> 01:23:51,911 WAS JUST TAKEN A FEW WEEKS AGO, 2096 01:23:51,911 --> 01:23:53,446 WITH MARIA SHRIVER, WHO IS A 2097 01:23:53,446 --> 01:23:56,416 LEADING FIGURE IN THE WOMEN'S 2098 01:23:56,416 --> 01:23:57,250 HEALTH RESEARCH INITIATIVE, 2099 01:23:57,250 --> 01:23:59,786 WHICH I'LL BE TALKING ABOUT IN A 2100 01:23:59,786 --> 01:24:01,220 MOMENT, AND TIM SHRIVER, HER 2101 01:24:01,220 --> 01:24:03,856 BROTHER, WHO SERVED ON OUR 2102 01:24:03,856 --> 01:24:05,525 ADVISORY COUNCIL, AND IS THE 2103 01:24:05,525 --> 01:24:07,126 EXECUTIVE DIRECTOR OF THE 2104 01:24:07,126 --> 01:24:08,861 SPECIAL OLYMPICS AND IS A 2105 01:24:08,861 --> 01:24:11,931 TREMENDOUS ADVOCATE FOR PEOPLE 2106 01:24:11,931 --> 01:24:14,133 WITH INTELLECTUAL DISABILITIES. 2107 01:24:14,133 --> 01:24:17,403 SO, ABOUT 55% OF OUR PORTFOLIO 2108 01:24:17,403 --> 01:24:21,340 IS IN PEDIATRIC HEALTH, AROUND 2109 01:24:21,340 --> 01:24:23,409 30% IN REPRODUCTIVE HEALTH, FROM 2110 01:24:23,409 --> 01:24:26,045 DEVELOPMENT OF REPRODUCTIVE 2111 01:24:26,045 --> 01:24:29,215 ORGANS TO CONTRACEPTION TO 2112 01:24:29,215 --> 01:24:31,951 PREGNANCY TO POSTPARTUM, AND UP 2113 01:24:31,951 --> 01:24:36,422 UNTIL EARLY MENOPAUSE INCLUDING 2114 01:24:36,422 --> 01:24:36,989 EARLY MENOPAUSE. 2115 01:24:36,989 --> 01:24:39,492 AND ABOUT 15% INCLUDES 2116 01:24:39,492 --> 01:24:41,160 INTELLECTUAL AND DEVELOPMENTAL 2117 01:24:41,160 --> 01:24:42,695 DISABILITIES AND REHABILITATION, 2118 01:24:42,695 --> 01:24:44,997 INCLUDING ADULT REHABILITATION. 2119 01:24:44,997 --> 01:24:47,366 AND THAT'S THE NATIONAL CENTER 2120 01:24:47,366 --> 01:24:48,134 FOR MEDICAL REHABILITATION 2121 01:24:48,134 --> 01:24:51,437 RESEARCH, WHICH SITS IN OUR 2122 01:24:51,437 --> 01:24:51,871 INSTITUTES. 2123 01:24:51,871 --> 01:24:53,306 NEXT SLIDE PLEASE. 2124 01:24:53,306 --> 01:24:56,476 SO, I'M GOING TO BRIEFLY TALK 2125 01:24:56,476 --> 01:24:59,212 ABOUT EACH OF THESE TOPICS. 2126 01:24:59,212 --> 01:25:01,080 TO DISTINGUISH WHAT WE DO FROM 2127 01:25:01,080 --> 01:25:03,583 OTHER ASPECTS OF WOMEN'S HEALTH 2128 01:25:03,583 --> 01:25:06,119 ACROSS NIH WE'RE CALLING IT 2129 01:25:06,119 --> 01:25:09,522 BELOW THE BELT, MEANING THE 2130 01:25:09,522 --> 01:25:11,357 REPRODUCTIVE ORGANS. 2131 01:25:11,357 --> 01:25:15,261 BELOW THAT WE HAVE SOME OF OUR 2132 01:25:15,261 --> 01:25:18,798 12 EXTRAMURAL BRANCHES THAT ARE 2133 01:25:18,798 --> 01:25:22,001 ALL FUNDING RESEARCH IN WOMEN'S 2134 01:25:22,001 --> 01:25:23,035 HEALTH, INCLUDING GYNECOLOGIC 2135 01:25:23,035 --> 01:25:27,773 HEALTH AND DISEASE, 2136 01:25:27,773 --> 01:25:28,708 CONTRACEPTION, FERTILITY AND 2137 01:25:28,708 --> 01:25:39,252 INFERTILITY, PREGNANCY AND PERI 2138 01:25:39,719 --> 01:25:40,586 NATALLOLOGY. 2139 01:25:40,586 --> 01:25:41,354 WE'VE INVESTED GOES TO $90 2140 01:25:41,354 --> 01:25:45,291 MILLION ON THE HUMAN PLACENTA 2141 01:25:45,291 --> 01:25:47,460 PROJECT BECAUSE WE BELIEVE THE 2142 01:25:47,460 --> 01:25:50,429 PLACENTA IS A KEY ORGAN THAT 2143 01:25:50,429 --> 01:25:54,934 AFFECTS BRAIN DEVELOPMENT AND 2144 01:25:54,934 --> 01:25:56,903 LIFETIME HEALTH. 2145 01:25:56,903 --> 01:25:58,838 HEALTH OF THE PLACENTA IS 2146 01:25:58,838 --> 01:25:59,639 EXTREMELY IMPORTANT, CONNECTED 2147 01:25:59,639 --> 01:26:02,275 TO RISK OF DISEASE LATER IN 2148 01:26:02,275 --> 01:26:03,442 LIFE. 2149 01:26:03,442 --> 01:26:06,445 HUMAN PLACENTA PROJECT STARTED 2150 01:26:06,445 --> 01:26:11,017 IN 2014, WITH THE GOAL OF 2151 01:26:11,017 --> 01:26:13,419 LOOKING AT THE PLACENTA NOT 2152 01:26:13,419 --> 01:26:18,324 INVASE IVELY AND IN REAL TIME. 2153 01:26:18,324 --> 01:26:19,992 WE CAN LOOK AFTER DELIVERY BUT 2154 01:26:19,992 --> 01:26:21,928 IT'S TOO LATE. 2155 01:26:21,928 --> 01:26:23,462 WHAT'S BEEN ACCOMPLISHED 2156 01:26:23,462 --> 01:26:25,798 INCLUDES ENHANCED IMAGING BOTH 2157 01:26:25,798 --> 01:26:27,667 WITH MRI AND ULTRASOUND TO GET A 2158 01:26:27,667 --> 01:26:29,902 MORE DETAILED VIEW OF THE 2159 01:26:29,902 --> 01:26:38,911 PLACENTA AND TO LOOK TO SEE HOW 2160 01:26:38,911 --> 01:26:39,812 BLOOD OXYGEN AND NUTRIENTS FLOW 2161 01:26:39,812 --> 01:26:41,180 ACROSS THE VESSELS. 2162 01:26:41,180 --> 01:26:43,983 THERE'S BEEN WORK IN 2163 01:26:43,983 --> 01:26:45,184 NON-INVASIVE BIOMARKERS FROM 2164 01:26:45,184 --> 01:26:46,919 MATERNAL BLOOD THAT REFLECT 2165 01:26:46,919 --> 01:26:54,460 HEALTH AND FUNCTION OF THE 2166 01:26:54,460 --> 01:26:56,262 PLACENTA TO INTERVENE EARLIER IF 2167 01:26:56,262 --> 01:26:56,562 NEEDED. 2168 01:26:56,562 --> 01:27:05,605 AS PART OF THE WOMEN'S HEALTH 2169 01:27:05,605 --> 01:27:06,138 RESEARCH INITIATIVE WE'RE 2170 01:27:06,138 --> 01:27:09,141 COMMITTING $3 MILLION TO A 2171 01:27:09,141 --> 01:27:09,842 CHALLENGE IN ENDOMETRIOSIS. 2172 01:27:09,842 --> 01:27:11,210 WE CALLED IT OUT IN OUR 2173 01:27:11,210 --> 01:27:16,782 STRATEGIC PLAN AS ONE OF OUR 2174 01:27:16,782 --> 01:27:17,250 ASPIRATIONAL GOALS. 2175 01:27:17,250 --> 01:27:20,186 WE'RE BASED ON THE LIFESPAN, NOT 2176 01:27:20,186 --> 01:27:22,088 NECESSARILY ASSOCIATED WITH 2177 01:27:22,088 --> 01:27:23,956 SPECIFIC DISEASES OR CONDITIONS. 2178 01:27:23,956 --> 01:27:26,559 BUT WE FELT THAT ENDOMETRIOSIS 2179 01:27:26,559 --> 01:27:29,262 WAS A CONDITION THAT IS 2180 01:27:29,262 --> 01:27:31,063 EXTREMELY COMMON, AFFECTS 1 IN 2181 01:27:31,063 --> 01:27:33,466 10 WOMEN INDEPENDENT OF RACIAL 2182 01:27:33,466 --> 01:27:34,867 OR ETHNIC ORIGIN. 2183 01:27:34,867 --> 01:27:36,802 AND THE BIG PROBLEM IS ON 2184 01:27:36,802 --> 01:27:41,007 AVERAGE IT TAKES 7 TO 10 YEARS 2185 01:27:41,007 --> 01:27:42,508 TO MAKE THE DIAGNOSE, AND MOST 2186 01:27:42,508 --> 01:27:44,277 OF THE TIME THE DIAGNOSIS IS 2187 01:27:44,277 --> 01:27:47,913 MADE BY AN INVASIVE PROCEDURE, 2188 01:27:47,913 --> 01:27:48,547 LAPAROSCOPY. 2189 01:27:48,547 --> 01:27:51,017 SO CURRENTLY THERE'S NO RELIABLE 2190 01:27:51,017 --> 01:27:55,121 BLOOD TEST OR A NON-INVASIVE 2191 01:27:55,121 --> 01:27:56,455 DIAGNOSTIC TEST. 2192 01:27:56,455 --> 01:27:59,292 SO, IT'S A LONG JOURNEY FOR 2193 01:27:59,292 --> 01:28:01,927 PEOPLE WHO HAVE IT, AND IT 2194 01:28:01,927 --> 01:28:03,229 RELIES ON MEDICAL HISTORY, 2195 01:28:03,229 --> 01:28:05,865 RELIES ON A CARE PROVIDER WHO 2196 01:28:05,865 --> 01:28:09,268 KNOWS WHAT IT IS. 2197 01:28:09,268 --> 01:28:16,275 AND EVENTUALLY IT DOES COME TO 2198 01:28:16,275 --> 01:28:17,777 LAPAROSCOPY. 2199 01:28:17,777 --> 01:28:20,813 SO, WE ARE GOING TO DEVOTE 2200 01:28:20,813 --> 01:28:23,816 RESOURCES TO A CHALLENGE TO 2201 01:28:23,816 --> 01:28:24,583 DEVELOP RELIABLE NON-INVASIVE 2202 01:28:24,583 --> 01:28:26,886 TESTS THAT ENABLE EARLY AND 2203 01:28:26,886 --> 01:28:29,522 ACCURATE DIAGNOSIS AND 2204 01:28:29,522 --> 01:28:29,855 TREATMENT. 2205 01:28:29,855 --> 01:28:33,025 NEXT SLIDE PLEASE. 2206 01:28:33,025 --> 01:28:35,194 SO, THE RADX-TECH MECHANISM THAT 2207 01:28:35,194 --> 01:28:37,296 WAS USED SO SUCCESSFULLY DURING 2208 01:28:37,296 --> 01:28:40,366 THE COVID PANDEMIC IS GOING TO 2209 01:28:40,366 --> 01:28:44,503 BE APPLIED TO A CHALLENGE IN 2210 01:28:44,503 --> 01:28:45,938 WHICH INVESTIGATORS, COMPANIES, 2211 01:28:45,938 --> 01:28:52,745 ARE GOING TO BE ASKED TO HELP US 2212 01:28:52,745 --> 01:28:54,313 TO BE ABLE TO DIAGNOSE 2213 01:28:54,313 --> 01:28:56,549 ENDOMETRIOSIS IN A MUCH SHORTER 2214 01:28:56,549 --> 01:28:57,883 PERIOD OF TIME. 2215 01:28:57,883 --> 01:28:59,885 AND THE ACT ENDOSTANDS FOR 2216 01:28:59,885 --> 01:29:03,656 ADVANCING CURES AND THERAPIES 2217 01:29:03,656 --> 01:29:04,357 AND ENDING ENDOMETRIOSIS 2218 01:29:04,357 --> 01:29:06,325 DIAGNOSTIC DELAY. 2219 01:29:06,325 --> 01:29:08,394 WE WILL BE PARTNERING WITH NIBIB 2220 01:29:08,394 --> 01:29:11,130 AND AGAIN WE'RE GOING TO 2221 01:29:11,130 --> 01:29:18,771 LEVERAGE THE VERY SUCCESSFUL 2222 01:29:18,771 --> 01:29:19,572 RAPID ACCELERATION OF 2223 01:29:19,572 --> 01:29:20,339 DIAGNOSTICS TECHNOLOGY 2224 01:29:20,339 --> 01:29:21,207 INNOVATION FUNNEL THAT RESULTED 2225 01:29:21,207 --> 01:29:23,242 FOR EXAMPLE IN SOME HOME-BASED 2226 01:29:23,242 --> 01:29:27,680 TESTS WE'VE BECOME QUITE 2227 01:29:27,680 --> 01:29:29,215 FAMILIAR WITH USING TO 2228 01:29:29,215 --> 01:29:30,082 SELF-DIAGNOSE COVID-19. 2229 01:29:30,082 --> 01:29:31,384 WE HOPE THAT THIS WILL 2230 01:29:31,384 --> 01:29:36,422 ACCELERATE THE TIME TO 2231 01:29:36,422 --> 01:29:38,724 DIAGNOSIS, ELIMINATE NEED FOR 2232 01:29:38,724 --> 01:29:39,825 LAPAROSCOPY, AND REDUCE COSTS 2233 01:29:39,825 --> 01:29:43,229 AND IMPROVE COMFORT FOR THE 2234 01:29:43,229 --> 01:29:44,430 PATIENT. 2235 01:29:44,430 --> 01:29:46,699 WE'RE LOOKING NOT JUST FROM 2236 01:29:46,699 --> 01:29:52,071 BLOOD BUT PERHAPS SALIVA, OR 2237 01:29:52,071 --> 01:29:53,839 EVEN MENSTRUAL EFFLUENT TO LOOK 2238 01:29:53,839 --> 01:29:55,674 FOR SPECIFIC BIOMARKERS. 2239 01:29:55,674 --> 01:29:58,043 AND, YOU KNOW, ALL ENDOMETRIOSIS 2240 01:29:58,043 --> 01:30:01,480 IS MALIGNANT IN THE SENSE THAT 2241 01:30:01,480 --> 01:30:03,682 IT'S PAINFUL, BUT SOME OF THE 2242 01:30:03,682 --> 01:30:07,386 LESIONS DO HAVE THE POTENTIAL TO 2243 01:30:07,386 --> 01:30:09,655 BECOME MALIGNANT IN THE 2244 01:30:09,655 --> 01:30:12,024 CANCEROUS TERM, AND WOMEN WHO 2245 01:30:12,024 --> 01:30:15,194 HAVE ENDOMETRIOSIS ARE AT RISK 2246 01:30:15,194 --> 01:30:19,064 FOR A VARIETY OF ASSOCIATED 2247 01:30:19,064 --> 01:30:19,698 CONDITIONS, PARTICULARLY 2248 01:30:19,698 --> 01:30:20,566 AUTOIMMUNE CONDITIONS. 2249 01:30:20,566 --> 01:30:23,436 WE ALSO ARE LOOKING FOR PEOPLE 2250 01:30:23,436 --> 01:30:25,171 WHO CAN UTILIZE EPIGENETIC OR 2251 01:30:25,171 --> 01:30:26,806 GENOMIC DATA WITH MACHINE 2252 01:30:26,806 --> 01:30:30,009 LEARNING TO, AGAIN, IDENTIFY 2253 01:30:30,009 --> 01:30:32,077 PEOPLE AT RISK AND DIAGNOSE 2254 01:30:32,077 --> 01:30:37,116 DISEASE AT AN EARLIER STAGE. 2255 01:30:37,116 --> 01:30:37,683 NEXT SLIDE PLEASE. 2256 01:30:37,683 --> 01:30:39,418 HERE IS THE SHARK TANK. 2257 01:30:39,418 --> 01:30:40,619 THAT'S WHY THERE'S A LITTLE 2258 01:30:40,619 --> 01:30:44,790 PICTURE OF A SHARK THERE. 2259 01:30:44,790 --> 01:30:48,327 AND WE ARE USING THIS TYPE OF 2260 01:30:48,327 --> 01:30:49,628 CHALLENGE IN ANOTHER AREA IN 2261 01:30:49,628 --> 01:30:52,798 MATERNAL HEALTH THAT I CAN TALK 2262 01:30:52,798 --> 01:30:56,869 ABOUT IN A MOMENT, BUT IT IS 2263 01:30:56,869 --> 01:30:58,871 PHASED, SO DIFFERENT INNOVATORS, 2264 01:30:58,871 --> 01:31:01,607 DIFFERENT COMPANIES, DIFFERENT 2265 01:31:01,607 --> 01:31:02,808 INVESTIGATORS WILL ENTER AND 2266 01:31:02,808 --> 01:31:06,078 THEN THE GROUP IS EVENTUALLY 2267 01:31:06,078 --> 01:31:09,281 WINNOWED DOWN BUT AT EACH STAGE, 2268 01:31:09,281 --> 01:31:10,249 AS INNOVATORS PROCEED TO THE 2269 01:31:10,249 --> 01:31:13,552 NEXT LEVEL, THEY DO GET A 2270 01:31:13,552 --> 01:31:16,689 FINANCIAL PRIZE. 2271 01:31:16,689 --> 01:31:18,524 NEXT SLIDE PLEASE. 2272 01:31:18,524 --> 01:31:20,426 SO ANOTHER AREA THAT WE'RE 2273 01:31:20,426 --> 01:31:22,595 INVOLVED, QUOTE/UNQUOTE, BELOW 2274 01:31:22,595 --> 01:31:26,298 THE BELT IS VIA THE 21ST CENTURY 2275 01:31:26,298 --> 01:31:26,832 CURES ACT. 2276 01:31:26,832 --> 01:31:29,502 WE HAD BEEN ASKED TO LEAD A TASK 2277 01:31:29,502 --> 01:31:32,771 FORCE ON RESEARCH SPECIFIC TO 2278 01:31:32,771 --> 01:31:33,973 PREGNANT AND LACTATING PEOPLE, 2279 01:31:33,973 --> 01:31:36,809 KNOWN AS PRGLAC. 2280 01:31:36,809 --> 01:31:41,614 AND THE CONCERN IS THAT MANY 2281 01:31:41,614 --> 01:31:43,148 MEDICATIONS, IN FACT MOST, HAVE 2282 01:31:43,148 --> 01:31:46,452 NOT BEEN TESTED FOR SAFETY AND 2283 01:31:46,452 --> 01:31:47,987 EFFICACY PERSPECTIVE ON PREGNANT 2284 01:31:47,987 --> 01:31:50,823 OR LACTATING PEOPLE. 2285 01:31:50,823 --> 01:31:52,691 SO THEREFORE PREGNANT PEOPLE FOR 2286 01:31:52,691 --> 01:31:54,894 EXAMPLE ARE FORCED TO DECIDE 2287 01:31:54,894 --> 01:31:56,395 BETWEEN MEDICATIONS THEY TAKE 2288 01:31:56,395 --> 01:31:59,932 FOR THEIR OWN HEALTH VERSUS NOT 2289 01:31:59,932 --> 01:32:02,234 TAKING ANYTHING, WITH THE 2290 01:32:02,234 --> 01:32:03,135 PERCEPTION, CULTURALLY 2291 01:32:03,135 --> 01:32:04,870 PERCEPTION, NOT TAKING ANYTHING 2292 01:32:04,870 --> 01:32:07,139 IS BETTER FOR THE BABY, THAT 2293 01:32:07,139 --> 01:32:10,109 PROBABLY MOST CASES IS NOT TRUE. 2294 01:32:10,109 --> 01:32:14,513 SO THIS HAS BEEN A VERY 2295 01:32:14,513 --> 01:32:16,048 IMPORTANT TASK FORCE THAT HAS 2296 01:32:16,048 --> 01:32:20,185 BEEN ONGOING FOR THE LAST SIX 2297 01:32:20,185 --> 01:32:21,520 YEARS. 2298 01:32:21,520 --> 01:32:23,822 WE CAME UP WITH 15 2299 01:32:23,822 --> 01:32:24,189 RECOMMENDATIONS. 2300 01:32:24,189 --> 01:32:27,560 THIS WAS JUST NOT JUST NICHD, 2301 01:32:27,560 --> 01:32:28,761 ALTHOUGH NICHD LED THE TASK 2302 01:32:28,761 --> 01:32:29,528 FORCE. 2303 01:32:29,528 --> 01:32:30,629 WE HAD OTHER INSTITUTES AND 2304 01:32:30,629 --> 01:32:33,899 CENTERS INVOLVED, OTHER FEDERAL 2305 01:32:33,899 --> 01:32:36,201 PARTNERS, ACADEMIC PARTNERS, 2306 01:32:36,201 --> 01:32:39,138 ADVOCACY ORGANIZATIONS, AND 2307 01:32:39,138 --> 01:32:39,471 PHARMA. 2308 01:32:39,471 --> 01:32:40,906 AND SO THE RECOMMENDATIONS WERE 2309 01:32:40,906 --> 01:32:43,642 TO INCLUDE PREGNANT AND 2310 01:32:43,642 --> 01:32:45,411 LACTATING PEOPLE IN CLINICAL 2311 01:32:45,411 --> 01:32:46,078 RESEARCH, TO INCREASE RESEARCH 2312 01:32:46,078 --> 01:32:48,914 ON THE SAFETY AND EFFICACY OF 2313 01:32:48,914 --> 01:32:50,883 THERAPEUTICS USED BY PREGNANT 2314 01:32:50,883 --> 01:32:52,718 AND LACTATING PEOPLE. 2315 01:32:52,718 --> 01:32:54,820 AND DEVELOP PROGRAMS TO DRIVE 2316 01:32:54,820 --> 01:32:57,656 DISCOVERY AND DEVELOPMENT OF 2317 01:32:57,656 --> 01:32:59,391 THERAPEUTICS, AND INCLUDE NEW 2318 01:32:59,391 --> 01:33:00,793 THERAPEUTICS FOR CONDITIONS 2319 01:33:00,793 --> 01:33:02,361 SPECIFIC TO PREGNANT AND 2320 01:33:02,361 --> 01:33:03,796 LACTATING PEOPLE. 2321 01:33:03,796 --> 01:33:05,431 AS WELL AS EXPANDING THE 2322 01:33:05,431 --> 01:33:07,166 WORKFORCE OF CLINICIANS AND 2323 01:33:07,166 --> 01:33:09,034 RESEARCHERS WHO HAVE EXPERTISE 2324 01:33:09,034 --> 01:33:12,204 IN THESE AREAS. 2325 01:33:12,204 --> 01:33:14,273 SO, THE 15 RECOMMENDATIONS HAVE 2326 01:33:14,273 --> 01:33:16,008 LONG BEEN MADE PUBLICLY 2327 01:33:16,008 --> 01:33:17,009 AVAILABLE. 2328 01:33:17,009 --> 01:33:18,544 THEN THERE WAS ANOTHER TASK 2329 01:33:18,544 --> 01:33:22,114 FORCE TO LOOK AT IMPLEMENTATION 2330 01:33:22,114 --> 01:33:23,749 OF THE RECOMMENDATIONS, AND NOW 2331 01:33:23,749 --> 01:33:26,518 AT OUR UPCOMING COUNCIL MEETING 2332 01:33:26,518 --> 01:33:28,787 WE'LL PROVIDE AN UPDATE ON WHERE 2333 01:33:28,787 --> 01:33:30,990 WE ARE, AND I THINK WHAT'S VERY 2334 01:33:30,990 --> 01:33:33,058 GRATIFYING, I READ THE REPORT, 2335 01:33:33,058 --> 01:33:36,228 ALMOST ALL OF THE 2336 01:33:36,228 --> 01:33:38,631 RECOMMENDATIONS HAVE HAD 2337 01:33:38,631 --> 01:33:41,567 SIGNIFICANT ADVANCES IN TERMS OF 2338 01:33:41,567 --> 01:33:42,668 EITHER BEING IMPLEMENTED OR 2339 01:33:42,668 --> 01:33:45,871 BEING ABOUT TO BE IMPLEMENTED, 2340 01:33:45,871 --> 01:33:47,506 AND MOST RECENTLY, FOR EXAMPLE, 2341 01:33:47,506 --> 01:33:50,442 THE NATIONAL ACADEMIES HAD A 2342 01:33:50,442 --> 01:33:53,846 MEETING LOOKING AT LEGAL 2343 01:33:53,846 --> 01:33:54,613 LIABILITIES FOR PHARMACEUTICAL 2344 01:33:54,613 --> 01:33:56,248 MANUFACTURERS, AND THEY COULD 2345 01:33:56,248 --> 01:34:00,119 NOT COME UP WITH AN EXAMPLE OF A 2346 01:34:00,119 --> 01:34:03,689 COMPANY THAT HAD BEEN SUED FOR 2347 01:34:03,689 --> 01:34:05,691 GIVING MEDICINE TO A PREGNANT 2348 01:34:05,691 --> 01:34:07,559 PERSON IN THE LAST SEVERAL 2349 01:34:07,559 --> 01:34:07,993 DECADES. 2350 01:34:07,993 --> 01:34:10,162 SO, AGAIN, WE'RE TRYING TO 2351 01:34:10,162 --> 01:34:12,831 CHANGE THE CULTURE, WE DO SENSE 2352 01:34:12,831 --> 01:34:16,635 MOVEMENT HERE. 2353 01:34:16,635 --> 01:34:17,736 NEXT SLIDE PLEASE. 2354 01:34:17,736 --> 01:34:20,039 WHAT HAS NICHD DONE? 2355 01:34:20,039 --> 01:34:21,674 WE'VE COMMITTED RESOURCES TO A 2356 01:34:21,674 --> 01:34:23,942 NUMBER OF DIFFERENT AREAS. 2357 01:34:23,942 --> 01:34:26,845 WE'VE CREATED A HUB THAT HAS AN 2358 01:34:26,845 --> 01:34:27,713 EDUCATIONAL GOAL. 2359 01:34:27,713 --> 01:34:30,849 IT ALSO IS AN OPPORTUNITY FOR 2360 01:34:30,849 --> 01:34:32,484 DIFFERENT INVESTIGATORS TO 2361 01:34:32,484 --> 01:34:34,987 EXPAND THEIR OWN RESEARCH ON 2362 01:34:34,987 --> 01:34:38,190 SAFE AND EFFECTIVE THERAPIES. 2363 01:34:38,190 --> 01:34:42,561 WE'RE ALSO FUNDING A GROUP IN 2364 01:34:42,561 --> 01:34:44,096 UTAH, CALLED THE CUDDLE STUDY, 2365 01:34:44,096 --> 01:34:46,632 WHERE THEY ARE LOOKING AT 2366 01:34:46,632 --> 01:34:51,670 COMMONLY USED DRUGS DURING 2367 01:34:51,670 --> 01:34:54,173 LACTATING -- DURING LACTATION, 2368 01:34:54,173 --> 01:34:55,474 AND IT'S AN OPPORTUNISTIC STUDY 2369 01:34:55,474 --> 01:34:58,744 WHERE THEY ARE TAKING A SAMPLE 2370 01:34:58,744 --> 01:35:00,946 OF BREAST MILK, TAKING MATERNAL 2371 01:35:00,946 --> 01:35:03,682 BLOOD SAMPLE, TAKING A HEEL 2372 01:35:03,682 --> 01:35:06,752 STICK BABY BLOOD SAMPLE, AND 2373 01:35:06,752 --> 01:35:08,387 THEY ARE ESSENTIALLY PROVING 2374 01:35:08,387 --> 01:35:10,355 THAT ALMOST NO MEDICATION IS 2375 01:35:10,355 --> 01:35:14,860 GETTING INTO THE BABY'S BLOOD. 2376 01:35:14,860 --> 01:35:17,162 SO, PROVIDING REASSURANCE TO 2377 01:35:17,162 --> 01:35:20,632 PARENTS THAT IT IS SAFE FOR THE 2378 01:35:20,632 --> 01:35:21,734 MOTHERS, FOR MEDICAL REASONS, TO 2379 01:35:21,734 --> 01:35:24,369 CONTINUE ON A GROUP OF 2380 01:35:24,369 --> 01:35:25,003 MEDICATIONS. 2381 01:35:25,003 --> 01:35:27,439 SO, THE ONES THEY HAVE JUST 2382 01:35:27,439 --> 01:35:32,578 MOVED MOST RECENTLY STUDY 2383 01:35:32,578 --> 01:35:33,679 INCLUDE AMOXICILLIN, 2384 01:35:33,679 --> 01:35:34,246 BUPRENORPHINE, HYDROCODONE. 2385 01:35:34,246 --> 01:35:37,082 BUT THIS IS THE EVIDENCE THAT'S 2386 01:35:37,082 --> 01:35:39,051 BEEN LACKING THAT IS IMPORTANT 2387 01:35:39,051 --> 01:35:40,686 FOR BOTH PEDIATRICIANS AND 2388 01:35:40,686 --> 01:35:42,755 OBSTETRICIANS TO BE REASSURED 2389 01:35:42,755 --> 01:35:44,857 THAT IT IS SAFE FOR THE MOTHER 2390 01:35:44,857 --> 01:35:47,893 TO CONTINUE TAKING THESE 2391 01:35:47,893 --> 01:35:48,560 MEDICINES. 2392 01:35:48,560 --> 01:35:57,102 NEXT SLIDE PLEASE. 2393 01:35:57,102 --> 01:36:03,242 WE SUPPORT RESEARCH NETWORKS FOR 2394 01:36:03,242 --> 01:36:05,544 MATERNAL AND INFANT HEALTH, 2395 01:36:05,544 --> 01:36:06,411 INCLUDING NEONATAL RESEARCH 2396 01:36:06,411 --> 01:36:07,813 NETWORK, GLOBAL NETWORK FOR 2397 01:36:07,813 --> 01:36:10,249 WOMEN'S AND CHILDREN HEALTH 2398 01:36:10,249 --> 01:36:10,716 RESEARCH. 2399 01:36:10,716 --> 01:36:14,920 AND WE MAKE SOME IMPORTANT 2400 01:36:14,920 --> 01:36:20,893 CHANGES, NETWORKS HAVE HAVE BEEN 2401 01:36:20,893 --> 01:36:22,161 AROUND 30-ISH YEARS, THEY HAD A 2402 01:36:22,161 --> 01:36:23,162 GROUP OF INVESTIGATORS WHO 2403 01:36:23,162 --> 01:36:24,229 WORKED TOGETHER, DETERMINED WHAT 2404 01:36:24,229 --> 01:36:26,632 WOULD BE STUDIED. 2405 01:36:26,632 --> 01:36:29,935 WE'VE BROKEN THAT OPEN, AND 2406 01:36:29,935 --> 01:36:31,236 INCREASED EXTERNAL PEER REVIEW 2407 01:36:31,236 --> 01:36:34,106 THESE NETWORKS AS WELL AS 2408 01:36:34,106 --> 01:36:35,841 PROVIDING AN INFRASTRUCTURE THAT 2409 01:36:35,841 --> 01:36:38,343 ALLOWS INVESTIGATORS FROM ALL 2410 01:36:38,343 --> 01:36:40,679 OVER THE COUNTRY NOT FOR THE 2411 01:36:40,679 --> 01:36:43,081 GLOBAL NETWORK BUT THE DOMESTIC 2412 01:36:43,081 --> 01:36:44,750 NETWORKS RESEARCHERS FROM ALL 2413 01:36:44,750 --> 01:36:47,586 OVER THE COUNTRY CAN PROPOSE 2414 01:36:47,586 --> 01:36:49,888 STUDIES THAT ARE THEN EXTERNALLY 2415 01:36:49,888 --> 01:36:51,190 VALIDATED, CAN USE THE 2416 01:36:51,190 --> 01:36:53,926 INFRASTRUCTURE OF THE NETWORKS. 2417 01:36:53,926 --> 01:36:56,128 THE GLOBAL NETWORK CONSISTS OF 2418 01:36:56,128 --> 01:37:00,499 EIGHT SITES IN SEVEN COUNTRIES, 2419 01:37:00,499 --> 01:37:05,504 THIS IS A LONG-TERM NETWORK THAT 2420 01:37:05,504 --> 01:37:09,007 VERY RECENTLY, I THINK NEXT 2421 01:37:09,007 --> 01:37:11,877 SLIDE PLEASE, YES, THE GLOBAL 2422 01:37:11,877 --> 01:37:14,580 NETWORK WAS VERY RECENTLY USED 2423 01:37:14,580 --> 01:37:19,885 TO STUDY A SINGLE DOSE 2424 01:37:19,885 --> 01:37:21,320 AZITHROMYCIN GIVEN TO WOMEN IN 2425 01:37:21,320 --> 01:37:25,457 LABOR AROUND THE WORLD, THIS WAS 2426 01:37:25,457 --> 01:37:27,559 A STUDY CO-SPONSORED BY THE 2427 01:37:27,559 --> 01:37:29,394 FORMER BILL AND MELINDA GATES 2428 01:37:29,394 --> 01:37:33,031 FOUNDATION, NOW THE GATES 2429 01:37:33,031 --> 01:37:36,635 FOUNDATION, THAT WAS TESTING 2430 01:37:36,635 --> 01:37:41,540 WHETHER SINGLE DOSE OF 2431 01:37:41,540 --> 01:37:49,982 AZITHROMYCIN COULD REDUCE 2432 01:37:49,982 --> 01:37:50,949 POSTPARTUM SEPSIS AND DEATH, 2433 01:37:50,949 --> 01:37:54,019 STOPPED EARLY BECAUSE A THIRD 2434 01:37:54,019 --> 01:37:56,822 FEWER WOMEN DEVELOPED SEPSIS IN 2435 01:37:56,822 --> 01:37:59,992 DEATH WITH A SINGLE DOSE OF 2436 01:37:59,992 --> 01:38:00,926 AZITHROMYCIN, DID NOT HAVE 2437 01:38:00,926 --> 01:38:01,927 AFFECT ON THE BABIES PROBABLY 2438 01:38:01,927 --> 01:38:03,528 BECAUSE OF AMOUNT OF EXPOSURE 2439 01:38:03,528 --> 01:38:10,669 FOR THE BABIES WAS SO LOW. 2440 01:38:10,669 --> 01:38:11,570 NEXT SLIDE PLEASE. 2441 01:38:11,570 --> 01:38:13,305 IT LED TO PEDIATRIC RESEARCH. 2442 01:38:13,305 --> 01:38:16,808 WE'VE GOT A NUMBER OF DIFFERENT 2443 01:38:16,808 --> 01:38:20,312 BRANCHES THAT ARE FOCUSING ON 2444 01:38:20,312 --> 01:38:22,848 TOPICS RELATED TO CHILDREN 2445 01:38:22,848 --> 01:38:24,416 INCLUDING DEVELOPMENTAL BIOLOGY, 2446 01:38:24,416 --> 01:38:26,451 CONGENITAL ANOMALIES, CHILD 2447 01:38:26,451 --> 01:38:27,653 DEVELOPMENT AND BEHAVIOR, 2448 01:38:27,653 --> 01:38:29,087 INTELLECTUAL AND DEVELOPMENTAL 2449 01:38:29,087 --> 01:38:32,791 DISABILITIES, GROWTH AND 2450 01:38:32,791 --> 01:38:34,126 NUTRITION, TRAUMA, CRITICAL 2451 01:38:34,126 --> 01:38:35,961 ILLNESS, INFECTIOUS DISEASE, 2452 01:38:35,961 --> 01:38:39,031 PHARMACOLOGY, AND POPULATION 2453 01:38:39,031 --> 01:38:39,731 DYNAMICS. 2454 01:38:39,731 --> 01:38:43,535 NEXT SLIDE PLEASE. 2455 01:38:43,535 --> 01:38:46,238 SO WE HAVE INTELLECTUAL AND 2456 01:38:46,238 --> 01:38:47,239 DEVELOPMENTAL DISABILITY 2457 01:38:47,239 --> 01:38:48,807 RESEARCH CENTERS. 2458 01:38:48,807 --> 01:38:50,509 THESE INCLUDE 15 RESEARCH 2459 01:38:50,509 --> 01:38:52,945 CENTERS ACROSS THE UNITED 2460 01:38:52,945 --> 01:38:53,478 STATES. 2461 01:38:53,478 --> 01:38:55,447 THESE ALSO INCLUDE 2462 01:38:55,447 --> 01:38:59,251 INFRASTRUCTURE AND RESEARCH 2463 01:38:59,251 --> 01:39:00,018 PROJECTS. 2464 01:39:00,018 --> 01:39:03,522 WE ALSO PARTNER LARGELY WITH 2465 01:39:03,522 --> 01:39:05,290 NIMH ON AUTISM RESEARCH. 2466 01:39:05,290 --> 01:39:06,825 WE HAVE AUTISM CENTERS OF 2467 01:39:06,825 --> 01:39:08,293 EXCELLENCE THAT ARE ACTUALLY 2468 01:39:08,293 --> 01:39:12,831 CO-SPONSORED BY A NUMBER OF 2469 01:39:12,831 --> 01:39:14,800 DIFFERENT INSTITUTES, AND THESE 2470 01:39:14,800 --> 01:39:17,302 CENTERS ARE PART OF THE CENTERS, 2471 01:39:17,302 --> 01:39:20,806 YOU KNOW, MAINLY FOCUSED ON 2472 01:39:20,806 --> 01:39:21,173 EARLY DIAGNOSIS. 2473 01:39:21,173 --> 01:39:23,775 BUT WE ALSO ARE STUDYING THE 2474 01:39:23,775 --> 01:39:25,978 BEST INTERVENTIONS FOR AUTISM 2475 01:39:25,978 --> 01:39:27,512 SPECTRUM DISORDER, AS WELL AS 2476 01:39:27,512 --> 01:39:29,815 SERVICES FOR PEOPLE THROUGHOUT 2477 01:39:29,815 --> 01:39:31,917 THE LIFESPAN. 2478 01:39:31,917 --> 01:39:33,185 WE'RE SPENDING $100 MILLION ON 2479 01:39:33,185 --> 01:39:34,720 OUR NINE AWARDS FOR THESE 2480 01:39:34,720 --> 01:39:37,689 CENTERS OF EXCELLENCE. 2481 01:39:37,689 --> 01:39:39,191 NEXT SLIDE. 2482 01:39:39,191 --> 01:39:44,129 A BIG AREA THAT, YOU KNOW, HAS 2483 01:39:44,129 --> 01:39:45,330 ALWAYS BEEN OF INTEREST SINCE 2484 01:39:45,330 --> 01:39:47,632 I'VE BEEN AT NIH, MORE SO DURING 2485 01:39:47,632 --> 01:39:50,936 THE PANDEMIC, RELIANCE ON 2486 01:39:50,936 --> 01:39:52,137 TECHNOLOGY AND DIGITAL MEDIA, 2487 01:39:52,137 --> 01:39:57,609 AND HOW IT AFFECTS TYPICAL CHILD 2488 01:39:57,609 --> 01:39:58,377 DEVELOPMENT. 2489 01:39:58,377 --> 01:40:01,580 SO, WE WERE GIVEN $15 MILLION OF 2490 01:40:01,580 --> 01:40:04,483 SET-ASIDE IN FISCAL 23 BUDGE 2491 01:40:04,483 --> 01:40:05,584 TOTE INVESTIGATE EFFECTS OF 2492 01:40:05,584 --> 01:40:08,186 TECHNOLOGY AND DIGITAL MEDIA ON 2493 01:40:08,186 --> 01:40:12,157 TYPICAL INFANT CHILD AND 2494 01:40:12,157 --> 01:40:13,025 ADOLESCENT DEVELOPMENT. 2495 01:40:13,025 --> 01:40:14,493 NIMH IS FOCUSED MORE ON EFFECTS 2496 01:40:14,493 --> 01:40:17,229 OF SOCIAL MEDIA, HOW IT AFFECTS 2497 01:40:17,229 --> 01:40:19,731 MENTAL HEALTH. 2498 01:40:19,731 --> 01:40:25,404 SO, WE HAVE GIVEN AWARDS TO 2499 01:40:25,404 --> 01:40:26,671 STUDY NOVEL TECHNOLOGY, AND 2500 01:40:26,671 --> 01:40:28,907 UNDERSTAND HOW HOW MUCH CHILDREN 2501 01:40:28,907 --> 01:40:30,876 ARE EXPOSED TO DIGITAL MEDIA. 2502 01:40:30,876 --> 01:40:33,412 BY THE WAY, PARENTS ALWAYS 2503 01:40:33,412 --> 01:40:38,650 UNDERESTIMATE HOW MUCH EXPOSURE 2504 01:40:38,650 --> 01:40:39,518 THEIR CHILDREN ARE HAVING. 2505 01:40:39,518 --> 01:40:41,253 AND WE'RE ALSO LOOKING AT HOW 2506 01:40:41,253 --> 01:40:44,756 THE USE OF DIGITAL MEDIA 2507 01:40:44,756 --> 01:40:46,625 CORRELATES WITH EMOTIONAL 2508 01:40:46,625 --> 01:40:48,827 REGULATION AND SOCIAL COMPETENCE 2509 01:40:48,827 --> 01:40:50,228 IN YOUNGER CHILDREN. 2510 01:40:50,228 --> 01:40:54,633 IN ADOLESCENTS WE'RE LOOKING AT 2511 01:40:54,633 --> 01:40:55,801 RELATIONSHIPS BETWEEN SOCIAL 2512 01:40:55,801 --> 01:40:57,369 MEDIA CONTENT, BEHAVIORS, BRAIN 2513 01:40:57,369 --> 01:40:59,071 ACTIVITY, HEALTH AND WELL-BEING. 2514 01:40:59,071 --> 01:41:06,445 WE RECENTLY HELD A WORKSHOP THAT 2515 01:41:06,445 --> 01:41:08,547 WILL BE SUMMARIZED IN 2516 01:41:08,547 --> 01:41:09,448 PUBLICATION AND GUIDE RESEARCH 2517 01:41:09,448 --> 01:41:13,151 IN THE NEXT COMING YEARS. 2518 01:41:13,151 --> 01:41:16,221 NEXT SLIDE PLEASE. 2519 01:41:16,221 --> 01:41:18,857 DR. KREGMAN KNOWS WE HAVE THE 2520 01:41:18,857 --> 01:41:19,424 NIH PEDIATRIC RESEARCH 2521 01:41:19,424 --> 01:41:22,227 CONSORTIUM, WHICH IS ALSO KNOWN 2522 01:41:22,227 --> 01:41:25,130 AS N-PeRC. 2523 01:41:25,130 --> 01:41:26,965 THAT WAS ESTABLISHED IN 2018 2524 01:41:26,965 --> 01:41:29,034 WHEN WE REALIZED MOST OF THE 2525 01:41:29,034 --> 01:41:31,870 INSTITUTES AND CENTERS DO HAVE 2526 01:41:31,870 --> 01:41:32,971 INTEREST IN CHILD HEALTH 2527 01:41:32,971 --> 01:41:35,040 RESEARCH, NICHD IS THE LEAD 2528 01:41:35,040 --> 01:41:38,110 FUNDER BUT NOT BY A LOT. 2529 01:41:38,110 --> 01:41:43,715 WE FUND 16% OF ALL OF THE CHILD 2530 01:41:43,715 --> 01:41:44,883 HEALTH RESEARCH ACROSS NIH. 2531 01:41:44,883 --> 01:41:47,185 NHLBI IS RIGHT BEHIND US, FIVE 2532 01:41:47,185 --> 01:41:49,921 OR SIX INSTITUTES ARE FUNDING 2533 01:41:49,921 --> 01:41:56,261 SIGNIFICANT AMOUNTS OF PEDIATRIC 2534 01:41:56,261 --> 01:41:56,795 RESEARCH. 2535 01:41:56,795 --> 01:41:58,563 THIS GROUP CONSISTS OF SENIOR 2536 01:41:58,563 --> 01:42:00,198 MEMBERS, REPRESENTATIVES FROM 2537 01:42:00,198 --> 01:42:03,502 EACH INSTITUTE AND CENTER, WHO 2538 01:42:03,502 --> 01:42:06,471 WORK TOGETHER ON AREAS OF 2539 01:42:06,471 --> 01:42:07,305 INTEREST TO ALL. 2540 01:42:07,305 --> 01:42:10,075 AND SO FAR, WE'VE BEEN WORKING 2541 01:42:10,075 --> 01:42:11,810 TOGETHER ON PEDIATRIC PAIN 2542 01:42:11,810 --> 01:42:13,512 RESEARCH, AND COLLABORATING AS 2543 01:42:13,512 --> 01:42:17,816 PART OF THE HEAL INITIATIVE. 2544 01:42:17,816 --> 01:42:19,017 PUBLIC/PRIVATE PARTNERSHIPS 2545 01:42:19,017 --> 01:42:20,785 SPECIFICALLY TO DEVELOP 2546 01:42:20,785 --> 01:42:22,320 PEDIATRIC MEDICAL DEVICES. 2547 01:42:22,320 --> 01:42:25,624 WE HELD A WORKSHOP, AND HAVE A 2548 01:42:25,624 --> 01:42:27,559 NOTICE OF SPECIAL INTEREST ON 2549 01:42:27,559 --> 01:42:29,561 HOW DO YOU MAKE THAT TRANSITION 2550 01:42:29,561 --> 01:42:31,429 FROM ADOLESCENT TO ADULT 2551 01:42:31,429 --> 01:42:32,831 HEALTHCARE, PARTICULARLY FOR 2552 01:42:32,831 --> 01:42:34,099 PEOPLE WITH CHRONIC DISEASE. 2553 01:42:34,099 --> 01:42:36,101 AT THE START OF THE PANDEMIC, 2554 01:42:36,101 --> 01:42:37,302 THERE WASN'T A LOT OF INTEREST 2555 01:42:37,302 --> 01:42:40,472 IN CHILDREN BECAUSE THE FOCUS 2556 01:42:40,472 --> 01:42:42,240 WAS ON OLDER PEOPLE. 2557 01:42:42,240 --> 01:42:43,341 SO THE GROUP ACTUALLY GOT 2558 01:42:43,341 --> 01:42:44,976 TOGETHER AT THE BEGINNING OF THE 2559 01:42:44,976 --> 01:42:48,046 PANDEMIC AND BEGAN TO THINK 2560 01:42:48,046 --> 01:42:49,548 ABOUT COMMON DATA ELEMENTS, AND 2561 01:42:49,548 --> 01:42:51,650 IMPORTANT TOPICS THAT WERE 2562 01:42:51,650 --> 01:42:55,587 AFFECTING CHILDREN, KIND OF WENT 2563 01:42:55,587 --> 01:42:58,089 INTO HIGH GEAR, WHEN MIS-C 2564 01:42:58,089 --> 01:42:59,624 BECAME A PHENOMENON. 2565 01:42:59,624 --> 01:43:01,960 THIS GROUP IS WORKING TOGETHER 2566 01:43:01,960 --> 01:43:03,495 TO DEVELOP PEDIATRIC CLINICAL 2567 01:43:03,495 --> 01:43:05,931 TRIALS AND ALSO TO EXPAND THE 2568 01:43:05,931 --> 01:43:11,236 PEDIATRIC WORKFORCE. 2569 01:43:11,236 --> 01:43:12,871 NEXT SLIDE PLEASE. 2570 01:43:12,871 --> 01:43:14,172 ANOTHER AREA THAT HAS OCCUPIED 2571 01:43:14,172 --> 01:43:17,609 QUITE A BIT OF TIME IS A VISION 2572 01:43:17,609 --> 01:43:19,878 FOR PEDIATRIC RESEARCH AT THE 2573 01:43:19,878 --> 01:43:23,715 NIH CLINICAL CENTER. 2574 01:43:23,715 --> 01:43:27,452 SO, I ALONG WITH BRIGITTE 2575 01:43:27,452 --> 01:43:29,854 WIDEMANN CO-LED A GROUP WITH 2576 01:43:29,854 --> 01:43:30,989 REPRESENTATIVES ACROSS MULTIPLE 2577 01:43:30,989 --> 01:43:32,691 INSTITUTES AND CENTERS TO SEE 2578 01:43:32,691 --> 01:43:35,293 WHAT COULD WE DO TO EXPAND 2579 01:43:35,293 --> 01:43:37,395 PEDIATRIC RESEARCH AT THE 2580 01:43:37,395 --> 01:43:38,930 CLINICAL CENTER. 2581 01:43:38,930 --> 01:43:41,366 AND MADE BOTH SCIENTIFIC 2582 01:43:41,366 --> 01:43:44,069 RECOMMENDATIONS AS WELL AS 2583 01:43:44,069 --> 01:43:46,338 INFRASTRUCTURE RECOMMENDATIONS. 2584 01:43:46,338 --> 01:43:47,806 ONE PROBLEM WE WERE TRYING TO 2585 01:43:47,806 --> 01:43:50,342 SOLVE WAS THAT IN GENERAL 2586 01:43:50,342 --> 01:43:52,077 CHILDREN UNDER AGE 3 CANNOT BE 2587 01:43:52,077 --> 01:43:54,279 TREATED AT THE CLINICAL CENTER, 2588 01:43:54,279 --> 01:43:56,915 SO THAT LIMITS A LOT OF THE VERY 2589 01:43:56,915 --> 01:43:57,916 INNOVATIVE GENE THERAPY WHICH 2590 01:43:57,916 --> 01:44:02,087 NEEDS TO BE DONE AS EARLY AS 2591 01:44:02,087 --> 01:44:04,589 POSSIBLE IN LIFE. 2592 01:44:04,589 --> 01:44:07,225 SOME CAR T THERAPY OPTIONS, AND 2593 01:44:07,225 --> 01:44:09,194 SO WE WERE TRYING TO GET AT WHAT 2594 01:44:09,194 --> 01:44:11,062 WOULD WE NEED TO BE ABLE TO 2595 01:44:11,062 --> 01:44:13,198 EXPAND THAT AND TRULY MAKE THE 2596 01:44:13,198 --> 01:44:14,666 CLINICAL CENTER A HOUSE OF HOPE 2597 01:44:14,666 --> 01:44:20,372 FOR PEOPLE OF ALL AGES. 2598 01:44:20,372 --> 01:44:23,642 WE HAVE A SERIES OF 2599 01:44:23,642 --> 01:44:25,076 RECOMMENDATIONS, SOME OF WHICH 2600 01:44:25,076 --> 01:44:26,945 REALLY HAVE VERY LITTLE COST 2601 01:44:26,945 --> 01:44:29,781 IMPLICATIONS, SO WE'RE TRYING TO 2602 01:44:29,781 --> 01:44:32,050 IMPLEMENT SOME OF THESE, AND 2603 01:44:32,050 --> 01:44:34,786 IMPORTANTLY AT THE VERY LEAST 2604 01:44:34,786 --> 01:44:37,222 IDENTIFY A REGISTRY OF 2605 01:44:37,222 --> 01:44:38,657 OPPORTUNITIES OF PEOPLE DOING 2606 01:44:38,657 --> 01:44:41,493 PEDIATRIC RESEARCH SO THAT WE 2607 01:44:41,493 --> 01:44:43,995 CAN BRING IN EITHER TRAINEES OR 2608 01:44:43,995 --> 01:44:45,263 YOUNG INVESTIGATORS FROM THE 2609 01:44:45,263 --> 01:44:48,133 OUTSIDE TO BEGIN TO WORK ON 2610 01:44:48,133 --> 01:44:51,670 PEDIATRIC TOPICS. 2611 01:44:51,670 --> 01:44:54,739 NEXT SLIDE PLEASE. 2612 01:44:54,739 --> 01:44:55,707 REHABILITATION, NEXT SLIDE. 2613 01:44:55,707 --> 01:44:57,742 SO AS I MENTIONED, WE'RE THE 2614 01:44:57,742 --> 01:45:03,248 HOME OF THE NATIONAL CENTER FOR 2615 01:45:03,248 --> 01:45:04,149 MEDICAL REHABILITATION RESEARCH. 2616 01:45:04,149 --> 01:45:06,785 THIS REALLY IS A VERY BROAD AREA 2617 01:45:06,785 --> 01:45:10,722 WHICH ALSO RECENTLY HAD A 2618 01:45:10,722 --> 01:45:11,823 STRATEGIC PLAN. 2619 01:45:11,823 --> 01:45:14,959 THIS IS AIMED TOWARDS ENHANCING 2620 01:45:14,959 --> 01:45:15,827 THE LIFE PRODUCTIVITY, 2621 01:45:15,827 --> 01:45:17,395 INDEPENDENCE AND QUALITY OF LIFE 2622 01:45:17,395 --> 01:45:20,231 FOR PEOPLE WITH DISABILITIES, 2623 01:45:20,231 --> 01:45:21,232 PHYSICAL DISABILITIES. 2624 01:45:21,232 --> 01:45:23,301 IT COLLABORATES WITH MANY OTHER 2625 01:45:23,301 --> 01:45:27,238 GOVERNMENT AGENCIES AND 2626 01:45:27,238 --> 01:45:27,605 ORGANIZATIONS. 2627 01:45:27,605 --> 01:45:28,773 NEXT SLIDE. 2628 01:45:28,773 --> 01:45:30,942 THESE ARE SOME OF THEIR 2629 01:45:30,942 --> 01:45:31,343 PRIORITIES. 2630 01:45:31,343 --> 01:45:35,113 THEY SUPPORT FULL RANGE OF 2631 01:45:35,113 --> 01:45:36,314 REHABILITATION RESEARCH IN 2632 01:45:36,314 --> 01:45:38,616 ADULTS AND CHILDREN INCLUDING 2633 01:45:38,616 --> 01:45:42,420 ADAPTATION, PLASTICITY, DEVICE 2634 01:45:42,420 --> 01:45:44,622 AND TECHNOLOGY DEVELOPMENT, 2635 01:45:44,622 --> 01:45:45,390 REHABILITATION DIAGNOSIS, 2636 01:45:45,390 --> 01:45:46,591 ENVIRONMENTAL FACTORS, ET 2637 01:45:46,591 --> 01:45:47,459 CETERA. 2638 01:45:47,459 --> 01:45:50,795 AND THIS IS VERY IMPORTANT 2639 01:45:50,795 --> 01:45:51,963 BECAUSE, YOU KNOW, THERE'S BEEN 2640 01:45:51,963 --> 01:45:55,867 A LOT OF INTEREST RECENTLY ON 2641 01:45:55,867 --> 01:45:59,504 ABLEISM IN MEDICINE, AND TRYING 2642 01:45:59,504 --> 01:46:02,006 TO MAKE PEOPLE AWARE OF ABLEISM 2643 01:46:02,006 --> 01:46:04,409 AND HOW IT'S A BARRIER TO CARE 2644 01:46:04,409 --> 01:46:09,647 AND HOW IT CONTRIBUTES TO HEALTH 2645 01:46:09,647 --> 01:46:10,548 DISPARITIES. 2646 01:46:10,548 --> 01:46:13,485 SO DISABILITIES WERE RECENTLY 2647 01:46:13,485 --> 01:46:16,354 INCLUDED AS ANOTHER MINORITY 2648 01:46:16,354 --> 01:46:19,057 GROUP THAT EXPERIENCES HEALTH 2649 01:46:19,057 --> 01:46:19,924 DISPARITIES. 2650 01:46:19,924 --> 01:46:22,460 SO THIS IS AN AREA WHERE NICHD 2651 01:46:22,460 --> 01:46:26,297 IS VERY ACTIVELY INVOLVED AS 2652 01:46:26,297 --> 01:46:26,698 WELL. 2653 01:46:26,698 --> 01:46:27,866 NEXT SLIDE. 2654 01:46:27,866 --> 01:46:28,266 NEXT SLIDE. 2655 01:46:28,266 --> 01:46:30,568 SO I MENTIONED AT THE BEGINNING 2656 01:46:30,568 --> 01:46:34,406 THAT WE'RE VERY INVOLVED IN SOME 2657 01:46:34,406 --> 01:46:36,007 OF THESE CROSS-NIH-WIDE 2658 01:46:36,007 --> 01:46:37,776 PROGRAMS, WHICH IS THE FOCUS OF 2659 01:46:37,776 --> 01:46:40,245 THE COUNCIL OF COUNCILS. 2660 01:46:40,245 --> 01:46:45,183 AND BECAUSE OF THE SERIOUS ISSUE 2661 01:46:45,183 --> 01:46:49,788 OF MATERNAL MORBIDITY AND 2662 01:46:49,788 --> 01:46:50,989 MORTALITY, WHICH IS EXCESSIVE, 2663 01:46:50,989 --> 01:46:53,925 CONSIDERING WHERE WE ARE 2664 01:46:53,925 --> 01:46:56,995 ECONOMICALLY, IN TERMS OF OUR 2665 01:46:56,995 --> 01:46:58,997 COUNTRY, WE'VE BEEN GRATEFUL IN 2666 01:46:58,997 --> 01:47:02,167 THIS YEAR'S BUDGET WE RECEIVED A 2667 01:47:02,167 --> 01:47:06,871 $40 MILLION APPROPRIATION FROM 2668 01:47:06,871 --> 01:47:09,841 CONGRESS TO CONTINUE THE 2669 01:47:09,841 --> 01:47:11,810 "IMPROVE" INITIATIVE. 2670 01:47:11,810 --> 01:47:13,311 IMPLEMENTING MATERNAL HEALTH AND 2671 01:47:13,311 --> 01:47:15,513 PREGNANCY OUTCOMES VISION FOR 2672 01:47:15,513 --> 01:47:17,782 EVERYONE, CO-LED BY NICHD, 2673 01:47:17,782 --> 01:47:20,084 NURSING INSTITUTE, OFFICE FOR 2674 01:47:20,084 --> 01:47:22,821 RESEARCH ON WOMEN'S HEALTH. 2675 01:47:22,821 --> 01:47:26,758 OUR GOALS ARE TO REDUCE 2676 01:47:26,758 --> 01:47:28,760 PREVENTIBLE CAUSES OF MATERNAL 2677 01:47:28,760 --> 01:47:30,595 MORBIDITY AND MORTALITY, 2678 01:47:30,595 --> 01:47:32,197 INCREASE LOCAL COMMUNITY 2679 01:47:32,197 --> 01:47:36,201 INVOLVEMENT TO DEVELOP LOCAL 2680 01:47:36,201 --> 01:47:37,902 SOLUTIONS, TO DO IMPLEMENTATION 2681 01:47:37,902 --> 01:47:39,270 RESEARCH TO MAKE A MEASURABLE 2682 01:47:39,270 --> 01:47:42,674 DIFFERENCE IN THE RATES OF 2683 01:47:42,674 --> 01:47:45,844 MORTALITY, AND TO ADDRESS 2684 01:47:45,844 --> 01:47:47,145 HEALTHCARE DISPARITIES, IN 2685 01:47:47,145 --> 01:47:49,314 PARTICULAR MATERNITY CARE 2686 01:47:49,314 --> 01:47:49,881 DESERTS. 2687 01:47:49,881 --> 01:47:50,782 NEXT SLIDE PLEASE. 2688 01:47:50,782 --> 01:47:54,385 I'M TRYING TO TALK ABOUT -- I 2689 01:47:54,385 --> 01:47:57,889 DON'T HAVE TIME TO TALK IN GREAT 2690 01:47:57,889 --> 01:47:59,991 DETAIL BUT SET UP TEN RESEARCH 2691 01:47:59,991 --> 01:48:02,160 CENTERS OF EXCELLENCE WITH 2692 01:48:02,160 --> 01:48:04,796 PARTNERSHIPS IN MANY AREAS OF 2693 01:48:04,796 --> 01:48:05,563 UNDERSERVED POPULATIONS. 2694 01:48:05,563 --> 01:48:06,531 WE HAVE ANOTHER CHALLENGE, SO 2695 01:48:06,531 --> 01:48:10,935 THIS IS THE CHALLENGE THAT IS 2696 01:48:10,935 --> 01:48:13,671 ONGOING RIGHT NOW, TO DEVELOP 2697 01:48:13,671 --> 01:48:16,808 NEW DIAGNOSTICS THAT COULD BE 2698 01:48:16,808 --> 01:48:18,042 APPLIED POSTPARTUM. 2699 01:48:18,042 --> 01:48:21,679 BECAUSE 60% OF MATERNAL DEATHS 2700 01:48:21,679 --> 01:48:23,281 OCCUR POSTPARTUM. 2701 01:48:23,281 --> 01:48:24,949 AND THERE'S A MAJOR NEED TO 2702 01:48:24,949 --> 01:48:27,552 IDENTIFY WOMEN WHO ARE AT RISK 2703 01:48:27,552 --> 01:48:28,653 OF SERIOUS COMPLICATIONS OR 2704 01:48:28,653 --> 01:48:30,622 DYING PARTICULARLY IF THEY LIVE 2705 01:48:30,622 --> 01:48:33,992 IN A MATERNITY CARE DESERT. 2706 01:48:33,992 --> 01:48:37,195 WE'RE ALSO TRYING TO EXPAND THE 2707 01:48:37,195 --> 01:48:39,097 KNOWLEDGE AND CAPABILITIES OF 2708 01:48:39,097 --> 01:48:43,001 LOCAL COMMUNITIES IN TERMS OF 2709 01:48:43,001 --> 01:48:45,503 DEVELOPING A RESEARCH 2710 01:48:45,503 --> 01:48:45,970 INFRASTRUCTURE. 2711 01:48:45,970 --> 01:48:49,807 AND GETTING THEM TO PARTNER IN 2712 01:48:49,807 --> 01:48:51,743 TERMS OF IMPLEMENTATION 2713 01:48:51,743 --> 01:48:52,076 RESEARCH. 2714 01:48:52,076 --> 01:48:54,546 LASTLY, IT'S VERY IMPORTANT TO 2715 01:48:54,546 --> 01:48:56,214 DEVELOP ELECTRONIC HEALTH CARE 2716 01:48:56,214 --> 01:48:58,182 RECORD STANDARDS FOR PREGNANCY 2717 01:48:58,182 --> 01:49:02,020 AND TO LINK THEM WITH THE MOTHER 2718 01:49:02,020 --> 01:49:03,454 POSTPARTUM AS WELL AS LINKING 2719 01:49:03,454 --> 01:49:05,189 WITH THE BABY TO ENABLE REAL 2720 01:49:05,189 --> 01:49:07,692 WORLD RESEARCH. 2721 01:49:07,692 --> 01:49:09,460 NEXT SLIDE PLEASE. 2722 01:49:09,460 --> 01:49:13,064 I MENTIONED INCLUDE AT THE 2723 01:49:13,064 --> 01:49:14,499 BEGINNING, LAUNCHED IN 2018, TO 2724 01:49:14,499 --> 01:49:17,468 ADVANCE THE QUALITY OF LIFE FOR 2725 01:49:17,468 --> 01:49:19,971 PEOPLE WITH DOWN SYNDROME. 2726 01:49:19,971 --> 01:49:22,273 AND IT'S UNIQUE IN THAT IT IS 2727 01:49:22,273 --> 01:49:23,708 INVESTIGATING CONDITIONS THAT 2728 01:49:23,708 --> 01:49:25,610 ARE BOTH MORE COMMON IN PEOPLE 2729 01:49:25,610 --> 01:49:28,813 WITH DOWN SYNDROME, SUCH AS 2730 01:49:28,813 --> 01:49:29,714 ALZHEIMER'S DISEASE, AND 2731 01:49:29,714 --> 01:49:32,283 CONDITIONS THAT ARE MUCH RARER 2732 01:49:32,283 --> 01:49:36,120 IN PEOPLE WHO HAVE DOWN 2733 01:49:36,120 --> 01:49:40,625 SYNDROME, SUCH AS MYOCARDIAL 2734 01:49:40,625 --> 01:49:41,025 INFARCTION. 2735 01:49:41,025 --> 01:49:43,561 AND IT ALSO HAS ALREADY 2736 01:49:43,561 --> 01:49:44,462 SIGNIFICANTLY INCREASED THE 2737 01:49:44,462 --> 01:49:46,731 NUMBER OF INVESTIGATORS AND 2738 01:49:46,731 --> 01:49:48,600 TRAINEES WHO ARE DOING RESEARCH 2739 01:49:48,600 --> 01:49:52,203 IN DOWN SYNDROME. 2740 01:49:52,203 --> 01:49:54,806 AS WELL AS INCREASING 2741 01:49:54,806 --> 01:49:56,574 PARTICIPATION IN RESEARCH ON THE 2742 01:49:56,574 --> 01:50:00,778 BASIS OF PEOPLE FROM DIVERSE 2743 01:50:00,778 --> 01:50:01,079 BACKGROUNDS. 2744 01:50:01,079 --> 01:50:04,482 THIS IS A PROGRAM THAT HAS 2745 01:50:04,482 --> 01:50:05,283 REALLY ENJOYED SIGNIFICANT 2746 01:50:05,283 --> 01:50:06,484 SUPPORT FROM CONGRESS AND IT HAS 2747 01:50:06,484 --> 01:50:08,353 THREE PARTS TO IT. 2748 01:50:08,353 --> 01:50:11,723 HIGH RISK, HIGH REWARD, BASIC 2749 01:50:11,723 --> 01:50:13,257 SCIENCE STUDIES, RATHER THAN 2750 01:50:13,257 --> 01:50:15,660 EXCLUDING PEOPLE WHO HAVE DOWN 2751 01:50:15,660 --> 01:50:17,295 SYNDROME FROM RESEARCH IT'S 2752 01:50:17,295 --> 01:50:21,699 INCLUDING, SO IT'S A PUN, 2753 01:50:21,699 --> 01:50:23,868 INCLUDE, INCLUDING PEOPLE WITH 2754 01:50:23,868 --> 01:50:27,572 DOWN SYNDROME IN RESEARCH AND 2755 01:50:27,572 --> 01:50:28,106 THEN THERE ARE ALREADY 13 2756 01:50:28,106 --> 01:50:31,109 ONGOING CLINICAL TRIALS THAT ARE 2757 01:50:31,109 --> 01:50:32,744 ADDRESSING ISSUES SUCH AS CAN 2758 01:50:32,744 --> 01:50:35,580 SLEEP APNEA STUDIES BE DONE AT 2759 01:50:35,580 --> 01:50:37,782 LOMB, HOW DO YOU TREAT 2760 01:50:37,782 --> 01:50:38,983 AUTOIMMUNE DISEASES MORE COMMON 2761 01:50:38,983 --> 01:50:41,953 IN PEOPLE WITH DOWN SYNDROME, SO 2762 01:50:41,953 --> 01:50:43,354 WE ARE ALREADY IMPROVING LIVES 2763 01:50:43,354 --> 01:50:46,958 OF PEOPLE WITH DOWN SYNDROME. 2764 01:50:46,958 --> 01:50:47,859 NEXT SLIDE. 2765 01:50:47,859 --> 01:50:50,361 SO THESE ARE SOME EXAMPLES, I'M 2766 01:50:50,361 --> 01:50:51,996 GOING TO KEEP GOING. 2767 01:50:51,996 --> 01:50:55,400 NEXT SLIDE. 2768 01:50:55,400 --> 01:50:56,701 SO I HAVE TIME. 2769 01:50:56,701 --> 01:50:58,236 THESE ARE THE EXAMPLES I 2770 01:50:58,236 --> 01:50:58,503 MENTIONED. 2771 01:50:58,503 --> 01:50:59,871 NEXT SLIDE. 2772 01:50:59,871 --> 01:51:00,772 WE'VE DEVELOPED NEW RESOURCES, 2773 01:51:00,772 --> 01:51:06,010 SO WE HAVE A NEW DATA HUB THAT 2774 01:51:06,010 --> 01:51:08,513 IS ENCOURAGING COLLABORATION. 2775 01:51:08,513 --> 01:51:12,350 IT HAS 74 TERABYTES OF DATA IN 2776 01:51:12,350 --> 01:51:17,588 TERMS OF CLINICAL PROFILES, 2777 01:51:17,588 --> 01:51:18,156 GENOMES, TRANSCRIPTOMES, 2778 01:51:18,156 --> 01:51:19,457 PROTEOME, METABOLOMES. 2779 01:51:19,457 --> 01:51:20,558 MY OWN LABORATORY TARA ALLUDED 2780 01:51:20,558 --> 01:51:23,261 TO AT THE BEGINNING, WE'RE 2781 01:51:23,261 --> 01:51:25,163 STUDYING SEVERAL MODEL, ANIMAL 2782 01:51:25,163 --> 01:51:28,766 MODELS OF DOWN SYNDROME, I'M 2783 01:51:28,766 --> 01:51:31,002 VERY EXCITED THAT DATA HUB FOR 2784 01:51:31,002 --> 01:51:32,904 THE MANY ANIMAL MODELS OF DOWN 2785 01:51:32,904 --> 01:51:34,572 SYNDROME WILL BE COMING OUT SOON 2786 01:51:34,572 --> 01:51:38,710 SO WE WILL BE ABLE TO UNDERSTAND 2787 01:51:38,710 --> 01:51:41,245 SOME OF THE DIFFERENCES THAT 2788 01:51:41,245 --> 01:51:44,382 EXIST IN THOSE MODELS, AND MAYBE 2789 01:51:44,382 --> 01:51:46,684 CUSTOMIZE DIFFERENT MODELS FOR 2790 01:51:46,684 --> 01:51:48,886 DIFFERENT APPLICATIONS. 2791 01:51:48,886 --> 01:51:50,755 WE'RE PARTICULARLY INTERESTED IN 2792 01:51:50,755 --> 01:51:54,926 PRENATAL PHENOTYPE OF THESE 2793 01:51:54,926 --> 01:51:55,259 ANIMALS. 2794 01:51:55,259 --> 01:51:56,894 NEXT SLIDE. 2795 01:51:56,894 --> 01:51:59,230 AND I BRIEFLY MENTIONED "HEAL" 2796 01:51:59,230 --> 01:51:59,964 AS WELL. 2797 01:51:59,964 --> 01:52:01,065 ONE OF OUR MOST SUCCESSFUL 2798 01:52:01,065 --> 01:52:02,834 CLINICAL TRIALS IN THE LAST FEW 2799 01:52:02,834 --> 01:52:06,304 YEARS HAS BEEN THE ACT NOW 2800 01:52:06,304 --> 01:52:11,576 STUDY, IN WHICH A LESS INVASIVE, 2801 01:52:11,576 --> 01:52:13,444 MORE FAMILY-ORIENTED APPROACH TO 2802 01:52:13,444 --> 01:52:15,613 TREATING BABIES WHO ARE 2803 01:52:15,613 --> 01:52:17,715 WITHDRAWING FROM EXPOSURE TO 2804 01:52:17,715 --> 01:52:20,017 OPIOIDS IN THE WOMB WAS COMPARED 2805 01:52:20,017 --> 01:52:22,887 TO THE TYPICAL STANDARD OF CARE 2806 01:52:22,887 --> 01:52:24,689 IN A PARTICULAR HOSPITAL. 2807 01:52:24,689 --> 01:52:27,692 AND THE RESULTS SHOWED THAT THE 2808 01:52:27,692 --> 01:52:30,628 BABIES WERE MEDICALLY READY FOR 2809 01:52:30,628 --> 01:52:33,297 DISCHARGE OVER A WEEK EARLIER 2810 01:52:33,297 --> 01:52:36,634 THAN WITH STANDARD OF CARE, AND 2811 01:52:36,634 --> 01:52:38,870 THEY USED MUCH LESS MEDICATION. 2812 01:52:38,870 --> 01:52:42,373 SO, THAT IS BEING INCORPORATED 2813 01:52:42,373 --> 01:52:44,142 INTO STANDARD OF CARE ACROSS THE 2814 01:52:44,142 --> 01:52:44,842 COUNTRY. 2815 01:52:44,842 --> 01:52:49,080 AND THEN THERE ARE SOME OTHER 2816 01:52:49,080 --> 01:52:50,414 ONGOING STUDIES. 2817 01:52:50,414 --> 01:52:51,182 WELL, PRESCRIPTION AFTER 2818 01:52:51,182 --> 01:52:54,018 CESAREAN TRIAL WAS AIMED AT 2819 01:52:54,018 --> 01:52:56,320 LOOKING AT DOES EVERYONE NEED AN 2820 01:52:56,320 --> 01:52:59,223 ENORMOUS SUPPLY OF OPIOIDS TO 2821 01:52:59,223 --> 01:53:01,793 RECOVER FROM A CESAREAN SECTION, 2822 01:53:01,793 --> 01:53:07,598 OR COULD THEY ONLY USE PAIN 2823 01:53:07,598 --> 01:53:08,699 MEDICATION AS NEEDED, ET CETERA. 2824 01:53:08,699 --> 01:53:10,001 NEXT SLIDE. 2825 01:53:10,001 --> 01:53:13,171 SO IN SUMMARY, AND I SEE THAT 2826 01:53:13,171 --> 01:53:14,605 THERE'S ALREADY A QUESTION, I 2827 01:53:14,605 --> 01:53:19,510 WANTED TO GIVE YOU A SENSE OF 2828 01:53:19,510 --> 01:53:20,945 THE VERY BROAD PORTFOLIO. 2829 01:53:20,945 --> 01:53:23,548 IT'S BROAD BUT IT'S FOCUSED IN 2830 01:53:23,548 --> 01:53:25,216 CERTAIN AREAS. 2831 01:53:25,216 --> 01:53:28,486 WE HAVE OUR KEY POPULATIONS, 2832 01:53:28,486 --> 01:53:29,387 PREGNANT AND LACTATING PEOPLE, 2833 01:53:29,387 --> 01:53:30,655 REALLY IT'S PEOPLE OF 2834 01:53:30,655 --> 01:53:33,191 REPRODUCTIVE AGE BECAUSE IT'S 2835 01:53:33,191 --> 01:53:37,895 NOT JUST FOCUSED ON PREGNANCY. 2836 01:53:37,895 --> 01:53:39,931 IT'S ACROSS THE REPRODUCTIVE 2837 01:53:39,931 --> 01:53:42,400 SPECTRUM, BOTH MALES AND 2838 01:53:42,400 --> 01:53:42,633 FEMALES. 2839 01:53:42,633 --> 01:53:45,369 CHILDREN AND PEOPLE WITH 2840 01:53:45,369 --> 01:53:46,671 PHYSICAL AND INTELLECTUAL 2841 01:53:46,671 --> 01:53:47,104 DISABILITIES. 2842 01:53:47,104 --> 01:53:50,274 WE LEAD RESEARCH ON GYNECOLOGIC 2843 01:53:50,274 --> 01:53:53,144 HEALTH, THE PLACENTA IS OUR 2844 01:53:53,144 --> 01:53:53,544 ORGAN. 2845 01:53:53,544 --> 01:53:55,847 MATERNAL HEALTH, CHILD 2846 01:53:55,847 --> 01:53:57,181 DEVELOPMENT AND INTELLECTUAL 2847 01:53:57,181 --> 01:53:59,016 DISABILITIES, AND WE ENJOY 2848 01:53:59,016 --> 01:54:01,552 PARTNERSHIP WITH MANY OTHER 2849 01:54:01,552 --> 01:54:02,086 INSTITUTES, CENTERS, AND 2850 01:54:02,086 --> 01:54:04,956 OFFICES, WHO CAN HELP US FURTHER 2851 01:54:04,956 --> 01:54:06,591 OUR MISSION AND ENABLE 2852 01:54:06,591 --> 01:54:07,091 SCIENTIFIC DISCOVERIES. 2853 01:54:07,091 --> 01:54:09,060 SO I THINK THAT'S IT. 2854 01:54:09,060 --> 01:54:12,830 AND I'M ABLE TO TAKE SOME 2855 01:54:12,830 --> 01:54:13,531 QUESTIONS. 2856 01:54:13,531 --> 01:54:14,265 NEXT SLIDE PLEASE. 2857 01:54:14,265 --> 01:54:16,434 WE CAN BRING THE SLIDES DOWN. 2858 01:54:16,434 --> 01:54:19,637 >> THANK YOU SO MUCH, DIANA. 2859 01:54:19,637 --> 01:54:20,838 YES, I EXPECTED NOTHING LESS 2860 01:54:20,838 --> 01:54:22,707 THAN TO SEE RICHARD'S HAND UP 2861 01:54:22,707 --> 01:54:23,674 RIGHT NOW. 2862 01:54:23,674 --> 01:54:24,442 RICHARD, WHY DON'T I TURN IT 2863 01:54:24,442 --> 01:54:26,644 OVER TO YOU TO ASK YOUR QUESTION 2864 01:54:26,644 --> 01:54:28,846 OR MAKE YOUR COMMENT. 2865 01:54:28,846 --> 01:54:32,016 >> THANKS VERY MUCH, DIANA. 2866 01:54:32,016 --> 01:54:33,084 NICE TO SEE YOU, ALBEIT 2867 01:54:33,084 --> 01:54:33,451 VIRTUALLY. 2868 01:54:33,451 --> 01:54:36,153 I REMEMBER THE DAY WHEN YOU 2869 01:54:36,153 --> 01:54:39,357 SHOWED UP AT THAT NOVEMBER NICHD 2870 01:54:39,357 --> 01:54:39,790 MEETING. 2871 01:54:39,790 --> 01:54:41,225 IT'S EXCITING TO SEE THE 2872 01:54:41,225 --> 01:54:42,326 PROGRESS OVER THESE YEARS. 2873 01:54:42,326 --> 01:54:46,364 IT'S HARD TO BELIEVE THAT IT'S 2874 01:54:46,364 --> 01:54:55,006 ACTUALLY THAT MANY YEARS AGO. 2875 01:54:55,006 --> 01:54:56,807 I WANTED TO CONGRATULATE YOU, 2876 01:54:56,807 --> 01:54:59,310 AND EVERYONE ELSE, WHO HAS 2877 01:54:59,310 --> 01:55:02,780 RESPONDED TO THE EFFORTS AROUND 2878 01:55:02,780 --> 01:55:04,115 DOWN SYNDROME. 2879 01:55:04,115 --> 01:55:07,652 I HAPPEN TO BE ON THE BOARD OF 2880 01:55:07,652 --> 01:55:09,787 THE GLOBAL DOWN SYNDROME 2881 01:55:09,787 --> 01:55:12,857 FOUNDATION, BACK WHEN IT STARTED 2882 01:55:12,857 --> 01:55:15,159 HERE IN DENVER, AROUND 2009. 2883 01:55:15,159 --> 01:55:16,794 AND THERE WAS ABOUT $15 MILLION 2884 01:55:16,794 --> 01:55:19,964 THAT WAS BEING SPENT ON DOWN 2885 01:55:19,964 --> 01:55:20,398 SYNDROME FUNDING. 2886 01:55:20,398 --> 01:55:22,934 AND TO SEE THE GROWTH AND 2887 01:55:22,934 --> 01:55:25,102 DEVELOPMENT OF THAT FUNDING AND 2888 01:55:25,102 --> 01:55:30,041 WHAT IT'S DONE IS TERRIFIC. 2889 01:55:30,041 --> 01:55:31,475 I WOULD ALSO LOVE TO SEE, AS YOU 2890 01:55:31,475 --> 01:55:36,047 GO INTO YOUR NEXT FIVE YEARS, OF 2891 01:55:36,047 --> 01:55:38,783 STRATEGIC PLANNING, A SIMILAR 2892 01:55:38,783 --> 01:55:42,520 KIND OF EFFORT IN THE AREA OF 2893 01:55:42,520 --> 01:55:46,691 PHYSICAL AND SEXUAL ABUSE AND 2894 01:55:46,691 --> 01:55:48,326 OTHER ADVERSE EXPERIENCES THAT 2895 01:55:48,326 --> 01:55:49,961 CHILDREN HAVE THAT WE NOW KNOW A 2896 01:55:49,961 --> 01:55:53,898 LOT MORE ABOUT THAN WE DID EIGHT 2897 01:55:53,898 --> 01:55:56,734 YEARS AGO, OF THAT IMPACT ON THE 2898 01:55:56,734 --> 01:55:58,736 THINGS THAT WE'RE ADDRESSING 2899 01:55:58,736 --> 01:56:02,106 PIECEMEAL, LIKE OBESITY AND 2900 01:56:02,106 --> 01:56:04,008 EATING DISORDERS AND SUICIDE AND 2901 01:56:04,008 --> 01:56:08,813 SUBSTANCE USE AND THE REST. 2902 01:56:08,813 --> 01:56:11,882 WE STILL HAVE A HUGE GAP IN THAT 2903 01:56:11,882 --> 01:56:12,483 AREA. 2904 01:56:12,483 --> 01:56:13,951 AND THE MORTALITY OF CHILDREN 2905 01:56:13,951 --> 01:56:18,122 WHO DIE OF PHYSICAL ABUSE IS 2906 01:56:18,122 --> 01:56:18,823 UNCHANGED IN 40 YEARS. 2907 01:56:18,823 --> 01:56:25,596 AND IT WOULD BE NICE TO SEE SOME 2908 01:56:25,596 --> 01:56:26,664 PROGRESS IN THAT AREA. 2909 01:56:26,664 --> 01:56:27,531 BUT THAT'S ALL. 2910 01:56:27,531 --> 01:56:29,467 I DON'T HAVE A QUESTION. 2911 01:56:29,467 --> 01:56:31,702 IT'S JUST I DON'T SIT ON YOUR 2912 01:56:31,702 --> 01:56:34,672 COUNCIL ANYMORE SO I CAN'T 2913 01:56:34,672 --> 01:56:35,306 WHINE. 2914 01:56:35,306 --> 01:56:36,807 >> SO FIRST OF ALL, THANK YOU 2915 01:56:36,807 --> 01:56:41,012 FOR YOUR SERVICE ON OUR COUNCI. 2916 01:56:41,012 --> 01:56:42,980 WE'LL BE HAVING A REQUEST FOR 2917 01:56:42,980 --> 01:56:49,353 INFORMATION IN THE NEXT FEW 2918 01:56:49,353 --> 01:56:50,554 MONTHS, I WILL INCORPORATE 2919 01:56:50,554 --> 01:56:52,323 INCLUDE YOUR COMMENTS IN 2920 01:56:52,323 --> 01:56:53,524 STRATEGIC PLANNING MEETINGS. 2921 01:56:53,524 --> 01:56:55,359 WE'RE THINKING ABOUT TRAUMA OF 2922 01:56:55,359 --> 01:56:57,228 ALL KINDS, NOT ONLY PHYSICAL AND 2923 01:56:57,228 --> 01:57:01,065 SEXUAL, BUT I TOTALLY AGREE WITH 2924 01:57:01,065 --> 01:57:04,368 YOU THAT THOSE KINDS OF TRAUMAS 2925 01:57:04,368 --> 01:57:07,538 REALLY UNDERLIE OTHER 2926 01:57:07,538 --> 01:57:08,806 CONDITIONS. 2927 01:57:08,806 --> 01:57:11,142 AND WE MAY NOT KNOW WHY SOMEONE 2928 01:57:11,142 --> 01:57:12,676 IS MASSIVELY OBESE OR HAVING 2929 01:57:12,676 --> 01:57:17,648 MENTAL HEALTH ISSUES, UNLESS WE 2930 01:57:17,648 --> 01:57:18,916 ADDRESS THOSE UNDERLYING ISSUES. 2931 01:57:18,916 --> 01:57:21,352 I TOTALLY AGREE IT'S SUPER 2932 01:57:21,352 --> 01:57:23,320 IMPORTANT TO INCLUDE THAT AND 2933 01:57:23,320 --> 01:57:26,824 ENCOURAGE YOU TO RESPOND TO THE 2934 01:57:26,824 --> 01:57:28,359 RFI. 2935 01:57:28,359 --> 01:57:32,263 I WANT TO THANK ADVOCACY OF 2936 01:57:32,263 --> 01:57:33,998 GLOBAL DOWN SYNDROME FOUNDATION 2937 01:57:33,998 --> 01:57:40,371 FOR -- MICHELLE WITTEN IS 2938 01:57:40,371 --> 01:57:43,407 TIRELESS IN TERMS OF TALKING 2939 01:57:43,407 --> 01:57:46,944 WITH MEMBERS OF CONGRESS, MAKING 2940 01:57:46,944 --> 01:57:49,780 THE WORK KNOWN. 2941 01:57:49,780 --> 01:57:51,148 AS SOMEONE, BOTH CLINICS AND 2942 01:57:51,148 --> 01:57:53,384 RESEARCHERS IN DOWN SYNDROME 2943 01:57:53,384 --> 01:57:54,385 FIELD, IT'S REALLY UNBELIEVABLE 2944 01:57:54,385 --> 01:57:56,787 TO SEE WHAT THAT MONEY HAS DONE. 2945 01:57:56,787 --> 01:58:01,692 YOU KNOW, WHEN YOU GO TO THE 2946 01:58:01,692 --> 01:58:02,359 TRISOMY 21 RESEARCH MEETINGS, 2947 01:58:02,359 --> 01:58:04,762 THE NEXT ONE IS NEXT WEEK 2948 01:58:04,762 --> 01:58:10,134 ACTUALLY, BUT WHEN YOU SEE THE 2949 01:58:10,134 --> 01:58:11,669 POPULATIONS OF POSTDOCS OR 2950 01:58:11,669 --> 01:58:13,070 GRADUATE STUDENTS WHO REALLY SEE 2951 01:58:13,070 --> 01:58:19,110 THIS AS A VIABLE FIELD NOW, IT'S 2952 01:58:19,110 --> 01:58:19,643 AMAZING. 2953 01:58:19,643 --> 01:58:22,580 AND THE FACT THAT IT'S 2954 01:58:22,580 --> 01:58:23,747 TRANSLATED TO ACTUAL MEASURABLE 2955 01:58:23,747 --> 01:58:26,884 IMPROVEMENTS IN THE LIVES OF 2956 01:58:26,884 --> 01:58:27,751 PEOPLE WITH DOWN SYNDROME, IT 2957 01:58:27,751 --> 01:58:30,154 SHOWS YOU WHAT CAN BE DONE WITH 2958 01:58:30,154 --> 01:58:32,957 FUNDING. 2959 01:58:32,957 --> 01:58:33,357 >> GREAT. 2960 01:58:33,357 --> 01:58:36,393 IT'S A REALLY AMAZING PROGRAM. 2961 01:58:36,393 --> 01:58:37,828 ALL RIGHT. 2962 01:58:37,828 --> 01:58:40,531 I KNOW MONICA HAD A QUESTION AND 2963 01:58:40,531 --> 01:58:42,299 THEN KENT HAD SOMETHING IN THE 2964 01:58:42,299 --> 01:58:42,633 CHAT. 2965 01:58:42,633 --> 01:58:45,369 WE'LL TURN IT TO MONICA FIRST. 2966 01:58:45,369 --> 01:58:46,971 >> THANK YOU SO MUCH FOR THAT 2967 01:58:46,971 --> 01:58:48,105 PRESENTATION. 2968 01:58:48,105 --> 01:58:49,540 THAT WAS REALLY GREAT. 2969 01:58:49,540 --> 01:58:54,011 I WANTED TO TURN TO HIV FOR A 2970 01:58:54,011 --> 01:58:55,613 MINUTE BECAUSE NICHD IS PIVOTAL 2971 01:58:55,613 --> 01:59:01,852 AND HAS BEEN FOR THE WOMEN TO 2972 01:59:01,852 --> 01:59:03,721 FETAL TRANSMISSION STUDIES AND 2973 01:59:03,721 --> 01:59:05,456 PEDIATRIC HIV, BUT IT'S SO 2974 01:59:05,456 --> 01:59:06,991 UNDERFUNDED IN THE SENSE THAT 2975 01:59:06,991 --> 01:59:08,192 CHILDREN LIVING WITH HIV 2976 01:59:08,192 --> 01:59:09,727 WORLDWIDE, THE GROUP THAT'S 2977 01:59:09,727 --> 01:59:17,601 DOING THE LEAST WELL IN TERMS OF 2978 01:59:17,601 --> 01:59:18,402 ACCESS TO ANTIRETROVIRAL 2979 01:59:18,402 --> 01:59:19,136 THERAPY, SUPPRESSION RATES. 2980 01:59:19,136 --> 01:59:20,571 I WANTED TO SEE IF YOU THINK 2981 01:59:20,571 --> 01:59:22,006 THERE'S A POSSIBILITY OF 2982 01:59:22,006 --> 01:59:24,074 REDIRECTING MORE RESERVES INTO 2983 01:59:24,074 --> 01:59:26,377 HIV AND PEDIATRIC HIV, GIVEN HOW 2984 01:59:26,377 --> 01:59:29,647 ONLY NICHD KIND OF HAS THAT 2985 01:59:29,647 --> 01:59:31,282 PURVIEW, THAT'S ONE QUESTION. 2986 01:59:31,282 --> 01:59:34,218 AND THEN I THINK THAT NICHD HAS 2987 01:59:34,218 --> 01:59:37,855 REALLY PUSHED THE ENVELOPE IN 2988 01:59:37,855 --> 01:59:40,591 TERMS OF STUDYING HIV DRUGS AND 2989 01:59:40,591 --> 01:59:42,326 PREGNANCY, WHY THAT FIELD SHOWED 2990 01:59:42,326 --> 01:59:44,728 US WE SHOULD BE JUSTIFYING 2991 01:59:44,728 --> 01:59:46,964 EXCLUSION RATHER THAN INCLUSION 2992 01:59:46,964 --> 01:59:48,132 OF PREGNANT WOMEN. 2993 01:59:48,132 --> 01:59:48,465 >> RIGHT. 2994 01:59:48,465 --> 01:59:51,635 WELL, THANK YOU FOR YOUR 2995 01:59:51,635 --> 01:59:52,836 QUESTION, DR. GANDHI. 2996 01:59:52,836 --> 01:59:54,371 YOU KNOW, WE'RE FORTUNATE IN 2997 01:59:54,371 --> 01:59:57,208 THAT MUCH OF OUR HIV PORTFOLIO 2998 01:59:57,208 --> 02:00:03,647 IS FUNDED BY THE OFFICE OF AIDS 2999 02:00:03,647 --> 02:00:05,616 RESEARCH AT NIH. 3000 02:00:05,616 --> 02:00:07,918 WE TYPICALLY PUT FORWARD 3001 02:00:07,918 --> 02:00:09,653 WHATEVER WE CAN, AND IN GENERAL 3002 02:00:09,653 --> 02:00:13,224 THEY ARE VERY GENEROUS IN 3003 02:00:13,224 --> 02:00:17,661 FUNDING US, IF IT IS MAINLY OR 3004 02:00:17,661 --> 02:00:18,762 ALMOST EXCLUSIVELY AFFECTING 3005 02:00:18,762 --> 02:00:20,931 POPULATIONS WITH HIV. 3006 02:00:20,931 --> 02:00:27,838 I MEAN, WE HAVE A NUMBER OF 3007 02:00:27,838 --> 02:00:30,374 PARTICULARLY INTERNATIONAL 3008 02:00:30,374 --> 02:00:32,977 GROUPS THAT ARE STUDYING WOMEN 3009 02:00:32,977 --> 02:00:35,179 AND INFANTS WITH HIV, AND IN 3010 02:00:35,179 --> 02:00:37,214 FACT, YOU KNOW, IN KENYA, I WENT 3011 02:00:37,214 --> 02:00:39,116 TO KENYA A NUMBER OF YEARS AGO 3012 02:00:39,116 --> 02:00:41,619 TO MEET WITH OUR INVESTIGATORS 3013 02:00:41,619 --> 02:00:45,889 WHO ALMOST ALL WERE BEING FUNDED 3014 02:00:45,889 --> 02:00:47,324 TO DO HIV, PERINATAL AND 3015 02:00:47,324 --> 02:00:48,259 MATERNAL STUDIES. 3016 02:00:48,259 --> 02:00:48,892 THAT BEING SAID, IN THE UNITED 3017 02:00:48,892 --> 02:00:56,734 STATES WE HAVE A BIG ISSUE, 3018 02:00:56,734 --> 02:00:57,835 GROWTH OF HIV, PARTICULARLY 3019 02:00:57,835 --> 02:00:59,803 YOUNG MEN HAVING SEX WITH YOUNG 3020 02:00:59,803 --> 02:00:59,970 MEN. 3021 02:00:59,970 --> 02:01:01,672 THAT'S A REAL CHALLENGE FOR US 3022 02:01:01,672 --> 02:01:02,640 STILL. 3023 02:01:02,640 --> 02:01:07,144 AND IT'S BEEN IDENTIFIED AS 3024 02:01:07,144 --> 02:01:07,344 SUCH. 3025 02:01:07,344 --> 02:01:09,246 SO, YOU KNOW, WE TRY TO USE 3026 02:01:09,246 --> 02:01:10,981 RESOURCES THAT ARE AVAILABLE TO 3027 02:01:10,981 --> 02:01:14,451 US, AND WORK WITH OFFICE OF AIDS 3028 02:01:14,451 --> 02:01:19,290 RESEARCH TO SHOW THEM EVERYTHING 3029 02:01:19,290 --> 02:01:20,491 THAT WE'RE DOING. 3030 02:01:20,491 --> 02:01:24,328 AND, YOU KNOW, SURE, WE CAN DO 3031 02:01:24,328 --> 02:01:24,862 MORE. 3032 02:01:24,862 --> 02:01:28,999 >> AND THE REP THAT NICHD HAS TO 3033 02:01:28,999 --> 02:01:32,770 OAR IS REALLY ACTIVE, VERY MUCH 3034 02:01:32,770 --> 02:01:37,441 A LEADER IN THAT AREA ACROSS ALL 3035 02:01:37,441 --> 02:01:39,977 OF NIH AND OF COURSE WE'RE IN 3036 02:01:39,977 --> 02:01:42,479 THE PROCESS OF SEARCHING FOR A 3037 02:01:42,479 --> 02:01:44,014 NEW OAR DIRECTOR, WE CAN HAVE 3038 02:01:44,014 --> 02:01:45,883 MORE DISCUSSIONS ON THIS, 3039 02:01:45,883 --> 02:01:48,485 MONICA, DOWN THE ROAD. 3040 02:01:48,485 --> 02:01:48,752 >> YEAH. 3041 02:01:48,752 --> 02:01:49,620 >> PERSON ON BOARD. 3042 02:01:49,620 --> 02:01:51,889 >> GREAT, THANK YOU SO MUCH. 3043 02:01:51,889 --> 02:01:53,457 >> DR. LLOYD HAD A QUESTION AND 3044 02:01:53,457 --> 02:01:56,593 THEN DR. KING. 3045 02:01:56,593 --> 02:01:56,894 >> YEP. 3046 02:01:56,894 --> 02:01:58,796 >> VERY QUICKLY, THANKS VERY 3047 02:01:58,796 --> 02:02:00,230 MUCH FOR THE PRESENTATION. 3048 02:02:00,230 --> 02:02:03,967 I THOUGHT I KNEW SO MUCH, BUT I 3049 02:02:03,967 --> 02:02:05,069 REALIZE AFTER HEARING YOU TALK 3050 02:02:05,069 --> 02:02:10,107 HOW LITTLE I KNEW ABOUT NICHD, 3051 02:02:10,107 --> 02:02:14,778 IMPRESSED WITH THE STRENGTH AND 3052 02:02:14,778 --> 02:02:15,012 BREADTH. 3053 02:02:15,012 --> 02:02:16,180 IF I MISSED, FORGIVE ME, WHAT 3054 02:02:16,180 --> 02:02:18,082 INTERACTION DO YOU HAVE WITH THE 3055 02:02:18,082 --> 02:02:19,383 "ALL OF US" PROGRAM IN TERMS OF 3056 02:02:19,383 --> 02:02:23,554 GROWING CHILDREN AND YOUNG 3057 02:02:23,554 --> 02:02:24,621 ADULTS? 3058 02:02:24,621 --> 02:02:28,258 >> YEAH, GREAT QUESTION. 3059 02:02:28,258 --> 02:02:30,728 SO, I'VE BEEN INVOLVED ON THE 3060 02:02:30,728 --> 02:02:32,396 STEERING COMMITTEE FOR "ALL OF 3061 02:02:32,396 --> 02:02:33,964 US" FOR ALMOST ALL THE TIME I'VE 3062 02:02:33,964 --> 02:02:36,900 BEEN HERE AND DURING THAT TIME 3063 02:02:36,900 --> 02:02:39,770 WE'VE ASKED EVERY YEAR WHEN ARE 3064 02:02:39,770 --> 02:02:43,841 CHILDREN GOING TO BE INCLUDED. 3065 02:02:43,841 --> 02:02:45,209 AND THEY HAVE MADE PARTICULARLY 3066 02:02:45,209 --> 02:02:48,812 THE LAST COUPLE YEARS SINCE THE 3067 02:02:48,812 --> 02:02:53,784 RECRUITMENT OF SARAH VAN DREYS, 3068 02:02:53,784 --> 02:02:56,186 A PEDIATRICIAN, THE LEAD 3069 02:02:56,186 --> 02:02:57,621 PEDIATRICS ON "ALL OF US," THEY 3070 02:02:57,621 --> 02:03:00,257 MADE A LOT OF PROGRESS IN TERMS 3071 02:03:00,257 --> 02:03:02,426 OF DEVELOPING AND INFRASTRUCTURE 3072 02:03:02,426 --> 02:03:08,766 THAT WILL ALLOW FOR RECRUITMENT 3073 02:03:08,766 --> 02:03:09,967 OF CHILDREN STARTING WITH 3074 02:03:09,967 --> 02:03:11,268 YOUNGER CHILDREN BORN TO WOMEN 3075 02:03:11,268 --> 02:03:12,403 ALREADY ENROLLED IN "ALL OF US" 3076 02:03:12,403 --> 02:03:13,637 BECAUSE THERE ARE A LOT OF 3077 02:03:13,637 --> 02:03:15,305 PREGNANT WOMEN IN "ALL OF US." 3078 02:03:15,305 --> 02:03:16,740 THAT'S THE GOOD NEWS. 3079 02:03:16,740 --> 02:03:21,678 THE BAD NEWS IS THE "ALL OF US" 3080 02:03:21,678 --> 02:03:27,184 PROGRAM TOOK A SIGNIFICANT, I 3081 02:03:27,184 --> 02:03:28,886 MEAN MAJOR, $184 MILLION HIT IN 3082 02:03:28,886 --> 02:03:32,289 TERMS OF THEIR BUDGET, JUST A 3083 02:03:32,289 --> 02:03:35,559 DEVASTATING CUT, AT A TIME -- 3084 02:03:35,559 --> 02:03:38,762 YEAH, 34%, AT A TIME WHEN THEY 3085 02:03:38,762 --> 02:03:41,165 WERE JUST STARTING TO RECRUIT 3086 02:03:41,165 --> 02:03:42,766 CHILDREN. 3087 02:03:42,766 --> 02:03:45,769 SO, THEY ARE LOOKING FOR SOME 3088 02:03:45,769 --> 02:03:47,171 SUPPORT FROM OTHER INSTITUTES 3089 02:03:47,171 --> 02:03:51,341 AND CENTERS TO TRY TO KEEP AS 3090 02:03:51,341 --> 02:03:52,776 MUCH OF THE PROGRAM GOING. 3091 02:03:52,776 --> 02:03:54,511 WE'RE HOPING TO BE ABLE TO 3092 02:03:54,511 --> 02:03:57,147 SUPPORT THEM TO MAINTAIN AT 3093 02:03:57,147 --> 02:04:00,217 LEAST A COUPLE CENTERS THAT ARE 3094 02:04:00,217 --> 02:04:02,186 ALREADY DIALED UP AND READY TO 3095 02:04:02,186 --> 02:04:02,352 GO. 3096 02:04:02,352 --> 02:04:04,721 THEY MAY NOT BE ABLE TO HAVE AS 3097 02:04:04,721 --> 02:04:06,356 MANY AS THEY THOUGHT THEY COULD, 3098 02:04:06,356 --> 02:04:07,991 BUT WE THINK IT'S REALLY 3099 02:04:07,991 --> 02:04:11,228 IMPORTANT NOT TO LOSE MOMENTUM 3100 02:04:11,228 --> 02:04:12,496 BECAUSE WE'VE BEEN WAITING FOR 3101 02:04:12,496 --> 02:04:15,365 SO LONG TO GET KIDS INTO "ALL OF 3102 02:04:15,365 --> 02:04:15,532 US." 3103 02:04:15,532 --> 02:04:16,900 YOU'RE RIGHT, YOU DIDN'T MISS 3104 02:04:16,900 --> 02:04:17,968 IT. 3105 02:04:17,968 --> 02:04:19,937 I DIDN'T HAVE TIME TO INCLUDE 3106 02:04:19,937 --> 02:04:20,103 IT. 3107 02:04:20,103 --> 02:04:22,573 >> IT'S STILL ONE OF THE TOP 3108 02:04:22,573 --> 02:04:24,341 PRIORITIES FOR THE PROGRAM, JUST 3109 02:04:24,341 --> 02:04:26,210 THE BUDGET CHALLENGES ARE A 3110 02:04:26,210 --> 02:04:27,511 MAJOR ISSUE RIGHT NOW. 3111 02:04:27,511 --> 02:04:31,215 JEAN, YOU ARE OUR LAST QUESTION. 3112 02:04:31,215 --> 02:04:31,482 >> OKAY. 3113 02:04:31,482 --> 02:04:32,316 THANK YOU. 3114 02:04:32,316 --> 02:04:34,952 THANK YOU FOR THE PRESENTATION. 3115 02:04:34,952 --> 02:04:37,654 SO MY CONCERN, I KNOW YOU 3116 02:04:37,654 --> 02:04:38,755 MENTIONED DISPARITIES, HEALTH 3117 02:04:38,755 --> 02:04:39,556 DISPARITIES IN PREGNANCY. 3118 02:04:39,556 --> 02:04:41,492 I THINK WE ALL KNOW FROM THE CDC 3119 02:04:41,492 --> 02:04:43,927 AND OTHER PLACES THAT BLACK 3120 02:04:43,927 --> 02:04:46,096 WOMEN ARE THREE TIMES MORE 3121 02:04:46,096 --> 02:04:47,931 LIKELY TO DIE OF 3122 02:04:47,931 --> 02:04:50,133 PREGNANCY-RELATED CAUSES THAN 3123 02:04:50,133 --> 02:04:51,001 WHITE WOMEN. 3124 02:04:51,001 --> 02:04:53,403 AND THAT'S WORSE THAN MANY THIRD 3125 02:04:53,403 --> 02:04:54,404 WORLD COUNTRIES. 3126 02:04:54,404 --> 02:04:57,474 I CANNOT -- I STILL CAN'T REALLY 3127 02:04:57,474 --> 02:04:59,209 SORT OF UNDERSTAND WHY WE'RE NOT 3128 02:04:59,209 --> 02:05:00,844 DOING MORE RESEARCH TO TRY TO 3129 02:05:00,844 --> 02:05:03,247 FIGURE OUT WAYS THAT WE COULD 3130 02:05:03,247 --> 02:05:03,514 HELP. 3131 02:05:03,514 --> 02:05:05,883 WE'RE LOSING A WHOLE GENERATION 3132 02:05:05,883 --> 02:05:07,217 OF PEOPLE THROUGH THESE REASONS 3133 02:05:07,217 --> 02:05:11,588 THAT ARE I THINK WE HAD SOLVED 3134 02:05:11,588 --> 02:05:13,423 FOR MANY YEARS, DOESN'T MATTER 3135 02:05:13,423 --> 02:05:15,526 SES OF BLACK WOMEN, IF SHE'S 3136 02:05:15,526 --> 02:05:16,426 COLLEGE EDUCATED, SO IT'S NOT 3137 02:05:16,426 --> 02:05:19,029 SOME OF THE THINGS WE MAY THINK 3138 02:05:19,029 --> 02:05:21,865 ABOUT THAT IS JUST AROUND 3139 02:05:21,865 --> 02:05:22,099 POVERTY. 3140 02:05:22,099 --> 02:05:23,967 YES, POVERTY PLAYS A ROLE BUT 3141 02:05:23,967 --> 02:05:25,802 THERE'S SO MANY THINGS WE DON'T 3142 02:05:25,802 --> 02:05:30,407 UNDERSTAND, WHY WOMEN WHO ARE 3143 02:05:30,407 --> 02:05:31,742 COLLEGE EDUCATED, IN SES BRACKET 3144 02:05:31,742 --> 02:05:33,377 WE WOULDN'T EXPECT THIS TO BE 3145 02:05:33,377 --> 02:05:36,880 HAPPENING AT THIS LEVEL. 3146 02:05:36,880 --> 02:05:38,849 SO I'M NOT SURE WHICH AGENCIES 3147 02:05:38,849 --> 02:05:40,484 HAD HELPING, HOW YOU'RE THINKING 3148 02:05:40,484 --> 02:05:43,654 ABOUT, NOT SOMETHING YOU CAN 3149 02:05:43,654 --> 02:05:45,455 SOLVE ALONE BUT IS THERE ANY WAY 3150 02:05:45,455 --> 02:05:47,624 WE CAN HELP AS A COUNCIL TO DRAW 3151 02:05:47,624 --> 02:05:49,359 ATTENTION TO FORCES THAT 3152 02:05:49,359 --> 02:05:53,630 CONTINUE TO REALLY RAGE IN OUR 3153 02:05:53,630 --> 02:05:54,197 COMMUNITIES? 3154 02:05:54,197 --> 02:05:55,599 >> YEAH, I AGREE 100%. 3155 02:05:55,599 --> 02:05:59,202 I OFTEN FRAME IT AS THE SERENA 3156 02:05:59,202 --> 02:06:01,271 WILLIAMS PROBLEM. 3157 02:06:01,271 --> 02:06:05,909 SERENA WILLIAMS IS WELL 3158 02:06:05,909 --> 02:06:07,110 EDUCATED, WEALTHY, INTERNATIONAL 3159 02:06:07,110 --> 02:06:09,379 SUPERSTAR, AND YET HER CARE 3160 02:06:09,379 --> 02:06:10,581 PROVIDERS DIDN'T LISTEN TO HER 3161 02:06:10,581 --> 02:06:13,016 WHEN SHE SAID I CAN'T BREATHE, 3162 02:06:13,016 --> 02:06:15,752 AND I KNOW I'VE HAD BLOOD CLOTS 3163 02:06:15,752 --> 02:06:19,056 BEFORE AND KNOW WHAT THAT FEELS 3164 02:06:19,056 --> 02:06:19,590 LIKE. 3165 02:06:19,590 --> 02:06:21,024 AND YET THEY STILL DIDN'T LISTEN 3166 02:06:21,024 --> 02:06:21,692 TO HER. 3167 02:06:21,692 --> 02:06:24,094 IF THAT CAN HAPPEN TO SERENA 3168 02:06:24,094 --> 02:06:25,395 WILLIAMS, IT CAN HAPPEN TO 3169 02:06:25,395 --> 02:06:26,029 ANYBODY. 3170 02:06:26,029 --> 02:06:28,999 THERE'S NO DOUBT THAT BLACK 3171 02:06:28,999 --> 02:06:31,935 WOMEN AND AMERICAN INDIANS AND 3172 02:06:31,935 --> 02:06:35,572 ALASKA NATIVE WOMEN ARE ALSO 3173 02:06:35,572 --> 02:06:37,341 EXPERIENCING INCREASED RATES OF 3174 02:06:37,341 --> 02:06:39,977 MORTALITY COMPARED TO WHITE 3175 02:06:39,977 --> 02:06:40,811 WOMEN AND HISPANIC WOMEN. 3176 02:06:40,811 --> 02:06:43,347 I DIDN'T HAVE TIME TO GO INTO 3177 02:06:43,347 --> 02:06:44,014 ALL THE DETAILS. 3178 02:06:44,014 --> 02:06:46,183 I'M HAPPY TO COME BACK AT A 3179 02:06:46,183 --> 02:06:52,055 FUTURE TIME TO TALK ABOUT THE 3180 02:06:52,055 --> 02:06:52,556 "IMPROVE" INITIATIVE. 3181 02:06:52,556 --> 02:06:54,725 BUT THERE ARE SPECIFIC ASPECTS 3182 02:06:54,725 --> 02:06:56,960 IN THE CENTERS OF EXCELLENCE, 3183 02:06:56,960 --> 02:07:00,330 FOR EXAMPLE, TRYING TO ADDRESS 3184 02:07:00,330 --> 02:07:01,898 THE SOCIAL AND BEHAVIORAL 3185 02:07:01,898 --> 02:07:03,967 ASPECTS, HOW MUCH DOES RACISM 3186 02:07:03,967 --> 02:07:06,036 PLAY A ROLE, HOW MUCH DOES 3187 02:07:06,036 --> 02:07:08,939 WEATHERING PLAY A ROLE IN THIS? 3188 02:07:08,939 --> 02:07:10,841 THIS IS PART OF THE REASON WHY 3189 02:07:10,841 --> 02:07:14,678 IT'S SO IMPORTANT TO HAVE THE 3190 02:07:14,678 --> 02:07:16,113 COMMUNITY INVOLVEMENT, BECAUSE 3191 02:07:16,113 --> 02:07:19,049 IT'S ONE THING FOR A WHITE 3192 02:07:19,049 --> 02:07:19,850 PHYSICIAN, ACADEMIC MEDICAL 3193 02:07:19,850 --> 02:07:21,718 CENTER, TO SAY SOMETHING TO A 3194 02:07:21,718 --> 02:07:23,920 PREGNANT PERSON OF COLOR BUT 3195 02:07:23,920 --> 02:07:25,555 IT'S ANOTHER THING IF YOU TRAIN 3196 02:07:25,555 --> 02:07:28,091 PEOPLE IN THE COMMUNITY AND 3197 02:07:28,091 --> 02:07:29,660 THERE'S A COMMUNITY EFFORT TO 3198 02:07:29,660 --> 02:07:32,129 INVOLVE DOULAS, FOR EXAMPLE, OR 3199 02:07:32,129 --> 02:07:33,630 TO INVOLVE CARE PROVIDERS WHO 3200 02:07:33,630 --> 02:07:36,400 MAY NOT BE PHYSICIANS BUT WHO 3201 02:07:36,400 --> 02:07:38,802 ARE FAMILIAR WITH THE CULTURE 3202 02:07:38,802 --> 02:07:41,405 AND PRACTICE IN THAT COMMUNITY. 3203 02:07:41,405 --> 02:07:44,174 SO, WE ARE VERY AWARE OF THE 3204 02:07:44,174 --> 02:07:44,708 DISPARITIES. 3205 02:07:44,708 --> 02:07:47,978 IT'S NOT JUST AN ACCESS ISSUE, 3206 02:07:47,978 --> 02:07:50,280 ALTHOUGH ACCESS IS EXTREMELY 3207 02:07:50,280 --> 02:07:51,915 IMPORTANT HERE, BECAUSE THERE 3208 02:07:51,915 --> 02:07:53,016 ARE TWO MILLION PREGNANT WOMEN 3209 02:07:53,016 --> 02:07:56,820 WHO ARE LIVING IN MATERNITY CARE 3210 02:07:56,820 --> 02:07:59,289 DESERTS, AND THESE ARE BOTH 3211 02:07:59,289 --> 02:08:00,724 RURAL AND URBAN AREAS. 3212 02:08:00,724 --> 02:08:03,226 BUT WHEN WE SAY MATERNITY CARE 3213 02:08:03,226 --> 02:08:05,629 DESERT, THERE'S NOT ONE 3214 02:08:05,629 --> 02:08:08,365 OBSTETRICIAN IN THEIR COUNTY. 3215 02:08:08,365 --> 02:08:11,301 SO, I RECENTLY SPOKE AT A 3216 02:08:11,301 --> 02:08:14,905 CONGRESSIONAL BRIEFING WITH A 3217 02:08:14,905 --> 02:08:16,139 PROVIDER, OBSTETRICIAN FROM 3218 02:08:16,139 --> 02:08:17,107 GEORGIA, SHE'S COVERING TWO 3219 02:08:17,107 --> 02:08:20,711 COUNTIES IN GEORGIA. 3220 02:08:20,711 --> 02:08:21,912 SHE'S THE ONLY OBSTETRICIAN. 3221 02:08:21,912 --> 02:08:24,748 AND IT'S NOT JUST THE CARE. 3222 02:08:24,748 --> 02:08:25,649 IT'S TRANSPORT. 3223 02:08:25,649 --> 02:08:27,484 IN MANY OF THESE RURAL 3224 02:08:27,484 --> 02:08:28,618 COMMUNITIES, WE CAN DEVELOP A 3225 02:08:28,618 --> 02:08:29,820 DEVICE THAT'S GOING TO SAY 3226 02:08:29,820 --> 02:08:31,455 SOMEONE IS AT RISK FOR 3227 02:08:31,455 --> 02:08:32,756 HEMORRHAGE, BUT WE'VE GOT TO GET 3228 02:08:32,756 --> 02:08:35,058 THEM OUT OF THAT COMMUNITY TO BE 3229 02:08:35,058 --> 02:08:37,360 ABLE TO BE TREATED. 3230 02:08:37,360 --> 02:08:38,662 AND I'VE LEARNED INCREASINGLY 3231 02:08:38,662 --> 02:08:41,631 OVER THE LAST FEW MONTHS WHAT A 3232 02:08:41,631 --> 02:08:43,500 CHALLENGE THAT IS. 3233 02:08:43,500 --> 02:08:45,035 SO IT'S A VERY COMPLEX PROBLEM, 3234 02:08:45,035 --> 02:08:47,404 ALL I CAN DO NOW IS ASSURE YOU 3235 02:08:47,404 --> 02:08:50,674 THAT IT IS A MAJOR FOCUS OF THE 3236 02:08:50,674 --> 02:08:53,009 "IMPROVE" INITIATIVE TO ADDRESS 3237 02:08:53,009 --> 02:08:53,610 DISPARITIES. 3238 02:08:53,610 --> 02:08:55,979 YOU KNOW, TO BEGIN TO BRING 3239 02:08:55,979 --> 02:08:57,080 OVERALL NUMBERS DOWN BUT 3240 02:08:57,080 --> 02:09:02,753 PARTICULARLY IN COMMUNITIES OF 3241 02:09:02,753 --> 02:09:03,186 COLOR. 3242 02:09:03,186 --> 02:09:04,421 >> THANKS SO MUCH, DIANA. 3243 02:09:04,421 --> 02:09:06,056 OBVIOUSLY SUCH AN IMPORTANT 3244 02:09:06,056 --> 02:09:09,659 TOPIC, AND A LOT MORE WORK THAT 3245 02:09:09,659 --> 02:09:12,062 WE AND OTHER AGENCIES AND 3246 02:09:12,062 --> 02:09:12,829 ORGANIZATIONS AND PARTNERS 3247 02:09:12,829 --> 02:09:14,464 ACROSS THE U.S. NEED TO SPEND 3248 02:09:14,464 --> 02:09:17,434 MORE EFFORT ON. 3249 02:09:17,434 --> 02:09:21,037 REALLY APPRECIATE YOU THINKING 3250 02:09:21,037 --> 02:09:22,572 OF SPENDING EFFORT, SPENDING 3251 02:09:22,572 --> 02:09:23,540 TIME WITH US TODAY TO TALK ALL 3252 02:09:23,540 --> 02:09:26,943 OF THE WIDE VARIETY OF THINGS 3253 02:09:26,943 --> 02:09:28,044 NICHD IS DOING AND MIGHT TAKE 3254 02:09:28,044 --> 02:09:30,113 YOU UP ON THE OFFER TO COME BACK 3255 02:09:30,113 --> 02:09:32,082 AND TALK ABOUT IMPROVE IN MORE 3256 02:09:32,082 --> 02:09:33,850 DETAIL AT FUTURE COUNCIL 3257 02:09:33,850 --> 02:09:35,152 MEETING. 3258 02:09:35,152 --> 02:09:35,552 >> GREAT. 3259 02:09:35,552 --> 02:09:37,521 THANKS FOR THE INVITATION. 3260 02:09:37,521 --> 02:09:38,088 TAKE CARE. 3261 02:09:38,088 --> 02:09:38,989 >> ALL RIGHT. 3262 02:09:38,989 --> 02:09:42,826 NOW WE'RE GOING TO TRANSITION TO 3263 02:09:42,826 --> 02:09:47,831 OUR NEXT TOPIC, A CONCEPT 3264 02:09:47,831 --> 02:09:49,366 CLEARANCE FOR. 3265 02:09:49,366 --> 02:09:57,240 AND SUSAN GREGURICK AND LAWYER 3266 02:09:57,240 --> 02:09:59,743 BIVEN FROM ODDS AND CHRISTINE 3267 02:09:59,743 --> 02:10:01,178 CUTILLO WILL TALK ABOUT 3268 02:10:01,178 --> 02:10:02,412 PREPARING THE NEXT GENERATION OF 3269 02:10:02,412 --> 02:10:04,381 BIOMEDICAL RESEARCH TEAMS FOR 3270 02:10:04,381 --> 02:10:06,016 ETHICAL A.I. WORKFORCE AND 3271 02:10:06,016 --> 02:10:07,984 CURRICULA DEVELOPMENT, THIS IS A 3272 02:10:07,984 --> 02:10:09,886 REALLY CRITICAL AREA OBVIOUSLY 3273 02:10:09,886 --> 02:10:13,023 THAT WE NEED TO DO MORE IN. 3274 02:10:13,023 --> 02:10:15,625 AND HELP TO UNDERSTAND THIS IS A 3275 02:10:15,625 --> 02:10:17,160 FAST-EVOLVING FIELD. 3276 02:10:17,160 --> 02:10:19,996 SO WITH THAT, I WILL TURN IT 3277 02:10:19,996 --> 02:10:22,299 OVER TO SUSAN, LAURA, AND 3278 02:10:22,299 --> 02:10:25,468 CHRISTINE, AND THEN WE'RE GOING 3279 02:10:25,468 --> 02:10:35,445 TO HAVE COMMENTS FROM TWO 3280 02:10:35,445 --> 02:10:35,745 DISCUSSANTS. 3281 02:10:35,745 --> 02:10:37,714 >> THANK YOU FOR ALLOWING US TO 3282 02:10:37,714 --> 02:10:38,682 PRESENT OTHER CONCEPT CLEARANCE 3283 02:10:38,682 --> 02:10:40,784 TO PREPARE THE NEXT GENERATION 3284 02:10:40,784 --> 02:10:48,792 OF BIOMEDICAL RESEARCH TEAMS FOR 3285 02:10:48,792 --> 02:10:49,759 ETHICAL A.I. 3286 02:10:49,759 --> 02:10:52,596 I'M THE ASSOCIATE DIRECTOR OF 3287 02:10:52,596 --> 02:10:55,565 DATA SCIENCE, LEAD OF OFFICE OF 3288 02:10:55,565 --> 02:11:00,804 SCIENCE STRATEGY, JOINED BY DR. 3289 02:11:00,804 --> 02:11:04,207 LAURA BIVEN, AND PROGRAM LEAD 3290 02:11:04,207 --> 02:11:09,446 FOR PROGRAM, CHRISTINA CUTILLO, 3291 02:11:09,446 --> 02:11:13,917 JUST JOINED ODSS, JOINED THIS 3292 02:11:13,917 --> 02:11:14,117 YEAR. 3293 02:11:14,117 --> 02:11:14,417 NEXT SLIDE. 3294 02:11:14,417 --> 02:11:16,553 THIS IS A LITTLE BIT OF SOME OF 3295 02:11:16,553 --> 02:11:20,290 THE MANY ACTIVITIES THAT NIH IS 3296 02:11:20,290 --> 02:11:21,057 ENGAGING IN, ARTIFICIAL 3297 02:11:21,057 --> 02:11:21,725 INTELLIGENCE. 3298 02:11:21,725 --> 02:11:24,561 AND THIS IS A SMALL SET OF THE 3299 02:11:24,561 --> 02:11:27,063 LARGER HHS A.I. ACTIVITIES THAT 3300 02:11:27,063 --> 02:11:28,832 ADDRESS THE A.I. EXECUTIVE 3301 02:11:28,832 --> 02:11:30,901 ORDER, JUST RECENTLY RELEASED 3302 02:11:30,901 --> 02:11:32,302 THIS PAST FALL. 3303 02:11:32,302 --> 02:11:35,805 TO REALLY IMPROVE NOT ONLY THE 3304 02:11:35,805 --> 02:11:37,908 WORKFORCE OF CITIZENS WHO CAN 3305 02:11:37,908 --> 02:11:45,548 USE AND ARE COGNIZANT OF A.I. 3306 02:11:45,548 --> 02:11:49,486 AND FRAMEWORKS NEEDED. 3307 02:11:49,486 --> 02:11:50,420 WE HAVE CROSS-CUTTING PROGRAMS, 3308 02:11:50,420 --> 02:11:54,324 HERE ARE A FEW. 3309 02:11:54,324 --> 02:11:57,961 YOU'RE FAMILIAR WITH BRIDGE2AI, 3310 02:11:57,961 --> 02:12:01,164 FOR GRAND CHALLENGES, FAMILIAR 3311 02:12:01,164 --> 02:12:04,768 WITH THE PROGRAM TO ENHANCE 3312 02:12:04,768 --> 02:12:06,403 EQUITY AND CAPACITY IN DIVERSE 3313 02:12:06,403 --> 02:12:06,836 COMMUNITIES. 3314 02:12:06,836 --> 02:12:16,579 YOU MAY NOT BE FAMILIAR WITH OUR 3315 02:12:16,579 --> 02:12:18,315 INITIATIVE TO DRIVE CAPABILITIES 3316 02:12:18,315 --> 02:12:19,316 AND DEVELOPMENT IN ARTIFICIAL 3317 02:12:19,316 --> 02:12:21,818 INTELLIGENCE, THERE'S A REALLY 3318 02:12:21,818 --> 02:12:25,455 GREAT ARTICLE, A SHORT LETTER IN 3319 02:12:25,455 --> 02:12:32,028 "SCIENCE," MAY 23, BY ERIC TOPOL 3320 02:12:32,028 --> 02:12:32,796 FOR FORECASTING COMMUNITIES, I 3321 02:12:32,796 --> 02:12:36,599 RECOMMEND IT. 3322 02:12:36,599 --> 02:12:40,337 IT'S A GOOD READ. 3323 02:12:40,337 --> 02:12:43,073 AND PROVIDING SUPPORT FOR HEALTH 3324 02:12:43,073 --> 02:12:43,640 DISPARITIES AND INTRAMURAL 3325 02:12:43,640 --> 02:12:47,444 RESEARCH CENTER FOR ALZHEIMER'S 3326 02:12:47,444 --> 02:12:49,079 AND RELATED DEMENTIA, DATA 3327 02:12:49,079 --> 02:12:52,182 APPROACHES FOR OUR DEVELOPING 3328 02:12:52,182 --> 02:12:53,783 RESEARCH AND ALZHEIMER'S AND 3329 02:12:53,783 --> 02:12:54,217 DEMENTIA. 3330 02:12:54,217 --> 02:12:56,720 WE'RE ALSO A LEAD AGENCY IN THE 3331 02:12:56,720 --> 02:13:00,657 NATIONAL A.I. RESEARCH RESOURCE, 3332 02:13:00,657 --> 02:13:03,159 AND CHRISTINE IS OUR PROGRAM 3333 02:13:03,159 --> 02:13:04,194 LEAD, WHICH SEEKS TO DEVELOP 3334 02:13:04,194 --> 02:13:07,263 NATIONAL SCALE A.I. DATA AND 3335 02:13:07,263 --> 02:13:08,798 COMPUTATIONAL RESOURCES FOR 3336 02:13:08,798 --> 02:13:11,835 RESEARCHERS ACROSS THE U.S. 3337 02:13:11,835 --> 02:13:14,237 EACH OF THESE PROGRAMS AND 3338 02:13:14,237 --> 02:13:17,407 COMPONENTS HAS A LITTLE BIT OF 3339 02:13:17,407 --> 02:13:19,609 TRAINING AND WORKFORCE ELEMENTS 3340 02:13:19,609 --> 02:13:24,180 WITHIN BUT NO FOCUSED INITIATIVE 3341 02:13:24,180 --> 02:13:29,219 INCLUDING ALL THE INSTITUTES AND 3342 02:13:29,219 --> 02:13:29,519 AND 3343 02:13:29,519 --> 02:13:31,955 CENTERS ON A.I. TRAINING, 3344 02:13:31,955 --> 02:13:32,722 COMPLEMENT TO EFFORTS WE'RE 3345 02:13:32,722 --> 02:13:34,157 SHOWING YOU TODAY. 3346 02:13:34,157 --> 02:13:37,560 IT HAS POTENTIAL TO TOUCH MANY 3347 02:13:37,560 --> 02:13:42,132 RESEARCHERS ACROSS NIH, WITH 3348 02:13:42,132 --> 02:13:44,100 LENS THAT ENCOMPASS THE THE LIFE 3349 02:13:44,100 --> 02:13:44,701 CYCLE. 3350 02:13:44,701 --> 02:13:46,503 I'LL TURN IT OVER TO LAURA TO 3351 02:13:46,503 --> 02:13:47,504 PRESENT THE CONCEPT CLEARANCE 3352 02:13:47,504 --> 02:13:49,939 AND PICK BACK UP WITH QUESTIONS 3353 02:13:49,939 --> 02:13:51,341 AND ANSWERS. 3354 02:13:51,341 --> 02:13:54,310 TO YOU, LAURA. 3355 02:13:54,310 --> 02:13:55,378 >> NEXT SLIDE. 3356 02:13:55,378 --> 02:13:58,014 BEFORE I DIVE INTO THE DETAILS 3357 02:13:58,014 --> 02:13:59,649 OF THE THREE INITIATIVES WE'RE 3358 02:13:59,649 --> 02:14:03,820 PUTTING FORWARD I ACKNOWLEDGE WE 3359 02:14:03,820 --> 02:14:04,988 HAVE PRESENTED RELATED TOPIC 3360 02:14:04,988 --> 02:14:08,792 BEFORE, I THINK IT WAS MAY OF 3361 02:14:08,792 --> 02:14:09,826 2021. 3362 02:14:09,826 --> 02:14:11,361 AND WE PRESENTED A CONCEPT 3363 02:14:11,361 --> 02:14:12,796 CLEARANCE FOR SOMETHING SIMILAR 3364 02:14:12,796 --> 02:14:16,766 AIMED AT SORT OF PREPARING THE 3365 02:14:16,766 --> 02:14:18,802 BIOMEDICAL WORKFORCE FOR A.I. 3366 02:14:18,802 --> 02:14:21,404 REVOLUTION, A.I. RESEARCH 3367 02:14:21,404 --> 02:14:21,871 EXPERIENCE. 3368 02:14:21,871 --> 02:14:22,639 WE REALLY ENCOURAGE YOU WITH 3369 02:14:22,639 --> 02:14:24,340 SOME OF THE FEEDBACK WE GOT. 3370 02:14:24,340 --> 02:14:28,311 AT THAT TIME WE WERE PROPOSING 3371 02:14:28,311 --> 02:14:30,180 COMPLEX TRAINING CENTERS, SCALED 3372 02:14:30,180 --> 02:14:31,614 BACK INTO A PHASED APPROACH, 3373 02:14:31,614 --> 02:14:33,683 PUTTING FORWARD FIRST PHASE OF 3374 02:14:33,683 --> 02:14:34,250 THAT TODAY. 3375 02:14:34,250 --> 02:14:37,854 WE ALSO HEARD YOU WITH THE IDEA 3376 02:14:37,854 --> 02:14:38,955 OF FIRST GETTING LANDSCAPE 3377 02:14:38,955 --> 02:14:41,024 ASSESSMENT, UNDERSTANDING WHAT 3378 02:14:41,024 --> 02:14:43,860 THE STATE IS OF TRAINING AND 3379 02:14:43,860 --> 02:14:44,427 DEVELOPMENT. 3380 02:14:44,427 --> 02:14:45,528 SOME CORE COMPETENCIES THAT 3381 02:14:45,528 --> 02:14:46,396 WE'RE PUTTING FORWARD. 3382 02:14:46,396 --> 02:14:47,730 TO DO SOME PILOTS. 3383 02:14:47,730 --> 02:14:49,566 WE'VE DONE THAT AS WELL. 3384 02:14:49,566 --> 02:14:51,534 I HOPE WE'LL CONVINCE YOU THAT 3385 02:14:51,534 --> 02:14:54,037 WHAT WE'RE PUTTING FORWARD IS 3386 02:14:54,037 --> 02:14:55,271 MUCH MORE MANAGEABLE, TARGETED 3387 02:14:55,271 --> 02:14:57,006 AT SOME OF THE KEY ASPECTS OF 3388 02:14:57,006 --> 02:14:58,875 THE WAYS IN WHICH BIOMEDICAL 3389 02:14:58,875 --> 02:15:00,743 RESEARCH REALLY CAN IMPACT AND 3390 02:15:00,743 --> 02:15:02,479 ALSO BENEFIT FROM A.I. 3391 02:15:02,479 --> 02:15:04,581 AND THOSE ARE AROUND THE DATA 3392 02:15:04,581 --> 02:15:07,183 THAT ARE CREATED THROUGH 3393 02:15:07,183 --> 02:15:11,454 BIOMEDICAL RESEARCH, ALSO 3394 02:15:11,454 --> 02:15:12,889 COLLABORATIONS THAT RESEARCHERS 3395 02:15:12,889 --> 02:15:14,991 ENGAGE IN. 3396 02:15:14,991 --> 02:15:17,026 THE FIRST INITIATIVE IS 3397 02:15:17,026 --> 02:15:18,461 MULTI-DISCIPLINARY POSTDOC 3398 02:15:18,461 --> 02:15:21,431 PROGRAM FOR ETHICAL A.I. IN 3399 02:15:21,431 --> 02:15:23,700 BIOMEDICAL AND BEHAVIORAL 3400 02:15:23,700 --> 02:15:26,136 RESEARCH, AN OPPORTUNITY FOR 3401 02:15:26,136 --> 02:15:31,574 POSTDOCS TO ENGAGE IN 3402 02:15:31,574 --> 02:15:32,142 MULTI-DISCIPLINARY RESEARCH, 3403 02:15:32,142 --> 02:15:33,576 MENTORED BY SOMEONE IN THE 3404 02:15:33,576 --> 02:15:34,878 BIOMEDICAL DISCIPLINE, ALSO WITH 3405 02:15:34,878 --> 02:15:36,946 A.I. EXPERTISE AND ALSO SOMEONE 3406 02:15:36,946 --> 02:15:37,947 WITH ETHICS EXPERTISE. 3407 02:15:37,947 --> 02:15:39,149 IT'S REALLY IMPORTANT TO HAVE 3408 02:15:39,149 --> 02:15:46,156 ALL THREE OF THOSE COMPONENTS IN 3409 02:15:46,156 --> 02:15:47,457 THIS RESEARCH ACTIVITY. 3410 02:15:47,457 --> 02:15:52,195 WE HEARD THE POSTDOC PHASE IS A 3411 02:15:52,195 --> 02:15:54,497 WONDERFUL OPPORTUNITY TO DEVELOP 3412 02:15:54,497 --> 02:15:55,999 THESE KINDS OF EXPERTISE IN 3413 02:15:55,999 --> 02:15:57,867 BIOMEDICAL RESEARCH COMMUNITY BY 3414 02:15:57,867 --> 02:15:58,868 BRINGING IN PEOPLE FROM ALL 3415 02:15:58,868 --> 02:16:00,036 DIFFERENT FIELDS AND ALSO FROM 3416 02:16:00,036 --> 02:16:03,673 TRAINING THEM IN THIS 3417 02:16:03,673 --> 02:16:04,807 MULTI-DISCIPLINARY ASPECT. 3418 02:16:04,807 --> 02:16:06,409 WE HAVE A BUDGET THAT WILL BE 3419 02:16:06,409 --> 02:16:06,976 GROWING. 3420 02:16:06,976 --> 02:16:08,912 WE HOPE TO IN A FEW YEARS HAVE A 3421 02:16:08,912 --> 02:16:11,014 STEADY STATE OF SOMETHING LIKE 3422 02:16:11,014 --> 02:16:11,848 15 AWARDS PER YEAR. 3423 02:16:11,848 --> 02:16:15,818 WE CAN GO TO THE NEXT SLIDE 3424 02:16:15,818 --> 02:16:16,219 PLEASE. 3425 02:16:16,219 --> 02:16:17,654 NEXT TWO INITIATIVES WE'RE 3426 02:16:17,654 --> 02:16:19,956 PUTTING FORWARD ARE AROUND 3427 02:16:19,956 --> 02:16:20,590 CURRICULUM DEVELOPMENT TRAINING 3428 02:16:20,590 --> 02:16:21,057 AND ASSESSMENT. 3429 02:16:21,057 --> 02:16:24,260 AND THE FIRST ONE HERE IS AROUND 3430 02:16:24,260 --> 02:16:25,328 UNDERGRADUATE AND GRADUATE 3431 02:16:25,328 --> 02:16:27,096 CURRICULUM MODULE OR TRAINING 3432 02:16:27,096 --> 02:16:29,933 DEVELOPMENT AND ASSESSMENT FOR 3433 02:16:29,933 --> 02:16:30,466 A.I.-READY BIOMEDICAL AND 3434 02:16:30,466 --> 02:16:31,334 BEHAVIORAL RESEARCHERS. 3435 02:16:31,334 --> 02:16:33,536 SO THIS IS AN OPPORTUNITY TO 3436 02:16:33,536 --> 02:16:34,404 DEVELOP NEW TRAINING 3437 02:16:34,404 --> 02:16:36,506 OPPORTUNITIES AND CURRICULA THAT 3438 02:16:36,506 --> 02:16:38,041 WILL TARGET BIOMEDICAL 3439 02:16:38,041 --> 02:16:38,908 RESEARCHERS, PEOPLE WHO WILL 3440 02:16:38,908 --> 02:16:42,278 BECOME PART OF OUR BIOMEDICAL 3441 02:16:42,278 --> 02:16:43,146 RESEARCH WORKFORCE. 3442 02:16:43,146 --> 02:16:45,582 AND REALLY TRAIN THEM UP IN THE 3443 02:16:45,582 --> 02:16:47,217 SKILLS AND COMPETENCIES NEEDED 3444 02:16:47,217 --> 02:16:49,719 TO CREATE FAIR AND A.I.-READY 3445 02:16:49,719 --> 02:16:51,154 DATA, ALSO TO COLLABORATE WITH 3446 02:16:51,154 --> 02:16:53,556 A.I. EXPERTS AND WITH ETHICISTS 3447 02:16:53,556 --> 02:16:56,826 ON NEW CAPABILITIES IN A.I. 3448 02:16:56,826 --> 02:16:59,462 AND SO WE'RE HOPING THAT -- I'LL 3449 02:16:59,462 --> 02:17:01,431 TELL YOU MORE DETAILS IN THE 3450 02:17:01,431 --> 02:17:03,933 COMING SLIDES. 3451 02:17:03,933 --> 02:17:06,769 NEXT SLIDE PLEASE. 3452 02:17:06,769 --> 02:17:08,972 THIS NEXT CURRICULUM DEVELOPMENT 3453 02:17:08,972 --> 02:17:10,840 INITIATIVE IS FOCUSED NOW ON 3454 02:17:10,840 --> 02:17:13,243 PEOPLE WHO WILL BECOME 3455 02:17:13,243 --> 02:17:15,678 BIOETHICISTS, ETHICISTS AND 3456 02:17:15,678 --> 02:17:18,047 COLLABORATORS WITH US IN A.I. 3457 02:17:18,047 --> 02:17:18,481 RESEARCH ACTIVITIES. 3458 02:17:18,481 --> 02:17:20,683 WE HEARD THIS VERY STRONGLY FROM 3459 02:17:20,683 --> 02:17:23,319 THE RESEARCH COMMUNITY AND 3460 02:17:23,319 --> 02:17:24,754 PEOPLE WE ENGAGED WITH, THERE'S 3461 02:17:24,754 --> 02:17:29,025 LACK OF EXPER EXPERTISE AT THAT 3462 02:17:29,025 --> 02:17:29,359 INTERSECTION. 3463 02:17:29,359 --> 02:17:31,094 THIS IS ATTEMPTING TO MEET THAT 3464 02:17:31,094 --> 02:17:31,494 NEED. 3465 02:17:31,494 --> 02:17:32,729 THERE'S AN OPPORTUNITY HERE TO 3466 02:17:32,729 --> 02:17:34,597 DEVELOP NEW CURRICULUM AND 3467 02:17:34,597 --> 02:17:35,365 TRAINING OPPORTUNITIES FOR 3468 02:17:35,365 --> 02:17:37,533 PEOPLE WHO WILL BE COMING INTO 3469 02:17:37,533 --> 02:17:39,636 THIS BIOETHICS WORKFORCE TO 3470 02:17:39,636 --> 02:17:41,804 REALLY HELP THEM UNDERSTAND THE 3471 02:17:41,804 --> 02:17:43,773 IMPLICATIONS OF ARTIFICIAL 3472 02:17:43,773 --> 02:17:48,678 INTELLIGENCE AND DATA IN A.I. 3473 02:17:48,678 --> 02:17:49,679 NEXT SLIDE PLEASE. 3474 02:17:49,679 --> 02:17:53,416 JUST TO COMPARE AND CONTRAST 3475 02:17:53,416 --> 02:17:54,951 SOME OF THE PROGRAMS, ON THE 3476 02:17:54,951 --> 02:17:57,120 LEFT-HAND SIDE WE'RE TALKING 3477 02:17:57,120 --> 02:17:58,121 ABOUT THE POSTDOC PROGRAM. 3478 02:17:58,121 --> 02:17:59,856 HERE WE HOPE TO TARGET A BROAD 3479 02:17:59,856 --> 02:18:02,592 POOL OF RESEARCHERS WITH THE 3480 02:18:02,592 --> 02:18:05,328 GOAL OF THEM REACHING RESEARCH 3481 02:18:05,328 --> 02:18:07,196 INDEPENDENCE IN THIS 3482 02:18:07,196 --> 02:18:08,831 MULTI-DISCIPLINARY INTERSECTION 3483 02:18:08,831 --> 02:18:10,700 OF FIELDS, AND BIOMEDICINE, 3484 02:18:10,700 --> 02:18:12,001 A.I., ETHICS, AND SUPPORT A 3485 02:18:12,001 --> 02:18:13,102 PORTFOLIO OF RESEARCH THAT 3486 02:18:13,102 --> 02:18:16,506 ADDRESSES THE WHOLE OF THE NIH 3487 02:18:16,506 --> 02:18:18,341 WATERFRONT OF MISSION SPACE. 3488 02:18:18,341 --> 02:18:19,342 SO WE'LL BE COLLABORATING WITH 3489 02:18:19,342 --> 02:18:21,978 OUR I.C. PARTNERS TO MAKE SURE 3490 02:18:21,978 --> 02:18:24,147 WE HAVE THAT PORTFOLIO APPROACH. 3491 02:18:24,147 --> 02:18:27,016 AND THEN WE HOPE TO SEE AN 3492 02:18:27,016 --> 02:18:28,184 UP-AND-COMING GENERATION OF 3493 02:18:28,184 --> 02:18:30,019 RESEARCHERS ABLE TO INNOVATE IN 3494 02:18:30,019 --> 02:18:33,122 THIS SPACE OF ARTIFICIAL 3495 02:18:33,122 --> 02:18:39,562 INTELLIGENCE AND BIOMEDICINE 3496 02:18:39,562 --> 02:18:41,664 ETHICS. 3497 02:18:41,664 --> 02:18:44,067 ON THE MIDDLE IS THE EFFORT 3498 02:18:44,067 --> 02:18:45,702 TARGETING BIOMEDICAL 3499 02:18:45,702 --> 02:18:46,002 RESEARCHERS. 3500 02:18:46,002 --> 02:18:48,237 WE'LL BE TARGETING THESE SKILLS 3501 02:18:48,237 --> 02:18:49,105 AND COMPETENCIES NEEDED TO MAKE 3502 02:18:49,105 --> 02:18:51,407 DATA FAIR AND A.I. READY. 3503 02:18:51,407 --> 02:18:52,842 SO THEY CAN UNDERSTAND SOME OF 3504 02:18:52,842 --> 02:18:54,277 THESE ETHICS CHALLENGES THAT 3505 02:18:54,277 --> 02:18:56,412 ARISE IN ARTIFICIAL 3506 02:18:56,412 --> 02:18:56,746 INTELLIGENCE. 3507 02:18:56,746 --> 02:18:58,181 AND THEY BE BE GOOD 3508 02:18:58,181 --> 02:18:59,582 COLLABORATORS IN THE TEAMS THAT 3509 02:18:59,582 --> 02:19:01,017 WE'RE IMAGINING. 3510 02:19:01,017 --> 02:19:04,253 ON THE RIGHT-HAND SIDE IS THE 3511 02:19:04,253 --> 02:19:05,722 EFFORT FOCUSED ON THE TRAINEES 3512 02:19:05,722 --> 02:19:08,925 WHO WILL BECOME PART OF THE 3513 02:19:08,925 --> 02:19:10,226 BIOETHICS COMMUNITY, AND WE'LL 3514 02:19:10,226 --> 02:19:10,993 ENHANCE THE ETHICAL DEVELOPMENT 3515 02:19:10,993 --> 02:19:14,297 OF A.I. AND HELP THEM BE GOOD 3516 02:19:14,297 --> 02:19:22,605 COLLABORATORS WITH US. 3517 02:19:22,605 --> 02:19:25,875 WE'LL SUPPORT A PORTFOLIO IN A 3518 02:19:25,875 --> 02:19:27,744 ADDRESSES MANY DATA TYPES AND 3519 02:19:27,744 --> 02:19:31,914 HOPE MANY ETHICS CHALLENGES. 3520 02:19:31,914 --> 02:19:34,217 SO NOT JUST PRIVACY AND THINKING 3521 02:19:34,217 --> 02:19:36,919 ABOUT SECURITY OF DATA BUT IT'S 3522 02:19:36,919 --> 02:19:42,191 ALSO THINGS LIKE HOW TO USE 3523 02:19:42,191 --> 02:19:47,764 PROXY DATA IN ARTIFICIAL 3524 02:19:47,764 --> 02:19:48,431 INTELLIGENCE, UNDERSTAND 3525 02:19:48,431 --> 02:19:49,098 UNCERTAINTY AND IMPLICATIONS ON 3526 02:19:49,098 --> 02:19:50,700 DIFFERENT COMMUNITIES. 3527 02:19:50,700 --> 02:19:54,237 WE HOPE TO BRING THESE TEAMS 3528 02:19:54,237 --> 02:19:56,305 TOGETHER AND SO WE HAVE -- NEXT 3529 02:19:56,305 --> 02:20:00,143 SLIDE, I'LL TALK ABOUT THAT. 3530 02:20:00,143 --> 02:20:01,577 SO, THE APPLICATION REQUIREMENTS 3531 02:20:01,577 --> 02:20:03,312 JUST TO UNDERSTAND HOW WE'LL BE 3532 02:20:03,312 --> 02:20:07,049 THINKING ABOUT ROLLING THIS OUT, 3533 02:20:07,049 --> 02:20:08,918 FOR THE POSTDOC PROGRAM THERE 3534 02:20:08,918 --> 02:20:14,924 WILL BE -- APPLICANTS WILL PUT 3535 02:20:14,924 --> 02:20:17,660 FORWARD A PROGRAM FOR RESEARCH, 3536 02:20:17,660 --> 02:20:19,529 HAVE ONE PRIMARY MENTOR, WE HOPE 3537 02:20:19,529 --> 02:20:22,365 THEY WILL ALSO HAVE TEAM OF 3538 02:20:22,365 --> 02:20:30,173 MENTORS THAT REALLY WILL GET AT 3539 02:20:30,173 --> 02:20:31,140 MULTI-DISCIPLINARY MENTORSHIP 3540 02:20:31,140 --> 02:20:33,109 APPROACH, AND COLLABORATION WITH 3541 02:20:33,109 --> 02:20:34,010 UNDERREPRESENTED ORGANIZATIONS, 3542 02:20:34,010 --> 02:20:35,411 PROJECTS WOULD BENEFIT FROM THE 3543 02:20:35,411 --> 02:20:37,380 MULTI-DISCIPLINARY APPROACH TO 3544 02:20:37,380 --> 02:20:40,116 IMAGINE THAT MENTORS COULD COME 3545 02:20:40,116 --> 02:20:40,783 FROM MULTIPLE INSTITUTIONS. 3546 02:20:40,783 --> 02:20:44,587 ON THE RIGHT-HAND SIDE FOR THE 3547 02:20:44,587 --> 02:20:46,456 CURRICULUM DEVELOPMENT, THE 3548 02:20:46,456 --> 02:20:47,757 PROPOSERS WOULD BE SPECIFYING 3549 02:20:47,757 --> 02:20:48,758 TRAINING MATERIALS AND 3550 02:20:48,758 --> 02:20:52,829 ACTIVITIES AND SKILLS AND 3551 02:20:52,829 --> 02:20:55,097 COMPETENCIES TARGETED, A CLEAR 3552 02:20:55,097 --> 02:20:57,733 PLAN FOR FORMATIVE ASSESSMENTS, 3553 02:20:57,733 --> 02:20:58,601 HOW TO DISSEMINATE MATERIALS, 3554 02:20:58,601 --> 02:21:00,269 THAT COULD BE THE TRAINING 3555 02:21:00,269 --> 02:21:02,405 MATERIALS BUT ALSO DATA AND 3556 02:21:02,405 --> 02:21:02,672 CODE. 3557 02:21:02,672 --> 02:21:06,843 THEY SHOULD HAVE RECRUIT AM PLN 3558 02:21:06,843 --> 02:21:09,545 AND TARGET DIFFERENT GROUPS. 3559 02:21:09,545 --> 02:21:11,414 SO FUTURE BIOMEDICAL RESEARCHERS 3560 02:21:11,414 --> 02:21:12,415 AND FUTURE BIOETHICISTS BUT 3561 02:21:12,415 --> 02:21:14,283 WE'LL HOPE TO BRING COHORTS 3562 02:21:14,283 --> 02:21:16,819 TOGETHER, OUR PLAN IS TO HAVE 3563 02:21:16,819 --> 02:21:19,088 JOINT P.I. MEETINGS, JOINT 3564 02:21:19,088 --> 02:21:20,289 MEETINGS FOR TRAINEES, ALSO 3565 02:21:20,289 --> 02:21:21,557 WE'RE HOPING TO HAVE AN 3566 02:21:21,557 --> 02:21:26,095 OPPORTUNITY WHERE SOME OF THE 3567 02:21:26,095 --> 02:21:35,571 AWARDEES CAN THING ABOUT 3568 02:21:35,571 --> 02:21:36,506 PRACTICUM OPPORTUNITIES. 3569 02:21:36,506 --> 02:21:38,107 NEXT SLIDE PLEASE. 3570 02:21:38,107 --> 02:21:40,076 AS WE MENTIONED, THIS IS -- 3571 02:21:40,076 --> 02:21:42,245 WE'RE THINKING ABOUT A PHASED 3572 02:21:42,245 --> 02:21:43,012 APPROACH. 3573 02:21:43,012 --> 02:21:44,780 SO FOR THE POSTDOC PROGRAM WE 3574 02:21:44,780 --> 02:21:48,851 WANT TO NURTURE A COMMUNITY OF 3575 02:21:48,851 --> 02:21:50,920 EXPERTS IN THIS INTERSECTION OF 3576 02:21:50,920 --> 02:21:52,121 BIOMEDICINE, ARTIFICIAL 3577 02:21:52,121 --> 02:21:52,588 INTELLIGENCE, ETHICS. 3578 02:21:52,588 --> 02:21:54,323 AND SO WE'LL BRING THEM TOGETHER 3579 02:21:54,323 --> 02:21:56,259 IN P.I. MEETINGS, NOT JUST 3580 02:21:56,259 --> 02:21:58,294 AMONGST THEMSELVES BUT ALSO WITH 3581 02:21:58,294 --> 02:22:00,796 OTHER PROGRAMS THAT MANY OF 3582 02:22:00,796 --> 02:22:02,532 WHICH SUSAN MENTIONED, BRINGING 3583 02:22:02,532 --> 02:22:05,368 THEM TOGETHER, INTEGRATING THEM 3584 02:22:05,368 --> 02:22:08,437 INTO THE NIH COMMUNITY OF 3585 02:22:08,437 --> 02:22:11,941 BIOMEDICAL RESEARCHERS AND ALSO 3586 02:22:11,941 --> 02:22:14,343 NURTURING THIS KEY EXPERTISE. 3587 02:22:14,343 --> 02:22:16,412 SIMILARLY FOR TRAINING AND 3588 02:22:16,412 --> 02:22:17,947 CURRICULUM DEVELOPMENT PROGRAMS, 3589 02:22:17,947 --> 02:22:20,249 THIS JUST THE BEGINNING. 3590 02:22:20,249 --> 02:22:21,017 DEVELOPING CURRICULUM AND 3591 02:22:21,017 --> 02:22:23,452 TRAINING OPPORTUNITIES, WE HOPE 3592 02:22:23,452 --> 02:22:25,955 TO THEN ALSO PROVIDE TOOLS AND 3593 02:22:25,955 --> 02:22:28,157 INFRASTRUCTURE FOR THE SHARING 3594 02:22:28,157 --> 02:22:29,692 OF THOSE OUTPUTS, SO THE 3595 02:22:29,692 --> 02:22:31,127 CURRICULUM CAN BE SHARED AND 3596 02:22:31,127 --> 02:22:33,296 PICKED UP BY OTHER INSTITUTIONS. 3597 02:22:33,296 --> 02:22:36,032 WE ALSO HOPE TO SUPPORT THAT 3598 02:22:36,032 --> 02:22:38,100 KIND OF UPTAKE OF THE 3599 02:22:38,100 --> 02:22:38,634 CURRICULUM. 3600 02:22:38,634 --> 02:22:41,504 SO WE COULD IMAGINE HAVING 3601 02:22:41,504 --> 02:22:42,705 FUTURE SOLICITATIONS THAT INVITE 3602 02:22:42,705 --> 02:22:43,806 OTHER ORGANIZATIONS TO PICK UP 3603 02:22:43,806 --> 02:22:45,675 SOME OF THE CURRICULUM AND 3604 02:22:45,675 --> 02:22:46,742 MODULES AND USE THEM. 3605 02:22:46,742 --> 02:22:49,378 AND THEN ALSO WE'RE GOING TO 3606 02:22:49,378 --> 02:22:51,113 THINK ABOUT THE FUTURE CAREER 3607 02:22:51,113 --> 02:22:53,082 PATHS OF TRAINEES. 3608 02:22:53,082 --> 02:22:57,687 SO, WE WANT -- WE'RE FOCUSING ON 3609 02:22:57,687 --> 02:23:00,089 MAKING SURE THAT THESE SKILLS 3610 02:23:00,089 --> 02:23:02,925 ARE TARGETING FUTURE BIOMEDICAL 3611 02:23:02,925 --> 02:23:03,926 RESEARCHERS AND BIOETHICISTS BUT 3612 02:23:03,926 --> 02:23:05,461 MAKE SURE THERE'S OPPORTUNITIES 3613 02:23:05,461 --> 02:23:07,430 FOR THEM AFTERWARDS, WITHIN OUR 3614 02:23:07,430 --> 02:23:08,965 RESEARCH COMMUNITY BUT ALSO 3615 02:23:08,965 --> 02:23:10,166 PERHAPS WITHIN INDUSTRY OR OTHER 3616 02:23:10,166 --> 02:23:11,567 CAREER PATHS. 3617 02:23:11,567 --> 02:23:13,869 SO WE'LL BE THINKING ABOUT 3618 02:23:13,869 --> 02:23:14,737 PARTNERSHIPS, PERHAPS WITH 3619 02:23:14,737 --> 02:23:18,674 INDUSTRY, PERHAPS WITH OTHER 3620 02:23:18,674 --> 02:23:19,976 AGENCIES AS WELL. 3621 02:23:19,976 --> 02:23:21,010 NEXT SLIDE. 3622 02:23:21,010 --> 02:23:24,046 I HAND OFF TO MY COLLEAGUES 3623 02:23:24,046 --> 02:23:24,914 CHRISTINE HERE. 3624 02:23:24,914 --> 02:23:27,984 >> THANK YOU SO MUCH, LAURA. 3625 02:23:27,984 --> 02:23:32,021 TAKING A STEP BACK WE WANT TO 3626 02:23:32,021 --> 02:23:33,456 HIGHLIGHT LEARNING FOR LANDSCAPE 3627 02:23:33,456 --> 02:23:34,757 ASSESSMENT AND ENGAGEMENT THAT 3628 02:23:34,757 --> 02:23:36,292 SHAPE DEVELOPMENT OF THE PROPOSE 3629 02:23:36,292 --> 02:23:40,229 THE KNISH -- PROPOSED 3630 02:23:40,229 --> 02:23:41,530 INITIATIVES, FIRST TO IDENTIFY 3631 02:23:41,530 --> 02:23:43,099 CORE SKILLS AND COMPETENCIES 3632 02:23:43,099 --> 02:23:44,000 NEEDED FOR BIOMEDICAL 3633 02:23:44,000 --> 02:23:46,068 RESEARCHERS TO MAKE DATA FAIR 3634 02:23:46,068 --> 02:23:48,571 AND A.I. READY. 3635 02:23:48,571 --> 02:23:49,772 LANDSCAPE ANALYSIS WAS PERFORMED 3636 02:23:49,772 --> 02:23:51,641 TO UNDERSTAND RECOMMENDATIONS 3637 02:23:51,641 --> 02:23:52,408 FROM RESEARCHERS THEMSELVES 3638 02:23:52,408 --> 02:23:55,578 WORKING AT THE FOREFRONT OF 3639 02:23:55,578 --> 02:23:56,245 BIOMEDICAL A.I. 3640 02:23:56,245 --> 02:23:58,848 INCLUDING COMPETENCIES NEEDED TO 3641 02:23:58,848 --> 02:23:59,749 GENERATE, HANDLE, PROCESS, 3642 02:23:59,749 --> 02:24:02,251 STORE, AND SHARE FAIR AND 3643 02:24:02,251 --> 02:24:03,119 A.I.-READY BIOMEDICAL DATA. 3644 02:24:03,119 --> 02:24:06,722 THE SKILLS IDENTIFIED TO FURTHER 3645 02:24:06,722 --> 02:24:10,026 THIS OVERARCHING GOAL MAKING 3646 02:24:10,026 --> 02:24:12,094 BIOMEDICAL RESEARCH DATA READY 3647 02:24:12,094 --> 02:24:14,497 INCLUDE FIVE COMPETENCIES, 3648 02:24:14,497 --> 02:24:15,798 DATASET DOCUMENTATION, ONTOLOGY, 3649 02:24:15,798 --> 02:24:18,768 DATA ENCODING, DOWN TO REUSE OF 3650 02:24:18,768 --> 02:24:20,736 EXISTING DATASETS. 3651 02:24:20,736 --> 02:24:22,972 A NOTE ETHICS WAS INITIALLY 3652 02:24:22,972 --> 02:24:25,541 IDENTIFIED AS A SEPARATE SKILL, 3653 02:24:25,541 --> 02:24:27,710 BUT THROUGH THE PROCESS NEED FOR 3654 02:24:27,710 --> 02:24:29,812 ETHICS TO BE EMBEDDED IN EACH, 3655 02:24:29,812 --> 02:24:34,283 DEFINED AS ETHICS FIRST 3656 02:24:34,283 --> 02:24:34,617 COMPETENCIES. 3657 02:24:34,617 --> 02:24:36,285 THESE SKILLS ARE A GOOD START 3658 02:24:36,285 --> 02:24:37,720 BUT NOT NECESSARILY RESTRICTIVE. 3659 02:24:37,720 --> 02:24:41,090 WE HOPE TO LEARN MORE ABOUT THIS 3660 02:24:41,090 --> 02:24:42,525 THROUGH THESE PROPOSED 3661 02:24:42,525 --> 02:24:43,092 SOLICITATIONS. 3662 02:24:43,092 --> 02:24:44,527 WE DID LEARN HOWEVER CURRENT 3663 02:24:44,527 --> 02:24:47,930 TRAININGS MAY ADDRESS ONE OR TWO 3664 02:24:47,930 --> 02:24:50,232 OF THESE BUT ADDRESSING DATA 3665 02:24:50,232 --> 02:24:50,766 CREATION, COLLECTION, 3666 02:24:50,766 --> 02:24:52,868 PREPARATION WITH THE VIEW OF 3667 02:24:52,868 --> 02:24:54,937 REUSE AND A.I. 3668 02:24:54,937 --> 02:24:56,472 AND WE ALSO LEARNED THERE'S A 3669 02:24:56,472 --> 02:24:58,741 GAP IN TRAINING WITH 3670 02:24:58,741 --> 02:25:00,409 DISCIPLINARY FOCUS, TRAINEES 3671 02:25:00,409 --> 02:25:02,611 WANT TO LEARN ABOUT FOR EXAMPLE 3672 02:25:02,611 --> 02:25:04,013 ONTOLOGY THAT RELATE TO 3673 02:25:04,013 --> 02:25:05,881 BIOMEDICAL INTERESTS OR 3674 02:25:05,881 --> 02:25:07,083 OPPORTUNITIES TO MAKE THEIR DATA 3675 02:25:07,083 --> 02:25:08,184 A.I. READY. 3676 02:25:08,184 --> 02:25:10,720 THESE WERE NOT IMBUED INTO 3677 02:25:10,720 --> 02:25:15,091 EXISTING OPPORTUNITIES. 3678 02:25:15,091 --> 02:25:16,392 NEXT SLIDE. 3679 02:25:16,392 --> 02:25:18,794 FOR THREE YEARS ODSS SPONSORED 3680 02:25:18,794 --> 02:25:20,429 SEVERAL SUPPLEMENTAL FUNDING 3681 02:25:20,429 --> 02:25:22,531 OPPORTUNITIES FOCUSED ON 3682 02:25:22,531 --> 02:25:24,467 TRAINING, ETHICS, AND DATA. 3683 02:25:24,467 --> 02:25:26,669 WE HAD TREMENDOUS INTEREST 3684 02:25:26,669 --> 02:25:28,337 ACROSS NIH, AND INSTITUTES THAT 3685 02:25:28,337 --> 02:25:30,172 PARTNERED WITH SHOWN ON THIS 3686 02:25:30,172 --> 02:25:31,073 SLIDE. 3687 02:25:31,073 --> 02:25:33,676 WE ALSO HAD A ROBUST RESPONSE IN 3688 02:25:33,676 --> 02:25:35,211 RESEARCH AND EDUCATION COMMUNITY 3689 02:25:35,211 --> 02:25:36,746 WITH NUMBER OF AWARDS SHOWN 3690 02:25:36,746 --> 02:25:36,946 HERE. 3691 02:25:36,946 --> 02:25:38,614 I'M GOING TO DESCRIBE MORE ABOUT 3692 02:25:38,614 --> 02:25:40,216 THE FEEDBACK WE RECEIVED FROM 3693 02:25:40,216 --> 02:25:41,884 THESE COHORTS IN A FEW SLIDES. 3694 02:25:41,884 --> 02:25:43,753 FIRST I'M GOING TO DELVE INTO A 3695 02:25:43,753 --> 02:25:48,591 EXAMPLES FROM EACH OF THOSE. 3696 02:25:48,591 --> 02:25:52,528 NEXT SLIDE. 3697 02:25:52,528 --> 02:25:54,830 THIS SHOWS HIGHLIGHTS, A 3698 02:25:54,830 --> 02:25:57,099 PRECURSOR FOR THIS INITIATIVE. 3699 02:25:57,099 --> 02:25:58,000 THIS OPPORTUNITY INVITED 3700 02:25:58,000 --> 02:25:59,835 EXISTING TRAINING CENTERS TO 3701 02:25:59,835 --> 02:26:01,370 DEVELOP NEW CURRICULA OR 3702 02:26:01,370 --> 02:26:02,238 TRAINING OPPORTUNITIES FOR 3703 02:26:02,238 --> 02:26:06,408 MAKING DATA FAIR AND A.I. READY. 3704 02:26:06,408 --> 02:26:07,510 FIRST HIGHLIGHT COMES FROM 3705 02:26:07,510 --> 02:26:08,711 UNC-CHAPEL HILL RESULTING IN A 3706 02:26:08,711 --> 02:26:11,113 TOOL KIT TO PROMOTE 3707 02:26:11,113 --> 02:26:12,314 TRAINEE-DRIVEN DATA GENERATION, 3708 02:26:12,314 --> 02:26:13,616 MANAGEMENT, ANNUAL SILLS 3709 02:26:13,616 --> 02:26:16,585 METHODS. 3710 02:26:16,585 --> 02:26:18,754 SPECIFIC TO ENVIRONMENTAL HEALTH 3711 02:26:18,754 --> 02:26:20,289 DATA AND ADDRESS GAPS IN 3712 02:26:20,289 --> 02:26:21,490 TRAINING AND CODING. 3713 02:26:21,490 --> 02:26:27,296 SECOND IN THE MIDDLE COMES FROM 3714 02:26:27,296 --> 02:26:28,731 MOFFITT CANCER CENTER, READING 3715 02:26:28,731 --> 02:26:31,567 PRINCIPLES WITH FOCUS ON 3716 02:26:31,567 --> 02:26:33,536 FAIRNESS AND HEALTH DISPARITIES. 3717 02:26:33,536 --> 02:26:34,937 LASTLY FROM THE UNIVERSITY OF 3718 02:26:34,937 --> 02:26:36,405 PUERTO RICO CANCER CENTERS, THEY 3719 02:26:36,405 --> 02:26:38,140 DEVELOPED TRAINING THAT FOCUSED 3720 02:26:38,140 --> 02:26:40,109 ON TECHNIQUES AND METHODS 3721 02:26:40,109 --> 02:26:41,644 SPECIFIC TO CANCER DATASETS IN 3722 02:26:41,644 --> 02:26:42,745 HISPANIC POPULATIONS. 3723 02:26:42,745 --> 02:26:44,814 BOTH MAKING THEM FAIR AND A.I. 3724 02:26:44,814 --> 02:26:48,918 READY, AND DEVELOPING PLODEL TO 3725 02:26:48,918 --> 02:26:54,456 ANALYZE 3726 02:26:54,456 --> 02:26:55,424 ANNUAL -- DEVELOPING A MODEL. 3727 02:26:55,424 --> 02:26:58,160 THERE SEEMED TO BE A HUNGER 3728 02:26:58,160 --> 02:26:59,261 AMONGST TRAINING CENTERS FOR 3729 02:26:59,261 --> 02:27:01,630 THIS TYPE OF TRAINING AND 3730 02:27:01,630 --> 02:27:01,997 DEVELOPING IT. 3731 02:27:01,997 --> 02:27:04,366 BRIDGING THAT GAP BETWEEN DATA 3732 02:27:04,366 --> 02:27:06,769 SCIENCE AND BIOMEDICAL TRAINING. 3733 02:27:06,769 --> 02:27:09,104 AND WE FELT IT WAS A KEYSTONE 3734 02:27:09,104 --> 02:27:11,207 OPPORTUNITY THAT LED US TO 3735 02:27:11,207 --> 02:27:14,243 TODAY. 3736 02:27:14,243 --> 02:27:20,616 NEXT SLIDE. 3737 02:27:20,616 --> 02:27:21,584 INITIALLY ODD SUPPORTED A 3738 02:27:21,584 --> 02:27:22,451 GENERATION OF SUPPORTING 3739 02:27:22,451 --> 02:27:23,886 PRACTICES AND RESOURCES AIDING 3740 02:27:23,886 --> 02:27:25,187 OTHERS IN MAKING ETHICAL 3741 02:27:25,187 --> 02:27:26,288 DECISIONS THROUGHOUT DEVELOPMENT 3742 02:27:26,288 --> 02:27:29,358 AND USE OF A.I. AND M.L. 3743 02:27:29,358 --> 02:27:33,229 THE MOST COMMON FOCUS AREAS WITH 3744 02:27:33,229 --> 02:27:35,497 COMMUNITY ENGAGEMENT, TRUST AND 3745 02:27:35,497 --> 02:27:35,731 EQUITY. 3746 02:27:35,731 --> 02:27:38,667 FIRST HIGHLIGHT ON THE TOP FROM 3747 02:27:38,667 --> 02:27:41,503 ICAHN SCHOOL OF MEDICINE AT 3748 02:27:41,503 --> 02:27:43,072 MOUNT SINAI EXAMINING 3749 02:27:43,072 --> 02:27:43,672 PERSPECTIVES AND OTHER 3750 02:27:43,672 --> 02:27:46,008 STAKEHOLDERS, ON A.I.-DRIVEN 3751 02:27:46,008 --> 02:27:51,580 AUTOMATED SCREENING IN SPECIFIC 3752 02:27:51,580 --> 02:27:53,115 SPACE OF COGNITIVE IMPAIRMENT, 3753 02:27:53,115 --> 02:27:55,517 EXPLAINED METHODS TO IMPROVE 3754 02:27:55,517 --> 02:27:56,919 TRUST AND DETECT BIASES IN 3755 02:27:56,919 --> 02:28:03,626 MODELS FOR ALZHEIMER'S DISEASE 3756 02:28:03,626 --> 02:28:06,028 AND RELATED DEPARTMENT. 3757 02:28:06,028 --> 02:28:08,898 SECONDA FRAMEWORK TO QUANTIFY 3758 02:28:08,898 --> 02:28:11,066 AND INCORPORATE UNCERTAINTY FOR 3759 02:28:11,066 --> 02:28:15,404 A.I.-BASED IMAGING AND USE OF 3760 02:28:15,404 --> 02:28:17,740 SYNTHETIC DATASETS. 3761 02:28:17,740 --> 02:28:18,707 POLICY AND ETHICAL 3762 02:28:18,707 --> 02:28:20,809 CONSIDERATIONS FOR SYNTHETIC 3763 02:28:20,809 --> 02:28:21,777 DATASETS IN PREDICTIVE MODELS 3764 02:28:21,777 --> 02:28:24,079 AND PUBLISHED AROUND THESE 3765 02:28:24,079 --> 02:28:24,380 AREAS. 3766 02:28:24,380 --> 02:28:25,915 THROUGH THIS PROGRAM WE LEARNED 3767 02:28:25,915 --> 02:28:27,549 THERE'S A KEEN INTEREST AMONGST 3768 02:28:27,549 --> 02:28:29,652 BIOMEDICAL P.I.s TO DELVE INTO 3769 02:28:29,652 --> 02:28:32,922 AND ENGAGE IN THE DEVELOPMENT OF 3770 02:28:32,922 --> 02:28:38,294 ETHICAL PRACTICES AND TOOLS. 3771 02:28:38,294 --> 02:28:39,828 IT'S BRIDGING DATA SCIENCE WITH 3772 02:28:39,828 --> 02:28:48,704 TRAINING AND ETHICS, AND THE 3773 02:28:48,704 --> 02:28:55,144 FEEDBACK LED US TO PROPOSED 3774 02:28:55,144 --> 02:28:56,111 SOLICITATIONS TODAY. 3775 02:28:56,111 --> 02:28:58,747 ODSS SUPPORTED BRINGING TOGETHER 3776 02:28:58,747 --> 02:29:04,386 EXPERTISE IN MEDICINE, TO MAKE 3777 02:29:04,386 --> 02:29:06,322 NIH DATA A.I. READY. 3778 02:29:06,322 --> 02:29:08,457 FIRST FROM OREGON HEALTH AND 3779 02:29:08,457 --> 02:29:10,793 SCIENCE UNIVERSITY, DEVELOPING 3780 02:29:10,793 --> 02:29:13,529 A.I. READY DATASETS FOR USE IN 3781 02:29:13,529 --> 02:29:14,830 AUTOMATED SPEECH RECOGNITION 3782 02:29:14,830 --> 02:29:15,297 MODELS. 3783 02:29:15,297 --> 02:29:17,566 THEY ALSO ENGAGED COMMUNITY IN 3784 02:29:17,566 --> 02:29:21,303 POST-STROKE SPEECH CHALLENGE TO 3785 02:29:21,303 --> 02:29:22,938 INVITE RESEARCHERS TO PROMOTE 3786 02:29:22,938 --> 02:29:25,774 AWARENESS OF DATASETS. 3787 02:29:25,774 --> 02:29:27,609 A SECOND COMES FROM UNC-CHAPEL 3788 02:29:27,609 --> 02:29:29,511 HILL, TO FILL IN MISSING BRAIN 3789 02:29:29,511 --> 02:29:36,719 IMAGES IN COHORT STUDY OF EARLY 3790 02:29:36,719 --> 02:29:38,787 BRAIN DEVELOPMENT, EXPANDING THE 3791 02:29:38,787 --> 02:29:39,989 POTENTIAL APPLICATIONS OF M.L. 3792 02:29:39,989 --> 02:29:43,625 APPROACHES TO LEVERAGE THE RICH 3793 02:29:43,625 --> 02:29:43,959 DATASET. 3794 02:29:43,959 --> 02:29:46,128 WE LEARNED THERE'S A NEED FOR 3795 02:29:46,128 --> 02:29:47,763 ENABLING TEAMS TO MAKE DATASETS 3796 02:29:47,763 --> 02:29:49,765 A.I. READY BUT ALSO ILLUSTRATING 3797 02:29:49,765 --> 02:29:50,833 MANY CHALLENGES ALONG THIS PATH 3798 02:29:50,833 --> 02:29:55,104 WHICH I'LL GO THROUGH ON THE 3799 02:29:55,104 --> 02:29:55,571 NEXT SLIDE. 3800 02:29:55,571 --> 02:29:58,941 THIS NEED TO EXPAND TRAINING IN 3801 02:29:58,941 --> 02:30:00,609 THIS AREA TO ENCOURAGE FROM 3802 02:30:00,609 --> 02:30:04,413 INITIAL RESEARCH AND DATA 3803 02:30:04,413 --> 02:30:05,214 PLANNING STAGES. 3804 02:30:05,214 --> 02:30:07,049 NEXT SLIDE PLEASE. 3805 02:30:07,049 --> 02:30:08,717 CONVENING RESEARCH TEAMS FROM 3806 02:30:08,717 --> 02:30:10,219 THESE COHORTS OF PROGRAMS WE 3807 02:30:10,219 --> 02:30:15,457 HELD TWO P.I. MEETINGS BRINGING 3808 02:30:15,457 --> 02:30:16,025 TOGETHER AWARDEES AND MANY 3809 02:30:16,025 --> 02:30:19,995 CHALLENGES WERE SHARED WITH US. 3810 02:30:19,995 --> 02:30:20,529 THESE CHALLENGES INCLUDED 3811 02:30:20,529 --> 02:30:23,599 BIOMEDICAL A.I. RESEARCH IS NOT 3812 02:30:23,599 --> 02:30:24,700 BRINGING TOGETHER NEEDED 3813 02:30:24,700 --> 02:30:25,467 MULTI-DISCIPLINARY TEAMS WITH 3814 02:30:25,467 --> 02:30:27,202 SPECIFIC CHALLENGES FOR THIS 3815 02:30:27,202 --> 02:30:29,738 ETHICAL RESPONSIBLE A.I. 3816 02:30:29,738 --> 02:30:30,372 PRACTICE. 3817 02:30:30,372 --> 02:30:32,808 BIOMEDICAL RESEARCHERS ARE ALSO 3818 02:30:32,808 --> 02:30:33,642 OFTEN NOT SUFFICIENTLY TRAINED 3819 02:30:33,642 --> 02:30:37,046 IN THE A.I. SPACE. 3820 02:30:37,046 --> 02:30:42,418 PARTICULARLY WITH REGARD TO FAIR 3821 02:30:42,418 --> 02:30:43,952 PRINCIPLES, NOT BEING 3822 02:30:43,952 --> 02:30:44,787 INCORPORATED INTO TRADITIONAL 3823 02:30:44,787 --> 02:30:48,357 COURSES BEING OFFERED. 3824 02:30:48,357 --> 02:30:53,495 AND FINALLY WE HEAR A DEARTH OF 3825 02:30:53,495 --> 02:30:56,031 BIOETHICISTS AND HUMANITIES 3826 02:30:56,031 --> 02:30:57,933 PROFESSIONALS CRITICAL PARTNERS 3827 02:30:57,933 --> 02:31:00,302 AND COLLABORATORS, ENGAGED IN 3828 02:31:00,302 --> 02:31:03,272 THE BIOMEDICAL-A.I. SPACE 3829 02:31:03,272 --> 02:31:07,209 SHOWING A NEED FOR TRAINING IN 3830 02:31:07,209 --> 02:31:09,478 BIOMEDICAL WITH CASES TO ENABLE 3831 02:31:09,478 --> 02:31:12,548 MOVEMENT INTO PRACTICE. 3832 02:31:12,548 --> 02:31:14,183 THE TEAM-BASED SCIENCE NEEDS TO 3833 02:31:14,183 --> 02:31:16,785 BE HIGHLIGHTED, INTERSECTION OF 3834 02:31:16,785 --> 02:31:21,957 ETHICS AND BIOMEDICAL A.I., 3835 02:31:21,957 --> 02:31:25,260 ENHANCING PATHWAYS AND NEED OF 3836 02:31:25,260 --> 02:31:27,329 FAIR DATA, BEGINNING THE EARLY 3837 02:31:27,329 --> 02:31:31,266 RESEARCH PLANNING PHASE. 3838 02:31:31,266 --> 02:31:31,934 ENGAGEMENT AND PARTICIPATORY 3839 02:31:31,934 --> 02:31:34,136 PRACTICES NEED TO BE 3840 02:31:34,136 --> 02:31:34,903 INCORPORATED INTO THESE 3841 02:31:34,903 --> 02:31:37,606 TRAININGS THAT ARE OFFERED. 3842 02:31:37,606 --> 02:31:39,374 ALL THESE TAKEN TOGETHER BROUGHT 3843 02:31:39,374 --> 02:31:41,477 US TO PROPOSED INITIATIVES WE'RE 3844 02:31:41,477 --> 02:31:41,877 DESCRIBING TODAY. 3845 02:31:41,877 --> 02:31:46,281 I'M GOING TO HAND IT OVER TO 3846 02:31:46,281 --> 02:31:56,658 SUSAN TO CLOSE US OUT. 3847 02:32:01,163 --> 02:32:03,031 >> CLOSING WHERE WE STARTED, THE 3848 02:32:03,031 --> 02:32:05,134 EXECUTIVE ORDER ON SAFE, SECURE, 3849 02:32:05,134 --> 02:32:07,436 TRUSTWORTHY A.I., WE NEED TO 3850 02:32:07,436 --> 02:32:10,038 PREPARE THE NEXT GENERATION OF 3851 02:32:10,038 --> 02:32:11,039 RESEARCHERS AND TEAMS FOR 3852 02:32:11,039 --> 02:32:13,876 ETHICAL A.I. TO ENSURE WE MAKE 3853 02:32:13,876 --> 02:32:16,278 GOOD ON OUR PROMISE OF A.I. IN 3854 02:32:16,278 --> 02:32:18,046 BIOMEDICAL RESEARCH AND 3855 02:32:18,046 --> 02:32:19,348 RESPONSIBILITIES THAT COME WITH 3856 02:32:19,348 --> 02:32:20,449 A.I., ITS DEVELOPMENT AND USE 3857 02:32:20,449 --> 02:32:21,416 ARE TAKEN CARE OF. 3858 02:32:21,416 --> 02:32:24,486 THIS IS A REALLY CRITICAL AND 3859 02:32:24,486 --> 02:32:25,254 IMPORTANT COMPONENT. 3860 02:32:25,254 --> 02:32:29,525 ONE MORE CLICK TO GET TO THE 3861 02:32:29,525 --> 02:32:30,626 NEXT STEPS. 3862 02:32:30,626 --> 02:32:32,261 THERE'S THE EXECUTIVE ORDER. 3863 02:32:32,261 --> 02:32:34,229 OUR WORK, BIOMEDICAL RESEARCH 3864 02:32:34,229 --> 02:32:37,399 WORK, IS A KEY COMPONENT OF THE 3865 02:32:37,399 --> 02:32:39,401 U.S. GOVERNMENT'S PRIORITIES ON 3866 02:32:39,401 --> 02:32:41,170 ARTIFICIAL INTELLIGENCE, 3867 02:32:41,170 --> 02:32:41,837 PROMINENTLY MENTIONED THROUGHOUT 3868 02:32:41,837 --> 02:32:42,304 THE EXECUTIVE ORDER. 3869 02:32:42,304 --> 02:32:45,307 AND MANY OF THE OTHER DOCUMENTS 3870 02:32:45,307 --> 02:32:46,642 YOU SEE LISTED HERE. 3871 02:32:46,642 --> 02:32:48,110 WE HAVE A RESPONSIBILITY TO 3872 02:32:48,110 --> 02:32:48,944 TRAIN BIOMEDICAL RESEARCHERS IN 3873 02:32:48,944 --> 02:32:50,979 THE A.I. SPACE. 3874 02:32:50,979 --> 02:32:53,315 WE'RE IN THE GENERATION OF A.I. 3875 02:32:53,315 --> 02:33:00,222 WE CAN'T REALLY JUST RELY ON 3876 02:33:00,222 --> 02:33:00,422 NSF. 3877 02:33:00,422 --> 02:33:04,393 THE WORK HAS SPECIFIC COMPONENTS 3878 02:33:04,393 --> 02:33:06,795 TO HELP DATA AND TO BIOMEDICAL 3879 02:33:06,795 --> 02:33:07,129 RESEARCH. 3880 02:33:07,129 --> 02:33:10,199 WE NEED TO BE CO-INVENTORS ON 3881 02:33:10,199 --> 02:33:16,772 A.I., NOT JUST CONSUMERS OF A.I. 3882 02:33:16,772 --> 02:33:20,008 I BELIEVE I FURNISH TO FRANCESCA 3883 02:33:20,008 --> 02:33:24,046 TO WORK ON THE CONCEPT ACTIONS. 3884 02:33:24,046 --> 02:33:24,646 >> ALL RIGHT. 3885 02:33:24,646 --> 02:33:26,148 THANKS, SUSAN. 3886 02:33:26,148 --> 02:33:28,650 WE'RE GOING TO HAVE A BIT OF 3887 02:33:28,650 --> 02:33:32,788 DISCUSSION BEFORE WE GO INTO THE 3888 02:33:32,788 --> 02:33:33,055 VOTE. 3889 02:33:33,055 --> 02:33:35,657 SO KEVIN, YOU'RE UP FIRST, IF 3890 02:33:35,657 --> 02:33:36,758 YOU HAVE COMMENTS OR QUESTIONS 3891 02:33:36,758 --> 02:33:40,462 OR THOUGHTS TO SHARE ABOUT THIS 3892 02:33:40,462 --> 02:33:40,696 CONCEPT. 3893 02:33:40,696 --> 02:33:41,930 >> THANK YOU. 3894 02:33:41,930 --> 02:33:43,932 WONDERFUL JOB, EVERYBODY. 3895 02:33:43,932 --> 02:33:45,567 I'M EXCITED BOTH ABOUT THESE 3896 02:33:45,567 --> 02:33:47,903 PROPOSALS BUT ALSO ABOUT THE 3897 02:33:47,903 --> 02:33:49,338 RESPONSE TO OUR INITIAL REVIEW 3898 02:33:49,338 --> 02:33:54,910 OF THESE CONCEPTS, HOW 3899 02:33:54,910 --> 02:33:56,445 RESPONSIVE YOU'VE BEEN. 3900 02:33:56,445 --> 02:33:56,878 CONGRATULATIONS. 3901 02:33:56,878 --> 02:33:59,081 HIGH LEVEL OF ENTHUSIASM FOR 3902 02:33:59,081 --> 02:34:05,320 INTENT AND STRUCTURE, EMPHASIS 3903 02:34:05,320 --> 02:34:08,156 ON TRAINING, ESPECIALLY 3904 02:34:08,156 --> 02:34:09,591 UNDERGRADS, THE WORK FORCE FOR 3905 02:34:09,591 --> 02:34:13,295 THE COUNTRY IS POPULATED WITH 3906 02:34:13,295 --> 02:34:14,396 TALENTED UNDERGRADUATE STUDENTS 3907 02:34:14,396 --> 02:34:17,032 SO DEVELOPING EDUCATIONAL 3908 02:34:17,032 --> 02:34:18,433 MATERIALS TO UNDERSTAND THEIR 3909 02:34:18,433 --> 02:34:20,535 NEEDS AND NEEDS OF DATA IS GOING 3910 02:34:20,535 --> 02:34:22,170 TO BE ESPECIALLY IMPORTANT FOR 3911 02:34:22,170 --> 02:34:22,938 THAT WORKFORCE. 3912 02:34:22,938 --> 02:34:25,240 THE INTENT OF THE PRE-DOCTORAL 3913 02:34:25,240 --> 02:34:27,542 WORK TO SUPPORT WELL AND LESSER 3914 02:34:27,542 --> 02:34:28,644 RESOURCED INSTITUTIONS, WHICH IS 3915 02:34:28,644 --> 02:34:29,511 A POSITIVE. 3916 02:34:29,511 --> 02:34:33,348 I RECOGNIZE WE DON'T NECESSARILY 3917 02:34:33,348 --> 02:34:34,316 HAVE A PLAN YET. 3918 02:34:34,316 --> 02:34:36,318 YOU'VE DONE IT SO WELL WITH MANY 3919 02:34:36,318 --> 02:34:39,054 OTHER INITIATIVES ON THE FIRST 3920 02:34:39,054 --> 02:34:39,388 SLIDE. 3921 02:34:39,388 --> 02:34:42,124 CONFIDENT YOU NOW HAVE INROADS 3922 02:34:42,124 --> 02:34:48,230 INTO THOSE PLACES. 3923 02:34:48,230 --> 02:34:49,097 LET'S SEE. 3924 02:34:49,097 --> 02:34:49,998 INFORMATION OBTAINED FROM THE 3925 02:34:49,998 --> 02:34:51,066 RESEARCH COMMUNITIES WAS A 3926 02:34:51,066 --> 02:34:52,734 THOUGHTFUL WAY TO ADDRESS WHAT 3927 02:34:52,734 --> 02:34:57,973 IS NECESSARY AND SHOULD HELP 3928 02:34:57,973 --> 02:34:59,508 WITH CURRICULUM DEVELOPMENT 3929 02:34:59,508 --> 02:34:59,808 AWARDS. 3930 02:34:59,808 --> 02:35:01,476 FUTURE PHASES WILL INCLUDE 3931 02:35:01,476 --> 02:35:02,678 MEETINGS AND GATHERINGS OF 3932 02:35:02,678 --> 02:35:04,012 MENTORS AND NIH PROGRAMS TO 3933 02:35:04,012 --> 02:35:07,416 CREATE COMMUNITY AT THE 3934 02:35:07,416 --> 02:35:08,850 INTERSECTION OF THESE TRICKY 3935 02:35:08,850 --> 02:35:11,586 ISSUES FOR POSTDOCTORAL 3936 02:35:11,586 --> 02:35:12,054 PROGRAMS. 3937 02:35:12,054 --> 02:35:16,158 THE FUTURE SPACES INCLUDE 3938 02:35:16,158 --> 02:35:18,226 ENHANCEMENTS, LESS CONCERNED 3939 02:35:18,226 --> 02:35:18,894 ABOUT SUSTAINABILITY AND 3940 02:35:18,894 --> 02:35:21,863 PARTNERSHIPS IF THIS GROUP OF 3941 02:35:21,863 --> 02:35:23,165 R25 AWARDEES ARE REQUIRED TO 3942 02:35:23,165 --> 02:35:24,900 WORK TOGETHER IN SOME CAPACITY 3943 02:35:24,900 --> 02:35:27,102 FROM THE BEGINNING. 3944 02:35:27,102 --> 02:35:28,203 MY FIRST COME WOULD BE IS THERE 3945 02:35:28,203 --> 02:35:30,372 A WAY TO GET THEM TO WORK 3946 02:35:30,372 --> 02:35:32,240 TOGETHER FROM THE BEGINNING AND 3947 02:35:32,240 --> 02:35:34,543 FURTHERMORE IS THERE A WAY WE 3948 02:35:34,543 --> 02:35:36,511 COULD GET THE POSTDOCS TOGETHER 3949 02:35:36,511 --> 02:35:38,080 SOONER THAN FUTURE PHASE BECAUSE 3950 02:35:38,080 --> 02:35:41,016 GIVEN HOW NEW THIS IS, THAT KIND 3951 02:35:41,016 --> 02:35:43,752 OF GROUP INFORMATION IS GOING TO 3952 02:35:43,752 --> 02:35:46,054 BE REAL HELPFUL. 3953 02:35:46,054 --> 02:35:50,525 THE R25 AWARDEES MY GUESS WILL 3954 02:35:50,525 --> 02:35:51,293 BE DEVELOPING COURSES INCLUDING 3955 02:35:51,293 --> 02:35:54,896 TOOLS AND INFRASTRUCTURE. 3956 02:35:54,896 --> 02:35:56,765 MY EXPERIENCE HERE IS THAT IF 3957 02:35:56,765 --> 02:35:57,866 THOSE TOOLS AND INFRASTRUCTURE 3958 02:35:57,866 --> 02:35:59,601 GET USED IN COURSES THAT ARE 3959 02:35:59,601 --> 02:36:02,003 NUMBERED IN THE SCHOOL, THEY 3960 02:36:02,003 --> 02:36:03,305 WILL ACTUALLY BE PROVIDED WITH 3961 02:36:03,305 --> 02:36:06,441 WAYS TO SUSTAIN THEM AS PART OF 3962 02:36:06,441 --> 02:36:06,808 THE COURSE. 3963 02:36:06,808 --> 02:36:08,910 I DON'T KNOW IT'S AS BIG A 3964 02:36:08,910 --> 02:36:10,178 CONCERN. 3965 02:36:10,178 --> 02:36:11,947 IF YOU SHIFTED FUNDING TO 3966 02:36:11,947 --> 02:36:14,383 SUPPORT THE GROUP EFFORTS MORE 3967 02:36:14,383 --> 02:36:15,150 THAN SUPPORT SUSTAINABILITY, I 3968 02:36:15,150 --> 02:36:18,854 WOULD BE EVEN MORE ENTHUSIASTIC. 3969 02:36:18,854 --> 02:36:20,389 WHICH IS HARD TO BEAT. 3970 02:36:20,389 --> 02:36:24,726 I HAVE A QUESTION ABOUT THE K01 3971 02:36:24,726 --> 02:36:25,894 AWARDEES, WHETHER THEY WILL BE 3972 02:36:25,894 --> 02:36:28,397 REQUIRED TO CREATE AND FOLLOW A 3973 02:36:28,397 --> 02:36:29,264 TEACHING PLAN. 3974 02:36:29,264 --> 02:36:32,100 PERHAPS GIVEN THAT IT'S A K 3975 02:36:32,100 --> 02:36:33,301 MECHANISM, THAT'S ASSUMED, BUT 3976 02:36:33,301 --> 02:36:34,503 IN THE DOCUMENTS THAT I HAVE 3977 02:36:34,503 --> 02:36:35,537 THERE WAS NO STATEMENT MADE 3978 02:36:35,537 --> 02:36:38,006 ABOUT WHAT THEY ARE GOING TO DO 3979 02:36:38,006 --> 02:36:40,075 IN TERMS OF THEIR OWN 3980 02:36:40,075 --> 02:36:41,610 DEVELOPMENT IN THIS AREA. 3981 02:36:41,610 --> 02:36:43,245 AND GIVEN THE FACT THESE ARE IN 3982 02:36:43,245 --> 02:36:44,813 PARALLEL IT MIGHT BE USEFUL TO 3983 02:36:44,813 --> 02:36:46,982 MAKE SURE THE K AWARDEES ARE 3984 02:36:46,982 --> 02:36:48,717 COMING FROM INSTITUTIONS THAT 3985 02:36:48,717 --> 02:36:50,485 YOU THINK COULD HAVE, FOR 3986 02:36:50,485 --> 02:36:54,656 EXAMPLE, BEEN AWARDED AN R25 3987 02:36:54,656 --> 02:36:55,757 BECAUSE THE CURRICULUM. 3988 02:36:55,757 --> 02:36:57,926 AS ALSO I WROTE AS NOTED IN THE 3989 02:36:57,926 --> 02:36:59,261 FINDINGS FROM RESEARCH 3990 02:36:59,261 --> 02:37:00,762 COMMUNITIES YOU LISTED, IT'S 3991 02:37:00,762 --> 02:37:01,963 UNLIKELY DOCTORAL STUDENTS IN 3992 02:37:01,963 --> 02:37:02,864 BIOMEDICAL RESEARCH WILL HAVE 3993 02:37:02,864 --> 02:37:04,366 LEARNED ABOUT ETHICAL AND FAIR 3994 02:37:04,366 --> 02:37:06,334 A.I. SO GIVING THEM A K AWORD 3995 02:37:06,334 --> 02:37:11,173 WOULD BE SIMILAR TO EDUCATIONAL 3996 02:37:11,173 --> 02:37:12,574 COMPONENT SIMILAR TO INFORMATICS 3997 02:37:12,574 --> 02:37:15,444 WHERE WE PHYSICIANS WHO GET 3998 02:37:15,444 --> 02:37:16,611 ADVANCED TRAINING OR FELLOWSHIPS 3999 02:37:16,611 --> 02:37:18,079 GO THROUGH A MASTER'S DEGREE 4000 02:37:18,079 --> 02:37:20,582 BECAUSE WE ASSUME THEY DON'T 4001 02:37:20,582 --> 02:37:22,317 HAVE THE ADDITIONAL EXPERIENCE. 4002 02:37:22,317 --> 02:37:25,587 MY LAST QUESTION WOULD BE WOULD 4003 02:37:25,587 --> 02:37:28,323 ONE INSTITUTIONING ELIGIBLE FOR 4004 02:37:28,323 --> 02:37:30,058 R25 AND K01 AWARDS, IT WOULD 4005 02:37:30,058 --> 02:37:31,960 SEEM THAT COULD HAPPEN AND I 4006 02:37:31,960 --> 02:37:33,261 DIDN'T KNOW WHETHER WE WERE 4007 02:37:33,261 --> 02:37:35,130 EMBRACING THAT OR GIVEN THE FACT 4008 02:37:35,130 --> 02:37:36,431 THE FUNDING IS PHASED IN WOULD 4009 02:37:36,431 --> 02:37:45,941 PREFER THAT NOT BE THE CASE. 4010 02:37:45,941 --> 02:37:47,042 THAT'S ALL I HAVE. 4011 02:37:47,042 --> 02:37:48,343 >> WOULD YOU LIKE ME TO TAKE 4012 02:37:48,343 --> 02:37:48,543 THOSE? 4013 02:37:48,543 --> 02:37:54,382 >> I CAN START AND PASS TO YOU. 4014 02:37:54,382 --> 02:37:56,218 I'M RESONATING WITH YOUR 4015 02:37:56,218 --> 02:37:56,985 COMMENTS. 4016 02:37:56,985 --> 02:37:58,587 I APPRECIATE YOUR INSIGHT INTO 4017 02:37:58,587 --> 02:37:58,954 SUSTAINABILITY. 4018 02:37:58,954 --> 02:38:00,789 I THINK WE'LL TAKE THAT UNDER 4019 02:38:00,789 --> 02:38:02,491 CONSIDERATION AS WE THINK ABOUT 4020 02:38:02,491 --> 02:38:06,228 HOW WE'LL SHIFT THE FUNDING AND 4021 02:38:06,228 --> 02:38:10,332 GET THE FOLKS FUNDED, POSTDOCS 4022 02:38:10,332 --> 02:38:11,900 AND GRADUATE STUDENTS TOGETHER 4023 02:38:11,900 --> 02:38:13,134 EARLY ON TO THINK ABOUT 4024 02:38:13,134 --> 02:38:14,002 COLLABORATIVE PROJECTS. 4025 02:38:14,002 --> 02:38:15,537 SUCH A GREAT IDEA. 4026 02:38:15,537 --> 02:38:19,674 YOU MADE A GOOD POINT ABOUT THE 4027 02:38:19,674 --> 02:38:22,544 K01, I'LL PASS TO LAURA FOR HER 4028 02:38:22,544 --> 02:38:24,713 COMMENTS, SHE MIGHT PASS TO 4029 02:38:24,713 --> 02:38:25,247 CHRISTINE TOO. 4030 02:38:25,247 --> 02:38:27,115 >> I WANT TO ADD MY THANKS. 4031 02:38:27,115 --> 02:38:29,317 THANK YOU FOR YOUR COMMENTS, FOR 4032 02:38:29,317 --> 02:38:32,287 THIS CONCEPT AND ALSO FOR THE 4033 02:38:32,287 --> 02:38:33,255 PREVIOUS ONE. 4034 02:38:33,255 --> 02:38:35,323 COMMENTS WERE HELPFUL IN SHAPING 4035 02:38:35,323 --> 02:38:38,326 HOW WE CAME TO TODAY. 4036 02:38:38,326 --> 02:38:40,595 I ALSO LIKE YOUR IDEA OF 4037 02:38:40,595 --> 02:38:41,796 BRINGING THE COHORTS TOGETHER 4038 02:38:41,796 --> 02:38:44,799 SOONER RATHER THAN LATER. 4039 02:38:44,799 --> 02:38:47,836 WE ENDEAVORED TO DO THAT WITH 4040 02:38:47,836 --> 02:38:48,803 SUPPLEMENTAL AWARDEES, THEY 4041 02:38:48,803 --> 02:38:50,338 APPRECIATED HAVING A KICKOFF 4042 02:38:50,338 --> 02:38:50,805 MEETING SOON. 4043 02:38:50,805 --> 02:38:53,108 THEY GOT TO GET EXPOSED TO THE 4044 02:38:53,108 --> 02:38:54,409 DIFFERENT ACTIVITIES ACROSS NIH 4045 02:38:54,409 --> 02:38:57,145 AND ARTIFICIAL INTELLIGENCE AND 4046 02:38:57,145 --> 02:38:59,214 ALSO TO EACH OTHER, THAT SEEMED 4047 02:38:59,214 --> 02:38:59,948 TO BE ENJOYED. 4048 02:38:59,948 --> 02:39:04,052 I WOULD LOVE TO DO MORE OF THAT. 4049 02:39:04,052 --> 02:39:04,886 ABOUT THE EDUCATION COMPONENT, 4050 02:39:04,886 --> 02:39:06,888 WE HADN'T MADE A DECISION, WERE 4051 02:39:06,888 --> 02:39:09,291 THINKING ABOUT LEAVING THAT AS A 4052 02:39:09,291 --> 02:39:10,725 PROPOSAL-DRIVEN THING, WOULD 4053 02:39:10,725 --> 02:39:14,129 LOVE YOUR ADVICE WHETHER WE 4054 02:39:14,129 --> 02:39:16,965 SHOULD BE MORE PRESCRIPTIVE ON 4055 02:39:16,965 --> 02:39:17,866 THAT FRONT. 4056 02:39:17,866 --> 02:39:23,438 >> MY ADVICE, YOU SHOULD BE MORE 4057 02:39:23,438 --> 02:39:23,772 PRESCRIPTIVE. 4058 02:39:23,772 --> 02:39:24,940 >> VERY GOOD. 4059 02:39:24,940 --> 02:39:28,243 YOU MENTIONED A COMMENT ABOUT 4060 02:39:28,243 --> 02:39:34,149 TEN INSTITUTIONS, R25 AND K01. 4061 02:39:34,149 --> 02:39:36,418 THERE'S NOTHING THAT WOULD 4062 02:39:36,418 --> 02:39:36,751 PRECLUDE THAT. 4063 02:39:36,751 --> 02:39:45,961 WE PRAY PRIORITIZE 4064 02:39:45,961 --> 02:39:47,028 UNDERREPRESENTED INSTITUTIONS, 4065 02:39:47,028 --> 02:39:48,129 MULTIPLE AWARDS, I WOULDN'T 4066 02:39:48,129 --> 02:39:52,200 PRECLUDE THAT AT ALL. 4067 02:39:52,200 --> 02:39:52,467 >> OKAY. 4068 02:39:52,467 --> 02:39:53,935 THANK YOU. 4069 02:39:53,935 --> 02:39:55,036 >> GREAT. 4070 02:39:55,036 --> 02:39:56,571 I'LL JUST MENTION, KEVIN, A 4071 02:39:56,571 --> 02:40:03,678 COMMENT MADE ME THINK ABOUT OUR 4072 02:40:03,678 --> 02:40:04,879 ERA EFFORT, THAT'S ANOTHER 4073 02:40:04,879 --> 02:40:07,382 PATHWAY IN WHICH WE CAN CONTINUE 4074 02:40:07,382 --> 02:40:09,484 TO ENGAGE A VARIETY OF EFFORTS, 4075 02:40:09,484 --> 02:40:10,885 MIGHT BE SOMETHING WE WANT TO 4076 02:40:10,885 --> 02:40:13,955 FLAG TO BRING TO AWARENESS OF 4077 02:40:13,955 --> 02:40:17,025 THE COUNCIL AT A NEXT MEETING. 4078 02:40:17,025 --> 02:40:17,792 >> YEAH. 4079 02:40:17,792 --> 02:40:19,527 >> LET'S SEE. 4080 02:40:19,527 --> 02:40:20,462 UNLESS THERE'S ANYTHING ELSE, 4081 02:40:20,462 --> 02:40:26,334 KEVIN, I'LL TURN IT OVER TO 4082 02:40:26,334 --> 02:40:27,335 RAFAEL. 4083 02:40:27,335 --> 02:40:29,304 ANYTHING ELSE YOU WISHED TO ADD 4084 02:40:29,304 --> 02:40:30,972 OR EMPHASIZE OR ASK ABOUT? 4085 02:40:30,972 --> 02:40:36,845 >> YES, I HAVE SOME CONCERNS AND 4086 02:40:36,845 --> 02:40:37,278 SUGGESTIONS. 4087 02:40:37,278 --> 02:40:40,148 SO THE GENERAL CONCERN REGARDS 4088 02:40:40,148 --> 02:40:42,217 CONFUSION AROUND TERMS LIKE A.I. 4089 02:40:42,217 --> 02:40:44,152 AND M.L. CURRENTLY, HOW THEY ARE 4090 02:40:44,152 --> 02:40:49,524 PRONE TO BEING USED AS MARKETING 4091 02:40:49,524 --> 02:40:50,725 TOOLS INSTEAD OF DESCRIBING 4092 02:40:50,725 --> 02:40:52,360 SCIENTIFIC GOALS. 4093 02:40:52,360 --> 02:40:55,997 SO BECAUSE OF THIS CONFUSION I 4094 02:40:55,997 --> 02:40:57,198 HAVE SOME CONCERNS ABOUT A 4095 02:40:57,198 --> 02:40:59,267 LITTLE BIT OF VAGUENESS I SEE IN 4096 02:40:59,267 --> 02:41:00,168 THE PROPOSAL. 4097 02:41:00,168 --> 02:41:03,972 I'M GOING TO GIVE YOU SOME 4098 02:41:03,972 --> 02:41:04,973 SUGGESTIONS, EXAMPLES THAT 4099 02:41:04,973 --> 02:41:06,274 HOPEFULLY CAN HELP. 4100 02:41:06,274 --> 02:41:10,345 SO FIRST, I WAS CURIOUS HOW NIH 4101 02:41:10,345 --> 02:41:11,012 DEFINES ARTIFICIAL INTELLIGENCE, 4102 02:41:11,012 --> 02:41:17,252 AND THE THING I FOUND BY GOOGLE, 4103 02:41:17,252 --> 02:41:19,421 FUTURE WHEN MACHINES LEARN TO 4104 02:41:19,421 --> 02:41:21,189 PERFORM TASKS RATHER THAN 4105 02:41:21,189 --> 02:41:26,561 CARRYING OUT COMPUTATIONS. 4106 02:41:26,561 --> 02:41:27,896 THAT'S VERY BROAD. 4107 02:41:27,896 --> 02:41:29,964 LIKE A CHESS PLAYER WOULD BE AN 4108 02:41:29,964 --> 02:41:32,701 A.I. TOOL. 4109 02:41:32,701 --> 02:41:34,669 SO YOU SEE THAT IT'S BEING USED 4110 02:41:34,669 --> 02:41:38,573 ALSO IN A BROAD WAY AMONG 4111 02:41:38,573 --> 02:41:39,941 NIH-FUNDED RESEARCH. 4112 02:41:39,941 --> 02:41:42,177 I'VE SEEN EXAMPLES WHERE THE 4113 02:41:42,177 --> 02:41:43,611 TITLE OF A PAPER INCLUDES THE 4114 02:41:43,611 --> 02:41:47,782 TERM A.I. BUT WHEN YOU LOOK AT 4115 02:41:47,782 --> 02:41:49,551 THE METHODS THERE'S LOGISTIC 4116 02:41:49,551 --> 02:41:52,587 REGRESSION TO A TRAINING SET, 4117 02:41:52,587 --> 02:41:55,557 PREDICTING OUTCOME USING THE 4118 02:41:55,557 --> 02:41:57,859 MODEL WHICH I GUESS THIS FALLS 4119 02:41:57,859 --> 02:41:58,460 UNDER DEFINITIONS EVENTUALLY 4120 02:41:58,460 --> 02:42:00,795 MACHINES DOING IT BUT IT DOESN'T 4121 02:42:00,795 --> 02:42:03,565 SEEM LIKE WE NEED A TERM LIKE 4122 02:42:03,565 --> 02:42:05,667 A.I. TO DESCRIBE SOMETHING THAT 4123 02:42:05,667 --> 02:42:08,503 SIMPLE THAT'S BEEN AROUND FOR 4124 02:42:08,503 --> 02:42:09,604 OVER 100 YEARS. 4125 02:42:09,604 --> 02:42:12,340 MAYBE A LITTLE BIT LESS. 4126 02:42:12,340 --> 02:42:14,743 BUT THERE'S OTHER EXAMPLES WHERE 4127 02:42:14,743 --> 02:42:18,980 IT SEEMS MORE APPROPRIATE LIKE 4128 02:42:18,980 --> 02:42:22,917 SURGICAL ROBOTS TRAINED A DATA, 4129 02:42:22,917 --> 02:42:24,152 THAT SEEMS LIKE A GOOD EXAMPLE 4130 02:42:24,152 --> 02:42:27,088 OF WHAT I THINK OF AS A.I. 4131 02:42:27,088 --> 02:42:29,023 ANOTHER EXAMPLE WOULD BE HOW 4132 02:42:29,023 --> 02:42:31,559 DOCTORS NOW, MAYBE THEY ARE NOT 4133 02:42:31,559 --> 02:42:33,328 NECESSARILY SAYING IT IN PUBLIC 4134 02:42:33,328 --> 02:42:34,963 BUT USING ChatGPT TO WRITE 4135 02:42:34,963 --> 02:42:39,667 MEDICAL NOTES OR EVEN GET 4136 02:42:39,667 --> 02:42:41,102 DIAGNOSIS. 4137 02:42:41,102 --> 02:42:43,171 THE FUNDED PROJECT I SAW, SEEM 4138 02:42:43,171 --> 02:42:46,207 TO BE FOCUSED ON WHAT I WOULD 4139 02:42:46,207 --> 02:42:47,242 DEFINE AS MACHINE LEARNING, 4140 02:42:47,242 --> 02:42:48,643 WHERE YOU HAVE THE GENERAL IDEA 4141 02:42:48,643 --> 02:42:52,280 THAT YOU HAVE A TRAINING SET 4142 02:42:52,280 --> 02:42:54,015 THAT THAT INCLUDES OUTCOMES, YOU 4143 02:42:54,015 --> 02:42:55,650 MAKE PREDICTIONS WITH THE FITTED 4144 02:42:55,650 --> 02:42:57,852 MODEL IN THE FUTURE. 4145 02:42:57,852 --> 02:42:59,387 YOU CAN GET A ROBOT TO DO THAT 4146 02:42:59,387 --> 02:43:04,993 BUT IT'S NOT NECESSARILY THE 4147 02:43:04,993 --> 02:43:06,161 CASE. 4148 02:43:06,161 --> 02:43:10,632 EXAMPLES OF THAT CURRENTLY 4149 02:43:10,632 --> 02:43:16,471 WORKED ON, POLYGENIC RISK 4150 02:43:16,471 --> 02:43:21,309 SCORES, DETECTION FROM IMAGING, 4151 02:43:21,309 --> 02:43:23,178 CANCER DETECTION FROM BLOOD. 4152 02:43:23,178 --> 02:43:28,183 DEFINING SCORES TO ASSESS 4153 02:43:28,183 --> 02:43:30,151 LIKELIHOOD OF HEART ATTACK. 4154 02:43:30,151 --> 02:43:32,120 THOSE OF MAYBE WHAT YOU'RE 4155 02:43:32,120 --> 02:43:35,957 THINKING OF WHEN YOU SAY A.I., 4156 02:43:35,957 --> 02:43:37,292 THESE ARE FOUR EXAMPLES, VERY 4157 02:43:37,292 --> 02:43:37,625 DIFFERENT. 4158 02:43:37,625 --> 02:43:40,762 THEY HAVE VERY DIFFERENT 4159 02:43:40,762 --> 02:43:43,631 CHALLENGES, METHODS ARE USED. 4160 02:43:43,631 --> 02:43:45,733 IT'S HARD FOR ME TO THINK HOW 4161 02:43:45,733 --> 02:43:49,771 YOU HAVE A DEFINITION OF A.I. 4162 02:43:49,771 --> 02:43:51,639 READY DATA FOR EXAMPLE WHEN 4163 02:43:51,639 --> 02:43:55,577 CONTEXTS ARE SO DIFFERENT. 4164 02:43:55,577 --> 02:43:58,546 SIMILARLY ETHICAL CONCERNS ARE 4165 02:43:58,546 --> 02:44:00,381 GOING TO BE DIFFERENT IN EACH. 4166 02:44:00,381 --> 02:44:01,482 ARE THERE GENERAL PRINCIPLES WE 4167 02:44:01,482 --> 02:44:04,652 COULD TALK ABOUT THAT WE COULD 4168 02:44:04,652 --> 02:44:06,387 BE FUNDING EVEN CURRICULA THAT 4169 02:44:06,387 --> 02:44:10,124 ARE CURRICULA THAT WOULD COVER 4170 02:44:10,124 --> 02:44:13,595 ALL THESE THINGS? 4171 02:44:13,595 --> 02:44:18,700 THAT'S MY CONCERN, TOO VAGUE AND 4172 02:44:18,700 --> 02:44:21,502 BROAD. 4173 02:44:21,502 --> 02:44:27,175 A.I. READY INVESTIGATORS, ONE OF 4174 02:44:27,175 --> 02:44:31,346 THE MOST CURRENTLY POPULAR 4175 02:44:31,346 --> 02:44:32,547 TECHNIQUES THAT ARE GETTING A 4176 02:44:32,547 --> 02:44:36,284 LOT OF ATTENTION, DEEP NEURAL 4177 02:44:36,284 --> 02:44:41,990 NETWORK, TRANSFORMERS, LARGE 4178 02:44:41,990 --> 02:44:43,725 LANGUAGE MODELS ARE COMPLICATED 4179 02:44:43,725 --> 02:44:45,493 MATHEMATICAL IDEAS. 4180 02:44:45,493 --> 02:44:46,361 I'M LEARNING ABOUT THEM, TOOK 4181 02:44:46,361 --> 02:44:49,664 QUITE A BIT OF TIME TO GO 4182 02:44:49,664 --> 02:44:53,368 THROUGH THE MATH. 4183 02:44:53,368 --> 02:44:58,072 RESEARCH TOPICS AND Ph.D., 4184 02:44:58,072 --> 02:44:59,741 UNDERGRADUATES OR OTHER FIELD, 4185 02:44:59,741 --> 02:45:02,577 BIOLOGY OR MEDICINE, TO BE 4186 02:45:02,577 --> 02:45:04,212 LEARNING THESE THINGS, A CONCERN 4187 02:45:04,212 --> 02:45:05,747 HERE WOULD BE YOU'RE TRAINING 4188 02:45:05,747 --> 02:45:10,018 THEM ENOUGH TO USE THE TOOLS 4189 02:45:10,018 --> 02:45:10,818 WITHOUT REALLY UNDERSTANDING, 4190 02:45:10,818 --> 02:45:12,287 THAT ALWAYS CONCERNS ME. 4191 02:45:12,287 --> 02:45:15,390 I SEE IT WITH THINGS LIKE 4192 02:45:15,390 --> 02:45:16,925 STATISTICS, PEOPLE APPLYING 4193 02:45:16,925 --> 02:45:17,425 STATISTICAL METHODOLOGY, 4194 02:45:17,425 --> 02:45:19,861 UNDERSTANDING IT, A LOT OF 4195 02:45:19,861 --> 02:45:21,496 MISTAKES ARE MADE. 4196 02:45:21,496 --> 02:45:23,364 SIMILARLY TRAINING AND ETHICS 4197 02:45:23,364 --> 02:45:25,433 AGAIN BECAUSE IT SEEMS LIKE EACH 4198 02:45:25,433 --> 02:45:26,434 EXAMPLE WOULD BE DIFFERENT, NOT 4199 02:45:26,434 --> 02:45:29,504 CLEAR HOW YOU COULD HAVE A 4200 02:45:29,504 --> 02:45:31,673 GENERAL PROGRAM IN IT, FOR ME AT 4201 02:45:31,673 --> 02:45:33,541 LEAST. 4202 02:45:33,541 --> 02:45:35,977 I I DON'T KNOW WHAT AN EXPERT 4203 02:45:35,977 --> 02:45:38,279 WOULD BE, IT'S SUCH A NEW FIELD. 4204 02:45:38,279 --> 02:45:39,781 WHO IS GOING TO BE TEACHING 4205 02:45:39,781 --> 02:45:40,114 THIS? 4206 02:45:40,114 --> 02:45:42,550 IT'S SO NEW AND WE'RE STILL 4207 02:45:42,550 --> 02:45:44,619 FIGURING IT ALL OUT. 4208 02:45:44,619 --> 02:45:48,890 SO MY -- AGAIN MY SPECIFIC 4209 02:45:48,890 --> 02:45:54,128 SUGGESTION IS THAT YOU FOCUS THE 4210 02:45:54,128 --> 02:45:56,230 PROPOSAL AND IDENTIFY SPECIFIC 4211 02:45:56,230 --> 02:45:57,665 CHALLENGES, ETHICAL CHALLENGES, 4212 02:45:57,665 --> 02:45:58,666 BECAUSE THERE ARE MANY. 4213 02:45:58,666 --> 02:46:01,703 I'M NOT GOING TO LIST EXAMPLES, 4214 02:46:01,703 --> 02:46:04,339 THINGS THAT ARE QUITE 4215 02:46:04,339 --> 02:46:06,407 CONCERNING, WHAT'S HAPPENING 4216 02:46:06,407 --> 02:46:07,075 NOW, IDENTIFY SPECIFIC ETHICAL 4217 02:46:07,075 --> 02:46:09,477 CHALLENGE AND HAVE A FUNDING 4218 02:46:09,477 --> 02:46:12,513 PROGRAM TO TRY TO SOLVE THE 4219 02:46:12,513 --> 02:46:16,150 SPECIFIC PROGRAMS, RATHER THAN 4220 02:46:16,150 --> 02:46:18,119 HAVING IT LIKE THE GENERAL 4221 02:46:18,119 --> 02:46:25,026 DESCRIPTION OF A.I.-READY 4222 02:46:25,026 --> 02:46:28,529 INVESTIGATORS, A.I. READY DATA. 4223 02:46:28,529 --> 02:46:34,769 THOSE ARE MY COMMENTS. 4224 02:46:34,769 --> 02:46:36,070 >> THANK YOU, DR. IRIZARRY, 4225 02:46:36,070 --> 02:46:37,071 THOSE ARE IMPORTANT COMMENTS 4226 02:46:37,071 --> 02:46:39,240 WE'LL TAKE TO HEART. 4227 02:46:39,240 --> 02:46:40,575 ARTIFICIAL INTELLIGENCE IS A 4228 02:46:40,575 --> 02:46:44,479 VERY LARGE AND BROAD FIELD 4229 02:46:44,479 --> 02:46:45,380 COVERING TRADITIONAL MACHINE 4230 02:46:45,380 --> 02:46:46,881 LEARNING, NEURAL NET, DEEP 4231 02:46:46,881 --> 02:46:48,416 LEARNING, NOW GENERATIVE A.I. 4232 02:46:48,416 --> 02:46:50,184 AND ALL OF THE APPLICATIONS 4233 02:46:50,184 --> 02:46:50,385 THERE. 4234 02:46:50,385 --> 02:46:52,253 SO WE CAN ABSOLUTELY CALL IT 4235 02:46:52,253 --> 02:46:53,121 VERY SPECIFIC NEEDS. 4236 02:46:53,121 --> 02:46:55,757 WE'RE LOOKING AND INTERESTED IN 4237 02:46:55,757 --> 02:46:56,858 WHAT THE INSTITUTIONS WILL 4238 02:46:56,858 --> 02:46:58,860 PROPOSE, AND I WOULD IMAGINE 4239 02:46:58,860 --> 02:47:00,161 THAT ONE APPLICATION WOULDN'T 4240 02:47:00,161 --> 02:47:01,562 COVER THE WATERSHED OF ALL THAT 4241 02:47:01,562 --> 02:47:04,966 IS NEEDED AND TRAINING AND 4242 02:47:04,966 --> 02:47:06,634 ETHICAL DEVELOPMENT. 4243 02:47:06,634 --> 02:47:08,036 BUT WOULD IDENTIFY CERTAIN AREAS 4244 02:47:08,036 --> 02:47:10,705 THEY WOULD LIKE TO FOCUS ON. 4245 02:47:10,705 --> 02:47:12,306 SO THAT'S VERY GOOD ADVICE. 4246 02:47:12,306 --> 02:47:14,175 YOU'RE RIGHT, THIS IS A NEW 4247 02:47:14,175 --> 02:47:16,344 FIELD, ETHICAL A.I. 4248 02:47:16,344 --> 02:47:18,980 I THINK BUILDING THE FOUNDATION 4249 02:47:18,980 --> 02:47:22,650 IN UNIVERSITIES IN AREAS OF 4250 02:47:22,650 --> 02:47:24,252 BIOMEDICAL RESEARCH, RESEARCH IS 4251 02:47:24,252 --> 02:47:25,319 INCREDIBLY IMPORTANT, THIS WILL 4252 02:47:25,319 --> 02:47:26,320 HOPEFULLY START AND SEED THAT 4253 02:47:26,320 --> 02:47:29,490 WORK TO A MUCH LARGER PROGRAM. 4254 02:47:29,490 --> 02:47:32,894 SO WE'LL DEFINITELY TAKE YOUR 4255 02:47:32,894 --> 02:47:34,395 CONSIDERATION, WE'RE DEVELOPING 4256 02:47:34,395 --> 02:47:35,963 THE ACTUAL FUNDING ANNOUNCEMENT 4257 02:47:35,963 --> 02:47:36,798 TO TARGET A PAGE AND A HALF TO 4258 02:47:36,798 --> 02:47:39,467 BE SPECIFIC, IN THE FUNDING 4259 02:47:39,467 --> 02:47:41,402 ANNOUNCEMENT CAN BE MUCH MORE 4260 02:47:41,402 --> 02:47:44,372 SPECIFIC ABOUT THE TYPES OF 4261 02:47:44,372 --> 02:47:46,107 AREAS WE'RE INTERESTED N MOST 4262 02:47:46,107 --> 02:47:47,208 INSTITUTES ARE PARTNERING WITH 4263 02:47:47,208 --> 02:47:49,310 US TO ADD THEIR INPUT AND THEIR 4264 02:47:49,310 --> 02:47:57,518 VALUE AND MISSIONS INTO FUNDING 4265 02:47:57,518 --> 02:47:57,852 ANNOUNCEMENTS. 4266 02:47:57,852 --> 02:47:59,187 I'LL PASS TO LAURA. 4267 02:47:59,187 --> 02:48:00,354 >> GREAT RESPONSE. 4268 02:48:00,354 --> 02:48:03,024 THIS IS A FAST-MOVING FIELD, 4269 02:48:03,024 --> 02:48:04,425 VERY MUCH NASCENT ON THE 4270 02:48:04,425 --> 02:48:07,061 EDUCATION COMPONENT AT LEAST. 4271 02:48:07,061 --> 02:48:09,664 AND SO WE'RE -- YET THERE'S A 4272 02:48:09,664 --> 02:48:12,200 HUGE NEED, A HUGE NEED FOR 4273 02:48:12,200 --> 02:48:12,967 RESEARCHERS TO UNDERSTAND AT 4274 02:48:12,967 --> 02:48:14,368 LEAST WHAT IT MEANS FOR THEIR 4275 02:48:14,368 --> 02:48:17,338 DATA TO BE USED DOWNSTREAM IN 4276 02:48:17,338 --> 02:48:17,839 ARTIFICIAL INTELLIGENCE 4277 02:48:17,839 --> 02:48:19,073 APPLICATIONS AND ALSO GOOD 4278 02:48:19,073 --> 02:48:20,608 COLLABORATORS AND TO HAVE ENOUGH 4279 02:48:20,608 --> 02:48:22,577 UNDERSTANDING OF A.I. SO THEY 4280 02:48:22,577 --> 02:48:25,313 CAN UNDERSTAND HOW TO 4281 02:48:25,313 --> 02:48:28,649 CO-INNOVATE AS SUSAN MENTIONED. 4282 02:48:28,649 --> 02:48:30,351 SO WE'RE TRYING TO MEET -- WALK 4283 02:48:30,351 --> 02:48:35,156 THAT BALANCE AND APPRECIATE YOUR 4284 02:48:35,156 --> 02:48:35,523 COMMENTS. 4285 02:48:35,523 --> 02:48:37,658 >> ONE ADDITION TO THAT AS WELL. 4286 02:48:37,658 --> 02:48:38,526 WE'RE NOT THINKING PEOPLE 4287 02:48:38,526 --> 02:48:43,030 TRAINED US IN THESE KRUK -- CUA 4288 02:48:43,030 --> 02:48:45,199 WOULD DO EVERYTHING ON THEIR 4289 02:48:45,199 --> 02:48:45,366 OWN. 4290 02:48:45,366 --> 02:48:46,534 YOU CAN TELL MULTI-DISCIPLINARY 4291 02:48:46,534 --> 02:48:48,069 TEAMS HAVE BEEN VIEWED 4292 02:48:48,069 --> 02:48:48,769 THROUGHOUT AND WE ANTICIPATE 4293 02:48:48,769 --> 02:48:51,772 THEY WILL BECOME PART OF THIS 4294 02:48:51,772 --> 02:48:52,773 MULTI-DISCIPLINARY TEAM LIKE 4295 02:48:52,773 --> 02:48:55,610 LAURA WAS MENTIONING. 4296 02:48:55,610 --> 02:48:58,679 >> WHY DON'T WE NOW TAKE A 4297 02:48:58,679 --> 02:49:00,748 MOMENT, BECAUSE WE'RE A COUPLE 4298 02:49:00,748 --> 02:49:02,183 MINUTES OVER ALREADY BUT LET'S 4299 02:49:02,183 --> 02:49:04,152 OPEN UP FOR OTHERS ON THE 4300 02:49:04,152 --> 02:49:06,454 COUNCIL TO ASK QUESTIONS. 4301 02:49:06,454 --> 02:49:08,956 I SEE MICHAEL, YOU HAVE -- YOU 4302 02:49:08,956 --> 02:49:10,691 WOULD LIKE TO ASK A QUESTION. 4303 02:49:10,691 --> 02:49:18,065 I'LL TURN IT OVER TO YOU FIRST. 4304 02:49:18,065 --> 02:49:19,700 >> THANKS. 4305 02:49:19,700 --> 02:49:20,801 HELPFUL SUGGESTION, PERHAPS, 4306 02:49:20,801 --> 02:49:26,607 LOOKING AT THE WAY THE SCHMIDT 4307 02:49:26,607 --> 02:49:27,608 A.I. POSTDOCTORAL PROGRAM WAS 4308 02:49:27,608 --> 02:49:29,343 ROLLED OUT, I DON'T KNOW IF 4309 02:49:29,343 --> 02:49:30,645 YOU'RE FAMILIAR BUT DID IT MAKE 4310 02:49:30,645 --> 02:49:35,249 AN EFFORT TO RESPOND TO SOME OF 4311 02:49:35,249 --> 02:49:36,984 RAFAEL'S CONCERNS BY PARTNERING 4312 02:49:36,984 --> 02:49:39,053 BETWEEN PEOPLE, YOU KNOW, THAT 4313 02:49:39,053 --> 02:49:42,156 WERE IN THE A.I. DOMAIN AND 4314 02:49:42,156 --> 02:49:44,125 THOSE INDIVIDUALS IN 4315 02:49:44,125 --> 02:49:45,993 APPLICATIONS, SPECIFIC 4316 02:49:45,993 --> 02:49:49,263 APPLICATION DOMAINS. 4317 02:49:49,263 --> 02:49:51,032 WE BROUGHT TOGETHER, SYNERGY'S, 4318 02:49:51,032 --> 02:49:58,105 POSTDOCS, IN THE MIDDLE WHERE 4319 02:49:58,105 --> 02:49:59,240 THEY WOULD GET THE UNDERSTANDING 4320 02:49:59,240 --> 02:50:00,975 IN THE APPLICATION DOMAIN AND 4321 02:50:00,975 --> 02:50:03,611 PROBLEM IN TECHNICAL DOMAIN, IN 4322 02:50:03,611 --> 02:50:05,146 THIS CASE, IT MIGHT BE 4323 02:50:05,146 --> 02:50:09,517 WORTHWHILE TAKING A LOOK AT THAT 4324 02:50:09,517 --> 02:50:09,750 PROGRAM. 4325 02:50:09,750 --> 02:50:11,586 >> I HAVE SPOKEN TO SCHMIDT 4326 02:50:11,586 --> 02:50:13,821 ABOUT THE PROGRAM, A NUMBER OF 4327 02:50:13,821 --> 02:50:16,691 PROGRAMS HAVE -- THAT'S 4328 02:50:16,691 --> 02:50:21,162 ABSOLUTELY A VERY GOOD POINT AND 4329 02:50:21,162 --> 02:50:23,331 WE WILL NOT ONLY TALK WITH THEM 4330 02:50:23,331 --> 02:50:29,904 AND LOOK AT FURTHER PARTNERSHIP. 4331 02:50:29,904 --> 02:50:32,607 >> I JUST TURNED MY MIC OFF 4332 02:50:32,607 --> 02:50:33,407 INSTEAD OF ON. 4333 02:50:33,407 --> 02:50:37,345 MONICA, YOU HAVE A QUESTION AS 4334 02:50:37,345 --> 02:50:37,945 WELL. 4335 02:50:37,945 --> 02:50:39,413 >> THIS IS ACTUALLY A GREAT WAY 4336 02:50:39,413 --> 02:50:43,584 TO EXPLORE IT, TRAINING 4337 02:50:43,584 --> 02:50:44,118 OPPORTUNITIES, K01s, R25s. 4338 02:50:44,118 --> 02:50:45,987 MY QUESTION IS ON THE OTHER END, 4339 02:50:45,987 --> 02:50:48,289 WHAT ARE YOUR ETHICAL POLICIES 4340 02:50:48,289 --> 02:50:49,957 AT THE NIH ABOUT A.I.? 4341 02:50:49,957 --> 02:50:54,295 I SEE YOU NEED TO REVEAL OR NOT 4342 02:50:54,295 --> 02:50:55,963 USE A.I. IN GRANT WRITING, 4343 02:50:55,963 --> 02:50:57,598 THAT'S TRUE OF MANY PAPERS, YOU 4344 02:50:57,598 --> 02:50:59,333 HAVE TO AT LEAST REVEAL IF 4345 02:50:59,333 --> 02:51:00,434 YOU'VE USED IT. 4346 02:51:00,434 --> 02:51:03,738 BUT IS THERE A STANDARDIZED -- 4347 02:51:03,738 --> 02:51:05,573 THE OTHER DISCUSSIONS HOW TO 4348 02:51:05,573 --> 02:51:08,309 DETECT IT, HOW TO -- PEOPLE 4349 02:51:08,309 --> 02:51:10,511 ARE -- I'M SURE A.I. AND HOW DO 4350 02:51:10,511 --> 02:51:12,713 YOU ETHICALLY INCORPORATE THAT 4351 02:51:12,713 --> 02:51:14,649 RIGHT NOW, INTO YOUR GRANT 4352 02:51:14,649 --> 02:51:18,386 WRITING PROCESS, AND REVIEW 4353 02:51:18,386 --> 02:51:18,719 PROCESS. 4354 02:51:18,719 --> 02:51:21,322 >> I DO KNOW WHAT WE'RE DOING 4355 02:51:21,322 --> 02:51:22,490 BUT I'LL SEE -- 4356 02:51:22,490 --> 02:51:24,292 >> YOU CAN GO, SUSAN. 4357 02:51:24,292 --> 02:51:27,228 I'LL FILL IN ADDITIONAL DETAILS. 4358 02:51:27,228 --> 02:51:29,897 >> WE DO HAVE A POLICY, ISSUED 4359 02:51:29,897 --> 02:51:33,034 BY OFFICE OF EXTERNAL RESEARCH, 4360 02:51:33,034 --> 02:51:37,438 THAT REVIEWERS OF NIH GRANTS 4361 02:51:37,438 --> 02:51:40,641 CANNOT USE ONLINE ChatGPT OR 4362 02:51:40,641 --> 02:51:42,843 BARD, ET CETERA, GENERATIVE A.I. 4363 02:51:42,843 --> 02:51:45,146 IN THEIR WORK REVIEWING GRANTS. 4364 02:51:45,146 --> 02:51:48,316 IT DOES VIOLATE CONFIDENTIALITY 4365 02:51:48,316 --> 02:51:51,919 AGREEMENT. 4366 02:51:51,919 --> 02:51:54,422 SECOND WE WANT REVIEWERS TO GIVE 4367 02:51:54,422 --> 02:51:55,756 US INTELLECTUAL INPUT INTO THE 4368 02:51:55,756 --> 02:51:56,190 GRANT. 4369 02:51:56,190 --> 02:52:00,027 THERE'S A THOUGHT THAT IF WE 4370 02:52:00,027 --> 02:52:01,228 WANTED ChatGPT TO REVIEW 4371 02:52:01,228 --> 02:52:02,963 GRANTS WE COULD DO THAT 4372 02:52:02,963 --> 02:52:03,531 OURSELVES. 4373 02:52:03,531 --> 02:52:04,732 THAT'S A FORMAL POLICY, AS I 4374 02:52:04,732 --> 02:52:06,701 UNDERSTAND WE DO NOT HAVE 4375 02:52:06,701 --> 02:52:16,877 NECESSARILY A POLICY ABOUT 4376 02:52:16,877 --> 02:52:18,312 RESEARCHERS USING GENERATIVE 4377 02:52:18,312 --> 02:52:19,747 A.I. TO WRITE GRANTS. 4378 02:52:19,747 --> 02:52:22,049 THERE'S A LOT OF HALLUCINATIONS, 4379 02:52:22,049 --> 02:52:25,653 WITH ChatGPT AND OTHERS, FOR 4380 02:52:25,653 --> 02:52:26,620 WRITING GRANTS. 4381 02:52:26,620 --> 02:52:28,389 WE DON'T NECESSARILY RECOMMEND 4382 02:52:28,389 --> 02:52:30,658 IT BUT THERE'S NO POLICY AGAINST 4383 02:52:30,658 --> 02:52:30,825 IT. 4384 02:52:30,825 --> 02:52:35,796 WE ARE LOOKING AT WAYS IN WHICH 4385 02:52:35,796 --> 02:52:38,065 WE CAN DETECT MATERIALS 4386 02:52:38,065 --> 02:52:40,634 GENERATED FROM GENERATIVE A.I. 4387 02:52:40,634 --> 02:52:42,503 BUT IT'S VERY HARD IN SOME CASES 4388 02:52:42,503 --> 02:52:44,805 TO DO THAT. 4389 02:52:44,805 --> 02:52:48,642 IT'S AS RAFAEL SAID, AN 4390 02:52:48,642 --> 02:52:53,114 INCREDIBLY FAST-MOVING FIELD 4391 02:52:53,114 --> 02:52:55,516 WITHIN A FEW MONTHS, OPEN A.I. 4392 02:52:55,516 --> 02:52:57,184 ALGORITHM WILL COME OUT, 4393 02:52:57,184 --> 02:53:00,654 MASSIVE, IT WILL GROW WHERE WE 4394 02:53:00,654 --> 02:53:02,890 ARE WITH ChatGPT OUT OF THE 4395 02:53:02,890 --> 02:53:03,324 WATER. 4396 02:53:03,324 --> 02:53:06,394 SUCH A FAST-MOVING FIELD THAT 4397 02:53:06,394 --> 02:53:11,031 DETECTION AND WATERMARKS, -- 4398 02:53:11,031 --> 02:53:12,500 WATERMARKINGS, IT'S GOING TO BE 4399 02:53:12,500 --> 02:53:12,700 HARD. 4400 02:53:12,700 --> 02:53:20,040 >> WE HAVE PILOTS ONGOING AS 4401 02:53:20,040 --> 02:53:21,475 SUSAN MENTIONED, LEVERAGING 4402 02:53:21,475 --> 02:53:23,344 RESOURCES TO IDENTIFY THOSE 4403 02:53:23,344 --> 02:53:26,280 APPLICATIONS THAT LEVERAGE THIS 4404 02:53:26,280 --> 02:53:27,381 TECHNOLOGY. 4405 02:53:27,381 --> 02:53:31,318 BUT IT'S REALLY NASCENT IN WHAT 4406 02:53:31,318 --> 02:53:33,387 WE'RE DOING, EVOLVING. 4407 02:53:33,387 --> 02:53:34,688 MORE TO COME. 4408 02:53:34,688 --> 02:53:35,790 SUSAN COVERED THAT NICELY. 4409 02:53:35,790 --> 02:53:37,858 IN THE INTEREST OF TIME I WANT 4410 02:53:37,858 --> 02:53:41,162 TO MAKE SURE THAT WE HAVE ENOUGH 4411 02:53:41,162 --> 02:53:42,463 TIME -- SUFFICIENT TIME TO COVER 4412 02:53:42,463 --> 02:53:44,765 THE LAST TWO TOPICS. 4413 02:53:44,765 --> 02:53:46,734 WHY DON'T WE -- I'M NOT SEEING 4414 02:53:46,734 --> 02:53:48,369 ANY OTHER ACTIVE QUESTIONS HERE. 4415 02:53:48,369 --> 02:53:53,741 WHY DON'T WE SHIFT TO THE VOTE 4416 02:53:53,741 --> 02:53:54,975 FOR THE CONCEPT. 4417 02:53:54,975 --> 02:53:56,577 >> THANK YOU. 4418 02:53:56,577 --> 02:54:02,183 WHAT I HEARD IS A LOT OF 4419 02:54:02,183 --> 02:54:03,484 ENTHUSIASM WITH SOME 4420 02:54:03,484 --> 02:54:04,919 RECOMMENDATIONS AND CONSTRUCTIVE 4421 02:54:04,919 --> 02:54:05,286 RECOMMENDATIONS. 4422 02:54:05,286 --> 02:54:08,189 I'M GOING WITH THE MOTION OR 4423 02:54:08,189 --> 02:54:10,257 CONCEPT AS IT WAS PRESENTED 4424 02:54:10,257 --> 02:54:12,126 ORIGINALLY AND SEE HOW THAT 4425 02:54:12,126 --> 02:54:12,560 GOES. 4426 02:54:12,560 --> 02:54:14,228 SO, I'M GOING TO CALL FOR A 4427 02:54:14,228 --> 02:54:15,095 VOTE. 4428 02:54:15,095 --> 02:54:19,033 MAY I HAVE A MOTION FOR APPROVAL 4429 02:54:19,033 --> 02:54:20,568 OF THE ODSS CONCEPT CLEARANCE 4430 02:54:20,568 --> 02:54:23,404 ENTITLED PREPARING THE NEXT 4431 02:54:23,404 --> 02:54:24,839 GENERATION OF BIOMEDICAL 4432 02:54:24,839 --> 02:54:28,342 RESEARCH TEAMS FOR ETHICAL A.I. 4433 02:54:28,342 --> 02:54:29,443 WORKFORCE AND CURRICULUM 4434 02:54:29,443 --> 02:54:29,743 DEVELOPMENT. 4435 02:54:29,743 --> 02:54:32,913 IS THERE SUCH A VOTE? 4436 02:54:32,913 --> 02:54:34,448 I SEE A MOVE. 4437 02:54:34,448 --> 02:54:35,983 I NEED ASK FOR A SECOND. 4438 02:54:35,983 --> 02:54:37,218 I SEE A SECOND. 4439 02:54:37,218 --> 02:54:38,519 THANK YOU VERY MUCH. 4440 02:54:38,519 --> 02:54:42,122 I'M GOING TO ASK IS THERE ANY 4441 02:54:42,122 --> 02:54:43,023 ADDITIONAL DISCUSSION ON THE 4442 02:54:43,023 --> 02:54:49,230 CONCEPT? 4443 02:54:49,230 --> 02:54:50,865 I DO NOT SEE ANYTHING. 4444 02:54:50,865 --> 02:54:53,834 SO THAT WILL MAKE ME MOVE IT 4445 02:54:53,834 --> 02:54:56,003 OVER TO CHRISTINA. 4446 02:54:56,003 --> 02:54:57,872 >> THANK YOU, DR. GRIEDER. 4447 02:54:57,872 --> 02:54:59,640 AS BEFORE, THE POLL SHOULD 4448 02:54:59,640 --> 02:55:03,244 APPEAR ON YOUR SCREEN WHEN IT IS 4449 02:55:03,244 --> 02:55:03,611 LAUNCHED. 4450 02:55:03,611 --> 02:55:05,012 PLEASE REMEMBER ONLY COUNCIL 4451 02:55:05,012 --> 02:55:06,280 MEMBERS SHOULD PARTICIPATE IN 4452 02:55:06,280 --> 02:55:07,615 THE POLL. 4453 02:55:07,615 --> 02:55:11,452 THE POLL WILL BE UP FOR 30 4454 02:55:11,452 --> 02:55:11,685 SECONDS. 4455 02:55:11,685 --> 02:55:20,528 IT'S STARTING NOW. 4456 02:55:20,528 --> 02:55:22,162 >> I THINK THE CAT VOTE IS NOT 4457 02:55:22,162 --> 02:55:27,001 GOING TO COUNT FOR THIS. 4458 02:55:27,001 --> 02:55:31,171 >> THAT'S A NO I THINK. 4459 02:55:31,171 --> 02:55:33,374 >> 15 SECONDS FOR THE VOTE. 4460 02:55:33,374 --> 02:55:35,009 >> YOU HAVE 15 SECONDS 4461 02:55:35,009 --> 02:55:35,276 REMAINING. 4462 02:55:35,276 --> 02:55:36,644 PLEASE REMEMBER TO HIT SUBMIT 4463 02:55:36,644 --> 02:55:47,054 FOR YOUR VOTE TO COUNT. 4464 02:55:49,156 --> 02:55:53,160 THE POLL IS NOW CLOSING. 4465 02:55:53,160 --> 02:55:55,129 WE'LL NOW SHARE THE RESULTS WITH 4466 02:55:55,129 --> 02:55:58,499 THE MEETING. 4467 02:55:58,499 --> 02:56:02,102 MOTION AS STATED HAS PASSED. 4468 02:56:02,102 --> 02:56:03,237 >> THANK YOU, CHRISTINA AND 4469 02:56:03,237 --> 02:56:04,605 COUNCIL MEMBERS AND PRESENTERS. 4470 02:56:04,605 --> 02:56:06,473 I'LL HAND IT BACK TO TARA. 4471 02:56:06,473 --> 02:56:07,708 >> ALL RIGHT. 4472 02:56:07,708 --> 02:56:09,677 THANK YOU SO MUCH. 4473 02:56:09,677 --> 02:56:15,916 COMMENTS ABOUT THE CAT VOTING 4474 02:56:15,916 --> 02:56:16,216 WERE GREAT. 4475 02:56:16,216 --> 02:56:17,651 VERY VOCAL CAT, SUSAN. 4476 02:56:17,651 --> 02:56:21,589 VERY OPINIONATED I GUESS ON A.I. 4477 02:56:21,589 --> 02:56:26,327 THANK YOU SO MUCH, SUSAN, LAURA, 4478 02:56:26,327 --> 02:56:28,495 AND CHRISTINE FOR THAT 4479 02:56:28,495 --> 02:56:28,963 PRESENTATION. 4480 02:56:28,963 --> 02:56:30,497 I KNOW WE'RE BEHIND SCHEDULE A 4481 02:56:30,497 --> 02:56:32,666 LITTLE BIT. 4482 02:56:32,666 --> 02:56:36,804 LET ME QUICKLY INTRODUCE AND 4483 02:56:36,804 --> 02:56:44,812 TURN IT OVER TO DR. STEFAN 4484 02:56:44,812 --> 02:56:46,046 PASIAKOS, DIRECTOR OF DIETARY 4485 02:56:46,046 --> 02:56:47,247 SUPPLEMENTS IN DPCPSI, TALKING 4486 02:56:47,247 --> 02:56:51,018 ABOUT A IN STRATEGIC PLAN FOR FY 4487 02:56:51,018 --> 02:56:51,285 25-29. 4488 02:56:51,285 --> 02:56:54,455 I'LL TURN IT OVER TO YOU, 4489 02:56:54,455 --> 02:56:55,022 STEFAN. 4490 02:56:55,022 --> 02:56:56,957 >> THANK YOU, TARA. 4491 02:56:56,957 --> 02:56:58,192 GOOD AFTERNOON. 4492 02:56:58,192 --> 02:56:59,293 I WANT TO RECOGNIZE COUNCIL 4493 02:56:59,293 --> 02:57:04,231 MEMBERS AND THOSE IN ATTENDANCE. 4494 02:57:04,231 --> 02:57:06,767 I AM AS SHE SAID RELATIVELY NO 4495 02:57:06,767 --> 02:57:08,702 DIRECTOR OF OFFICE OF DIETARY 4496 02:57:08,702 --> 02:57:11,105 SUPPLEMENTS, JUST ABOUT A YEAR 4497 02:57:11,105 --> 02:57:13,207 INTO MY APPOINTMENT. 4498 02:57:13,207 --> 02:57:13,674 EXCITING OPPORTUNITY, 4499 02:57:13,674 --> 02:57:15,042 CULMINATION OF THE LAST EIGHT OR 4500 02:57:15,042 --> 02:57:20,848 NINE MONTHS OF WORK IN THE 4501 02:57:20,848 --> 02:57:23,150 OFFICE, AN OPPORTUNITY TO SHARE 4502 02:57:23,150 --> 02:57:27,521 PRINCIPLES AND FOUNDATIONS TO 4503 02:57:27,521 --> 02:57:28,722 GUIDE ODSS THROUGH 2029, A 4504 02:57:28,722 --> 02:57:32,660 BLUEPRINT TO BUILD A COORDINATED 4505 02:57:32,660 --> 02:57:34,495 PROGRAM HERE AT NIH. 4506 02:57:34,495 --> 02:57:36,397 I'M PASSIONATE ABOUT THIS FIELD, 4507 02:57:36,397 --> 02:57:37,464 STEMMING FROM MY TRAINING, 15 4508 02:57:37,464 --> 02:57:46,440 YEARS OF LEADING A LAB IN 4509 02:57:46,440 --> 02:57:47,708 DIETARY SCIENCE. 4510 02:57:47,708 --> 02:57:49,910 SUPPLEMENTS ARE PART OF THE 4511 02:57:49,910 --> 02:57:53,213 AMERICAN LANDSCAPE, $60 4512 02:57:53,213 --> 02:57:53,881 $60 BILLION 4513 02:57:53,881 --> 02:57:58,485 A YEAR INDUSTRY, MORE THAN HALF 4514 02:57:58,485 --> 02:58:00,688 REPORT USING SUPPLEMENTS. 4515 02:58:00,688 --> 02:58:08,262 IN SOME SEGMENTS CAN INCREASE 4516 02:58:08,262 --> 02:58:08,562 BEYOND 70%. 4517 02:58:08,562 --> 02:58:11,432 HEALTH BENEFITS CAN SOMETIMES BE 4518 02:58:11,432 --> 02:58:13,400 BASED ON MISINFORMATION OR 4519 02:58:13,400 --> 02:58:14,601 INCONCLUSIVE SCIENCE, IN SOME 4520 02:58:14,601 --> 02:58:16,670 CASES WHEN TAKEN IN EXCESS CAN 4521 02:58:16,670 --> 02:58:17,871 CAUSE HARM. 4522 02:58:17,871 --> 02:58:21,175 GIVEN THIS DATA SCIENCE 4523 02:58:21,175 --> 02:58:23,043 CONSTANTLY EVOLVING OUR JOB IS 4524 02:58:23,043 --> 02:58:27,648 TO BE HONEST BROKERS FOR SCIENCE 4525 02:58:27,648 --> 02:58:30,818 OF DIETARY SUPPLEMENTS SO THE 4526 02:58:30,818 --> 02:58:32,352 AMERICAN PUBLIC HAS THE 4527 02:58:32,352 --> 02:58:33,420 INFORMATION THEY NEED. 4528 02:58:33,420 --> 02:58:34,621 WHAT YOU'LL HEAR OVER THE NEXT 4529 02:58:34,621 --> 02:58:39,326 20 MINUTES IS A BOLD VISION FOR 4530 02:58:39,326 --> 02:58:42,730 ODS, BUILT UPON STAFF, PASSION, 4531 02:58:42,730 --> 02:58:43,430 TALENT, DEDICATION AND 4532 02:58:43,430 --> 02:58:46,934 ACCOMPLISHMENTS OVER THE LAST 4533 02:58:46,934 --> 02:58:48,202 SEVERAL DECADES, OBJECTIVE OF 4534 02:58:48,202 --> 02:58:50,637 FACILITATING INNOVATION AND NEW 4535 02:58:50,637 --> 02:58:51,839 SCIENCE BY PRIORITIZING 4536 02:58:51,839 --> 02:58:53,140 COORDINATION AND COLLABORATION 4537 02:58:53,140 --> 02:58:57,745 HERE AT NIH. 4538 02:58:57,745 --> 02:58:58,946 NEXT SLIDE. 4539 02:58:58,946 --> 02:59:00,280 DEVELOPMENT OF STRATEGIC PLAN 4540 02:59:00,280 --> 02:59:03,984 DOES NOT HAPPEN IN A VACUUM. 4541 02:59:03,984 --> 02:59:08,489 THERE ARE COORDINATED STEPS. 4542 02:59:08,489 --> 02:59:10,557 LET ME TAKE YOU THROUGH THE 4543 02:59:10,557 --> 02:59:10,791 PROCESS. 4544 02:59:10,791 --> 02:59:13,527 THE OFFICE OF DIETARY 4545 02:59:13,527 --> 02:59:15,395 SUPPLEMENTS HAS BEEN WITHOUT 4546 02:59:15,395 --> 02:59:16,263 ACTIVE STRATEGIC PLAN SINCE 2021 4547 02:59:16,263 --> 02:59:20,100 BECAUSE THE OFFICE WAS WITHOUT A 4548 02:59:20,100 --> 02:59:26,106 PERMANENT DIRECTOR FROM 2019 TO 4549 02:59:26,106 --> 02:59:27,875 LAST JULY. 4550 02:59:27,875 --> 02:59:29,743 AN UNPUBLISHED STRATEGIC PLAN 4551 02:59:29,743 --> 02:59:30,944 WAS VETTED. 4552 02:59:30,944 --> 02:59:35,549 DPCPSI LEADERSHIP SLIDED NOT TO 4553 02:59:35,549 --> 02:59:37,217 PUBLISH -- DECIDED TO HOLD OFF. 4554 02:59:37,217 --> 02:59:40,354 WHEN I WAS HIRED I REVIEWED THAT 4555 02:59:40,354 --> 02:59:41,722 DRAFT AND PRIORITY TO IMPLEMENT 4556 02:59:41,722 --> 02:59:45,192 NEW VISION TO CARRY US INTO THE 4557 02:59:45,192 --> 02:59:47,694 FUTURE, WHAT YOU'RE GOING TO 4558 02:59:47,694 --> 02:59:53,400 HEAR ABOUT TODAY. 4559 02:59:53,400 --> 02:59:55,702 THAT FEEDBACK COUPLED WITH 4560 02:59:55,702 --> 02:59:58,005 FEEDBACK FROM PARTNERS, AS WELL 4561 02:59:58,005 --> 02:59:59,973 AS REVIEW OF ONGOING EFFORTS. 4562 02:59:59,973 --> 03:00:02,376 WE CAME TOGETHER AS OFFICE TO 4563 03:00:02,376 --> 03:00:04,144 RESET AND ESTABLISH NEW VISION, 4564 03:00:04,144 --> 03:00:06,013 MISSION, VALUE SET. 4565 03:00:06,013 --> 03:00:10,050 THE PLAN WAS DRAFTED, SENT OUT 4566 03:00:10,050 --> 03:00:11,919 ACROSS NIH WITH OTHER FEDERAL 4567 03:00:11,919 --> 03:00:14,855 AGENCIES AND WITH LEADING TRADE 4568 03:00:14,855 --> 03:00:17,691 ORGANIZATIONS IN DIETARY 4569 03:00:17,691 --> 03:00:17,991 SUPPLEMENTS. 4570 03:00:17,991 --> 03:00:20,727 YOU'LL HEARING THOSE RESULTS 4571 03:00:20,727 --> 03:00:20,994 TODAY. 4572 03:00:20,994 --> 03:00:27,334 GOAL IS TO PUBLISH A PLAN 4573 03:00:27,334 --> 03:00:28,402 OPERATIONALIZED IN 2025. 4574 03:00:28,402 --> 03:00:31,104 I FELT IT WAS CRITICALLY 4575 03:00:31,104 --> 03:00:33,340 IMPORTANT TO GET TO KNOW THE 4576 03:00:33,340 --> 03:00:36,176 PEOPLE, THE OFFICE, WHAT THEY 4577 03:00:36,176 --> 03:00:39,780 DO, HOW THE OFFICE EVOLVED OVER 4578 03:00:39,780 --> 03:00:42,749 30 YEARS, AND REESTABLISH WHO WE 4579 03:00:42,749 --> 03:00:44,518 ARE, NOT TO FORCE CHANGE FOR THE 4580 03:00:44,518 --> 03:00:48,889 SAKE OF CHANGE BUT MY INTENT WAS 4581 03:00:48,889 --> 03:00:52,926 TO TAKE WHAT I HOLD TRUE AS 4582 03:00:52,926 --> 03:00:53,927 SCIENTIST AND LEADER AND WE'VE 4583 03:00:53,927 --> 03:01:00,334 INTO THE OFFICE -- WEAVE INTO 4584 03:01:00,334 --> 03:01:01,168 THE OFFICE. 4585 03:01:01,168 --> 03:01:02,469 WE'RE A COORDINATING OFFICE IN 4586 03:01:02,469 --> 03:01:04,571 DPCPSI OUR VISION IS TO BE 4587 03:01:04,571 --> 03:01:05,772 SCIENTIFIC AUTHORITY AND 4588 03:01:05,772 --> 03:01:07,307 CONVENING BODIES FOR ADVANCING 4589 03:01:07,307 --> 03:01:08,408 DIETARY SUPPLEMENTS. 4590 03:01:08,408 --> 03:01:11,111 OUR MISSION IS SIMPLE IF YOU 4591 03:01:11,111 --> 03:01:15,182 BOIL IT DOWN TO A FEW WORDS, TO 4592 03:01:15,182 --> 03:01:17,484 COORDINATE CUTTING-EDGE RESEARCH 4593 03:01:17,484 --> 03:01:20,988 PRIMARILY HERE AT NIH. 4594 03:01:20,988 --> 03:01:25,592 TO BE SUCCESSFUL WE MUST BE 4595 03:01:25,592 --> 03:01:28,095 GROUNDED IN VALUES. 4596 03:01:28,095 --> 03:01:30,864 WE'LL APPROACH EFFORTS WITH 4597 03:01:30,864 --> 03:01:32,499 RESPECT FOR NIH, THE FEDERAL 4598 03:01:32,499 --> 03:01:33,600 GOVERNMENT AND ITS PRIORITIES, 4599 03:01:33,600 --> 03:01:35,002 AND PUBLIC HEALTH. 4600 03:01:35,002 --> 03:01:36,536 CURIOSITY IS CRITICAL. 4601 03:01:36,536 --> 03:01:39,039 WE NEED INNOVATIVE THOUGHT, TO 4602 03:01:39,039 --> 03:01:40,140 BE CREATIVE, AND WE NEED TO 4603 03:01:40,140 --> 03:01:41,341 THINK BIG. 4604 03:01:41,341 --> 03:01:42,342 MOST IMPORTANTLY WHILE THINKING 4605 03:01:42,342 --> 03:01:44,411 BIG WE NEED TO BE PRAGMATIC WITH 4606 03:01:44,411 --> 03:01:46,380 HOW WE FUNCTION. 4607 03:01:46,380 --> 03:01:48,015 WE NEED TO BE ACCOUNTABLE TO DO 4608 03:01:48,015 --> 03:01:55,255 WHAT WE SAY WE'RE GOING TO DO. 4609 03:01:55,255 --> 03:01:57,024 DELIVER ON THE STRATEGIC PLAN. 4610 03:01:57,024 --> 03:02:03,563 FOR THOSE IN ATTENDANCE, AND 4611 03:02:03,563 --> 03:02:05,432 THOSE FAMILIAR WITH THE OFFICE 4612 03:02:05,432 --> 03:02:06,099 OF DIETARY SUPPLEMENTS, YOU'LL 4613 03:02:06,099 --> 03:02:11,238 NOTICE WHAT WE PUT FORWARD IS A 4614 03:02:11,238 --> 03:02:12,873 REIMAGINING OF THE OFFICE. 4615 03:02:12,873 --> 03:02:15,742 OUR BLUEPRINT IS CENTERED ON 4616 03:02:15,742 --> 03:02:18,278 THREE GOALS, BASIS OF OUR 4617 03:02:18,278 --> 03:02:19,579 PROGRAMS AND PRIORITIES. 4618 03:02:19,579 --> 03:02:21,014 RESEARCH IS NUMBER ONE. 4619 03:02:21,014 --> 03:02:23,750 WHAT I MEAN IS ODS WILL 4620 03:02:23,750 --> 03:02:26,153 PRIORITIZE ABOVE ALL ALSO 4621 03:02:26,153 --> 03:02:27,788 COORDINATION AND SUPPORT OF 4622 03:02:27,788 --> 03:02:33,060 RESEARCH HERE AT NIH BY 4623 03:02:33,060 --> 03:02:34,928 EMPHASIZING SCIENTIFIC 4624 03:02:34,928 --> 03:02:35,662 DISCIPLINES. 4625 03:02:35,662 --> 03:02:36,997 RESEARCH CAPACITY, SECOND GOAL, 4626 03:02:36,997 --> 03:02:38,532 HOW WE ENABLE PROGRESS, TO USE 4627 03:02:38,532 --> 03:02:42,936 ALL AVAILABLE TOOLS AT OUR 4628 03:02:42,936 --> 03:02:52,980 DISPOSAL IN THE DIVISION. 4629 03:02:52,980 --> 03:02:55,382 FUNDING ROBUST AND RELEVANT 4630 03:02:55,382 --> 03:02:56,383 RESEARCH PORTFOLIO. 4631 03:02:56,383 --> 03:02:57,117 OPERATIONS AND RESOURCES TO 4632 03:02:57,117 --> 03:03:01,421 IMPLEMENT A SERIES OF SYSTEMS 4633 03:03:01,421 --> 03:03:03,056 AND POLICIES THAT SUPPORT 4634 03:03:03,056 --> 03:03:06,259 PROFESSIONAL DEVELOPMENT IN MANY 4635 03:03:06,259 --> 03:03:07,094 WAYS, PRIORITIZING DIVERSITY, 4636 03:03:07,094 --> 03:03:08,729 EQUITY, AND INCLUSION, AND 4637 03:03:08,729 --> 03:03:10,397 ENSURES MANY AUDIENCES ARE 4638 03:03:10,397 --> 03:03:15,435 WELL-INFORMED ABOUT ROLE OF 4639 03:03:15,435 --> 03:03:16,970 DIETARY SUPPLEMENTS AND HEALTH. 4640 03:03:16,970 --> 03:03:17,738 NEXT SLIDE. 4641 03:03:17,738 --> 03:03:19,506 SO ON THIS SLIDE YOU SEE A 4642 03:03:19,506 --> 03:03:22,843 FIGURE THAT REPRESENTS THE 4643 03:03:22,843 --> 03:03:23,543 ORGANIZATIONAL STRUCTURE. 4644 03:03:23,543 --> 03:03:25,645 IT WAS APPARENT WHEN I CAME ON 4645 03:03:25,645 --> 03:03:28,949 BOARD I WAS AN OUTSIDER TO NIH, 4646 03:03:28,949 --> 03:03:30,684 TO DPCPSI, AND I DIDN'T KNOW 4647 03:03:30,684 --> 03:03:32,652 MUCH ABOUT THE OFFICE OF DIETARY 4648 03:03:32,652 --> 03:03:33,620 SUPPLEMENTS OTHER THAN WHAT I 4649 03:03:33,620 --> 03:03:36,390 FOUND ON THE WEBSITE AND KNEW IN 4650 03:03:36,390 --> 03:03:37,691 TERMS OF PEER-REVIEWED 4651 03:03:37,691 --> 03:03:38,759 PUBLICATIONS. 4652 03:03:38,759 --> 03:03:40,961 I CAME TO REALIZE ODS IS A SMALL 4653 03:03:40,961 --> 03:03:42,462 OFFICE WITH A MODERATE SIZE 4654 03:03:42,462 --> 03:03:44,564 BUDGET, WE HAVE TO DO IS A LOT 4655 03:03:44,564 --> 03:03:47,768 WITH VERY LITTLE IN TERMS OF 4656 03:03:47,768 --> 03:03:49,669 STAFFING AND MANPOWER. 4657 03:03:49,669 --> 03:03:51,705 CRITICALLY IMPORTANT TO ODS NOT 4658 03:03:51,705 --> 03:03:55,542 BE STRUCTURED THAT LEADS TO 4659 03:03:55,542 --> 03:04:01,014 SILOED ACTIVITIES OR STIFLE 4660 03:04:01,014 --> 03:04:03,850 CREATIVITY, OR DETRACT FROM OUR 4661 03:04:03,850 --> 03:04:04,618 ABILITY TO COLLABORATE. 4662 03:04:04,618 --> 03:04:07,587 WHAT I WANT YOU TO TAKE AWAY IS 4663 03:04:07,587 --> 03:04:10,757 ODS WILL ADOPT AND FUNCTION AS A 4664 03:04:10,757 --> 03:04:13,393 TRULY INTERCONNECTED PRO-ACTIVE 4665 03:04:13,393 --> 03:04:14,361 AND PRIORITY-BASED COORDINATING 4666 03:04:14,361 --> 03:04:15,028 OFFICE. 4667 03:04:15,028 --> 03:04:18,532 WE'RE GOING TO START AT THE 4668 03:04:18,532 --> 03:04:18,865 CENTER. 4669 03:04:18,865 --> 03:04:21,701 THE FIRST STEP IS CENTER OUR 4670 03:04:21,701 --> 03:04:23,437 EFFORTS ON SHARED SCIENTIFIC 4671 03:04:23,437 --> 03:04:23,770 PRIORITIES. 4672 03:04:23,770 --> 03:04:33,847 WE WENT THROUGH BROAD SCIENTIFIC 4673 03:04:33,847 --> 03:04:35,348 INTERESTS ACROSS NIH. 4674 03:04:35,348 --> 03:04:38,652 THE STRATEGIC PLAN, THOSE ARE 4675 03:04:38,652 --> 03:04:41,621 CROSS-CUTTING THEMES, DIVERSE 4676 03:04:41,621 --> 03:04:42,722 POPULATIONS, HEALTHY LIFESPAN, 4677 03:04:42,722 --> 03:04:43,123 RESILIENCE. 4678 03:04:43,123 --> 03:04:45,358 TO ADDRESS THOSE WE NEED 4679 03:04:45,358 --> 03:04:46,893 RESEARCH PROGRAMS AND FINANCIAL 4680 03:04:46,893 --> 03:04:50,063 EXPERTISE TO MAKE SCIENTIFIC 4681 03:04:50,063 --> 03:04:50,597 ADVANCES. 4682 03:04:50,597 --> 03:04:54,568 THESE ARE PROGRAMS WITH 4683 03:04:54,568 --> 03:04:56,770 BIOLOGICAL, ANALYTICAL, 4684 03:04:56,770 --> 03:04:58,171 POPULATION SCIENCES. 4685 03:04:58,171 --> 03:05:00,373 RESEARCH CAPACITY MUST BE 4686 03:05:00,373 --> 03:05:00,774 EMPHASIZED. 4687 03:05:00,774 --> 03:05:02,676 THAT'S THE NEXT LAYER IN THE 4688 03:05:02,676 --> 03:05:03,877 ORGANIZATIONAL STRUCTURE. 4689 03:05:03,877 --> 03:05:05,846 THAT INCLUDES METHODOLOGY AND 4690 03:05:05,846 --> 03:05:09,015 RESEARCH FUNDING STRATEGY 4691 03:05:09,015 --> 03:05:09,282 PROGRAMS. 4692 03:05:09,282 --> 03:05:10,550 AND FINALLY INFORMING WHAT WE 4693 03:05:10,550 --> 03:05:12,519 DO, WHAT PEOPLE SEE IN THE 4694 03:05:12,519 --> 03:05:15,255 OFFICE, OUR OPERATIONS AND 4695 03:05:15,255 --> 03:05:16,123 RESOURCES PROGRAMS. 4696 03:05:16,123 --> 03:05:18,658 THOSE INCLUDE SCIENCE AND HEALTH 4697 03:05:18,658 --> 03:05:20,293 COMMUNICATIONS PROGRAM, DIETARY 4698 03:05:20,293 --> 03:05:22,028 SUPPLEMENT DATABASES, MANAGEMENT 4699 03:05:22,028 --> 03:05:23,230 AND ADMINISTRATIVE SUPPORT. 4700 03:05:23,230 --> 03:05:25,198 SO ALL OF THE PROGRAMMATIC 4701 03:05:25,198 --> 03:05:26,867 LAYERS OUTLINED IN THIS FIGURE 4702 03:05:26,867 --> 03:05:28,401 ARE NEEDED TO COORDINATE 4703 03:05:28,401 --> 03:05:29,269 RELEVANT AND INNOVATIVE SCIENCE 4704 03:05:29,269 --> 03:05:35,075 TO MAKE BEST USE OF TAXPAYER 4705 03:05:35,075 --> 03:05:35,475 DOLLARS. 4706 03:05:35,475 --> 03:05:36,510 NEXT SLIDE. 4707 03:05:36,510 --> 03:05:39,346 THE NEXT THREE SLIDES PRESENT 4708 03:05:39,346 --> 03:05:41,314 CROSS-CUTTING THEMES AND 4709 03:05:41,314 --> 03:05:41,882 OBJECTIVES. 4710 03:05:41,882 --> 03:05:43,416 FIRST DIVERSE POPULATIONS. 4711 03:05:43,416 --> 03:05:46,353 FOCUS ON DIVERSE POPULATIONS 4712 03:05:46,353 --> 03:05:46,920 STRESSES IMPORTANCE OF 4713 03:05:46,920 --> 03:05:48,722 UNDERSTANDING UNIQUENESS OF THE 4714 03:05:48,722 --> 03:05:50,857 MANY POPULATION SUBGROUPS IN THE 4715 03:05:50,857 --> 03:05:52,459 UNITED STATES. 4716 03:05:52,459 --> 03:05:53,260 DIVERSE POPULATIONS INCLUDE 4717 03:05:53,260 --> 03:05:56,096 THOSE DESIGNATED BY NIH AS 4718 03:05:56,096 --> 03:05:57,063 POPULATIONS WITH HEALTH 4719 03:05:57,063 --> 03:05:58,064 DISPARITIES. 4720 03:05:58,064 --> 03:06:00,367 SUCH AS RACIAL AND ETHNIC 4721 03:06:00,367 --> 03:06:02,002 MINORITY GROUPS, LOWER 4722 03:06:02,002 --> 03:06:02,869 SOCIOECONOMIC STATUS, 4723 03:06:02,869 --> 03:06:04,404 UNDERSERVED RURAL COMMUNITIES, 4724 03:06:04,404 --> 03:06:06,373 SEXUAL AND GENDER BUY MINORITY 4725 03:06:06,373 --> 03:06:07,474 GROUPS, PEOPLE WITH 4726 03:06:07,474 --> 03:06:08,008 DISABILITIED. 4727 03:06:08,008 --> 03:06:10,977 WE INCLUDE PEOPLE OF DIFFERENT 4728 03:06:10,977 --> 03:06:13,480 AGE, SEX, GENDER, GEOGRAPHIC 4729 03:06:13,480 --> 03:06:15,682 LOCATION, HEALTH STATUS, 4730 03:06:15,682 --> 03:06:17,617 LANGUAGE AND CITIZENSHIP STATUS. 4731 03:06:17,617 --> 03:06:19,419 AS AN OFFICE AND FIELD WE NEED 4732 03:06:19,419 --> 03:06:22,389 TO DO A BETTER JOB UNDERSTANDING 4733 03:06:22,389 --> 03:06:25,458 HOW DIFFERENT POPULATION 4734 03:06:25,458 --> 03:06:26,660 CHARACTERISTICS AND 4735 03:06:26,660 --> 03:06:29,029 INTERSECTIONALITY IMPACT USE OF 4736 03:06:29,029 --> 03:06:31,765 NUTRIENTS AND PHYTOCHEMICALS IN 4737 03:06:31,765 --> 03:06:33,133 DIETARY SUPPLEMENTS AND TRIP TO 4738 03:06:33,133 --> 03:06:35,302 FOOD INTAKE AND HOW IT MAY 4739 03:06:35,302 --> 03:06:38,705 INFLUENCE HELP ACROSS THE 4740 03:06:38,705 --> 03:06:38,972 LIFESPAN. 4741 03:06:38,972 --> 03:06:41,208 OUR EFFORTS WILL ENSURE DIVERSE 4742 03:06:41,208 --> 03:06:42,976 POPULATIONS ARE EQUITABLY 4743 03:06:42,976 --> 03:06:44,311 REPRESENTED IN SCIENCE AND WE 4744 03:06:44,311 --> 03:06:47,047 SUPPORT AND HAVE ACCESS TO 4745 03:06:47,047 --> 03:06:52,786 PUBLIC HEALTH INFORMATION WE 4746 03:06:52,786 --> 03:06:53,086 DISSEMINATE. 4747 03:06:53,086 --> 03:06:54,821 NEXT SLIDE PLEASE. 4748 03:06:54,821 --> 03:06:57,757 SECOND THEME IS HEALTHY 4749 03:06:57,757 --> 03:07:00,493 LIFESPAN, SELF-EXPLANATORY. 4750 03:07:00,493 --> 03:07:02,596 I'LL GIVE CONTEXT. 4751 03:07:02,596 --> 03:07:05,999 THROUGHOUT LIFE PEOPLE 4752 03:07:05,999 --> 03:07:07,867 EXPERIENCE PHASES, PHYSICAL, 4753 03:07:07,867 --> 03:07:09,069 COGNITIVE, GROWTH, DEVELOPMENT, 4754 03:07:09,069 --> 03:07:10,804 MATURATION, UNFORTUNATELY 4755 03:07:10,804 --> 03:07:11,471 DECLINE. 4756 03:07:11,471 --> 03:07:15,208 EACH STAGE WHETHER PREGNANCY, 4757 03:07:15,208 --> 03:07:16,276 INFANCY, CHILDHOOD, ADOLESCENCE, 4758 03:07:16,276 --> 03:07:21,648 ADULTHOOD, OLD AGE, COINCIDES 4759 03:07:21,648 --> 03:07:23,383 WITH CHANGING NUTRITIONAL NEEDS. 4760 03:07:23,383 --> 03:07:25,919 THIS PROVIDES OPPORTUNITY TO 4761 03:07:25,919 --> 03:07:27,120 EXPLORE ASSOCIATIONS BETWEEN 4762 03:07:27,120 --> 03:07:28,989 SUPPLEMENT USE, DISEASE 4763 03:07:28,989 --> 03:07:29,956 PREVENTION AND HEALTH 4764 03:07:29,956 --> 03:07:32,792 OPTIMIZATION AT LIFE STAGES. 4765 03:07:32,792 --> 03:07:36,229 BIOLOGICAL MECHANISMS THROUGH 4766 03:07:36,229 --> 03:07:40,800 WHICH SUPPLEMENTS MAY IMPACT 4767 03:07:40,800 --> 03:07:41,201 HEALTH. 4768 03:07:41,201 --> 03:07:43,770 TOPICS OF INTEREST ARE MANY, IN 4769 03:07:43,770 --> 03:07:45,105 TICKLES MEDICATIONS. 4770 03:07:45,105 --> 03:07:48,475 AND LIFESTYLE FACTORS SUCH AS 4771 03:07:48,475 --> 03:07:50,644 SLEEP, PHYSICAL ACTIVITY, 4772 03:07:50,644 --> 03:07:52,078 UNDERLYING DIETARY INTAKE. 4773 03:07:52,078 --> 03:07:55,815 SOME DISEASES AND CONDITIONS 4774 03:07:55,815 --> 03:08:00,420 BEING CONSIDERED, MUCOSAL 4775 03:08:00,420 --> 03:08:02,922 IMMUNITY, DIGESTIVE HEALTH, 4776 03:08:02,922 --> 03:08:08,528 AUTOIMMUNE DISEASE AND 4777 03:08:08,528 --> 03:08:16,403 CARDIOVASCULAR DISEASE. 4778 03:08:16,403 --> 03:08:17,704 OBESITY, PHYSICAL ACTIVITY, 4779 03:08:17,704 --> 03:08:19,372 CARDIOMETABOLIC, SARCOPENIA AND 4780 03:08:19,372 --> 03:08:22,208 AGE-RELATED COGNITIVE DECLINE. 4781 03:08:22,208 --> 03:08:24,611 FINAL CROSS-CUTTING THEME IS 4782 03:08:24,611 --> 03:08:28,782 RESILIENCE, FOCUSED FRAMED BY 4783 03:08:28,782 --> 03:08:34,120 TRANS-NIH GROUP, WORKING GROUP 4784 03:08:34,120 --> 03:08:34,888 DEFINITION. 4785 03:08:34,888 --> 03:08:35,455 CAPACITY TO RESIST, ADAPT, 4786 03:08:35,455 --> 03:08:39,392 RECOVER OH GROW FROM A 4787 03:08:39,392 --> 03:08:39,659 CHALLENGE. 4788 03:08:39,659 --> 03:08:48,368 IT'S UNDERSTOOD RESILIENCY MAY 4789 03:08:48,368 --> 03:08:57,911 BE ATTRIBUTED TO PHENOTYPIC 4790 03:08:57,911 --> 03:08:58,211 SIGNATURES. 4791 03:08:58,211 --> 03:08:59,846 QUESTIONS IN THIS THEME COULD BE 4792 03:08:59,846 --> 03:09:05,985 ARE IS THERE DIFFERENCES IN HOW 4793 03:09:05,985 --> 03:09:07,087 DIETARY SUPPLEMENTS INFLUENCE 4794 03:09:07,087 --> 03:09:09,656 PATHWAYS AND DO THEY DIFFER BY 4795 03:09:09,656 --> 03:09:10,357 SUBGROUPS? 4796 03:09:10,357 --> 03:09:15,061 WHAT ARE CRITICAL LIFE STAGES 4797 03:09:15,061 --> 03:09:17,063 FOR OPTIMIZING RESILIENCE, AND 4798 03:09:17,063 --> 03:09:18,898 HOW DOES DOSING, TIMING AND 4799 03:09:18,898 --> 03:09:20,800 DURATION OF DIETARY SUPPLEMENT 4800 03:09:20,800 --> 03:09:22,469 USE AFFECT RESILIENCE PATHWAYS 4801 03:09:22,469 --> 03:09:25,238 IN DIFFERENT POPULATIONS ACROSS 4802 03:09:25,238 --> 03:09:27,774 THE LIFESPAN. 4803 03:09:27,774 --> 03:09:31,277 AS I CLOSE OUT THIS SECTION, I 4804 03:09:31,277 --> 03:09:32,379 WANT TO HIGHLIGHT OUR RECENT 4805 03:09:32,379 --> 03:09:35,615 WORK THAT WILL COME TOGETHER IN 4806 03:09:35,615 --> 03:09:37,951 COMING MONTHS, BECAUSE WHAT THIS 4807 03:09:37,951 --> 03:09:40,687 DESCRIBES IS LAYING FOUNDATION 4808 03:09:40,687 --> 03:09:41,688 FOR COORDINATIONING CONCEPT 4809 03:09:41,688 --> 03:09:42,155 INITIATIVES. 4810 03:09:42,155 --> 03:09:43,857 WITH THE FOCUS ON WOMEN'S HEALTH 4811 03:09:43,857 --> 03:09:46,359 HERE AT NIH, WE'RE WORKING 4812 03:09:46,359 --> 03:09:50,196 CLOSELY TO IDENTIFY KNOWLEDGE 4813 03:09:50,196 --> 03:09:52,365 GAPS, HOW DIETARY SUPPLEMENTS 4814 03:09:52,365 --> 03:09:54,801 IMPACT HEALTH PROMOTION ACROSS 4815 03:09:54,801 --> 03:09:56,870 THE LIFESPAN IN POPULATIONS OF 4816 03:09:56,870 --> 03:09:58,505 WOMEN, AS WOMEN AGE REQUIREMENTS 4817 03:09:58,505 --> 03:09:59,072 CHANGE. 4818 03:09:59,072 --> 03:10:00,707 THE OFFICE WILL CONSIDER 4819 03:10:00,707 --> 03:10:03,009 UNDERSTANDING USE AND IMPACT OF 4820 03:10:03,009 --> 03:10:05,345 DIETARY SUPPLEMENTS AT DIFFERENT 4821 03:10:05,345 --> 03:10:07,480 LIFE STAGES, INCLUDING PRE AND 4822 03:10:07,480 --> 03:10:10,216 POST NATAL FEW TRIGS, PERI AND 4823 03:10:10,216 --> 03:10:11,651 POSTMENOPAUSAL PERIODS. 4824 03:10:11,651 --> 03:10:13,620 WE'RE WORKING TO BUILD 4825 03:10:13,620 --> 03:10:14,821 PARTNERSHIPS TO IDENTIFY 4826 03:10:14,821 --> 03:10:18,758 RESEARCH GAPS AND REFINE HOW 4827 03:10:18,758 --> 03:10:20,994 SUCH WORK WILL EVENTUALLY 4828 03:10:20,994 --> 03:10:26,433 MANIFEST. 4829 03:10:26,433 --> 03:10:28,067 NEXT SLIDE PLEASE. 4830 03:10:28,067 --> 03:10:30,670 THESE SLIDES DETAIL RESEARCH 4831 03:10:30,670 --> 03:10:34,507 CAPACITY AND OPERATIONS AND 4832 03:10:34,507 --> 03:10:36,242 RESOURCES PROGRAM, OBJECTIVES, 4833 03:10:36,242 --> 03:10:40,747 PRIORITIES IN EACH PROGRAM. 4834 03:10:40,747 --> 03:10:42,382 OBJECTIVES TO COORDINATE 4835 03:10:42,382 --> 03:10:45,218 RESEARCH ANALYSES TO IDENTIFY 4836 03:10:45,218 --> 03:10:46,753 RESEARCH KNOWLEDGE GAPS, 4837 03:10:46,753 --> 03:10:48,188 COLLABORATE CLOSELY WITH NIH ICO 4838 03:10:48,188 --> 03:10:50,256 PROGRAM STAFF TO IDENTIFY 4839 03:10:50,256 --> 03:10:52,992 RESEARCH TOPICS OF INTEREST THAT 4840 03:10:52,992 --> 03:10:54,861 ADDRESS KNOWLEDGE GAPS ALIGNING 4841 03:10:54,861 --> 03:10:57,464 WITH ODS CROSS-CUTTING THEMES 4842 03:10:57,464 --> 03:10:59,232 AND ICO INTEREST AREAS. 4843 03:10:59,232 --> 03:11:05,371 AND FINALLY CURED NATE -- 4844 03:11:05,371 --> 03:11:06,039 COORDINATE RESEARCH INITIATIVES, 4845 03:11:06,039 --> 03:11:08,741 FOR EACH THEME ACROSS BIOLOGICAL 4846 03:11:08,741 --> 03:11:11,077 POPULATION AND ANALYTICAL 4847 03:11:11,077 --> 03:11:14,347 SCIENCES PROGRAM. 4848 03:11:14,347 --> 03:11:15,748 NEXT SLIDE PLEASE. 4849 03:11:15,748 --> 03:11:17,817 FIRST PROGRAM IS BIOLOGICAL 4850 03:11:17,817 --> 03:11:19,586 SCIENCES, PRIORITY LAID OUT 4851 03:11:19,586 --> 03:11:19,819 THERE. 4852 03:11:19,819 --> 03:11:23,423 I WILL SAY ODS HAS FOCUSED 4853 03:11:23,423 --> 03:11:24,757 THROUGHOUT ITS HISTORY, AND WILL 4854 03:11:24,757 --> 03:11:27,227 CONTINUE TO DO SO AND LOOK TO 4855 03:11:27,227 --> 03:11:29,863 ADVANCE BIOLOGICAL STUDY OF 4856 03:11:29,863 --> 03:11:31,297 EFFECTS ON HEALTH, AND INTERNAL 4857 03:11:31,297 --> 03:11:34,367 AND EXTERNAL FACTORS THAT MAY 4858 03:11:34,367 --> 03:11:36,135 MODULATE THEIR EFFECTS. 4859 03:11:36,135 --> 03:11:38,104 TO SUPPORT THE THEMES WE'LL 4860 03:11:38,104 --> 03:11:39,539 FOCUS ON UNDERSTANDING 4861 03:11:39,539 --> 03:11:45,979 BIOLOGICAL MECHANISMS FOR WHICH 4862 03:11:45,979 --> 03:11:47,280 DIETARY SUPPLEMENTS AFFECT 4863 03:11:47,280 --> 03:11:48,581 PATHWAYS, UNDERSTANDING 4864 03:11:48,581 --> 03:11:50,250 INTERACTIONS WITH DIET, 4865 03:11:50,250 --> 03:11:52,785 SUPPLEMENT USE, INDIVIDUAL 4866 03:11:52,785 --> 03:11:55,288 HEALTH BEHAVIORS AND EXPOSOMES, 4867 03:11:55,288 --> 03:11:56,356 THE ENVIRONMENTAL EXPOSURES THAT 4868 03:11:56,356 --> 03:12:00,426 MAY INFLUENCE HEALTH AS WELL. 4869 03:12:00,426 --> 03:12:01,561 NEXT SLIDE PLEASE. 4870 03:12:01,561 --> 03:12:04,597 SECOND RESEARCH PROGRAM IS 4871 03:12:04,597 --> 03:12:05,632 POPULATION SCIENCES, NUTRITION 4872 03:12:05,632 --> 03:12:09,969 EPIDEMIOLOGY HAS BEEN A CRITICAL 4873 03:12:09,969 --> 03:12:10,737 COMPONENT SINCE INCEPTION, A 4874 03:12:10,737 --> 03:12:12,972 MAIN STAY FOR THE OFFICE, IT 4875 03:12:12,972 --> 03:12:15,375 WILL REMAIN A VITAL COMPONENT 4876 03:12:15,375 --> 03:12:19,112 MOVING FORWARD. 4877 03:12:19,112 --> 03:12:19,712 ESPECIALLY FOR IDENTIFYING 4878 03:12:19,712 --> 03:12:26,986 DEFICIENCIES IN THE AMERICAN 4879 03:12:26,986 --> 03:12:33,226 PUBLIC THAT MIGHT AFFECT HEALTH. 4880 03:12:33,226 --> 03:12:36,496 IT'S CRITICALLY IMPORTANT TO 4881 03:12:36,496 --> 03:12:38,164 CREATE COMPLETE PROFILE, NOT 4882 03:12:38,164 --> 03:12:41,568 ONLY ASSESSING DIETARY INTAKE 4883 03:12:41,568 --> 03:12:42,335 FROM FOODS AND BEVERAGES 4884 03:12:42,335 --> 03:12:45,271 NOT TO LEAVE OUT SUPPLEMENTS. 4885 03:12:45,271 --> 03:12:48,308 MORE THAN HALF OF THE U.S. 4886 03:12:48,308 --> 03:12:51,844 POPULATION REPORTS USING DIETARY 4887 03:12:51,844 --> 03:12:53,479 SUPPLEMENTS, THEY PLAY A ROLE 4888 03:12:53,479 --> 03:12:54,581 REGARDLESS OF EFFICACY AND 4889 03:12:54,581 --> 03:12:55,648 CANNOT BE OVERLOOKED. 4890 03:12:55,648 --> 03:12:56,849 THIS IS PARTICULARLY IMPORTANT 4891 03:12:56,849 --> 03:12:59,152 AS RELATES TO POPULATION WITH 4892 03:12:59,152 --> 03:13:00,153 HEALTH DISPARITIES. 4893 03:13:00,153 --> 03:13:01,888 MINORITY AND UNDERREPRESENTED 4894 03:13:01,888 --> 03:13:04,791 AND UNDERSERVED POPULATIONS. 4895 03:13:04,791 --> 03:13:06,359 IT IS IMPERATIVE DEMOGRAPHICS 4896 03:13:06,359 --> 03:13:09,529 ARE REPRESENTED IN SCIENTIFIC 4897 03:13:09,529 --> 03:13:10,430 RESEARCH SO RECOMMENDATIONS FOR 4898 03:13:10,430 --> 03:13:11,531 SPECIFIC SUBGROUPS CAN BE 4899 03:13:11,531 --> 03:13:11,798 DEVELOPED. 4900 03:13:11,798 --> 03:13:15,034 AND THIS IS JUST LIKE THE OFFICE 4901 03:13:15,034 --> 03:13:16,235 OF NUTRITION RESEARCH AND NIH'S 4902 03:13:16,235 --> 03:13:19,639 EFFORTS TO GET AWAY FROM A 4903 03:13:19,639 --> 03:13:20,340 ONE-SIZE-FITS-ALL APPROACH FOR 4904 03:13:20,340 --> 03:13:22,342 RESEARCH, WE'RE TAKING THE SAME 4905 03:13:22,342 --> 03:13:24,110 APPROACH TO UNDERSTAND 4906 03:13:24,110 --> 03:13:24,978 HETEROGENEITY AND RESPONSE TO 4907 03:13:24,978 --> 03:13:31,117 DIETARY SUPPLEMENTS AS WELL AS 4908 03:13:31,117 --> 03:13:32,185 OVERALL DIET. 4909 03:13:32,185 --> 03:13:35,922 THE FINAL PROGRAM IS ANALYTICAL 4910 03:13:35,922 --> 03:13:38,157 SCIENCES, TO ADVANCE STUDY OF 4911 03:13:38,157 --> 03:13:38,958 COMPOSITION, QUALITY, 4912 03:13:38,958 --> 03:13:49,302 STAKEHOLDER BECAUSE 4913 03:13:50,670 --> 03:13:53,106 THEY CONTAIN A MIXTURE OF 4914 03:13:53,106 --> 03:13:54,407 PRODUCTS AND BOTANICALS. 4915 03:13:54,407 --> 03:13:57,043 EVEN MARKETED WITH A SINGLE 4916 03:13:57,043 --> 03:14:03,483 BIOACTIVE NUTRIENT MAY BE QUITE 4917 03:14:03,483 --> 03:14:04,584 COMPLEX, MULTIPLE INGREDIENTS, 4918 03:14:04,584 --> 03:14:05,318 INSIPIENT INGREDIENTS WITHOUT 4919 03:14:05,318 --> 03:14:05,918 BIOLOGICAL EFFECT. 4920 03:14:05,918 --> 03:14:09,422 IF WE'RE GOING TO DESIGN 4921 03:14:09,422 --> 03:14:10,757 RESEARCH, HELPED COORDINATE 4922 03:14:10,757 --> 03:14:13,259 RESEARCH, PRODUCTS USED IN 4923 03:14:13,259 --> 03:14:14,560 INVESTIGATIONS ARE RIGOROUSLY 4924 03:14:14,560 --> 03:14:15,294 IDENTIFIED AND CHARACTERIZED. 4925 03:14:15,294 --> 03:14:16,763 THE OFFICE HAS BEEN DOING THIS 4926 03:14:16,763 --> 03:14:19,832 FOR QUITE A WHILE NOW. 4927 03:14:19,832 --> 03:14:20,700 THE KNOWLEDGE GAINED AND 4928 03:14:20,700 --> 03:14:22,035 RESOURCES DEVELOPED THROUGH 4929 03:14:22,035 --> 03:14:25,071 EXISTING PROGRAMS OF THE OFFICE 4930 03:14:25,071 --> 03:14:27,607 SPECIFICALLY ANALYTICAL METHODS 4931 03:14:27,607 --> 03:14:29,542 AND REFERENCE MATERIALS PROGRAM 4932 03:14:29,542 --> 03:14:35,014 AND A COLLABORATION WITH NCCIH, 4933 03:14:35,014 --> 03:14:36,115 CONSORTIUM FOR ADVANCING 4934 03:14:36,115 --> 03:14:37,417 RESEARCH ON BOTANICALS AND 4935 03:14:37,417 --> 03:14:41,821 NATURAL PRODUCTS, PROVIDES A 4936 03:14:41,821 --> 03:14:43,489 JUMP START TO IDENTIFY 4937 03:14:43,489 --> 03:14:44,757 INTEGRITY, RESEARCH GAPS WITH 4938 03:14:44,757 --> 03:14:46,959 FOCUS ON A NUMBER OF THINGS 4939 03:14:46,959 --> 03:14:49,696 LISTED IN THE BULLETS, WITH THE 4940 03:14:49,696 --> 03:14:51,130 OBJECTIVE OF ENSURING WHEN WE 4941 03:14:51,130 --> 03:14:57,136 STUDY DIETARY SUPPLEMENTS WE 4942 03:14:57,136 --> 03:14:58,805 KNOW WHAT WE'RE STUDYING. 4943 03:14:58,805 --> 03:15:00,740 MOVING INTO OUR CAPACITY 4944 03:15:00,740 --> 03:15:03,910 PROGRAMS, WE HAVE TWO, AND TWO 4945 03:15:03,910 --> 03:15:05,878 OBJECTIVES, STRAIGHTFORWARD, TO 4946 03:15:05,878 --> 03:15:08,281 DEVELOP BEST PRACTICES FOR 4947 03:15:08,281 --> 03:15:11,150 DIETARY SUPPLEMENT SCIENCE AND 4948 03:15:11,150 --> 03:15:13,586 IDENTIFY STRATEGIC FUNDING 4949 03:15:13,586 --> 03:15:20,126 MECHANISM TO STIMULATE EFFECTIVE 4950 03:15:20,126 --> 03:15:20,693 RESEARCH. 4951 03:15:20,693 --> 03:15:25,598 THE FIRST PROGRAM IS 4952 03:15:25,598 --> 03:15:25,898 METHODOLOGY. 4953 03:15:25,898 --> 03:15:27,233 DIETARY SUPPLEMENT RESEARCH IS 4954 03:15:27,233 --> 03:15:29,902 CELL CULTURE, ANIMAL AND 4955 03:15:29,902 --> 03:15:30,670 CLINICAL STUDIES, 4956 03:15:30,670 --> 03:15:31,537 POPULATION-BASED STUDIES WITH 4957 03:15:31,537 --> 03:15:34,273 NUMEROUS AREAS OF FOCUS. 4958 03:15:34,273 --> 03:15:35,808 ABILITY TO COMPARE, REPRODUCE, 4959 03:15:35,808 --> 03:15:37,744 REPLICATE PUBLISHED RESEARCH IS 4960 03:15:37,744 --> 03:15:38,845 ESSENTIAL FOR BUILDING CONSENSUS 4961 03:15:38,845 --> 03:15:41,814 AS WELL AS KNOWLEDGE BASE, AND 4962 03:15:41,814 --> 03:15:44,650 FOR RESEARCH THIS REQUIRES 4963 03:15:44,650 --> 03:15:45,651 DEVELOPMENT OF BEST PRACTICE 4964 03:15:45,651 --> 03:15:46,853 GUIDANCE, FOR METHODOLOGY AND 4965 03:15:46,853 --> 03:15:48,154 TECHNIQUES THAT CAN BE APPLIED 4966 03:15:48,154 --> 03:15:50,456 TO A VARIETY OF RESEARCH 4967 03:15:50,456 --> 03:15:54,393 PARADIGMS, WITH FOCUS ON 4968 03:15:54,393 --> 03:15:54,961 EXPERIMENTAL DESIGN, 4969 03:15:54,961 --> 03:15:58,231 INTERVENTION DEVELOPMENT, 4970 03:15:58,231 --> 03:15:59,766 MEASUREMENT, ANALYSIS, FINALLY 4971 03:15:59,766 --> 03:16:00,867 REPORTING IN PEER-REVIEWED 4972 03:16:00,867 --> 03:16:01,934 LITERATURE, WORKING WITH 4973 03:16:01,934 --> 03:16:03,603 COLLEAGUES AND PARTNERS TO 4974 03:16:03,603 --> 03:16:05,471 DEVELOP BEST PRACTICES AND WE'LL 4975 03:16:05,471 --> 03:16:09,642 SERVE AS RESOURCE FOR NIH FOR 4976 03:16:09,642 --> 03:16:10,943 IMPLEMENTATION OF THESE 4977 03:16:10,943 --> 03:16:11,377 PRACTICES. 4978 03:16:11,377 --> 03:16:14,013 THE OFFICE WILL DEVELOP 4979 03:16:14,013 --> 03:16:14,747 EQUITABLE POPULATION-BASED 4980 03:16:14,747 --> 03:16:15,982 RESEARCH DESIGNS AND DATA 4981 03:16:15,982 --> 03:16:18,251 COLLECTION TOOLS TO ENSURE 4982 03:16:18,251 --> 03:16:22,321 ADEQUATE REPRESENTATION OF 4983 03:16:22,321 --> 03:16:25,358 DIVERSE SUBPOPULATIONS AND 4984 03:16:25,358 --> 03:16:26,159 COMPREHENSIVE DATA COLLECTION IS 4985 03:16:26,159 --> 03:16:28,861 SEEN IN WHAT WE DO GOING 4986 03:16:28,861 --> 03:16:29,328 FORWARD. 4987 03:16:29,328 --> 03:16:32,598 THIS AREA IN TERMS OF 4988 03:16:32,598 --> 03:16:33,933 METHODOLOGY WILL BE AN AREA WE 4989 03:16:33,933 --> 03:16:34,901 START RIGHT AWAY. 4990 03:16:34,901 --> 03:16:38,838 WE HAVE ABILITY AND KNOW-HOW TO 4991 03:16:38,838 --> 03:16:41,140 DO THIS, AND WILL WORK WITH 4992 03:16:41,140 --> 03:16:43,676 DPCPSI OFFICES AND I.C.S RIGHT 4993 03:16:43,676 --> 03:16:47,914 AWAY TO BETTER THE FIELD OF 4994 03:16:47,914 --> 03:16:49,549 DIETARY SUPPLEMENT RESEARCH. 4995 03:16:49,549 --> 03:16:50,683 RESEARCH FUNDING STRATEGY 4996 03:16:50,683 --> 03:16:52,952 PROGRAM IS BUILT ON ODS STRONG 4997 03:16:52,952 --> 03:16:54,520 HISTORY OF PARTNERSHIP WITHIN 4998 03:16:54,520 --> 03:16:54,921 NIH. 4999 03:16:54,921 --> 03:16:56,589 ACROSS THE FEDERAL GOVERNMENT. 5000 03:16:56,589 --> 03:16:58,357 GOING FORWARD THE OFFICE WILL 5001 03:16:58,357 --> 03:17:02,829 SEEK TO INCREASE ITS FOCUS ON 5002 03:17:02,829 --> 03:17:03,396 COORDINATING AND INITIATING 5003 03:17:03,396 --> 03:17:05,231 COLLABORATIONS ACROSS NIH. 5004 03:17:05,231 --> 03:17:07,834 CRITICAL FACTOR WILL BE 5005 03:17:07,834 --> 03:17:09,168 IDENTIFICATION OF BEST POSSIBLE 5006 03:17:09,168 --> 03:17:12,004 FUNDING MECHANISM AVAILABLE FOR 5007 03:17:12,004 --> 03:17:13,105 FACILITATING EFFICIENT RESEARCH. 5008 03:17:13,105 --> 03:17:15,908 THIS IS NOT A NEW FOCUS FOR ODS 5009 03:17:15,908 --> 03:17:18,044 BUT NEW IN THE SENSE WE'RE 5010 03:17:18,044 --> 03:17:19,812 LOOKING TO BOOST CAPACITY AS 5011 03:17:19,812 --> 03:17:21,147 COORDINATING OFFICE. 5012 03:17:21,147 --> 03:17:22,982 WE HAVE USED FUNDING MECHANISMS 5013 03:17:22,982 --> 03:17:24,517 TO CO-FUND RESEARCH IN THE PAST, 5014 03:17:24,517 --> 03:17:29,889 THE FOCUS OF THIS PROGRAM WILL 5015 03:17:29,889 --> 03:17:32,391 BE USE KNOWLEDGE TO BEING AT THE 5016 03:17:32,391 --> 03:17:34,827 GROUND LEVEL OF STIMULATING 5017 03:17:34,827 --> 03:17:35,761 SCIENCE TO COORDINATE EFFORT TO 5018 03:17:35,761 --> 03:17:38,297 HELP PULL I.C.s TOGETHER TO 5019 03:17:38,297 --> 03:17:44,403 ADDRESS CONTEMPORARY ISSUES . 5020 03:17:44,403 --> 03:17:47,607 WE AIM TO DIVERSIFY FUNDING 5021 03:17:47,607 --> 03:17:49,342 APPROACHES ACROSS PROGRAMS, AND 5022 03:17:49,342 --> 03:17:52,511 WE'LL TRAIN ODS STAFF IN 5023 03:17:52,511 --> 03:17:54,480 DEVELOPMENT OF NIH FUNDING 5024 03:17:54,480 --> 03:17:55,448 OPPORTUNITIES, CONTRACT 5025 03:17:55,448 --> 03:17:58,417 DEVELOPMENT, INTERAGENCY 5026 03:17:58,417 --> 03:17:59,852 AGREEMENTS AND TRANSACTIONAL 5027 03:17:59,852 --> 03:18:00,586 AUTHORITIES. 5028 03:18:00,586 --> 03:18:03,256 STREAMLINED FUNDING PROCESS 5029 03:18:03,256 --> 03:18:05,124 WE'LL COORDINATE ODS-WIDE 5030 03:18:05,124 --> 03:18:06,859 PROCESSES FOR DETERMINING 5031 03:18:06,859 --> 03:18:08,828 FUNDING AWARDS AND GATHER 5032 03:18:08,828 --> 03:18:09,528 RESEARCH PROGRESS AND FINDINGS 5033 03:18:09,528 --> 03:18:11,364 TO HELP INFORM RETURN ON 5034 03:18:11,364 --> 03:18:13,900 INVESTMENT EVALUATION FOR OUR 5035 03:18:13,900 --> 03:18:17,603 SUPPORTED EFFORTS. 5036 03:18:17,603 --> 03:18:18,905 NEXT SLIDE. 5037 03:18:18,905 --> 03:18:21,974 WE HAVE OUR OPERATIONS AND 5038 03:18:21,974 --> 03:18:24,577 RESOURCES PROGRAMS, FOUR 5039 03:18:24,577 --> 03:18:27,780 OBJECTIVES HERE, INCLUDING 5040 03:18:27,780 --> 03:18:28,881 TRANSLATING AND DISSEMINATING 5041 03:18:28,881 --> 03:18:31,617 RESEARCH FINDINGS, SUPPORTING 5042 03:18:31,617 --> 03:18:33,252 DIETARY SUPPLEMENT DATABASES, 5043 03:18:33,252 --> 03:18:34,654 SUPPORTING USE OF PORTFOLIO 5044 03:18:34,654 --> 03:18:35,454 ANALYSES AND OTHER TOOLS 5045 03:18:35,454 --> 03:18:38,624 AVAILABLE TO US HERE AT NIH TO 5046 03:18:38,624 --> 03:18:40,793 EVALUATE RESEARCH BEING DONE, 5047 03:18:40,793 --> 03:18:41,827 AND COORDINATING COLLABORATIONS 5048 03:18:41,827 --> 03:18:44,630 AND PARTNERSHIPS WITHIN NIH AND 5049 03:18:44,630 --> 03:18:50,002 OTHER FEDERAL AGENCIES. 5050 03:18:50,002 --> 03:18:51,637 NEXT SLIDE. 5051 03:18:51,637 --> 03:18:52,738 SCIENCE AND HEALTH 5052 03:18:52,738 --> 03:18:54,473 COMMUNICATIONS, TO ACHIEVE OUR 5053 03:18:54,473 --> 03:18:57,443 MISSION IT'S IMPORTANT -- THE 5054 03:18:57,443 --> 03:18:58,978 IMPORTANCE OF SCIENCE AND 5055 03:18:58,978 --> 03:19:05,117 HEALTH -- TO ACLEAVE ITS 5056 03:19:05,117 --> 03:19:07,620 MISSION, IMPORTANCE CANNOT BE 5057 03:19:07,620 --> 03:19:07,920 OVERSTATED. 5058 03:19:07,920 --> 03:19:09,388 COMMUNICATING AND TRANSLATING IS 5059 03:19:09,388 --> 03:19:11,557 KEY TO OUR AUDIENCES. 5060 03:19:11,557 --> 03:19:12,892 IT'S BEEN WOVEN INTO THE GOALS 5061 03:19:12,892 --> 03:19:14,961 AND OUTPUTS OF OUR OFFICE FOR 5062 03:19:14,961 --> 03:19:16,696 THE PAST SEVERAL YEARS. 5063 03:19:16,696 --> 03:19:17,930 COMMUNICATION ACTIVITIES IN THE 5064 03:19:17,930 --> 03:19:20,132 OFFICE WILL FOCUS ON INFORMING 5065 03:19:20,132 --> 03:19:22,868 ODS AUDIENCES ABOUT THE WORK AND 5066 03:19:22,868 --> 03:19:25,137 ACCOMPLISHMENTS OF THE OFFICE, 5067 03:19:25,137 --> 03:19:29,942 AM PLY FIG -- AMPLIFYING WHAT WE 5068 03:19:29,942 --> 03:19:30,843 DO, IMPROVING RESOURCES TO 5069 03:19:30,843 --> 03:19:34,747 SUPPORT THE GOAL OF 5070 03:19:34,747 --> 03:19:35,281 COMMUNICATING ADVANCES AND 5071 03:19:35,281 --> 03:19:36,749 MAKING SURE OUR MESSAGE GETS OUT 5072 03:19:36,749 --> 03:19:39,585 TO THE RIGHT AUDIENCES AND THEY 5073 03:19:39,585 --> 03:19:42,021 ARE USING MESSAGES EFFECTIVELY. 5074 03:19:42,021 --> 03:19:44,090 LASTLY TO SUPPORT ODS 5075 03:19:44,090 --> 03:19:44,423 ACTIVITIES. 5076 03:19:44,423 --> 03:19:47,159 NOT JUST WHEN ACTIVITY IS DONE 5077 03:19:47,159 --> 03:19:48,461 BUT AT THE PLANNING STAGES, 5078 03:19:48,461 --> 03:19:49,462 KNOWING WHAT WE NEED TO 5079 03:19:49,462 --> 03:19:53,499 UNDERSTAND AND GET OUT TO THE 5080 03:19:53,499 --> 03:19:55,901 PUBLIC, HELPING MESSAGE ACROSS 5081 03:19:55,901 --> 03:19:57,036 ICOS AND FEDERAL PARTNERS AND 5082 03:19:57,036 --> 03:20:02,675 GET THE INFORMATION TO THE 5083 03:20:02,675 --> 03:20:03,442 PUBLIC. 5084 03:20:03,442 --> 03:20:04,810 NEXT SLIDE. 5085 03:20:04,810 --> 03:20:11,550 DATABASES IN TERMS OF DIETARY 5086 03:20:11,550 --> 03:20:13,519 SUPPLEMENTS, PROVIDING DETAILED 5087 03:20:13,519 --> 03:20:14,920 INFORMATION ON SUPPLEMENTS AND 5088 03:20:14,920 --> 03:20:16,622 INGREDIENTS AS WELL AS RESEARCH 5089 03:20:16,622 --> 03:20:19,325 BEING CONDUCTED ON THESE 5090 03:20:19,325 --> 03:20:19,625 SUPPLEMENTS. 5091 03:20:19,625 --> 03:20:21,293 THESE DATABASES USED BY RESEARCH 5092 03:20:21,293 --> 03:20:22,495 POLICYMAKERS AND THE PUBLIC 5093 03:20:22,495 --> 03:20:26,332 INCLUDE DATABASES SUCH AS 5094 03:20:26,332 --> 03:20:27,433 DIETARY SUPPLEMENT LABEL 5095 03:20:27,433 --> 03:20:28,300 DATABASE, DIETARY SUPPLEMENT 5096 03:20:28,300 --> 03:20:30,603 AGREEMENT DATABASE IN 5097 03:20:30,603 --> 03:20:31,470 COLLABORATION WITH USDA, 5098 03:20:31,470 --> 03:20:35,608 COMPUTER ACCESS TO RESEARCH ON 5099 03:20:35,608 --> 03:20:37,476 DIETARY SUPPLEMENTS, CARDS 5100 03:20:37,476 --> 03:20:39,578 DATABASE, RECORD OF FEDERALLY 5101 03:20:39,578 --> 03:20:42,615 FUNDED RESEARCH ON DIETARY 5102 03:20:42,615 --> 03:20:43,049 SUPPLEMENTS. 5103 03:20:43,049 --> 03:20:43,716 WE'LL MAINTAIN DATABASES, 5104 03:20:43,716 --> 03:20:46,886 ENSURING THE PUBLIC IS ABLE TO 5105 03:20:46,886 --> 03:20:49,321 USE THEM EFFECTIVELY. 5106 03:20:49,321 --> 03:20:50,156 NEXT SLIDE PLEASE. 5107 03:20:50,156 --> 03:20:52,024 THIS IS THE LAST SLIDE OF THE 5108 03:20:52,024 --> 03:20:52,358 PRESENTATION. 5109 03:20:52,358 --> 03:20:54,894 WHAT WE HAVE HERE IS OUR 5110 03:20:54,894 --> 03:20:56,228 MANAGEMENT AND ADMINISTRATIVE 5111 03:20:56,228 --> 03:20:56,862 SUPPORT. 5112 03:20:56,862 --> 03:21:00,232 THE PROGRAM HERE WILL AIM TO 5113 03:21:00,232 --> 03:21:01,567 BOLSTER EFFICIENCY, 5114 03:21:01,567 --> 03:21:02,535 ACCOUNTABILITY, AND THE 5115 03:21:02,535 --> 03:21:03,536 PRODUCTIVITY AS A COORDINATING 5116 03:21:03,536 --> 03:21:04,837 OFFICE IN DPCPSI. 5117 03:21:04,837 --> 03:21:07,139 THIS WILL INCLUDE SUPPORTING 5118 03:21:07,139 --> 03:21:09,108 WORKSHOPS, EXPERT PANEL 5119 03:21:09,108 --> 03:21:09,942 DISCUSSIONS, SUPPORTING 5120 03:21:09,942 --> 03:21:11,544 WORKFORCE DEVELOPMENT. 5121 03:21:11,544 --> 03:21:12,945 BUDGET FORECASTING, PROGRAM 5122 03:21:12,945 --> 03:21:21,921 ANALYSIS AND EVALUATION AND ALL 5123 03:21:21,921 --> 03:21:22,688 DAY-TO-DAY ADMINISTRATIVE ACTION 5124 03:21:22,688 --> 03:21:23,689 TO MAKE SURE WE CAN FUNCTION. 5125 03:21:23,689 --> 03:21:24,557 NEXT SLIDE PLEASE. 5126 03:21:24,557 --> 03:21:26,792 THAT TAKES CARE OF MY 5127 03:21:26,792 --> 03:21:28,160 PRESENTATION TODAY. 5128 03:21:28,160 --> 03:21:31,464 SHORT AND TO THE POINT. 5129 03:21:31,464 --> 03:21:34,834 I HOPE YOU -- I HOPE HE 5130 03:21:34,834 --> 03:21:35,734 DEMONSTRATED THROUGH THE BRIEF 5131 03:21:35,734 --> 03:21:37,136 DESCRIPTION PRIORITIES AND GOALS 5132 03:21:37,136 --> 03:21:39,205 FOR THE OFFICE MOVING FORWARD. 5133 03:21:39,205 --> 03:21:40,973 I BELIEVE THAT I'M CONFIDENT 5134 03:21:40,973 --> 03:21:46,145 THAT THE LAYERS OF THIS PROGRAM 5135 03:21:46,145 --> 03:21:47,580 WITHIN OFFICE AND OVERLAP WILL 5136 03:21:47,580 --> 03:21:49,682 ESTABLISH A BLUEPRINT FOR FUTURE 5137 03:21:49,682 --> 03:21:52,084 RESEARCH THAT IN THE END WILL 5138 03:21:52,084 --> 03:21:52,618 INFORM PUBLIC HEALTH. 5139 03:21:52,618 --> 03:21:55,154 I WANT TO THANK THE COUNCIL FOR 5140 03:21:55,154 --> 03:21:57,323 TIME AND ATTENTION AND EVERYONE 5141 03:21:57,323 --> 03:21:58,324 IN ATTENDANCE TODAY. 5142 03:21:58,324 --> 03:22:00,159 I WELCOME QUESTIONS AND FEEDBACK 5143 03:22:00,159 --> 03:22:01,694 ABOUT WHAT THE OFFICE IS DOING 5144 03:22:01,694 --> 03:22:08,934 OVER THE NEXT FIVE YEARS. 5145 03:22:08,934 --> 03:22:09,468 THANK YOU. 5146 03:22:09,468 --> 03:22:10,903 >> HE'S BEEN BUSY FOR THE LAST 5147 03:22:10,903 --> 03:22:13,305 YEAR TRYING TO DEVELOP OUT THIS 5148 03:22:13,305 --> 03:22:18,344 VISION AND PLAN AND DO SO IN A 5149 03:22:18,344 --> 03:22:19,178 REALLY COLLABORATIVE WAY TO 5150 03:22:19,178 --> 03:22:21,847 ENHANCE THAT FUNCTION OF THE 5151 03:22:21,847 --> 03:22:24,650 OFFICE GOING FORWARD. 5152 03:22:24,650 --> 03:22:26,986 SO LET ME TURN IT OVER TO THE 5153 03:22:26,986 --> 03:22:29,622 COUNCIL TO SEE IF THERE ARE ANY 5154 03:22:29,622 --> 03:22:30,589 QUESTIONS IN PARTICULAR ABOUT 5155 03:22:30,589 --> 03:22:32,791 THE PLAN AND THE VISION THAT 5156 03:22:32,791 --> 03:22:43,102 STEPHAN LAID OUT. 5157 03:22:44,870 --> 03:22:45,838 5158 03:22:45,838 --> 03:22:46,605 ALL RIGHT. 5159 03:22:46,605 --> 03:22:52,745 I SEE ONE HAND AND ONE QUESTION. 5160 03:22:52,745 --> 03:22:53,612 KENT FIRST. 5161 03:22:53,612 --> 03:22:57,650 >> I CAN'T FIND THE HAND RAISING 5162 03:22:57,650 --> 03:22:57,850 THING. 5163 03:22:57,850 --> 03:22:59,618 SORRY FOR WRITING. 5164 03:22:59,618 --> 03:23:02,054 THANKS FOR YOUR PRESENTATION. 5165 03:23:02,054 --> 03:23:05,090 A FEW QUICK THINGS. 5166 03:23:05,090 --> 03:23:07,626 SO 94 IS WHEN THE OFFICE WAS 5167 03:23:07,626 --> 03:23:09,695 ESTABLISHED, THAT'S 30 YEARS. 5168 03:23:09,695 --> 03:23:11,163 CAN YOU JUST IDENTIFY ONE OR TWO 5169 03:23:11,163 --> 03:23:12,665 OF THE MAJOR IMPACTS THE OFFICE 5170 03:23:12,665 --> 03:23:15,734 HAS HAD OVER THE LAST 30 YEARS? 5171 03:23:15,734 --> 03:23:21,307 >> THERE'S A LOT OF THEM. 5172 03:23:21,307 --> 03:23:23,842 THE OFFICE HAS BEEN AT THE 5173 03:23:23,842 --> 03:23:25,811 FOREFRONT OF ADVANCING THE 5174 03:23:25,811 --> 03:23:26,011 FIELD. 5175 03:23:26,011 --> 03:23:29,949 THAT COULD BE A COUPLE QUICK 5176 03:23:29,949 --> 03:23:31,250 EXAMPLES, UNDERSTANDING WHAT'S 5177 03:23:31,250 --> 03:23:33,385 IN THAT THE PRODUCTS, 5178 03:23:33,385 --> 03:23:35,054 BOTANICALS, HOW TO CHARACTERIZE 5179 03:23:35,054 --> 03:23:37,656 THOSE, IMPORTANTLY UNDERSTANDING 5180 03:23:37,656 --> 03:23:41,727 HOW THEY MAY IMPACT HEALTH. 5181 03:23:41,727 --> 03:23:42,494 UNDERSTANDING VITAMIN D, 5182 03:23:42,494 --> 03:23:45,764 STANDARDIZING VITAMIN D 5183 03:23:45,764 --> 03:23:47,967 ASSESSMENT IN TERMS OF 5184 03:23:47,967 --> 03:23:49,268 BIOMARKERS IN SUPPLEMENT USE, 5185 03:23:49,268 --> 03:23:51,570 ANOTHER MAIN OUTCOME. 5186 03:23:51,570 --> 03:23:54,173 ANOTHER IMPORTANT FACTOR THAT 5187 03:23:54,173 --> 03:23:58,344 MIGHT BE OVERLOOKED IN TERMS OF 5188 03:23:58,344 --> 03:23:59,778 WHAT GETS DONE, WE INFORM 5189 03:23:59,778 --> 03:24:01,513 DIETARY POLICY. 5190 03:24:01,513 --> 03:24:04,149 THE WORK WE DO IN COLLABORATION 5191 03:24:04,149 --> 03:24:05,784 WITH NCI AND CDC REALLY HELPS 5192 03:24:05,784 --> 03:24:07,453 UNDERSTAND WHAT THE AMERICAN 5193 03:24:07,453 --> 03:24:09,521 PUBLIC IS EATING, UNDERSTANDING 5194 03:24:09,521 --> 03:24:11,590 TRENDS IN SUPPLEMENT USE AS 5195 03:24:11,590 --> 03:24:13,092 RELATES TO NUTRIENT INTAKE, HOW 5196 03:24:13,092 --> 03:24:17,930 TO ANALYZE DATA TO GIVE A 5197 03:24:17,930 --> 03:24:20,065 COMPLETE NUTRIENT PROFILE, 5198 03:24:20,065 --> 03:24:28,807 INFORMING GUIDELINES FOR 5199 03:24:28,807 --> 03:24:29,074 AMERICANS. 5200 03:24:29,074 --> 03:24:31,277 THERE ARE MANY MORE. 5201 03:24:31,277 --> 03:24:33,679 PROVIDING CRITICAL INFORMATION, 5202 03:24:33,679 --> 03:24:44,189 ONE EXAMPLE WOULD BE PRENATAL 5203 03:24:44,790 --> 03:24:46,392 VITAMINS, MULTI-VITAMINS. 5204 03:24:46,392 --> 03:24:47,893 THE REASON DATABASES IS 5205 03:24:47,893 --> 03:24:48,494 IMPORTANT DIETARY SUPPLEMENTS 5206 03:24:48,494 --> 03:24:51,964 SAY THEY HAVE CERTAIN THINGS IN 5207 03:24:51,964 --> 03:24:53,065 THEM, OUR DATABASES UNDERSTAND 5208 03:24:53,065 --> 03:24:54,833 WHAT'S ACTUALLY IN THEM. 5209 03:24:54,833 --> 03:24:57,770 WE ANALYZE INGREDIENTS AND 5210 03:24:57,770 --> 03:24:58,737 REPORT ON THEM. 5211 03:24:58,737 --> 03:25:00,606 THE AMERICAN PUBLIC KNOW WHAT IS 5212 03:25:00,606 --> 03:25:01,273 THEY ARE TAKING. 5213 03:25:01,273 --> 03:25:02,474 >> I APPRECIATE THAT. 5214 03:25:02,474 --> 03:25:08,914 I WAS TRYING TO -- I WAS 5215 03:25:08,914 --> 03:25:11,116 IMPRESSED, YOU DID NOT MENTION 5216 03:25:11,116 --> 03:25:12,017 FDA. 5217 03:25:12,017 --> 03:25:13,652 FDA DOESN'T REGULATE -- IT 5218 03:25:13,652 --> 03:25:15,854 REGULATES SUPPLEMENTS, DOESN'T 5219 03:25:15,854 --> 03:25:19,058 APPROVE THEM FOR DISEASE OR 5220 03:25:19,058 --> 03:25:20,759 DISEASE TREATMENTS. 5221 03:25:20,759 --> 03:25:22,494 MY QUESTION IS BASED ON THE FACT 5222 03:25:22,494 --> 03:25:24,596 IT APPEARS AS THOUGH THE OFFICE 5223 03:25:24,596 --> 03:25:26,098 IS SUPPORTING, YOU PLAN TO 5224 03:25:26,098 --> 03:25:29,401 SUPPORT MORE RESEARCH TO 5225 03:25:29,401 --> 03:25:31,136 EVALUATE EXISTING SUPPLEMENTS I 5226 03:25:31,136 --> 03:25:33,439 GUESS ON THE MARKET. 5227 03:25:33,439 --> 03:25:37,276 AND YET IT WON'T HAVE ANY 5228 03:25:37,276 --> 03:25:39,244 REGULATORY EFFECT OR APPROVAL IN 5229 03:25:39,244 --> 03:25:43,082 TERMS OF ABILITY TO SELL THESE 5230 03:25:43,082 --> 03:25:43,515 SUPPLEMENTS. 5231 03:25:43,515 --> 03:25:45,250 SO WHICH WOULD SEEM WHAT YOU'RE 5232 03:25:45,250 --> 03:25:47,219 TRYING TO DO IS WHAT FDA SHOULD 5233 03:25:47,219 --> 03:25:50,189 BE DOING, IF YOU WANT TO SEE ARE 5234 03:25:50,189 --> 03:25:52,491 THESE THINGS GOOD OR BAD, AND 5235 03:25:52,491 --> 03:25:54,226 SHOULD THEY BE USED OR SHOULDN'T 5236 03:25:54,226 --> 03:25:58,163 BE USED, IT'S MY OWN NAIVETE OF 5237 03:25:58,163 --> 03:25:59,164 UNDERSTANDING, YOU KNOW, WHY 5238 03:25:59,164 --> 03:26:01,567 ISN'T FDA DOING THIS AS OPPOSED 5239 03:26:01,567 --> 03:26:02,768 TO NIH DOING THIS. 5240 03:26:02,768 --> 03:26:07,373 >> WELL, WHEN THE LAW WAS PASSED 5241 03:26:07,373 --> 03:26:10,542 IN 94, THEY DELINEATED ROLES 5242 03:26:10,542 --> 03:26:13,846 BETWEEN FDA AND NIH. 5243 03:26:13,846 --> 03:26:15,814 OUR JOB WAS FACILITATE RESEARCH, 5244 03:26:15,814 --> 03:26:17,883 AND THEY HELD THE OTHER SIDE OF 5245 03:26:17,883 --> 03:26:19,518 THE EQUATION, WHICH IS TO THE 5246 03:26:19,518 --> 03:26:20,619 EXTENT WHICH THEY ARE REGULATED 5247 03:26:20,619 --> 03:26:26,759 AND OVERSEEN BY THE FDA. 5248 03:26:26,759 --> 03:26:37,302 WE WORK WITH THE FDA, WE WORK IN 5249 03:26:38,404 --> 03:26:41,507 CLOSE RELATIONSHIP WITH THEM, 5250 03:26:41,507 --> 03:26:43,275 OD-S, THEY COMMUNICATE AND HELP 5251 03:26:43,275 --> 03:26:45,978 WHAT WE DO, I UNDERSTAND YOUR 5252 03:26:45,978 --> 03:26:47,513 CONCERN IT DOESN'T END IN THEIR 5253 03:26:47,513 --> 03:26:48,781 RECOMMENDATION OF A PRODUCT OR 5254 03:26:48,781 --> 03:26:50,382 NOT BUT THERE IS SYNERGY BETWEEN 5255 03:26:50,382 --> 03:26:56,188 THE TWO ORGANIZATIONS AND WE DO 5256 03:26:56,188 --> 03:26:58,690 WORK CLOSELY TOGETHER. 5257 03:26:58,690 --> 03:27:00,359 >> GENERALLY SPEAKING, NOT JUST 5258 03:27:00,359 --> 03:27:03,195 ODS IN PARTICULAR, BUT NIH BEING 5259 03:27:03,195 --> 03:27:06,031 THE RESEARCH ARM, WE PROVIDE 5260 03:27:06,031 --> 03:27:07,332 EVIDENCE BASE THAT INFORMS 5261 03:27:07,332 --> 03:27:10,869 DECISION MAKING, FDA CAN UTILIZE 5262 03:27:10,869 --> 03:27:13,705 THAT, AS APPROPRIATE WHAT IS 5263 03:27:13,705 --> 03:27:18,544 RELEVANT FOR THEIR WORK. 5264 03:27:18,544 --> 03:27:21,480 IT'S KIND OF COMPLICATED AS 5265 03:27:21,480 --> 03:27:21,747 MENTIONED. 5266 03:27:21,747 --> 03:27:25,851 I SEE A NUMBER OF HANDS. 5267 03:27:25,851 --> 03:27:31,890 WE'LL GO RHONDA, RAFAEL, LAUREN. 5268 03:27:31,890 --> 03:27:36,061 >> CAN YOU HEAR ME? 5269 03:27:36,061 --> 03:27:36,895 >> YES. 5270 03:27:36,895 --> 03:27:40,199 >> FIRST THAT WAS A FANTASTIC 5271 03:27:40,199 --> 03:27:40,532 PRESENTATION. 5272 03:27:40,532 --> 03:27:42,835 I LEARNED A LOT ABOUT WHAT 5273 03:27:42,835 --> 03:27:44,303 YOU'RE INTENDING TO DO, AND IT 5274 03:27:44,303 --> 03:27:45,904 WAS HUGE. 5275 03:27:45,904 --> 03:27:47,105 THERE ARE SEVERAL QUESTIONS I 5276 03:27:47,105 --> 03:27:47,539 HAD. 5277 03:27:47,539 --> 03:27:51,910 I HAD A QUESTION ABOUT THE FDA 5278 03:27:51,910 --> 03:27:52,678 AFFILIATION. 5279 03:27:52,678 --> 03:27:55,647 I THINK YOU HAVE ARTICULATED 5280 03:27:55,647 --> 03:27:56,648 THAT. 5281 03:27:56,648 --> 03:27:57,850 HERE'S WHAT I'M HEARING, OF 5282 03:27:57,850 --> 03:27:59,151 GREAT IMPORTANCE, PARTICULARLY 5283 03:27:59,151 --> 03:28:01,920 SINCE WE'RE TALKING ABOUT A $60 5284 03:28:01,920 --> 03:28:04,223 BILLION A YEAR INDUSTRY. 5285 03:28:04,223 --> 03:28:08,694 BUILDING A STRONG INVESTMENT IN 5286 03:28:08,694 --> 03:28:10,996 THE PRIVATE SECTOR, 50%-PLUS, 5287 03:28:10,996 --> 03:28:12,064 DEPENDING ON AGE OF INDIVIDUALS 5288 03:28:12,064 --> 03:28:13,732 USING THIS. 5289 03:28:13,732 --> 03:28:21,940 THIS IS A HUGE AREA THAT HAS 5290 03:28:21,940 --> 03:28:24,142 POTENTIAL TO HAVE TREMENDOUS 5291 03:28:24,142 --> 03:28:25,010 POSITIVE AND NEGATIVE IMPACT ON 5292 03:28:25,010 --> 03:28:25,911 THE POPULATION. 5293 03:28:25,911 --> 03:28:28,313 YOU TALKED ABOUT HAVING A 5294 03:28:28,313 --> 03:28:29,181 DATABASE AND EDUCATION. 5295 03:28:29,181 --> 03:28:33,151 I'M TRYING TO UNDERSTAND WHERE 5296 03:28:33,151 --> 03:28:35,454 YOUR PRIORITIES ARE FOR 5297 03:28:35,454 --> 03:28:36,989 SHORT-TERM TURNAROUND, ONE HAS 5298 03:28:36,989 --> 03:28:39,057 TO DO WITH PUBLIC EDUCATION AS 5299 03:28:39,057 --> 03:28:43,095 RELATES TO WHAT YOU'RE DOING TO 5300 03:28:43,095 --> 03:28:44,796 RESEARCH EXISTING SUPPLEMENTS 5301 03:28:44,796 --> 03:28:45,631 OUT THERE. 5302 03:28:45,631 --> 03:28:47,032 THAT'S EXCEPTIONALLY POWERFUL. 5303 03:28:47,032 --> 03:28:51,537 I HOPE IT'S TOP ON YOUR LIST IN 5304 03:28:51,537 --> 03:28:52,504 TERMS OF TURNING OVER 5305 03:28:52,504 --> 03:28:53,405 INFORMATION THAT CAN BE 5306 03:28:53,405 --> 03:28:54,706 AVAILABLE TO THE PUBLIC. 5307 03:28:54,706 --> 03:29:00,078 THE OTHER THING I WORRY ABOUT IS 5308 03:29:00,078 --> 03:29:01,280 SUSTAINABILITY. 5309 03:29:01,280 --> 03:29:03,348 WE'RE IN A ERA WHERE FUNDING 5310 03:29:03,348 --> 03:29:07,152 GETS CUT AFTER A PERIOD OF TIME, 5311 03:29:07,152 --> 03:29:11,223 AND WONDERING WHETHER OR NOT 5312 03:29:11,223 --> 03:29:11,790 THERE'S SUSTAINABILITY PLAN 5313 03:29:11,790 --> 03:29:13,759 PARTICULARLY WHEN YOU DEAL IN AN 5314 03:29:13,759 --> 03:29:17,095 AREA THAT HAS VERY STRONG AND 5315 03:29:17,095 --> 03:29:19,531 LARGE AMOUNTS OF PRIVATE SECTOR 5316 03:29:19,531 --> 03:29:20,165 INVESTMENT. 5317 03:29:20,165 --> 03:29:22,067 IS THERE ANY THOUGHT ABOUT HOW 5318 03:29:22,067 --> 03:29:27,539 TO USE SOME OF THAT TO HELP 5319 03:29:27,539 --> 03:29:28,840 BOLSTER AND SUPPORT 5320 03:29:28,840 --> 03:29:29,608 SUSTAINABILITY? 5321 03:29:29,608 --> 03:29:32,678 I THOUGH THAT SOUNDS WEIRD BUT I 5322 03:29:32,678 --> 03:29:35,080 THINK IT'S SOMETHING THAT AS A 5323 03:29:35,080 --> 03:29:36,281 GOVERNMENTAL AGENCY IS SOMETHING 5324 03:29:36,281 --> 03:29:39,518 THAT NEEDS TO BE ENTERTAINED IN 5325 03:29:39,518 --> 03:29:39,751 THOUGHT. 5326 03:29:39,751 --> 03:29:40,686 THANK YOU. 5327 03:29:40,686 --> 03:29:42,220 >> THANKS FOR THOSE COMMENTS AND 5328 03:29:42,220 --> 03:29:42,854 QUESTIONS. 5329 03:29:42,854 --> 03:29:46,458 LET ME TACKLE THE FIRST PART. 5330 03:29:46,458 --> 03:29:48,193 WHAT YOU HEARD, THANK YOU FOR 5331 03:29:48,193 --> 03:29:50,529 THE POSITIVE FEEDBACK ON THE 5332 03:29:50,529 --> 03:29:51,697 STRATEGIC PLAN. 5333 03:29:51,697 --> 03:29:53,932 IT'S BEEN A BUSY NINE MONTHS AS 5334 03:29:53,932 --> 03:29:54,800 TARA MENTIONED. 5335 03:29:54,800 --> 03:29:56,401 THE GOOD THING, I TALKED ABOUT 5336 03:29:56,401 --> 03:29:56,702 THE FUTURE. 5337 03:29:56,702 --> 03:29:59,605 WE HAVE A LOT OF ONGOING WORK, 5338 03:29:59,605 --> 03:30:01,673 THE OFFICE HAS BEEN AROUND 30 5339 03:30:01,673 --> 03:30:02,541 YEARS, EXISTING PROGRAMS 5340 03:30:02,541 --> 03:30:05,243 CONTINUE TO PLUG AWAY AT THEIR 5341 03:30:05,243 --> 03:30:05,544 OBJECTIVES. 5342 03:30:05,544 --> 03:30:12,050 ONE IMPORTANT ASPECT IS 5343 03:30:12,050 --> 03:30:12,451 EDUCATION. 5344 03:30:12,451 --> 03:30:14,453 GETTING INFORMATION TO THE 5345 03:30:14,453 --> 03:30:14,686 PUBLIC. 5346 03:30:14,686 --> 03:30:17,656 WE HAVE A SET OF RESOURCES ON 5347 03:30:17,656 --> 03:30:18,523 NUTRIENTS, DIETARY SUPPLEMENTS, 5348 03:30:18,523 --> 03:30:23,662 USE OF THEM, ON OUR WEBSITE, 5349 03:30:23,662 --> 03:30:25,097 HEAVILY ACCESSED, FDA RELIES ON 5350 03:30:25,097 --> 03:30:26,732 WHAT WE PUT OUT THERE. 5351 03:30:26,732 --> 03:30:30,769 WE PUT ON EDUCATION SERVICES FOR 5352 03:30:30,769 --> 03:30:32,404 ACADEMICS, CONSUMERS, 5353 03:30:32,404 --> 03:30:34,072 PRACTITIONERS, THAT'S BY WAY OF 5354 03:30:34,072 --> 03:30:34,840 RESEARCH PRACTICUM EVERY YEAR, 5355 03:30:34,840 --> 03:30:36,475 WE MOVE THAT TO EVERY OTHER 5356 03:30:36,475 --> 03:30:39,144 YEAR, THAT'S HELD IN MAY, TO 5357 03:30:39,144 --> 03:30:44,249 EDUCATE PEOPLE ON THE FIELD OF 5358 03:30:44,249 --> 03:30:45,450 DIETARY SUPPLEMENTS TO USE IN 5359 03:30:45,450 --> 03:30:46,218 THE AMERICAN PUBLIC. 5360 03:30:46,218 --> 03:30:48,720 THAT WON'T GO AWAY. 5361 03:30:48,720 --> 03:30:51,023 WE WORK CLOSELY TO FUND AND 5362 03:30:51,023 --> 03:30:52,224 DEVELOP SCHOLARS IN THIS AREA. 5363 03:30:52,224 --> 03:30:56,161 WE'LL LOOK TO DO MORE, TO BRING 5364 03:30:56,161 --> 03:30:57,462 IN JUNIOR SCIENTISTS AND 5365 03:30:57,462 --> 03:30:59,364 PRE-DOCTORAL FELLOWS TO GET 5366 03:30:59,364 --> 03:31:00,332 ENGRAINED AND ENTRENCHED IN 5367 03:31:00,332 --> 03:31:01,333 UNDERSTANDING THE FIELD. 5368 03:31:01,333 --> 03:31:03,635 THAT'S KEY TO WHAT WE DO. 5369 03:31:03,635 --> 03:31:06,705 IN TERMS OF NEAR-TERM WINS WE'LL 5370 03:31:06,705 --> 03:31:10,308 CONTINUE, WE HAVE A COUPLE 5371 03:31:10,308 --> 03:31:12,077 THINGS, NEAR--TERM LOW-HANGING 5372 03:31:12,077 --> 03:31:13,812 FRUITS, EFFORTS AREN'T SMALL. 5373 03:31:13,812 --> 03:31:16,014 I MENTIONED ONE BEING AN EFFORT 5374 03:31:16,014 --> 03:31:17,983 OR CONCEPT TO DEVELOP NEW 5375 03:31:17,983 --> 03:31:21,053 GUIDELINES OF PRACTICES FOR 5376 03:31:21,053 --> 03:31:22,120 DIETARY SUPPLEMENT SCIENCE. 5377 03:31:22,120 --> 03:31:23,121 THERE'S THIS IDEA OR NOTION 5378 03:31:23,121 --> 03:31:27,693 BECAUSE IT'S NOT A DRUG STUDY 5379 03:31:27,693 --> 03:31:29,027 NUTRITION AND DIETARY SUPPLEMENT 5380 03:31:29,027 --> 03:31:32,798 SCIENCE IS NOT AS COMPLEX AND 5381 03:31:32,798 --> 03:31:34,299 RIGOROUSLY CONTROLLED. 5382 03:31:34,299 --> 03:31:37,536 A FIELD HAS HOLES IN IT, 5383 03:31:37,536 --> 03:31:38,537 HOPEFULLY THAT WILL IMPROVE 5384 03:31:38,537 --> 03:31:40,605 FUNDING DECISIONS AND IN TURN 5385 03:31:40,605 --> 03:31:43,775 HELP IMPROVE THE RESEARCH THAT 5386 03:31:43,775 --> 03:31:45,010 GETS PUBLISHED, SOME NEAR--TERM 5387 03:31:45,010 --> 03:31:51,216 SMALL WINS WE'RE TRYING TO DO. 5388 03:31:51,216 --> 03:31:52,117 SUSTAINABILITY, LEVERAGING OR 5389 03:31:52,117 --> 03:31:56,088 WORKING WITH THE PUBLIC TO 5390 03:31:56,088 --> 03:31:58,490 LEVERAGE FUNDS IN CASE WE'RE 5391 03:31:58,490 --> 03:32:02,728 REDUCED IN FUNDS, IS THAT WHAT 5392 03:32:02,728 --> 03:32:03,729 YOU'RE GETTING AT? 5393 03:32:03,729 --> 03:32:07,866 I WASN'T CLEAR. 5394 03:32:07,866 --> 03:32:10,969 >> MORE ALONG THE LINE YOU HAVE 5395 03:32:10,969 --> 03:32:12,537 UNIQUE CAPABILITY OF 5396 03:32:12,537 --> 03:32:15,006 RESEARCHING, VERIFYING VALIDITY 5397 03:32:15,006 --> 03:32:16,441 OF A SUPPLEMENT IN SOME WAY. 5398 03:32:16,441 --> 03:32:20,779 I KNOW THERE ARE LABS OUT THERE 5399 03:32:20,779 --> 03:32:23,014 THAT DO THAT BUT I DON'T KNOW 5400 03:32:23,014 --> 03:32:28,553 WHETHER OR NOT -- AS A MATTER OF 5401 03:32:28,553 --> 03:32:29,988 FACT MOST SUPPLEMENTS DON'T GO 5402 03:32:29,988 --> 03:32:31,189 THROUGH THE LACKS. 5403 03:32:31,189 --> 03:32:32,524 AS YOU BUILD GUIDELINES AND 5404 03:32:32,524 --> 03:32:34,926 INFRASTRUCTURE THERE'S AN 5405 03:32:34,926 --> 03:32:36,995 OPPORTUNITY TO CONSIDER WHAT 5406 03:32:36,995 --> 03:32:38,864 YOUR STAMP OF APPROVAL OR WHAT 5407 03:32:38,864 --> 03:32:40,398 YOU'RE EXPECTING YOUR RESOURCES 5408 03:32:40,398 --> 03:32:44,770 TO RESEARCH CAN DO TO HELP BRING 5409 03:32:44,770 --> 03:32:46,071 THE INVESTORS IN THESE 5410 03:32:46,071 --> 03:32:46,805 SUPPLEMENTAL COMPANIES UNDER 5411 03:32:46,805 --> 03:32:51,009 YOUR WING SO WE HAVE VIABLE AND 5412 03:32:51,009 --> 03:32:53,278 USEFUL INFORMATION AND NOT JUST 5413 03:32:53,278 --> 03:32:55,046 WORD OF MOUTH FROM SOMEONE WHO 5414 03:32:55,046 --> 03:32:56,081 DIDN'T REALLY -- 5415 03:32:56,081 --> 03:32:58,316 >> I GET IT. 5416 03:32:58,316 --> 03:32:59,284 >> OKAY. 5417 03:32:59,284 --> 03:33:01,486 >> WE LIVED ON THIS FOR PROBABLY 5418 03:33:01,486 --> 03:33:04,322 20 YEARS NOW, AT THIS POINT. 5419 03:33:04,322 --> 03:33:07,058 I MENTIONED ANALYTICAL REFERENCE 5420 03:33:07,058 --> 03:33:14,800 MATERIALS PROGRAM LED BY DR. 5421 03:33:14,800 --> 03:33:18,036 ADAM CUSACK, BASICALLY THE 5422 03:33:18,036 --> 03:33:19,671 DIETARY SUPPLEMENT INDUSTRY, 5423 03:33:19,671 --> 03:33:20,572 WHAT'S IMPORTANT TO THEM, 5424 03:33:20,572 --> 03:33:22,974 PRODUCTS ON THE MARKET, WHERE 5425 03:33:22,974 --> 03:33:30,215 ARE WE MISSING THE ABILITY, WE 5426 03:33:30,215 --> 03:33:31,650 WORK WITH OTHER LABORATORIES, TO 5427 03:33:31,650 --> 03:33:33,385 MAKE SURE WE'RE ADDRESSING 5428 03:33:33,385 --> 03:33:34,486 APPROPRIATE QUESTIONS SO THAT 5429 03:33:34,486 --> 03:33:36,454 THE AMERICAN PUBLIC CAN HAVE 5430 03:33:36,454 --> 03:33:38,323 SOME CONFIDENCE THAT THEY'RE 5431 03:33:38,323 --> 03:33:41,059 TAKING IS THEY SAY THEY ARE 5432 03:33:41,059 --> 03:33:41,827 TAKING. 5433 03:33:41,827 --> 03:33:43,895 WE PARTICIPATE IN PROFESSIONAL 5434 03:33:43,895 --> 03:33:45,664 SOCIETIES THAT OVERSEE THAT KIND 5435 03:33:45,664 --> 03:33:46,731 OF WORK REGULARLY AND WE'RE 5436 03:33:46,731 --> 03:33:48,700 CONTINUING TO ADVANCE THAT WORK. 5437 03:33:48,700 --> 03:33:51,102 THAT'S ONE PIECE OF THE COG OF 5438 03:33:51,102 --> 03:33:54,873 IMPROVING THE METHODS AND RIGOR 5439 03:33:54,873 --> 03:33:56,074 AND CONFIDENCE IN DIETARY 5440 03:33:56,074 --> 03:33:57,709 SUPPLEMENT SCIENCE AND WE'LL SEE 5441 03:33:57,709 --> 03:34:02,848 IT MOVING FORWARD. 5442 03:34:02,848 --> 03:34:04,816 >> LAUREN, YOU'RE THE FINAL 5443 03:34:04,816 --> 03:34:05,784 QUESTION, WITH INSIGHT FROM YOUR 5444 03:34:05,784 --> 03:34:07,185 PREVIOUS ROLE AT FDA. 5445 03:34:07,185 --> 03:34:09,387 >> I COULDN'T HELP MYSELF. 5446 03:34:09,387 --> 03:34:11,590 I APPRECIATE THE COMMENTS ABOUT 5447 03:34:11,590 --> 03:34:13,892 THE COORDINATION WITH FDA 5448 03:34:13,892 --> 03:34:16,862 INCLUDING FROM YOU, TARA. 5449 03:34:16,862 --> 03:34:17,629 IN THE MESSAGING, SORRY ABOUT 5450 03:34:17,629 --> 03:34:21,032 THE DOG IN THE BACKGROUND, I 5451 03:34:21,032 --> 03:34:23,235 WOULD JUST -- SO SORRY. 5452 03:34:23,235 --> 03:34:27,472 I WOULD JUST -- YOU KNOW, IN 5453 03:34:27,472 --> 03:34:30,976 YOUR METHOD OF COMMUNICATION BE 5454 03:34:30,976 --> 03:34:32,510 THOUGHTFUL ABOUT NOT GIVING THE 5455 03:34:32,510 --> 03:34:34,713 IMPRESSION OF SAFETY FROM NIH 5456 03:34:34,713 --> 03:34:35,313 PERSPECTIVE WHEN FDA'S 5457 03:34:35,313 --> 03:34:38,316 AUTHORITIES IN THIS AREA ARE 5458 03:34:38,316 --> 03:34:39,517 LIMITED. 5459 03:34:39,517 --> 03:34:42,120 PUTTING INFORMATION FOR 5460 03:34:42,120 --> 03:34:44,122 CONSUMERS IS IMPORTANT 5461 03:34:44,122 --> 03:34:47,826 RECOGNIZING IT'S NOT REGULATED 5462 03:34:47,826 --> 03:34:49,694 BY DRUGS. 5463 03:34:49,694 --> 03:34:50,462 THERE ARE MORE LIMITED 5464 03:34:50,462 --> 03:34:51,229 AUTHORITIES. 5465 03:34:51,229 --> 03:34:54,299 I THOUGHT IT WAS A STRONG AND 5466 03:34:54,299 --> 03:34:55,267 THOUGHTFUL STRATEGIC PLAN, 5467 03:34:55,267 --> 03:34:56,835 PARTICULARLY SOMEONE NEW COMING 5468 03:34:56,835 --> 03:34:58,103 IN. 5469 03:34:58,103 --> 03:35:04,910 I WAS VERY IMPRESSED BY HOW 5470 03:35:04,910 --> 03:35:05,777 COMPREHENSIVE AWAY. 5471 03:35:05,777 --> 03:35:09,648 THE LAST THING, HOW YOU'RE GOING 5472 03:35:09,648 --> 03:35:11,716 TO TAKE ON MORE CONTROVERSIAL 5473 03:35:11,716 --> 03:35:16,621 FROM A REGULATORY PERSPECTIVE 5474 03:35:16,621 --> 03:35:17,122 ISSUES, SUPPLEMENTS, OR 5475 03:35:17,122 --> 03:35:18,690 INGREDIENTS THAT ARE COMMONLY 5476 03:35:18,690 --> 03:35:21,092 FOUND IN COMPLEMENTS THAT MAY 5477 03:35:21,092 --> 03:35:25,931 NOT BE AUTHORIZED, CBD, AN 5478 03:35:25,931 --> 03:35:27,265 OBVIOUS EXAMPLE, MORE WIDELY 5479 03:35:27,265 --> 03:35:29,734 YOU'VE, NOT AUTHORIZED TO BE IN 5480 03:35:29,734 --> 03:35:32,804 SUPPLEMENTS, HOW YOU'RE TACKLING 5481 03:35:32,804 --> 03:35:34,239 SOMETHING LIKE THAT. 5482 03:35:34,239 --> 03:35:35,674 >> WELL, THANK YOU FOR THE 5483 03:35:35,674 --> 03:35:36,541 POSITIVE FEEDBACK ON THE 5484 03:35:36,541 --> 03:35:38,510 STRATEGIC PLAN AND FOR SOME OF 5485 03:35:38,510 --> 03:35:41,179 THE POINTS OF CLARITY WITH FDA. 5486 03:35:41,179 --> 03:35:44,783 I GET IT. 5487 03:35:44,783 --> 03:35:47,052 SAFETY IS THIS WEIRD TERM, IN 5488 03:35:47,052 --> 03:35:48,820 THE CONTEXT OF NIH, IT'S NOT OUR 5489 03:35:48,820 --> 03:35:51,656 NAME WHEN YOU THINK ABOUT THE 5490 03:35:51,656 --> 03:35:53,291 CONTEXT OF REGULATORY, AND TO 5491 03:35:53,291 --> 03:35:54,626 WHAT AUTHORITY FDA CAN COMMENT 5492 03:35:54,626 --> 03:36:01,499 ON THIS SO I GET IT. 5493 03:36:01,499 --> 03:36:03,468 HOW DO WE ADDRESS THAT? 5494 03:36:03,468 --> 03:36:05,570 CBD BECAUSE OF FDA RULING OR 5495 03:36:05,570 --> 03:36:07,539 STANCE ON CBD IS NOT SOMETHING 5496 03:36:07,539 --> 03:36:08,807 WE'RE ENTERTAINING. 5497 03:36:08,807 --> 03:36:11,009 I DO SEE THAT EVOLVING. 5498 03:36:11,009 --> 03:36:17,615 THERE'S NO WAY TO GET AROUND IT 5499 03:36:17,615 --> 03:36:19,751 NCCIH HAS A PRETTY SIGNIFICANT 5500 03:36:19,751 --> 03:36:22,854 WORK GOING INTO THAT AREA, CBD, 5501 03:36:22,854 --> 03:36:26,992 BUT HOW THAT BLEEDS INTO DIETARY 5502 03:36:26,992 --> 03:36:27,792 SUPPLEMENTS AND WHERE WE PLAY A 5503 03:36:27,792 --> 03:36:29,094 ROLE I'M THE NEW SURE. 5504 03:36:29,094 --> 03:36:30,295 IT WILL BE CAREFULLY THOUGHT YOU 5505 03:36:30,295 --> 03:36:31,830 THE TO MAKE SURE WE'RE STAYING 5506 03:36:31,830 --> 03:36:34,632 IN OUR LANE, WHAT'S SPELLED OUT 5507 03:36:34,632 --> 03:36:45,176 IN THE OLD 1994 LAW, DSHEA LAW. 5508 03:36:45,176 --> 03:36:46,845 IT'S A NON-ANSWER BUT BEST I CAN 5509 03:36:46,845 --> 03:36:47,178 DO. 5510 03:36:47,178 --> 03:36:49,014 >> A FAIR ANSWER. 5511 03:36:49,014 --> 03:36:51,549 I WONDERED IF YOU THOUGHT ABOUT 5512 03:36:51,549 --> 03:36:51,850 THAT. 5513 03:36:51,850 --> 03:36:55,020 >> MORE TO COME ON THAT, I'M 5514 03:36:55,020 --> 03:36:57,422 SURE, FROM VARIETY OF 5515 03:36:57,422 --> 03:36:59,624 PERSPECTIVES. 5516 03:36:59,624 --> 03:37:03,228 I WANT TO MAKE SURE WE SAVE TIME 5517 03:37:03,228 --> 03:37:12,237 FOR OUR LAST CONVERSATION, SO I 5518 03:37:12,237 --> 03:37:15,507 WILL THANK STEFAN FOR HIS 5519 03:37:15,507 --> 03:37:16,041 PRESENTATION. 5520 03:37:16,041 --> 03:37:21,413 WE'LL SHIFT GERBES -- GEARS TO 5521 03:37:21,413 --> 03:37:23,915 THE NEW EFFORT THE WHITE HOUSE 5522 03:37:23,915 --> 03:37:25,650 HAS BEEN PUSHING FORWARD AND 5523 03:37:25,650 --> 03:37:28,520 SUPPORTING, WHICH IS THE WOMEN'S 5524 03:37:28,520 --> 03:37:30,789 HEALTH RESEARCH INITIATIVE, SO 5525 03:37:30,789 --> 03:37:34,092 DR. VIVIAN OTA WANG WHO YOU 5526 03:37:34,092 --> 03:37:36,094 HEARD ABOUT EARLIER THIS 5527 03:37:36,094 --> 03:37:37,662 MORNING, THE RELATIVELY NEW 5528 03:37:37,662 --> 03:37:39,030 DEPUTY DIRECTOR OF OFFICE OF 5529 03:37:39,030 --> 03:37:40,598 RESEARCH ON WOMEN'S HEALTH IS 5530 03:37:40,598 --> 03:37:45,737 HERE TO TALK ABOUT THE WORK THEY 5531 03:37:45,737 --> 03:37:48,306 ARE DOING TO HELP USHER THAT IN, 5532 03:37:48,306 --> 03:37:49,007 IN RESPONSE TO THE EXECUTIVE 5533 03:37:49,007 --> 03:37:52,777 ORDER IN MARCH. 5534 03:37:52,777 --> 03:37:53,278 WITH THAT, VIVIAN? 5535 03:37:53,278 --> 03:37:57,649 >> THANK YOU, TARA, FOR THE NICE 5536 03:37:57,649 --> 03:37:57,982 INTRODUCTION. 5537 03:37:57,982 --> 03:37:58,750 GOOD AFTERNOON, EVERYONE. 5538 03:37:58,750 --> 03:38:02,487 SO WHAT I WOULD LIKE TO DO IS, 5539 03:38:02,487 --> 03:38:04,856 NEXT SLIDE, IS PROVIDE SOME 5540 03:38:04,856 --> 03:38:06,524 CONTEXT ABOUT WOMEN'S HEALTH AND 5541 03:38:06,524 --> 03:38:09,794 WE'RE GOING TO LAUNCH INTO 5542 03:38:09,794 --> 03:38:11,863 REALLY MORE DEPTH OF THE WHITE 5543 03:38:11,863 --> 03:38:13,531 HOUSE'S INITIATIVE ON WOMEN'S 5544 03:38:13,531 --> 03:38:15,366 HEALTH RESEARCH. 5545 03:38:15,366 --> 03:38:16,801 JUST WANTED TO REMIND EVERYONE 5546 03:38:16,801 --> 03:38:18,636 AS WE START THINKING ABOUT 5547 03:38:18,636 --> 03:38:20,538 HEALTH, THAT MEN AND WOMEN 5548 03:38:20,538 --> 03:38:21,406 FOLLOW DIFFERENT PATHS TO HEALTH 5549 03:38:21,406 --> 03:38:22,373 AND DISEASE. 5550 03:38:22,373 --> 03:38:23,775 WE MAY HAVE A STARTING POINT 5551 03:38:23,775 --> 03:38:27,412 THAT MAY APPEAR TO BE THE SAME 5552 03:38:27,412 --> 03:38:30,815 BUT REALLY DEPENDING ON OUR 5553 03:38:30,815 --> 03:38:32,050 GENETICS, OUR BIOLOGY, SOCIAL 5554 03:38:32,050 --> 03:38:34,319 ENVIRONMENTS WE LIVE, THAT OUR 5555 03:38:34,319 --> 03:38:37,589 PATHS TO DISEASE AND HEALTH HAVE 5556 03:38:37,589 --> 03:38:39,257 DIFFERENT ENDPOINT. 5557 03:38:39,257 --> 03:38:45,463 NEXT SLIDE PLEASE. 5558 03:38:45,463 --> 03:38:46,264 WOMEN DIFFERENTLY EXPERIENCE 5559 03:38:46,264 --> 03:38:48,333 HEALTH AND DISEASE. 5560 03:38:48,333 --> 03:38:51,202 ON THE LEFT IS FEMALES AND MALES 5561 03:38:51,202 --> 03:38:54,272 ON THE RIGHT, YOU'RE GOING TO 5562 03:38:54,272 --> 03:38:56,774 NOTICE BASED ON AGE WOMEN -- 5563 03:38:56,774 --> 03:38:59,144 FEMALES AND MALES EXPERIENCE 5564 03:38:59,144 --> 03:39:01,613 HEALTH DIFFERENTLY BASED ON 5565 03:39:01,613 --> 03:39:03,114 FREQUENCY, BASED ON MAGNITUDE, 5566 03:39:03,114 --> 03:39:05,984 NUMBER OF DISEASES THAT THEY ARE 5567 03:39:05,984 --> 03:39:06,317 EXPERIENCING. 5568 03:39:06,317 --> 03:39:08,119 SO FOR EXAMPLE IF YOU LOOK AT 5569 03:39:08,119 --> 03:39:12,624 THE DARK BLUE ON THE LEFT, 5570 03:39:12,624 --> 03:39:14,626 YOU'LL SEE FEMALES EXPERIENCE -- 5571 03:39:14,626 --> 03:39:18,096 DARK BLUE IS SEROLOGIC DISEASE, 5572 03:39:18,096 --> 03:39:20,598 EXPERIENCES EARLIER AND MORE 5573 03:39:20,598 --> 03:39:21,966 FREQUENTLY THROUGHOUT THEIR LIFE 5574 03:39:21,966 --> 03:39:22,834 THAN MEN. 5575 03:39:22,834 --> 03:39:27,772 WE CAN ALSO LOOK AT THE PINK 5576 03:39:27,772 --> 03:39:29,474 AREA, THAT'S THE MUSCULOSKELETAL 5577 03:39:29,474 --> 03:39:29,941 DISEASES. 5578 03:39:29,941 --> 03:39:32,243 THERE'S ALSO A HIGHER FREQUENCY 5579 03:39:32,243 --> 03:39:34,546 AND LONGER EXPERIENCE OF THESE 5580 03:39:34,546 --> 03:39:36,381 DISEASES AS WELL. 5581 03:39:36,381 --> 03:39:38,149 AND FOR ME IT'S JUST TO SHOW 5582 03:39:38,149 --> 03:39:40,251 CONTEXT OF HOW WE'RE THINKING 5583 03:39:40,251 --> 03:39:41,152 ABOUT WOMEN'S HEALTH RESEARCH 5584 03:39:41,152 --> 03:39:43,188 THAT FOR THE OFFICE OF RESEARCH 5585 03:39:43,188 --> 03:39:45,590 ON WOMEN'S HEALTH WE'RE LOOKING 5586 03:39:45,590 --> 03:39:50,962 AT THE LIFESPAN, THE ENTIRE 5587 03:39:50,962 --> 03:39:52,063 LIFESPAN OF WOMEN. 5588 03:39:52,063 --> 03:39:55,133 NEXT SLIDE PLEASE. 5589 03:39:55,133 --> 03:39:57,435 AND THIS IS TO ILLUSTRATE THIS 5590 03:39:57,435 --> 03:39:58,636 IS NOT A NEW ISSUE FOR THE 5591 03:39:58,636 --> 03:40:01,272 NATIONAL INSTITUTES OF HEALTH. 5592 03:40:01,272 --> 03:40:04,642 WE'VE HAD AN ENDURING AND ROBUST 5593 03:40:04,642 --> 03:40:06,177 COMMITMENT AND INTEREST IN 5594 03:40:06,177 --> 03:40:07,145 WOMEN'S HEALTH RESEARCH. 5595 03:40:07,145 --> 03:40:09,681 ON THE LEFT IT'S BEEN EMBEDDED 5596 03:40:09,681 --> 03:40:11,316 IN A STRATEGIC PLAN NOT ONLY IN 5597 03:40:11,316 --> 03:40:14,819 TERMS OF NAGS NATIONAL 5598 03:40:14,819 --> 03:40:16,254 INSTITUTES OF HEALTH BUT OFFICE 5599 03:40:16,254 --> 03:40:20,992 OF RE RESEARCH ON WOMEN'S HEALT. 5600 03:40:20,992 --> 03:40:25,563 WE'VE PARTNERED WITH THE FORMER 5601 03:40:25,563 --> 03:40:28,266 BILL AND MELINDA GATES 5602 03:40:28,266 --> 03:40:31,369 FOUNDATION AS WELL AS NATIONAL 5603 03:40:31,369 --> 03:40:34,105 ACADEMIES TO GET INFORMATION AND 5604 03:40:34,105 --> 03:40:36,074 DATA ABOUT THE STATUS OF WOMEN'S 5605 03:40:36,074 --> 03:40:39,210 HEALTH RESEARCH AND WOMEN'S 5606 03:40:39,210 --> 03:40:40,745 HEALTH. 5607 03:40:40,745 --> 03:40:43,147 AND THEN IMPORTANTLY I'LL END 5608 03:40:43,147 --> 03:40:44,449 THE DISCUSSION TODAY, WE'RE 5609 03:40:44,449 --> 03:40:47,318 IMPORTANTLY PARTNERING WITH U.S. 5610 03:40:47,318 --> 03:40:49,420 GOVERNMENT-RELATED SISTERS AND 5611 03:40:49,420 --> 03:40:52,690 BROTHERS AS WELL AS RELATED 5612 03:40:52,690 --> 03:40:52,957 DIRECTIVE. 5613 03:40:52,957 --> 03:40:54,225 NEXT SLIDE PLEASE. 5614 03:40:54,225 --> 03:40:57,629 SO OUR FOUNDATION IS REALLY THE 5615 03:40:57,629 --> 03:40:58,930 NIH-WIDE STRATEGIC PLAN. 5616 03:40:58,930 --> 03:41:01,232 AND I WANTED TO ILLUSTRATE THAT 5617 03:41:01,232 --> 03:41:04,702 AS YOU KNOW THE NIH STRATEGIC 5618 03:41:04,702 --> 03:41:07,338 OBJECTIVES ARE AROUND RESEARCH 5619 03:41:07,338 --> 03:41:08,439 AREAS, RESEARCH CAPACITY, 5620 03:41:08,439 --> 03:41:08,840 RESEARCH CONDUCT. 5621 03:41:08,840 --> 03:41:10,975 BUT REALLY WANTED TO ONCE AGAIN 5622 03:41:10,975 --> 03:41:13,845 BRING TO YOUR ATTENTION THAT 5623 03:41:13,845 --> 03:41:15,947 WOMENS HEALTH IS ONE OF THE 5624 03:41:15,947 --> 03:41:18,316 CROSS-CUTTING THINKS THE 5625 03:41:18,316 --> 03:41:18,650 -- THEMES THE 5626 03:41:18,650 --> 03:41:20,151 NATIONAL INSTITUTES OF HEALTH IS 5627 03:41:20,151 --> 03:41:20,785 IDENTIFIED FOR BEING IMPORTANT 5628 03:41:20,785 --> 03:41:24,222 FOR THE WORK AND THINKING WE'RE 5629 03:41:24,222 --> 03:41:24,656 DOING. 5630 03:41:24,656 --> 03:41:25,423 NEXT SLIDE PLEASE. 5631 03:41:25,423 --> 03:41:27,625 HOW DOES THIS FIT WITH OFFICE OF 5632 03:41:27,625 --> 03:41:30,361 RESEARCH ON WOMEN'S HEALTH? 5633 03:41:30,361 --> 03:41:32,563 PART OF THAT CROSS-CUTTING 5634 03:41:32,563 --> 03:41:35,600 VISION OF NIH WAS REALLY TRYING 5635 03:41:35,600 --> 03:41:38,469 TO FOCUS NIH'S VISION ON SEX AND 5636 03:41:38,469 --> 03:41:39,937 GENDER INTEGRATED INTO 5637 03:41:39,937 --> 03:41:43,374 BIOMEDICAL RESEARCH AS A GENERAL 5638 03:41:43,374 --> 03:41:44,475 PRINCIPLE. 5639 03:41:44,475 --> 03:41:46,144 WITH THE UNDERSTANDING THAT 5640 03:41:46,144 --> 03:41:49,547 EVERY WOMAN TRULY RECEIVES 5641 03:41:49,547 --> 03:41:51,182 EVIDENCE-BASED CARE AND WE NEED 5642 03:41:51,182 --> 03:41:53,151 TO INVEST IN WOMEN AND SCIENCE 5643 03:41:53,151 --> 03:41:55,086 CAREERS TO REACH FULL POTENTIAL, 5644 03:41:55,086 --> 03:41:57,622 NOT ONLY IN EARLY PART OF THE 5645 03:41:57,622 --> 03:41:59,924 CAREER BUT THROUGHOUT THE SENIOR 5646 03:41:59,924 --> 03:42:02,994 PART OF THEIR CAREER AS WELL. 5647 03:42:02,994 --> 03:42:04,295 WE'RE DOING THAT THROUGH OFFICE 5648 03:42:04,295 --> 03:42:06,064 OF RESEARCH ON WOMEN'S HEALTH, 5649 03:42:06,064 --> 03:42:09,534 OUR MISSION IS TO EXPAND AND 5650 03:42:09,534 --> 03:42:10,768 ENHANCE WOMEN HELLS RESEARCH, 5651 03:42:10,768 --> 03:42:13,471 WE'RE KEEN ON INCLUDING WOMEN 5652 03:42:13,471 --> 03:42:16,240 AND MINORITY GROUPS IN CLINICAL 5653 03:42:16,240 --> 03:42:18,543 RESEARCH, AND AS WELL AS 5654 03:42:18,543 --> 03:42:19,944 PROVIDING PROGRAMS AND FUNDING 5655 03:42:19,944 --> 03:42:21,846 RESOURCES TO PROMOTE CAREER 5656 03:42:21,846 --> 03:42:23,681 DEVELOPMENT FOR WOMEN IN 5657 03:42:23,681 --> 03:42:27,185 BIOMEDICAL CAREERS. 5658 03:42:27,185 --> 03:42:27,652 NEXT SLIDE PLEASE. 5659 03:42:27,652 --> 03:42:29,053 SO I WANTED TO BRING TO YOUR 5660 03:42:29,053 --> 03:42:33,558 ATTENTION THAT THIS IS OUR NEWLY 5661 03:42:33,558 --> 03:42:35,193 RELEASED 2024 TO 2528 NIH-WIDE 5662 03:42:35,193 --> 03:42:37,395 STRATEGIC PLAN FOR WOMEN'S 5663 03:42:37,395 --> 03:42:37,762 HEALTH RESEARCH. 5664 03:42:37,762 --> 03:42:39,597 IT WAS JUST RELEASED A COUPLE 5665 03:42:39,597 --> 03:42:40,765 WEEKS AGO. 5666 03:42:40,765 --> 03:42:44,736 AND I JUST WANTED TO BRING -- TO 5667 03:42:44,736 --> 03:42:46,237 HIGHLIGHT TRAINING AND EDUCATION 5668 03:42:46,237 --> 03:42:47,572 AND RESEARCH IS OUR FOUNDATION 5669 03:42:47,572 --> 03:42:50,975 TO THE WORK THAT WE'RE DOING. 5670 03:42:50,975 --> 03:42:52,710 AND IN THE STRATEGIC PLAN WE'RE 5671 03:42:52,710 --> 03:42:55,446 FOCUSING ON DATA SCIENCE AND 5672 03:42:55,446 --> 03:42:57,949 MANAGEMENT, WE'RE LOOKING AT THE 5673 03:42:57,949 --> 03:43:02,553 BENCH TO BEDSIDE BY BASIC AND 5674 03:43:02,553 --> 03:43:03,755 TRANSLATIONAL RESEARCH, █AND 5675 03:43:03,755 --> 03:43:04,422 INCORPORATING COMMUNITY 5676 03:43:04,422 --> 03:43:05,423 ENGAGEMENT AS AN ESSENTIAL 5677 03:43:05,423 --> 03:43:09,427 RESOURCE TO THE WORK THAT WE'RE 5678 03:43:09,427 --> 03:43:09,761 DOING. 5679 03:43:09,761 --> 03:43:10,962 NEXT SLIDE PLEASE. 5680 03:43:10,962 --> 03:43:14,599 SO PART OF THE RESEARCH IS WE'RE 5681 03:43:14,599 --> 03:43:17,869 REALLY TRYING TO TRANSFORM 5682 03:43:17,869 --> 03:43:23,875 WOMEN'S HEALTH THROUGH THE 5683 03:43:23,875 --> 03:43:24,208 LIFESPAN. 5684 03:43:24,208 --> 03:43:28,346 YOU HEARD EARLY WITH DR. 5685 03:43:28,346 --> 03:43:32,450 BIANCHI, THAT PUNCUATES MATERNAL 5686 03:43:32,450 --> 03:43:33,284 HEALTH ISSUES THAT NICHD HAS 5687 03:43:33,284 --> 03:43:39,323 BEEN THE LEADER IN THINKING AND 5688 03:43:39,323 --> 03:43:40,725 DOING OF THAT. 5689 03:43:40,725 --> 03:43:46,564 LOOKING IN ADDITION TO THOSE 5690 03:43:46,564 --> 03:43:47,932 PUNCTUATED EFFORTS, THROUGHOUT 5691 03:43:47,932 --> 03:43:49,934 THE LIFESPAN OF A WOMAN HOW 5692 03:43:49,934 --> 03:43:50,935 INTERSECTION OF BIOLOGICAL 5693 03:43:50,935 --> 03:43:53,204 FACTORS BUT LOOKING AT 5694 03:43:53,204 --> 03:43:55,072 INTERACTION OF SOCIAL FACTORS AS 5695 03:43:55,072 --> 03:43:56,307 WELL THAT AFFECT WOMEN'S HEALTH. 5696 03:43:56,307 --> 03:43:58,810 WE'RE GOING TO BE DOING THAT 5697 03:43:58,810 --> 03:44:01,479 THROUGH INNOVATIVE RESEARCH 5698 03:44:01,479 --> 03:44:02,313 METHODS AND DEVELOPMENT, THROUGH 5699 03:44:02,313 --> 03:44:03,381 WHAT YOU HEARD EARLIER ABOUT 5700 03:44:03,381 --> 03:44:06,684 SOME WAYS THAT WE'RE DOING IT IN 5701 03:44:06,684 --> 03:44:08,553 DATA SCIENCE, AND PROMOTING 5702 03:44:08,553 --> 03:44:09,620 CUTTING EDGE TECHNOLOGIES. 5703 03:44:09,620 --> 03:44:13,224 TO DO THAT, WE'RE ALSO 5704 03:44:13,224 --> 03:44:14,559 SUPPORTING BIOMEDICAL WORKFORCE 5705 03:44:14,559 --> 03:44:16,060 TRAINING AND CAREER DEVELOPMENT, 5706 03:44:16,060 --> 03:44:18,262 IN THAT WAY WE COULD FULLY 5707 03:44:18,262 --> 03:44:20,364 ADVANCE BASIC SCIENCE AND 5708 03:44:20,364 --> 03:44:22,099 TRANSLATIONAL RESEARCH TO 5709 03:44:22,099 --> 03:44:24,068 IMPROVE THE HEALTH OF WOMEN. 5710 03:44:24,068 --> 03:44:26,804 AND LAST BUT NOT LEAST IS THAT 5711 03:44:26,804 --> 03:44:29,207 PART OF OUR BEDROCK IS COMMUNITY 5712 03:44:29,207 --> 03:44:30,942 ENGAGEMENT, AND THAT IS ONE OF 5713 03:44:30,942 --> 03:44:35,580 THE WAYS WE'RE PROMOTING 5714 03:44:35,580 --> 03:44:38,182 IMPLEMENTATION SCIENCE FOR THIS 5715 03:44:38,182 --> 03:44:38,382 AREA. 5716 03:44:38,382 --> 03:44:39,517 NEXT SLIDE PLEASE. 5717 03:44:39,517 --> 03:44:41,586 HERE WE GO. 5718 03:44:41,586 --> 03:44:47,458 SO, I'M JUST TO GIVE A WHIRLWIND 5719 03:44:47,458 --> 03:44:50,127 TOUR OF THE WHITE HOUSE 5720 03:44:50,127 --> 03:44:50,428 INITIATIVE. 5721 03:44:50,428 --> 03:44:52,797 A SNAPSHOT OF HOW BUSY WE'VE 5722 03:44:52,797 --> 03:44:55,500 BEEN, THE WHITE HOUSE RESEARCH 5723 03:44:55,500 --> 03:44:59,637 INITIATIVE WAS ANNOUNCED LAST 5724 03:44:59,637 --> 03:45:02,139 NOVEMBER, NOVEMBER 13, WHERE THE 5725 03:45:02,139 --> 03:45:03,808 PRESIDENT SIGNED THIS 5726 03:45:03,808 --> 03:45:04,242 MEMORANDUM. 5727 03:45:04,242 --> 03:45:06,844 THAT STARTED A CLOCK FOR THE 5728 03:45:06,844 --> 03:45:07,745 NATIONAL INSTITUTES OF HEALTH, 5729 03:45:07,745 --> 03:45:09,814 WE HAD TO FIGURE OUT WHAT ARE 5730 03:45:09,814 --> 03:45:12,550 SOME WALES WE'RE GOING TO THINK 5731 03:45:12,550 --> 03:45:13,518 ABOUT WOMEN'S HEALTH RESEARCH, 5732 03:45:13,518 --> 03:45:19,323 AS YOU CAN SEE WE HAD A 5733 03:45:19,323 --> 03:45:19,590 DEADLINE. 5734 03:45:19,590 --> 03:45:22,927 YOU CAN IMAGINE HOW MANY OF US 5735 03:45:22,927 --> 03:45:24,228 SPENT BETWEEN THANKSGIVING AND 5736 03:45:24,228 --> 03:45:30,167 THE END OF THE YEAR TRYING TO 5737 03:45:30,167 --> 03:45:33,237 REALLY DISCUSS WITH INSTITUTE 5738 03:45:33,237 --> 03:45:34,305 DIRECTORS WITH BRAINSTORMING 5739 03:45:34,305 --> 03:45:36,274 SESSIONS, WE DID DATA CALLS TO 5740 03:45:36,274 --> 03:45:38,042 FIGURE OUT WHAT ARE THE 5741 03:45:38,042 --> 03:45:41,212 ACTIVITIES WE'RE DOING ACROSS 5742 03:45:41,212 --> 03:45:41,379 NIH. 5743 03:45:41,379 --> 03:45:42,847 AND WE TRIED TO FIGURE OUT WHAT 5744 03:45:42,847 --> 03:45:46,117 WOULD BE THE BEST WAY FOR US TO 5745 03:45:46,117 --> 03:45:47,451 THINK ABOUT WOMEN'S HEALTH 5746 03:45:47,451 --> 03:45:49,720 RESEARCH AS WE MOVE FORWARD WITH 5747 03:45:49,720 --> 03:45:51,389 THIS MEMORANDUM THAT REALLY 5748 03:45:51,389 --> 03:45:55,960 LAUNCHED THE INITIATIVE. 5749 03:45:55,960 --> 03:45:59,397 NEXT SLIDE PLEASE. 5750 03:45:59,397 --> 03:46:04,068 SO IN MARCH, PRESIDENT BIDEN HAD 5751 03:46:04,068 --> 03:46:06,804 THE EXECUTIVE ORDER 14120, 5752 03:46:06,804 --> 03:46:07,905 ADVANCING WOMEN'S HEALTH 5753 03:46:07,905 --> 03:46:09,640 RESEARCH AND INNOVATION. 5754 03:46:09,640 --> 03:46:11,509 IT'S TRULY THE MOST 5755 03:46:11,509 --> 03:46:12,510 COMPREHENSIVE SET OF EXECUTIVE 5756 03:46:12,510 --> 03:46:14,579 ORDERS TO EXPAND AND IMPROVE 5757 03:46:14,579 --> 03:46:15,680 RESEARCH ON WOMEN'S HEALTH. 5758 03:46:15,680 --> 03:46:21,786 SOY AS YOU CAN SEE WE'VE HAD 5759 03:46:21,786 --> 03:46:22,987 LEADERSHIP INCLUDING DR. 5760 03:46:22,987 --> 03:46:24,422 BERTAGNOLLI AND OFFICE OF 5761 03:46:24,422 --> 03:46:26,290 RESEARCH ON WOMEN'S HEALTH 5762 03:46:26,290 --> 03:46:28,793 DIRECTOR DR. JANINE CLAYTON. 5763 03:46:28,793 --> 03:46:30,995 I WAS ALSO THERE WITH TARA 5764 03:46:30,995 --> 03:46:33,064 SCHWETZ AND OTHER LEADERS OF 5765 03:46:33,064 --> 03:46:35,232 NIH, A VERY EXCITING TIME. 5766 03:46:35,232 --> 03:46:37,335 IMPORTANTLY WHAT THE EXECUTIVE 5767 03:46:37,335 --> 03:46:43,140 ORDER IS TRYING TO FOCUS ON IS 5768 03:46:43,140 --> 03:46:43,708 INTEGRATING WOMEN'S HEALTH 5769 03:46:43,708 --> 03:46:51,015 ACROSS THE ENTIRE FEDERAL 5770 03:46:51,015 --> 03:46:53,851 RESEARCH PORTFOLIO TO DEVELOP 5771 03:46:53,851 --> 03:46:56,053 AND STRENGTHEN DATA STANDARDS IN 5772 03:46:56,053 --> 03:46:57,788 RELEVANT RESEARCH AND FUNDING 5773 03:46:57,788 --> 03:46:58,789 OPPORTUNITIES. 5774 03:46:58,789 --> 03:47:00,858 IT'S REALLY TRYING TO PRIORITIZE 5775 03:47:00,858 --> 03:47:02,426 INVESTMENTS IN WOMEN'S HEALTH, 5776 03:47:02,426 --> 03:47:05,363 REALLY LOOKING AT HIGH IMPACT 5777 03:47:05,363 --> 03:47:08,532 RESEARCH AND INNOVATION. 5778 03:47:08,532 --> 03:47:10,501 IMPORTANTLY, IT'S GALVANIZING 5779 03:47:10,501 --> 03:47:12,136 RESEARCH IN WOMEN'S MID-LIFE 5780 03:47:12,136 --> 03:47:12,570 HEALTH. 5781 03:47:12,570 --> 03:47:15,439 PEOPLE ASK HOW COME WOMEN'S 5782 03:47:15,439 --> 03:47:15,806 MIDLINE HEALTH? 5783 03:47:15,806 --> 03:47:18,476 WHAT WE KNOW ABOUT THIS PERIOD 5784 03:47:18,476 --> 03:47:20,878 OF LIFE IN WOMEN, IT'S ONE OF 5785 03:47:20,878 --> 03:47:22,980 THESE PIVOTAL POINTS WHERE A LOT 5786 03:47:22,980 --> 03:47:28,653 OF CHRONIC DISEASES ACTUALLY 5787 03:47:28,653 --> 03:47:28,953 EMERGE. 5788 03:47:28,953 --> 03:47:31,288 SO UNDERSTANDING RESEARCH GAP 5789 03:47:31,288 --> 03:47:33,591 THAT OCCUR AFTER MENOPAUSE AND 5790 03:47:33,591 --> 03:47:35,693 CONDITIONS AND DISEASES THAT ARE 5791 03:47:35,693 --> 03:47:37,662 ASSOCIATED WITH IT ARE REALLY AN 5792 03:47:37,662 --> 03:47:39,830 IMPORTANT PIECE OF THAT MISSING 5793 03:47:39,830 --> 03:47:40,064 PUZZLE. 5794 03:47:40,064 --> 03:47:42,900 AND PART OF THAT IS ALSO 5795 03:47:42,900 --> 03:47:45,202 COMMITMENT TO ASSESSING UNMET 5796 03:47:45,202 --> 03:47:46,604 NEEDS TO SUPPORT WOMEN'S HEALTH 5797 03:47:46,604 --> 03:47:50,007 RESEARCH NOT ONLY LOOKING AT 5798 03:47:50,007 --> 03:47:51,676 FEDERAL FUNDING BUT REALLY 5799 03:47:51,676 --> 03:47:54,245 FIGURING OUT IF THERE ARE 5800 03:47:54,245 --> 03:47:58,249 CHANGES WE NEED TO MAKE, 5801 03:47:58,249 --> 03:48:01,786 STATUTORY, REGULATORY, BUDGETARY 5802 03:48:01,786 --> 03:48:03,821 TO MAXIMIZE SUPPORT TO BROADEN 5803 03:48:03,821 --> 03:48:06,657 THE SCOPE OF WOMEN'S HEALTH 5804 03:48:06,657 --> 03:48:09,727 RESEARCH NEEDS ACROSS THE U.S. 5805 03:48:09,727 --> 03:48:13,330 GOVERNMENT. 5806 03:48:13,330 --> 03:48:15,966 NEXT SLIDE PLEASE. 5807 03:48:15,966 --> 03:48:17,001 THIS IS AN ILLUSTRATION, ACROSS 5808 03:48:17,001 --> 03:48:19,704 THE U.S. GOVERNMENT WE HAVE 11 5809 03:48:19,704 --> 03:48:21,872 PARTNERS, WHAT WE'RE DOING IS 5810 03:48:21,872 --> 03:48:24,408 WE'RE COLLABORATING THROUGH WHAT 5811 03:48:24,408 --> 03:48:25,976 WE CALL MULTI-AGENCY 5812 03:48:25,976 --> 03:48:31,015 CROSS-CUTTING PROGRAMS, AS A WAY 5813 03:48:31,015 --> 03:48:33,084 TO POTENTIALLY FUND 5814 03:48:33,084 --> 03:48:35,352 INTERDISCIPLINARY RESEARCH 5815 03:48:35,352 --> 03:48:39,323 HEALTH RESEARCH TOWARDS 5816 03:48:39,323 --> 03:48:44,128 TRANSFORMING WOMEN'S HEALTH 5817 03:48:44,128 --> 03:48:44,395 RESEARCH. 5818 03:48:44,395 --> 03:48:45,029 IT'S HIGHLIGHTING 5819 03:48:45,029 --> 03:48:46,530 INTERDISCIPLINARY RESEARCH, IN A 5820 03:48:46,530 --> 03:48:49,600 LOT OF WAYS THAT'S THE LIVED 5821 03:48:49,600 --> 03:48:51,669 EXPERIENCE OF WOMEN THAT WE HAVE 5822 03:48:51,669 --> 03:48:58,375 DIFFERENT FACTORS THAT INFLUENCE 5823 03:48:58,375 --> 03:49:00,244 OUR HEALTH THIS IS TRYING TO 5824 03:49:00,244 --> 03:49:10,788 SUPPORT RESEARCH REFLECTING THAT 5825 03:49:11,255 --> 03:49:11,622 REALITY. 5826 03:49:11,622 --> 03:49:17,428 A WE'RE TAKING A LIFE COURSE 5827 03:49:17,428 --> 03:49:17,762 APPROACH. 5828 03:49:17,762 --> 03:49:19,396 AN INTEGRATION OF BIOLOGICAL 5829 03:49:19,396 --> 03:49:21,132 FACTORS AND SOCIAL AND 5830 03:49:21,132 --> 03:49:22,466 ENVIRONMENTAL EXPOSURES AND 5831 03:49:22,466 --> 03:49:23,434 DETERMINANTS OF HEALTH. 5832 03:49:23,434 --> 03:49:28,806 AND THAT AS PART OF NIH'S 5833 03:49:28,806 --> 03:49:32,743 COMMITMENT, FY 2025, WE HAVE A 5834 03:49:32,743 --> 03:49:34,478 $200 MILLION EFFORT AS A WAY TO 5835 03:49:34,478 --> 03:49:36,881 CLOSE WOMEN'S HEALTH RESEARCH 5836 03:49:36,881 --> 03:49:41,919 GAPS ACROSS THE LIFESPAN BY 5837 03:49:41,919 --> 03:49:43,587 SUPPORTING NEW INTERDISCIPLINARY 5838 03:49:43,587 --> 03:49:45,556 RESEARCH THAT'S GOING ACROSS THE 5839 03:49:45,556 --> 03:49:47,024 TRADITIONAL NIH INSTITUTES AND 5840 03:49:47,024 --> 03:49:47,358 CENTERS. 5841 03:49:47,358 --> 03:49:48,592 AND SO YOU CAN IMAGINE WHAT 5842 03:49:48,592 --> 03:49:51,095 WE'RE TRYING TO DO IS TO 5843 03:49:51,095 --> 03:49:53,964 INTEGRATE SORT OF THAT 5844 03:49:53,964 --> 03:49:56,267 INTERSTITIAL SPACE OF WHERE 5845 03:49:56,267 --> 03:49:57,568 RESEARCH NESTS THAT DEPENDS ON A 5846 03:49:57,568 --> 03:50:05,142 LOT OF DISCIPLINES. 5847 03:50:05,142 --> 03:50:09,079 WE HAVE TIGER TEAM OF INSTITUTE 5848 03:50:09,079 --> 03:50:12,616 DIRECTORS CO-CHAIRED BY JANINE 5849 03:50:12,616 --> 03:50:19,089 CLAYTON AND DIRECTORS FROM 5850 03:50:19,089 --> 03:50:24,328 NATIONAL INSTITUTES OF AGING, 5851 03:50:24,328 --> 03:50:24,829 MUSCULOSKELETAL AND SKIN 5852 03:50:24,829 --> 03:50:29,466 DISEASE, EUNICE KENNEDY SHRIVER 5853 03:50:29,466 --> 03:50:31,535 INSTITUTE, DRUG ABUSE, A NICE 5854 03:50:31,535 --> 03:50:34,038 COMPLEMENT OF DIRECTORS THAT'S 5855 03:50:34,038 --> 03:50:36,807 LOOKING ACROSS THE DIASPORA OF 5856 03:50:36,807 --> 03:50:43,581 DISEASES THAT ARE DEEPLY 5857 03:50:43,581 --> 03:50:44,248 AFFECTING WOMEN'S HEALTH. 5858 03:50:44,248 --> 03:50:47,751 I WANT TO FOCUS ON SOME ACTIONS 5859 03:50:47,751 --> 03:50:49,720 WE'RE TAKING, ALIGNING EFFORTS 5860 03:50:49,720 --> 03:50:52,656 FOR EXECUTIVE ORDER 5861 03:50:52,656 --> 03:50:53,057 REQUIREMENTS. 5862 03:50:53,057 --> 03:50:56,060 SO, THE LISTING ON THE LEFT ARE 5863 03:50:56,060 --> 03:50:57,061 THE BROAD CATEGORIES. 5864 03:50:57,061 --> 03:50:58,996 WE WANT TO CREATE A FRONT DOOR 5865 03:50:58,996 --> 03:51:01,198 TO NIH FOR THE FUNDING 5866 03:51:01,198 --> 03:51:02,533 OPPORTUNITIES OF WOMEN'S HEALTH. 5867 03:51:02,533 --> 03:51:05,135 AND SO ONE OF THE FIRST THINGS 5868 03:51:05,135 --> 03:51:07,538 THAT WE'VE ALREADY DONE IS THAT 5869 03:51:07,538 --> 03:51:12,343 WE RELEASED A NOTICE OF 5870 03:51:12,343 --> 03:51:13,978 INTEREST, SPECIAL INTEREST, 5871 03:51:13,978 --> 03:51:15,212 NIH-WIDE FOR WOMEN'S HEALTH 5872 03:51:15,212 --> 03:51:15,613 RESEARCH. 5873 03:51:15,613 --> 03:51:18,949 ESSENTIALLY WHAT THIS DID IS WE 5874 03:51:18,949 --> 03:51:22,119 ATTACHED THIS NOSI TO ALL PARENT 5875 03:51:22,119 --> 03:51:23,754 FUNDING OPPORTUNITIES FOR NIH, 5876 03:51:23,754 --> 03:51:25,489 AND ALL OF THE INSTITUTES AND 5877 03:51:25,489 --> 03:51:29,860 CENTERS AND OFFICES HAVE SIGNED 5878 03:51:29,860 --> 03:51:30,895 ON TO THAT. 5879 03:51:30,895 --> 03:51:38,869 THIS IS ONE WAY TO SPREAD 5880 03:51:38,869 --> 03:51:40,404 DIASPORA ACROSS THE ENTIRE NIH, 5881 03:51:40,404 --> 03:51:44,675 WORKING ON STANDARDIZING DATA Y 5882 03:51:44,675 --> 03:51:46,977 TRYING TO DEVELOP AND IDENTIFY 5883 03:51:46,977 --> 03:51:49,079 NEW COMMON DATA ELEMENTS RELATED 5884 03:51:49,079 --> 03:51:51,348 TO WOMEN'S HEALTH, THAT WILL 5885 03:51:51,348 --> 03:51:58,555 HELP RESEARCHERS SHARE AND 5886 03:51:58,555 --> 03:52:00,524 COMBINE DATASETS, AND IMPROVE 5887 03:52:00,524 --> 03:52:03,827 ACCURACY AND RIGOR OF DATASETS. 5888 03:52:03,827 --> 03:52:04,695 IMPORTANTLY WE'RE SUPPORTING 5889 03:52:04,695 --> 03:52:05,896 INNOVATION THROUGH PRIVATE 5890 03:52:05,896 --> 03:52:07,631 SECTOR INNOVATION THROUGH THE 5891 03:52:07,631 --> 03:52:08,265 SMALL BUSINESS INNOVATION 5892 03:52:08,265 --> 03:52:10,701 RESEARCH PROGRAM AND SMALL 5893 03:52:10,701 --> 03:52:12,469 BUSINESS TECHNOLOGY TRANSFER 5894 03:52:12,469 --> 03:52:12,937 PROGRAM. 5895 03:52:12,937 --> 03:52:15,873 WE HAVE A COMMITMENT TO FURTHER 5896 03:52:15,873 --> 03:52:18,042 INCREASING UP TO 50% OF ITS 5897 03:52:18,042 --> 03:52:23,180 INVESTMENT IN RESEARCH AND 5898 03:52:23,180 --> 03:52:26,684 DEVELOPMENT ON WOMEN'S HEALTH. 5899 03:52:26,684 --> 03:52:27,718 WE'RE CREATING MENOPAUSE 5900 03:52:27,718 --> 03:52:30,521 RESEARCH AGENDA THROUGH THE 5901 03:52:30,521 --> 03:52:32,056 PATHWAYS TO PREVENTION SERIES, 5902 03:52:32,056 --> 03:52:35,125 THE NEXT SERIES ON 5903 03:52:35,125 --> 03:52:35,759 MENOPAUSE-RELATED ISSUES, THAT 5904 03:52:35,759 --> 03:52:39,930 WAS JUST ANNOUNCED A WEEK AGO AT 5905 03:52:39,930 --> 03:52:41,532 OUR NATIONAL WOMEN'S HEALTH 5906 03:52:41,532 --> 03:52:41,799 WEEK. 5907 03:52:41,799 --> 03:52:43,334 LAST, REALLY GOING BACK INTO 5908 03:52:43,334 --> 03:52:45,402 LOOKING AT WAYS TO IMPROVE THE 5909 03:52:45,402 --> 03:52:47,271 HEALTH OF WOMEN, EARLY DETECTION 5910 03:52:47,271 --> 03:52:47,705 AND TREATMENT. 5911 03:52:47,705 --> 03:52:49,540 ONE OF THE WAYS WE'RE DOING THAT 5912 03:52:49,540 --> 03:52:57,348 IS WE'RE GOING TO LOOK AT 5913 03:52:57,348 --> 03:52:58,515 BIOMARKER DISCOVERY AND 5914 03:52:58,515 --> 03:53:01,285 VALIDATION, TO LOOK ACROSS THE 5915 03:53:01,285 --> 03:53:02,386 DIASPORA OF PREVENTION, 5916 03:53:02,386 --> 03:53:04,121 DIAGNOSIS AND TREATMENT OF 5917 03:53:04,121 --> 03:53:06,623 CONDITIONS THAT UNIQUELY AFFECT 5918 03:53:06,623 --> 03:53:06,924 WOMEN. 5919 03:53:06,924 --> 03:53:07,524 NEXT SLIDE PLEASE. 5920 03:53:07,524 --> 03:53:09,059 THIS IS THE NOTICE I TALKED 5921 03:53:09,059 --> 03:53:09,660 ABOUT. 5922 03:53:09,660 --> 03:53:12,763 I WANTED TO GIVE IT TO YOU AS A 5923 03:53:12,763 --> 03:53:15,499 REFERENCE SO YOU CAN GO BACK TO 5924 03:53:15,499 --> 03:53:16,266 IT EASILY. 5925 03:53:16,266 --> 03:53:17,701 AND THAT THE FIRST AVAILABLE DUE 5926 03:53:17,701 --> 03:53:20,671 DATE FOR GRANTS WE'VE PASSED IT, 5927 03:53:20,671 --> 03:53:25,376 BEGINNING OF MAY. 5928 03:53:25,376 --> 03:53:26,377 NEXT SLIDE PLEASE. 5929 03:53:26,377 --> 03:53:28,112 THAT'S ALL I HAVE. 5930 03:53:28,112 --> 03:53:29,546 I'M HOPING I LEFT A LITTLE BIT 5931 03:53:29,546 --> 03:53:30,948 OF TIME FOR QUESTIONS OR 5932 03:53:30,948 --> 03:53:32,816 COMMENTS YOU MAY HAVE. 5933 03:53:32,816 --> 03:53:35,519 I WANT TO RECOGNIZE DR. TARA 5934 03:53:35,519 --> 03:53:38,622 SCHWETZ, WHO HAS BEEN AT OUR 5935 03:53:38,622 --> 03:53:39,356 SIDE THROUGH THICK AND THIN 5936 03:53:39,356 --> 03:53:41,992 TRYING TO GET THIS DONE, QUITE 5937 03:53:41,992 --> 03:53:45,496 AN ASSET FOR US. 5938 03:53:45,496 --> 03:53:46,397 THANK YOU, TASHA. 5939 03:53:46,397 --> 03:53:47,031 >> THANKS. 5940 03:53:47,031 --> 03:53:50,000 WE HAVE A COUPLE MINUTES FOR 5941 03:53:50,000 --> 03:53:52,403 QUESTIONS AND VERY SHORT CLOSING 5942 03:53:52,403 --> 03:53:52,636 REMARKS. 5943 03:53:52,636 --> 03:53:55,906 LET ME OPEN TO SEE IF ANYONE HAS 5944 03:53:55,906 --> 03:53:58,075 ANY QUESTIONS OR IF THAT WAS 5945 03:53:58,075 --> 03:54:01,678 JUST SO NICELY LAID OUT THAT 5946 03:54:01,678 --> 03:54:02,146 EVERYONE UNDERSTANDS. 5947 03:54:02,146 --> 03:54:05,516 LET'S SEE. 5948 03:54:05,516 --> 03:54:07,818 5949 03:54:07,818 --> 03:54:10,220 OBVIOUSLY THIS HAS BEEN A SPRINT 5950 03:54:10,220 --> 03:54:12,423 OF AN EFFORT I WOULD SAY OVER 5951 03:54:12,423 --> 03:54:16,894 THE LAST SIX OR SO MONTHS, AND 5952 03:54:16,894 --> 03:54:19,296 ORWH HAS BEEN LEADING THE CHARGE 5953 03:54:19,296 --> 03:54:21,065 ON A LOT OF THIS EFFORT BUT 5954 03:54:21,065 --> 03:54:26,837 WE'RE TRYING TO MAKE THIS A BIG 5955 03:54:26,837 --> 03:54:27,738 CROSS-CUTTING APPROACH, ACROSS 5956 03:54:27,738 --> 03:54:29,373 ALL OF NIH BECAUSE THIS IS A 5957 03:54:29,373 --> 03:54:32,009 TOPIC THAT COVERS ALL OF THE 5958 03:54:32,009 --> 03:54:33,410 DIFFERENT INSTITUTES AND 5959 03:54:33,410 --> 03:54:33,744 CENTERS. 5960 03:54:33,744 --> 03:54:35,145 AND THERE'S MUCH MORE TO COME ON 5961 03:54:35,145 --> 03:54:38,115 THIS BECAUSE THIS IS OBVIOUSLY A 5962 03:54:38,115 --> 03:54:39,950 PRIORITY OF THE ADMINISTRATION 5963 03:54:39,950 --> 03:54:42,152 AND SO WE'LL SEE HOW THINGS 5964 03:54:42,152 --> 03:54:46,090 SHAKE OUT MOVING FORWARD. 5965 03:54:46,090 --> 03:54:48,192 STILL NOT SEEING ANY COMMENTS OR 5966 03:54:48,192 --> 03:54:49,593 QUESTIONS IN THE CHAT OR ANY 5967 03:54:49,593 --> 03:54:50,894 HANDS UP. 5968 03:54:50,894 --> 03:54:52,796 WITH THAT, THANK YOU, VIVIAN, 5969 03:54:52,796 --> 03:54:56,333 FOR THAT GREAT OVERVIEW AND 5970 03:54:56,333 --> 03:54:56,667 PRESENTATION. 5971 03:54:56,667 --> 03:54:59,570 I THINK IT'S THE END OF THE DAY. 5972 03:54:59,570 --> 03:55:06,009 FOLKS ARE WANTING TO SIGN OFF. 5973 03:55:06,009 --> 03:55:10,280 LET ME JUST BRIEFLY SAY QUICKLY 5974 03:55:10,280 --> 03:55:13,117 THAT WE APPROVED TWO CONCEPTS 5975 03:55:13,117 --> 03:55:13,317 TODAY. 5976 03:55:13,317 --> 03:55:16,987 SO PHASE 2 OF THE SCGE COMMON 5977 03:55:16,987 --> 03:55:19,056 FINANCED PROGRAM AND FOR A NEW 5978 03:55:19,056 --> 03:55:21,358 TRAINING AND WORKFORCE EFFORT ON 5979 03:55:21,358 --> 03:55:23,093 ETHICAL A.I. 5980 03:55:23,093 --> 03:55:26,697 WE HEARD A LOT ABOUT VARIOUS 5981 03:55:26,697 --> 03:55:28,465 EFFORTS OF NICHD, DIETARY 5982 03:55:28,465 --> 03:55:30,334 SUPPLEMENTS, ORWH WHICH WE JUST 5983 03:55:30,334 --> 03:55:31,869 HEARD, AMONG OTHERS. 5984 03:55:31,869 --> 03:55:34,805 SO LOTS GOING ON HERE. 5985 03:55:34,805 --> 03:55:37,774 I ALSO NOTED A COUPLE TOPICS FOR 5986 03:55:37,774 --> 03:55:40,043 CONSIDERATION OF FUTURE COUNCIL 5987 03:55:40,043 --> 03:55:41,278 MEETINGS, THAT INCLUDES LEARNING 5988 03:55:41,278 --> 03:55:44,381 MORE ABOUT THE IMPROVE PROGRAM 5989 03:55:44,381 --> 03:55:45,949 ON MATERNAL MORBIDITY AND 5990 03:55:45,949 --> 03:55:49,052 MORTALITY, AND THE NEW ERA 5991 03:55:49,052 --> 03:55:50,854 INITIATIVE TO ENGAGE RESEARCH 5992 03:55:50,854 --> 03:55:51,488 ACTIVE INSTITUTIONS, THERE'S 5993 03:55:51,488 --> 03:55:51,889 PROBABLY MORE. 5994 03:55:51,889 --> 03:55:52,990 OF COURSE IF YOU HAVE 5995 03:55:52,990 --> 03:55:58,328 SUGGESTIONS WE'RE OPEN TO THAT 5996 03:55:58,328 --> 03:56:04,468 SO FEEL FREE TO E-MAIL ME, 5997 03:56:04,468 --> 03:56:06,103 FRANCESCA, TINA, ROBIN, WE'LL 5998 03:56:06,103 --> 03:56:07,337 GET IT ON THE AGENDA. 5999 03:56:07,337 --> 03:56:09,506 THANK YOU FOR YOUR INPUT. 6000 03:56:09,506 --> 03:56:14,678 YOU COME PREPARED, ESPECIALLY 6001 03:56:14,678 --> 03:56:17,181 DISCUSSANTS ON THE TOPICS COME 6002 03:56:17,181 --> 03:56:20,584 PREPARED FOR DISCUSSIONS, 6003 03:56:20,584 --> 03:56:21,218 APPRECIATE YOUR THOROUGH 6004 03:56:21,218 --> 03:56:21,618 REVIEWS. 6005 03:56:21,618 --> 03:56:23,320 ONE MORE THING BEFORE WE SIGN 6006 03:56:23,320 --> 03:56:26,256 OFF, REMINDER, WE HAVE THE NEXT 6007 03:56:26,256 --> 03:56:27,357 COUNCIL OF COUNCILS MEETING, 6008 03:56:27,357 --> 03:56:29,927 WHICH IS SCHEDULED FOR SEPTEMBER 6009 03:56:29,927 --> 03:56:37,634 12-13, THAT IS GOING TO BE IN 6010 03:56:37,634 --> 03:56:38,001 PERSON. 6011 03:56:38,001 --> 03:56:39,069 AS MENTIONED BEFORE. 6012 03:56:39,069 --> 03:56:40,037 WE'RE EXCITED ABOUT MEETING YOU 6013 03:56:40,037 --> 03:56:40,304 IN PERSON. 6014 03:56:40,304 --> 03:56:42,439 I HAD THE OPPORTUNITY TO MEET 6015 03:56:42,439 --> 03:56:45,108 JENNIFER LAST WEEK AT THE NIA 6016 03:56:45,108 --> 03:56:46,310 COUNCIL MEETING, LOOKING FORWARD 6017 03:56:46,310 --> 03:56:50,380 TO GETTING THAT THIRD DIMENSION. 6018 03:56:50,380 --> 03:56:55,852 SO WITH THAT, MORE TO COME FOR 6019 03:56:55,852 --> 03:56:56,119 SEPTEMBER. 6020 03:56:56,119 --> 03:56:58,222 HAVE A WONDERFUL SUMMER. 6021 03:56:58,222 --> 03:57:00,557 WE'LL SEE YOU ALL AS WE APPROACH 6022 03:57:00,557 --> 03:57:00,991 FALL. 6023 03:57:00,991 --> 03:57:02,859 WITH THAT, WE'RE ADJOURNED. 6024 03:57:02,859 --> 03:57:03,293 THANK YOU, EVERYONE. 6025 03:57:03,293 --> 03:57:05,696 [END OF PROGRAM] 6026 03:57:05,696 --> 03:57:11,702 6027 03:57:11,702 --> 03:57:21,745 6028 04:03:50,166 --> 04:03:50,333 ... 6029 04:03:50,333 --> 04:04:00,410 ... 6030 04:04:15,759 --> 04:04:17,160 >> OKAY. 6031 04:04:17,160 --> 04:04:19,262 GOOD MORNING, EVERYONE. 6032 04:04:19,262 --> 04:04:22,399 THIS IS THE ONE-DAY MEETING OF 6033 04:04:22,399 --> 04:04:24,601 THE NIH COUNCIL OF COUNCILS, NOW 6034 04:04:24,601 --> 04:04:29,339 IN SESSION, IN PUBLIC SESSION 6035 04:04:29,339 --> 04:04:30,473 SHOWN LIVE TO ANYONE WHO WISHES 6036 04:04:30,473 --> 04:04:33,410 TO TUNE IN. 6037 04:04:33,410 --> 04:04:37,147 I'M TARA SCHWETZ, NIH DEPUTY 6038 04:04:37,147 --> 04:04:39,115 DIRECTOR FOR DPCPSI, REALLY GLAD 6039 04:04:39,115 --> 04:04:43,720 TO BE HERE WITH YOU ALL AGAIN 6040 04:04:43,720 --> 04:04:46,156 FOR THE COUNCIL MEMBERS TODAY. 6041 04:04:46,156 --> 04:04:56,132 I'M JOINED HERE IN THE ROOM BY 6042 04:04:56,132 --> 04:04:57,534 DR. FRANZISKA GRIEDER AND 6043 04:04:57,534 --> 04:04:59,169 ADDITIONAL COLLEAGUES HERE WITH 6044 04:04:59,169 --> 04:05:06,743 ME INCLUDING THE DPCPSI DEPUTY 6045 04:05:06,743 --> 04:05:08,778 DIRECTOR, SENIOR ADVISER AND 6046 04:05:08,778 --> 04:05:11,781 PROGRAM ANALYST WHO HELPS 6047 04:05:11,781 --> 04:05:12,982 COORDINATE COUNCIL OF COUNCILS, 6048 04:05:12,982 --> 04:05:16,186 SO I WANT TO THANK THE COUNCIL 6049 04:05:16,186 --> 04:05:17,387 MEETING PLANNING TEAM MEMBERS 6050 04:05:17,387 --> 04:05:19,689 FOR ALL OF THEIR WORK AND 6051 04:05:19,689 --> 04:05:21,958 SUPPORT OF ALL THE COUNCIL 6052 04:05:21,958 --> 04:05:23,293 ACTIVITIES AS THESE THINGS, YOU 6053 04:05:23,293 --> 04:05:25,261 KNOW, GENERALLY GO PRETTY 6054 04:05:25,261 --> 04:05:25,528 SMOOTHLY. 6055 04:05:25,528 --> 04:05:27,363 BUT IT TAKES A LOT OF TIME AND 6056 04:05:27,363 --> 04:05:31,201 PLANNING TO MAKE THAT HAPPEN. 6057 04:05:31,201 --> 04:05:34,370 BEFORE WE REALLY KICK IN TO FULL 6058 04:05:34,370 --> 04:05:36,106 GEAR ON FULL OPEN SESSION HERE, 6059 04:05:36,106 --> 04:05:46,416 I'M GOING TO TURN IT TO 6060 04:05:46,416 --> 04:05:51,121 FRANZESKA FOR PROCEDURES BEFORE 6061 04:05:51,121 --> 04:05:51,988 ROLL CALL. 6062 04:05:51,988 --> 04:05:53,623 >> GOOD MORNING TO EVERYBODY. 6063 04:05:53,623 --> 04:05:57,260 I WILL RUN THROUGH SOME RULES 6064 04:05:57,260 --> 04:05:59,329 WHICH WILL HELP ENSURE EVERYBODY 6065 04:05:59,329 --> 04:06:01,297 IS ABLE TO CONTRIBUTE. 6066 04:06:01,297 --> 04:06:04,601 WE ASK THAT YOU REMAIN MUTED 6067 04:06:04,601 --> 04:06:06,770 WHEN YOU'RE NOT SPEAKING, 6068 04:06:06,770 --> 04:06:07,771 ACTIVELY SPEAKING. 6069 04:06:07,771 --> 04:06:18,148 PLEASE NOTE THE HOST. 6070 04:06:23,186 --> 04:06:27,490 >> GOOD MORNING, EVERYONE. 6071 04:06:27,490 --> 04:06:28,358 THIS VIRTUAL ONE-DAY MEETING OF 6072 04:06:28,358 --> 04:06:30,160 THE COUNCIL OF COUNCILS IS NOW 6073 04:06:30,160 --> 04:06:31,461 IN SESSION. 6074 04:06:31,461 --> 04:06:33,963 IN PUBLIC SESSION, IT'S BEING 6075 04:06:33,963 --> 04:06:36,166 SHOWN LIVE TO ANYONE WHO WISHES 6076 04:06:36,166 --> 04:06:38,234 TO WATCH AND TUNE IN. 6077 04:06:38,234 --> 04:06:40,436 SO I'M TARA SCHWETZ, NIH DEPUTY 6078 04:06:40,436 --> 04:06:42,972 DIRECTOR FOR PROGRAM 6079 04:06:42,972 --> 04:06:43,473 COORDINATION, PLANNING, 6080 04:06:43,473 --> 04:06:44,908 STRATEGIC INITIATIVES, AND 6081 04:06:44,908 --> 04:06:48,077 REALLY GLAD TO BE HERE WITH YOU 6082 04:06:48,077 --> 04:06:51,481 ALL AGAIN FOR THE COUNCIL 6083 04:06:51,481 --> 04:06:51,915 MEMBERS TODAY. 6084 04:06:51,915 --> 04:06:56,853 I'M JOINED HERE IN THE ROOM BY 6085 04:06:56,853 --> 04:06:58,054 DR. FRANCESCA GRIEDER, EXECUTIVE 6086 04:06:58,054 --> 04:07:00,557 SECRETARY OF THE COUNCIL OF 6087 04:07:00,557 --> 04:07:03,293 COUNCILS, AS WELL AS A NUMBER OF 6088 04:07:03,293 --> 04:07:05,495 ADDITIONAL COLLEAGUES HERE WITH 6089 04:07:05,495 --> 04:07:10,400 ME INCLUDING THE DPCPSI DEPUTY 6090 04:07:10,400 --> 04:07:14,003 DIRECTOR ROBIN KOWOZOI, SENIOR 6091 04:07:14,003 --> 04:07:19,909 ADVISER AND A PROGRAM ANALYST. 6092 04:07:19,909 --> 04:07:22,645 I WANT TO THANK THE COUNCIL 6093 04:07:22,645 --> 04:07:23,746 MEETING PLANNING TEAM MEMBERS 6094 04:07:23,746 --> 04:07:26,049 FOR ALL OF THEIR WORK IN SUPPORT 6095 04:07:26,049 --> 04:07:28,585 OF ALL THE COUNCIL ACTIVITIES AS 6096 04:07:28,585 --> 04:07:30,453 THESE THINGS, YOU KNOW, 6097 04:07:30,453 --> 04:07:31,855 GENERALLY GO PRETTY SMOOTHLY BUT 6098 04:07:31,855 --> 04:07:35,558 IT TAKES A LOT OF TIME AND 6099 04:07:35,558 --> 04:07:37,794 PLANNING TO MAKE THAT HAPPEN. 6100 04:07:37,794 --> 04:07:40,730 BEFORE WE REALLY KICK IN TO FULL 6101 04:07:40,730 --> 04:07:42,332 GEAR ON FULL OPEN SESSION HERE, 6102 04:07:42,332 --> 04:07:50,039 I'M GOING TO TURN IT OVER TO 6103 04:07:50,039 --> 04:07:51,441 FRANKCESKA FOR PROCEDURES BEFORE 6104 04:07:51,441 --> 04:07:52,508 WE GET GOING. 6105 04:07:52,508 --> 04:07:58,314 >> THANK YOU, TARA. 6106 04:07:58,314 --> 04:08:00,516 GOOD MORNING, EVERYBODY. 6107 04:08:00,516 --> 04:08:03,152 I WILL RUN THROUGH SOME RULES 6108 04:08:03,152 --> 04:08:05,321 WHICH WILL HELP ENSURE THAT 6109 04:08:05,321 --> 04:08:07,757 EVERYBODY IS ABLE TO CONTRIBUTE. 6110 04:08:07,757 --> 04:08:10,793 WE ASK THAT YOU REMAIN MUTED 6111 04:08:10,793 --> 04:08:12,795 WHEN YOU'RE NOT SPEAKING, 6112 04:08:12,795 --> 04:08:13,763 ACTIVELY SPEAKING. 6113 04:08:13,763 --> 04:08:24,207 PLEASE NOTE THAT THE HOST